data_1pmx_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1pmx _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.798 0.332 . . . . 75.5 110.941 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.2 p -128.99 170.81 13.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 31.379999999999999 110.769 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.5 tp -130.87 110.08 11.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 28.27 111.164 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.5 m -140.19 161.19 38.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 32.909999999999997 110.766 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -143.04 37.32 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.792 -0.718 . . . . 20.0 112.669 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.31 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.723 0.297 . . . . 21.73 111.201 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.14 -40.4 89.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 63.420000000000002 110.996 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 -46.64 62.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 20.390000000000001 110.828 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.25 -33.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 20.0 111.165 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.3 -42.34 96.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 31.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.17 -49.21 72.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 20.0 111.072 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.26 -39.82 88.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 22.050000000000001 110.905 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -74.69 -31.75 61.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 32.759999999999998 110.701 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -77.9 -32.01 51.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 27.25 110.837 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.4 t -87.64 -67.68 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 25.510000000000002 110.831 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.4 m -70.41 -51.49 29.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 29.489999999999998 110.922 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.5 -113.31 5.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.772 . . . . 40.609999999999999 112.918 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.09 7.48 13.3 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.892 0.701 . . . . 79.049999999999997 112.892 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.11 -30.99 58.46 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.969 -0.457 . . . . 50.600000000000001 110.886 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.19 75.98 1.31 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.648 -0.787 . . . . 35.479999999999997 112.197 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CD1' HD12 ' A' ' 14' ' ' LEU . 31.0 p90 -69.86 150.35 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 25.52 111.333 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 3.0 p90 -124.78 138.91 54.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 56.07 110.462 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD2' ' CG2' ' A' ' 43' ' ' ILE . 14.7 m-85 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 29.300000000000001 111.278 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.424 ' CG2' ' CD2' ' A' ' 25' ' ' PHE . 4.5 tp . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.747 0.308 . . . . 25.609999999999999 110.823 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.24 -68.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.27 -0.423 . . . . 29.899999999999999 111.058 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.8 -17.6 37.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.101 0.408 . . . . 39.039999999999999 112.101 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.45 -38.48 13.24 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.936 0.717 . . . . 45.600000000000001 112.936 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.12 -27.69 7.93 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.993 0.738 . . . . 28.23 112.993 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.64 -45.2 22.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 25.890000000000001 110.633 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -79.86 -35.92 37.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 32.640000000000001 110.395 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mtp85 -123.92 156.32 36.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 41.060000000000002 110.071 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -82.41 111.58 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.795 0.331 . . . . 42.619999999999997 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.1 p -105.49 -163.05 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.849 0.357 . . . . 28.050000000000001 110.974 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -113.75 147.47 38.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 46.350000000000001 110.287 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.49 -27.29 69.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 23.789999999999999 111.705 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -58.32 -26.9 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.606 0.241 . . . . 74.930000000000007 111.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -60.76 -29.81 69.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.604 0.24 . . . . 64.420000000000002 111.07 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.86 -30.96 64.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 32.640000000000001 111.619 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -69.34 -34.11 74.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.449 -0.341 . . . . 41.859999999999999 111.413 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.2 mtm -58.66 -45.01 90.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.924 0.392 . . . . 38.659999999999997 111.305 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.419 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 79.5 m-85 -67.49 -27.74 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 25.27 111.586 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.6 m -60.53 130.76 48.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 25.039999999999999 110.775 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.02 162.24 55.64 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.212 -0.449 . . . . 36.049999999999997 111.184 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -76.18 -25.53 9.99 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.008 1.806 . . . . 54.359999999999999 112.713 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.825 0.345 . . . . 71.540000000000006 111.273 -179.853 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.83 0.348 . . . . 20.0 110.937 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -82.01 72.24 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.08 0.467 . . . . 20.0 110.857 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -125.62 -45.38 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 20.0 110.625 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -144.82 174.62 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 20.0 110.797 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 33.0 t -68.64 -30.75 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 20.0 111.094 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.16 -39.56 65.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 20.0 111.267 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.93 -40.17 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 20.0 111.832 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 20.0 110.992 -179.827 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.861 0.362 . . . . 75.5 110.974 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.0 p -129.96 176.29 8.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 31.379999999999999 110.823 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 tp -136.27 115.52 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 28.27 111.164 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 m -140.23 159.79 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 32.909999999999997 111.013 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.32 -146.6 44.43 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.792 -0.718 . . . . 20.0 112.811 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.26 66.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.732 0.301 . . . . 21.73 111.32 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 63.420000000000002 110.748 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 tp -71.69 -49.69 37.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 20.390000000000001 110.516 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.08 -32.01 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 20.0 111.002 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.47 -44.36 87.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 31.0 110.846 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.79 -48.02 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 20.0 111.071 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 23' ' ' PHE . 14.2 mt -60.38 -41.74 94.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 22.050000000000001 110.764 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.99 -31.98 64.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 32.759999999999998 110.736 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -76.84 -30.9 56.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.506 . . . . 27.25 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.1 t -90.1 -56.78 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 25.510000000000002 110.939 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.14 -51.34 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 29.489999999999998 111.178 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.49 -112.51 5.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 40.609999999999999 112.593 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.85 7.75 22.79 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.777 0.658 . . . . 79.049999999999997 112.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -81.76 -33.39 30.97 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 122.106 -0.371 . . . . 50.600000000000001 111.152 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.52 115.13 1.97 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.655 -0.783 . . . . 35.479999999999997 112.141 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.417 ' CD1' HD12 ' A' ' 14' ' ' LEU . 20.6 p90 -106.13 156.29 18.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 25.52 111.456 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 2.5 p90 -124.6 127.7 47.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 56.07 110.322 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.372 -0.376 . . . . 29.300000000000001 111.665 -179.182 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.9 tp . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 120.814 0.34 . . . . 25.609999999999999 111.099 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.08 -59.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 29.899999999999999 111.49 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.43 -22.58 64.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.293 -0.412 . . . . 39.039999999999999 112.088 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.21 -23.71 21.19 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.437 0.532 . . . . 45.600000000000001 112.437 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.0 m -114.2 -43.63 3.2 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.067 0.395 . . . . 28.23 112.067 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -74.5 -54.04 8.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.74 0.305 . . . . 25.890000000000001 110.95 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.97 -32.61 67.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 32.640000000000001 110.652 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -133.0 150.86 52.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.515 . . . . 41.060000000000002 110.499 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.8 p -73.09 127.56 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 42.619999999999997 110.995 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.62 -173.25 2.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 28.050000000000001 111.132 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.88 54.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 46.350000000000001 109.824 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.02 -24.92 4.15 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 23.789999999999999 112.419 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -63.35 -30.51 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 74.930000000000007 111.113 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.51 -30.04 62.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.327 -0.397 . . . . 64.420000000000002 111.703 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mt -56.39 -34.8 67.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 32.640000000000001 111.953 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.28 -24.38 63.03 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.9 0.333 . . . . 41.859999999999999 111.9 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -68.13 -34.22 75.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 38.659999999999997 110.942 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.418 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 44.0 m-85 -78.75 -28.72 44.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 25.27 111.434 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.4 m -60.43 126.43 27.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 25.039999999999999 110.808 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.04 153.77 32.87 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.27 -0.423 . . . . 36.049999999999997 111.371 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 -24.55 13.0 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.971 1.78 . . . . 54.359999999999999 112.728 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.898 0.38 . . . . 71.540000000000006 111.366 -179.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.757 0.313 . . . . 20.0 111.101 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -97.92 36.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 20.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.35 -42.09 9.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 20.0 111.0 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 70.2 m -144.74 175.9 9.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 20.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 27.6 t -72.13 -30.11 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 20.0 111.138 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.08 -39.96 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.375 -0.375 . . . . 20.0 111.041 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.78 84.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 20.0 111.298 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.468 . . . . 20.0 111.419 -179.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.939 0.399 . . . . 75.5 110.964 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 p -134.22 161.84 33.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 31.379999999999999 110.456 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tp -119.98 115.62 24.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 28.27 111.165 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.25 164.22 30.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 32.909999999999997 110.991 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.8 -143.6 46.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.84 -0.695 . . . . 20.0 112.848 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.8 68.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 21.73 111.283 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.82 -39.94 90.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 63.420000000000002 110.742 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.6 tp -67.76 -46.69 71.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 20.390000000000001 110.542 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.84 -31.86 49.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 20.0 110.878 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.97 -36.48 84.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 31.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.94 -46.47 57.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 20.0 111.025 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.41 HD12 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.31 -43.03 96.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 22.050000000000001 110.795 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -68.9 -31.76 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 32.759999999999998 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.17 -31.71 49.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 27.25 110.837 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 t -88.9 -67.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 25.510000000000002 110.881 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.25 -51.25 25.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 29.489999999999998 110.984 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.57 -115.12 6.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.668 -0.777 . . . . 40.609999999999999 112.731 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.81 7.37 15.33 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.729 0.64 . . . . 79.049999999999997 112.729 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -35.92 74.03 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 118.097 0.408 . . . . 50.600000000000001 110.886 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.37 62.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 35.479999999999997 112.255 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.41 ' CD1' HD12 ' A' ' 14' ' ' LEU . 27.5 p90 -59.2 159.45 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 25.52 111.271 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.05 123.9 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 56.07 110.637 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 29.300000000000001 111.074 -179.838 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 60' ' ' TYR . 3.3 tp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 25.609999999999999 110.997 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.61 -54.13 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 29.899999999999999 111.466 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.407 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.1 m-20 -70.89 -23.3 62.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 39.039999999999999 111.954 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -90.06 -23.89 21.32 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.221 0.452 . . . . 45.600000000000001 112.221 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -115.66 -45.7 2.88 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.098 0.407 . . . . 28.23 112.098 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.0 t -73.1 -51.37 18.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.676 0.274 . . . . 25.890000000000001 111.117 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 26.5 m-85 -70.4 -32.47 70.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.895 0.378 . . . . 32.640000000000001 110.809 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -137.92 147.28 44.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 41.060000000000002 110.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -65.16 134.07 52.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 42.619999999999997 110.983 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -126.34 -172.51 2.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 28.050000000000001 111.066 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -116.68 142.98 46.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 46.350000000000001 110.088 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.405 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 2.1 mp -55.55 -27.57 49.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 23.789999999999999 111.937 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -60.59 -26.46 66.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.549 -0.296 . . . . 74.930000000000007 111.578 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.4 -30.55 70.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.806 0.336 . . . . 64.420000000000002 111.159 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.1 -28.7 62.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 32.640000000000001 111.676 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -32.31 71.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 41.859999999999999 111.139 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.54 -43.81 96.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.394 -0.366 . . . . 38.659999999999997 111.094 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CE2' HD12 ' A' ' 43' ' ' ILE . 96.3 m-85 -69.24 -27.61 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 25.27 111.546 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.5 m -59.58 132.23 53.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 25.039999999999999 110.954 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.83 162.81 26.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.151 -0.477 . . . . 36.049999999999997 111.244 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.1 -32.11 1.96 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.056 1.837 . . . . 54.359999999999999 112.581 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 71.540000000000006 111.077 -179.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.76 0.314 . . . . 20.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.405 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -94.63 46.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.468 0.651 . . . . 20.0 110.665 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -109.66 -30.8 7.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 20.0 110.966 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 66.0 m -156.37 -179.02 7.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 20.0 111.156 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 51.4 t -80.66 -28.75 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 20.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.63 -39.49 73.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.353 . . . . 20.0 111.478 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -36.91 66.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 20.0 111.997 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 20.0 111.256 -179.545 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.856 0.36 . . . . 75.5 110.925 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -127.93 178.1 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 31.379999999999999 110.585 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.1 tp -135.48 108.99 7.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 28.27 111.099 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.5 m -140.16 167.88 21.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.196 -0.456 . . . . 32.909999999999997 110.992 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.62 -137.19 50.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.879 -0.677 . . . . 20.0 112.778 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.91 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.638 0.256 . . . . 21.73 111.343 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.84 -42.53 97.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.385 -0.37 . . . . 63.420000000000002 110.989 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.7 tp -68.72 -42.68 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 20.390000000000001 110.936 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.67 -34.58 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 20.0 110.928 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.23 -35.04 79.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 31.0 110.967 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.99 -49.38 29.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 20.0 111.363 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 23' ' ' PHE . 11.8 mt -57.9 -30.41 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 22.050000000000001 111.171 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -80.78 -31.48 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 32.759999999999998 110.609 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -76.6 -33.88 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 27.25 110.81 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.48 -40.36 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 25.510000000000002 111.406 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 m -100.27 -51.93 3.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 29.489999999999998 111.315 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.18 -110.38 3.17 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.655 -0.783 . . . . 40.609999999999999 112.723 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.19 7.62 37.14 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.846 0.684 . . . . 79.049999999999997 112.846 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.67 -38.45 86.84 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.029 -0.419 . . . . 50.600000000000001 110.844 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.88 60.41 0.88 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 35.479999999999997 112.233 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CD1' HD12 ' A' ' 14' ' ' LEU . 27.0 p90 -58.07 140.56 52.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 25.52 111.345 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -123.96 127.69 48.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 56.07 110.501 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 29.300000000000001 111.509 -179.478 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.414 HD12 ' CE1' ' A' ' 60' ' ' TYR . 2.9 tp . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.724 0.297 . . . . 25.609999999999999 111.05 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.98 -58.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 29.899999999999999 111.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.59 -22.58 63.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 39.039999999999999 112.027 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.17 -19.76 23.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.562 0.578 . . . . 45.600000000000001 112.562 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.8 m -121.81 -41.74 2.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.192 0.441 . . . . 28.23 112.192 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.7 t -73.97 -53.9 9.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 25.890000000000001 110.963 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -65.67 -34.05 77.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 32.640000000000001 110.617 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -139.01 148.31 43.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 41.060000000000002 110.717 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 p -65.73 131.88 47.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 42.619999999999997 110.989 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.0 p -122.17 -171.92 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 28.050000000000001 110.883 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -111.53 132.78 54.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 46.350000000000001 110.131 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.422 ' HB2' ' CG ' ' B' ' 104' ' ' PHE . 0.3 OUTLIER -53.43 -24.28 12.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.332 0.493 . . . . 23.789999999999999 112.332 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.65 -26.96 67.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.477 0.177 . . . . 74.930000000000007 111.477 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -68.58 -28.83 67.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.649 0.261 . . . . 64.420000000000002 111.271 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.8 mt -56.08 -28.84 59.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.447 -0.342 . . . . 32.640000000000001 111.788 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -68.66 -32.22 71.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 41.859999999999999 111.193 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.3 mtm -62.64 -49.77 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 38.659999999999997 111.148 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.414 ' CE1' HD12 ' A' ' 43' ' ' ILE . 84.6 m-85 -56.83 -28.56 61.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 25.27 111.675 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -59.23 141.73 53.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 25.039999999999999 111.197 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.43 176.59 3.49 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.235 -0.438 . . . . 36.049999999999997 110.985 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.21 -34.81 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.018 1.812 . . . . 54.359999999999999 112.701 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 71.540000000000006 111.058 -179.858 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.496 0.188 . . . . 20.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.422 ' CG ' ' HB2' ' A' ' 54' ' ' LEU . 2.8 m-30 -96.52 32.84 1.93 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.718 0.295 . . . . 20.0 111.353 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -88.51 -33.49 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.892 0.377 . . . . 20.0 110.447 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.8 p -155.86 174.82 14.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 20.0 110.407 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.08 -30.87 28.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.41 -0.359 . . . . 20.0 111.131 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.19 96.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 20.0 111.09 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.83 83.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 20.0 111.078 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 tp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 20.0 111.157 -179.917 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.743 0.306 . . . . 75.5 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -129.33 -171.39 2.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 31.379999999999999 110.607 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 tp -140.28 111.84 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.494 -0.321 . . . . 28.27 111.195 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.4 m -140.15 162.95 34.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 32.909999999999997 111.148 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.91 -139.53 48.37 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.815 -0.707 . . . . 20.0 113.052 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.34 64.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.625 0.25 . . . . 21.73 111.485 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.0 -39.79 91.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.439 -0.346 . . . . 63.420000000000002 110.855 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.81 -45.38 61.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 20.390000000000001 110.737 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.12 -31.41 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 20.0 111.019 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.62 -45.01 84.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 31.0 111.008 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 -47.33 80.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 20.0 111.155 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -60.74 -36.25 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 22.050000000000001 110.798 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -79.1 -31.58 44.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 32.759999999999998 110.794 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -79.0 -31.7 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 27.25 110.869 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -88.14 -68.1 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 25.510000000000002 110.945 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.8 m -67.99 -51.32 48.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 29.489999999999998 111.053 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.35 -114.3 5.37 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.767 . . . . 40.609999999999999 112.835 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -84.41 7.55 19.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.805 0.668 . . . . 79.049999999999997 112.805 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -71.95 -30.74 65.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.036 0.38 . . . . 50.600000000000001 110.936 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.34 67.72 1.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 35.479999999999997 112.082 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.417 ' CD1' HD12 ' A' ' 14' ' ' LEU . 30.6 p90 -60.46 164.85 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 25.52 111.501 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -144.32 125.25 14.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.72 -0.673 . . . . 56.07 110.465 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 29.300000000000001 111.428 -179.555 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.786 0.327 . . . . 25.609999999999999 111.009 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.69 -64.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 29.899999999999999 111.682 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.404 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 12.0 m-20 -67.47 -19.73 65.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.276 -0.42 . . . . 39.039999999999999 112.116 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.29 -25.56 20.46 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 111.961 0.356 . . . . 45.600000000000001 111.961 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 96.9 m -117.25 -51.52 2.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.108 0.41 . . . . 28.23 112.108 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 t -63.43 -44.04 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 25.890000000000001 111.153 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.4 m-85 -74.96 -49.23 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.443 -0.344 . . . . 32.640000000000001 110.604 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.84 150.0 45.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 41.060000000000002 110.364 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 143.39 56.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.899 0.38 . . . . 42.619999999999997 111.02 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 p -138.03 -166.36 1.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.132 -0.485 . . . . 28.050000000000001 110.932 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -113.55 138.79 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 46.350000000000001 109.851 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.405 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 3.3 mm? -61.32 -27.03 68.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.564 -0.289 . . . . 23.789999999999999 111.524 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -55.81 -26.51 46.73 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.736 0.273 . . . . 74.930000000000007 111.736 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -63.1 -28.07 69.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.68 0.276 . . . . 64.420000000000002 111.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . 0.419 HD11 ' CZ ' ' B' ' 104' ' ' PHE . 6.9 mt -56.26 -31.34 63.49 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.792 0.33 . . . . 32.640000000000001 111.426 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -67.02 -33.58 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 41.859999999999999 111.334 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.8 mtm -59.41 -54.07 50.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 38.659999999999997 111.064 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.42 ' CE2' HD12 ' A' ' 43' ' ' ILE . 78.9 m-85 -57.83 -26.96 62.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.974 -0.557 . . . . 25.27 111.614 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.3 m -60.19 130.3 45.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.836 0.35 . . . . 25.039999999999999 110.806 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.0 156.28 80.99 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.286 -0.415 . . . . 36.049999999999997 111.129 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.84 -26.49 9.57 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.033 1.822 . . . . 54.359999999999999 112.527 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 71.540000000000006 111.178 -179.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.718 0.294 . . . . 20.0 111.011 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.419 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 2.2 m-30 -87.87 55.77 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.26 0.552 . . . . 20.0 111.079 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.48 -35.62 6.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 20.0 110.165 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.1 m -160.28 174.72 13.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 20.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 23.5 t -72.44 -31.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 20.0 110.818 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.95 90.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 20.0 111.062 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.88 78.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 20.0 111.213 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 67.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 20.0 111.151 179.993 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.748 0.309 . . . . 75.5 110.854 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 p -124.9 175.96 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 31.379999999999999 110.73 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.6 tp -129.52 110.25 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 28.27 111.213 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.9 m -140.22 161.7 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 32.909999999999997 110.933 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.36 -139.3 45.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.802 -0.713 . . . . 20.0 112.843 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.09 66.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.343 . . . . 21.73 111.454 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.39 -41.29 93.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 63.420000000000002 110.942 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.18 -43.87 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 20.390000000000001 110.73 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.42 -31.78 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 20.0 110.968 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.42 -42.12 92.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 31.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.01 -48.51 70.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 20.0 111.168 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.436 ' CD1' ' CD2' ' A' ' 23' ' ' PHE . 17.6 mt -60.12 -38.47 83.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 22.050000000000001 110.827 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -73.26 -32.38 64.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 32.759999999999998 110.594 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -79.35 -32.08 43.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.047 -0.524 . . . . 27.25 110.755 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -87.32 -44.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.042 -0.526 . . . . 25.510000000000002 110.905 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -100.43 -51.63 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 29.489999999999998 111.233 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.09 -95.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.967 -0.635 . . . . 40.609999999999999 112.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.58 -28.42 26.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 79.049999999999997 111.459 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -57.7 -34.28 69.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.799 0.333 . . . . 50.600000000000001 111.365 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.75 150.93 27.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 35.479999999999997 112.214 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CD2' ' CD1' ' A' ' 14' ' ' LEU . 15.5 p90 -141.33 145.02 34.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.965 0.412 . . . . 25.52 111.143 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -109.52 127.67 54.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 56.07 110.771 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 29.300000000000001 110.827 179.923 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.421 HD11 ' CE1' ' A' ' 60' ' ' TYR . 3.1 tp . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.759 0.314 . . . . 25.609999999999999 110.991 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.8 t -58.27 -57.97 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 29.899999999999999 111.446 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.4 m-20 -68.32 -22.22 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 39.039999999999999 111.932 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.31 -23.87 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.276 0.473 . . . . 45.600000000000001 112.276 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.8 m -117.22 -46.68 2.69 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.238 0.459 . . . . 28.23 112.238 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.7 t -71.26 -52.47 18.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.312 . . . . 25.890000000000001 111.072 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 15.1 m-85 -64.44 -37.09 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 32.640000000000001 110.798 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -140.31 149.85 43.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 41.060000000000002 110.913 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -60.06 140.65 56.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 42.619999999999997 111.11 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -133.12 -174.63 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 28.050000000000001 110.817 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.89 127.63 53.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.995 -0.548 . . . . 46.350000000000001 109.929 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.81 -26.56 24.61 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.173 -0.467 . . . . 23.789999999999999 111.979 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -58.11 -22.71 51.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.606 -0.27 . . . . 74.930000000000007 111.498 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -81.21 7.04 12.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.883 0.698 . . . . 64.420000000000002 112.883 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.1 mt -90.06 -39.21 13.05 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.032 -0.417 . . . . 32.640000000000001 111.333 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.05 67.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 41.859999999999999 111.52 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.2 ptp -63.84 -31.8 73.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.466 -0.334 . . . . 38.659999999999997 111.466 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.421 ' CE1' HD11 ' A' ' 43' ' ' ILE . 65.6 m-85 -70.52 -29.07 65.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 25.27 111.445 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.7 m -61.18 130.28 45.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 25.039999999999999 111.12 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.44 157.37 13.39 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.095 -0.502 . . . . 36.049999999999997 111.191 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.99 -24.78 38.95 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.888 1.726 . . . . 54.359999999999999 112.785 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 71.540000000000006 111.044 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 90.8 m . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.596 0.236 . . . . 20.0 111.242 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -96.04 37.89 1.21 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.853 0.359 . . . . 20.0 111.256 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.13 -51.07 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 20.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 54.3 p -142.11 174.96 10.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 20.0 110.801 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.67 -36.49 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 20.0 111.093 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.8 82.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 20.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.78 92.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 20.0 111.147 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 20.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.916 0.389 . . . . 75.5 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 p -136.19 147.77 47.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 31.379999999999999 110.451 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tp -109.49 114.31 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 28.27 111.148 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.2 m -140.37 162.06 36.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 32.909999999999997 110.999 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.49 -145.86 46.37 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.874 -0.679 . . . . 20.0 113.048 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.57 65.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.794 0.33 . . . . 21.73 111.461 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.15 -43.11 96.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 63.420000000000002 110.898 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.61 -43.7 84.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 20.390000000000001 110.499 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.37 -33.35 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 20.0 111.006 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.0 -48.82 80.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 31.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.45 86.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 20.0 111.172 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.405 HD12 ' CD1' ' A' ' 23' ' ' PHE . 24.2 mt -60.0 -39.61 86.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 22.050000000000001 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -75.79 -31.38 59.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 32.759999999999998 110.84 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -79.3 -30.75 43.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 27.25 111.085 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.28 -48.22 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 25.510000000000002 111.023 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 m -86.9 -51.27 6.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.392 -0.367 . . . . 29.489999999999998 111.191 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.86 -109.41 2.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.671 -0.776 . . . . 40.609999999999999 112.492 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.85 7.77 35.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.611 0.597 . . . . 79.049999999999997 112.611 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -72.52 -30.12 64.19 Favored 'General case' 0 C--O 1.231 0.092 0 O-C-N 122.041 -0.412 . . . . 50.600000000000001 111.044 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.15 84.39 0.8 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 35.479999999999997 112.136 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.405 ' CD1' HD12 ' A' ' 14' ' ' LEU . 38.3 p90 -84.47 171.56 12.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.127 0.489 . . . . 25.52 111.389 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -145.27 124.3 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.63 . . . . 56.07 110.47 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 29.300000000000001 111.491 -179.605 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.439 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 2.3 tp . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.87 0.367 . . . . 25.609999999999999 111.076 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.1 -59.53 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 29.899999999999999 111.537 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.414 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.43 -21.56 63.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.06 0.393 . . . . 39.039999999999999 112.06 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.14 -24.11 21.16 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 112.258 0.466 . . . . 45.600000000000001 112.258 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 75.9 m -116.49 -45.57 2.81 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.13 0.419 . . . . 28.23 112.13 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.2 t -71.88 -53.03 14.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 25.890000000000001 110.995 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 22.5 m-85 -67.45 -37.16 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 32.640000000000001 110.57 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -134.01 145.86 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 41.060000000000002 110.347 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 p -66.87 124.24 22.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.287 -0.415 . . . . 42.619999999999997 111.038 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -111.99 -174.92 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 28.050000000000001 111.278 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.88 138.64 45.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 46.350000000000001 109.951 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.402 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 3.2 mp -53.55 -31.45 46.49 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.134 0.42 . . . . 23.789999999999999 112.134 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -57.66 -28.45 63.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 74.930000000000007 111.424 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.2 mmm-85 -68.87 -22.5 64.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.515 -0.311 . . . . 64.420000000000002 111.609 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.54 -40.53 87.53 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.871 0.367 . . . . 32.640000000000001 110.592 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -62.5 -32.95 73.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 41.859999999999999 109.887 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.69 -31.37 57.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.711 -0.677 . . . . 38.659999999999997 111.335 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 96.3 m-85 -85.37 -29.15 24.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 25.27 111.569 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 65.4 m -58.34 130.39 46.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 25.039999999999999 111.258 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.36 163.42 14.55 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.538 . . . . 36.049999999999997 111.313 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -80.64 -24.89 4.8 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.101 1.867 . . . . 54.359999999999999 112.872 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.36 . . . . 71.540000000000006 111.151 -179.718 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.747 0.308 . . . . 20.0 110.911 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 1.7 m-85 -83.34 66.28 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 20.0 110.947 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -124.33 -45.07 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 20.0 110.611 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 17.0 p -147.0 174.94 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 20.0 110.58 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.92 -31.02 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 20.0 111.004 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.46 70.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 20.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.55 68.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 20.0 111.79 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.305 0 CA-C-N 116.291 -0.413 . . . . 20.0 111.372 -179.786 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.795 0.331 . . . . 75.5 110.967 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.2 p -137.64 176.5 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 31.379999999999999 110.596 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tp -135.93 110.08 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 28.27 111.251 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -140.22 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 32.909999999999997 110.963 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.04 -144.79 40.26 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.854 -0.688 . . . . 20.0 112.915 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.75 64.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.785 0.326 . . . . 21.73 111.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.67 -46.52 90.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 63.420000000000002 110.805 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.37 -44.94 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.052 -0.522 . . . . 20.390000000000001 110.766 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.77 -33.96 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 20.0 111.139 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.69 -31.02 71.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 31.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.66 -47.49 31.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 20.0 110.966 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.419 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 14.8 mt -61.73 -47.09 86.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.209 -0.451 . . . . 22.050000000000001 110.871 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -32.29 73.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 32.759999999999998 110.665 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.68 -34.38 58.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 27.25 110.971 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -86.71 -61.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 25.510000000000002 110.96 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.1 m -76.78 -51.58 11.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 29.489999999999998 111.139 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.22 -122.46 29.13 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.895 -0.669 . . . . 40.609999999999999 113.059 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -58.71 -25.71 63.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.855 0.317 . . . . 79.049999999999997 111.855 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 -56.02 -30.03 61.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.75 0.31 . . . . 50.600000000000001 111.751 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.01 104.99 0.4 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.686 -0.769 . . . . 35.479999999999997 111.955 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 14' ' ' LEU . 41.4 p90 -93.21 153.37 18.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 25.52 111.554 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.6 139.74 46.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.783 -0.644 . . . . 56.07 110.469 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.37 -0.377 . . . . 29.300000000000001 110.862 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.418 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 4.2 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.875 0.369 . . . . 25.609999999999999 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.22 -66.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 29.899999999999999 111.104 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.9 m-20 -61.06 -20.73 62.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.11 0.411 . . . . 39.039999999999999 112.11 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.96 -28.79 17.81 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.261 0.837 . . . . 45.600000000000001 113.261 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -33.95 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.937 0.717 . . . . 28.23 112.937 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 45.5 t -73.67 -33.66 64.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 25.890000000000001 110.478 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.9 m-85 -84.84 -47.75 10.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 32.640000000000001 110.342 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 160.71 22.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.805 -0.634 . . . . 41.060000000000002 109.957 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 p -79.25 116.4 19.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.735 0.303 . . . . 42.619999999999997 111.059 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.59 -171.06 1.77 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.799 0.333 . . . . 28.050000000000001 110.911 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.28 134.6 45.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 46.350000000000001 110.338 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.6 -27.39 62.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.005 -0.543 . . . . 23.789999999999999 111.759 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -26.21 62.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.636 0.236 . . . . 74.930000000000007 111.636 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -62.31 -28.4 69.71 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.601 0.238 . . . . 64.420000000000002 111.192 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 mt -56.1 -29.15 60.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.745 0.307 . . . . 32.640000000000001 111.627 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -69.71 -29.74 67.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 41.859999999999999 111.396 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.3 mtm -65.23 -49.84 68.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.841 0.353 . . . . 38.659999999999997 111.265 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.418 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 87.7 m-85 -56.52 -25.59 52.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 25.27 111.855 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.2 m -64.64 134.66 54.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.398 . . . . 25.039999999999999 111.055 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 158.67 66.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 36.049999999999997 111.024 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 -30.33 56.83 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.897 1.731 . . . . 54.359999999999999 112.757 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.387 . . . . 71.540000000000006 110.875 -179.865 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.699 0.285 . . . . 20.0 111.231 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -98.6 32.86 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.456 -0.338 . . . . 20.0 111.041 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -86.47 -33.08 20.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 20.0 110.54 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.1 t -158.58 174.84 14.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 20.0 110.528 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.02 -31.06 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 20.0 111.162 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.35 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 20.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.52 -50.2 70.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 20.0 111.888 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 20.0 111.051 -179.947 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.922 0.392 . . . . 75.5 110.978 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 p -122.1 171.05 9.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 31.379999999999999 110.609 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.1 tp -128.66 113.32 15.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.386 -0.37 . . . . 28.27 111.035 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.18 164.09 31.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.915 0.388 . . . . 32.909999999999997 111.234 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 57.5 -137.86 48.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.016 -0.612 . . . . 20.0 113.003 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.86 66.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.687 0.279 . . . . 21.73 111.664 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.03 -38.97 77.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.823 0.344 . . . . 63.420000000000002 111.278 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 tp -72.33 -39.92 67.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 20.390000000000001 110.493 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -33.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.518 . . . . 20.0 111.143 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.67 -50.13 70.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 31.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -50.78 72.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 20.0 111.147 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.413 HD12 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -60.28 -42.21 94.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 22.050000000000001 110.875 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -71.84 -31.8 66.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 32.759999999999998 110.69 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -78.09 -31.28 50.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 27.25 110.871 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.13 -60.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 25.510000000000002 111.038 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 m -78.61 -51.54 9.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 29.489999999999998 111.033 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.88 -103.67 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 40.609999999999999 113.14 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.93 -5.28 56.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.074 0.768 . . . . 79.049999999999997 113.074 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -42.51 91.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.205 0.457 . . . . 50.600000000000001 111.113 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.24 65.78 0.81 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 35.479999999999997 112.342 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.413 ' CD1' HD12 ' A' ' 14' ' ' LEU . 26.6 p90 -58.87 156.36 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.921 0.391 . . . . 25.52 111.411 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 117.07 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 56.07 110.212 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.421 -0.354 . . . . 29.300000000000001 111.493 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.451 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 1.7 tt . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 111.755 0.28 . . . . 25.609999999999999 111.755 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -56.34 -55.4 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.939 0.4 . . . . 29.899999999999999 111.582 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.407 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.11 -21.75 64.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 39.039999999999999 111.906 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -90.39 -25.11 20.57 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.192 0.441 . . . . 45.600000000000001 112.192 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -114.36 -45.03 3.05 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.265 0.469 . . . . 28.23 112.265 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.3 t -73.25 -55.14 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 25.890000000000001 111.167 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 20.7 m-85 -63.81 -33.81 76.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.884 0.373 . . . . 32.640000000000001 110.873 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 ptm85 -142.05 150.69 41.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 41.060000000000002 110.854 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 p -62.87 137.29 58.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.594 . . . . 42.619999999999997 110.949 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -128.12 175.09 8.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 28.050000000000001 110.904 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.84 128.06 45.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 46.350000000000001 110.291 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -54.12 -25.72 23.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 23.789999999999999 112.274 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -59.53 -30.02 68.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 74.930000000000007 111.011 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 mmm-85 -65.96 -26.87 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 64.420000000000002 111.393 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.51 -30.95 63.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.869 0.366 . . . . 32.640000000000001 111.491 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.28 -26.63 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 41.859999999999999 111.809 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 57.4 mtm -67.56 -52.2 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 38.659999999999997 111.545 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 93.0 m-85 -54.48 -25.45 25.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 25.27 112.222 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.0 m -61.74 131.11 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 25.039999999999999 110.979 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.65 169.87 0.94 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.155 -0.475 . . . . 36.049999999999997 111.079 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.7 -33.2 3.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.847 1.698 . . . . 54.359999999999999 112.488 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 71.540000000000006 110.986 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 24.7 t . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.655 0.264 . . . . 20.0 111.451 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.27 32.82 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.448 -0.342 . . . . 20.0 111.099 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -80.03 -51.12 9.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 20.0 110.459 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 34.4 p -143.44 173.92 11.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.94 -0.573 . . . . 20.0 110.425 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.4 t -61.74 -30.45 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 20.0 111.308 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.46 -39.47 70.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 20.0 111.412 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.37 74.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 20.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.532 -0.304 . . . . 20.0 111.115 -179.599 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.757 0.313 . . . . 75.5 110.787 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.8 p -133.46 177.1 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 31.379999999999999 111.156 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.3 tp -140.22 118.74 12.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.272 -0.422 . . . . 28.27 111.318 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.0 m -140.44 159.52 42.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.354 -0.385 . . . . 32.909999999999997 111.072 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.1 -149.53 47.61 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.953 -0.642 . . . . 20.0 113.017 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.87 62.16 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.748 0.309 . . . . 21.73 111.65 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.07 -39.5 86.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 63.420000000000002 110.685 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.0 tp -71.11 -47.5 57.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 20.390000000000001 110.314 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.89 -31.61 54.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.958 -0.565 . . . . 20.0 110.948 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.72 -42.64 90.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 31.0 110.782 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.49 88.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 20.0 111.087 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' A' ' 23' ' ' PHE . 13.4 mt -59.7 -42.59 93.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 22.050000000000001 110.939 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.32 -31.33 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 32.759999999999998 110.876 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -76.84 -31.77 57.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 27.25 110.943 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 t -90.07 -59.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 25.510000000000002 110.927 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.4 m -77.86 -51.59 10.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 29.489999999999998 110.949 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.79 -121.89 26.55 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.939 -0.648 . . . . 40.609999999999999 113.108 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.25 -24.58 66.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.845 0.313 . . . . 79.049999999999997 111.845 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.0 mtm-85 -55.46 -27.31 47.39 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.897 0.332 . . . . 50.600000000000001 111.897 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 109.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.563 -0.827 . . . . 35.479999999999997 111.973 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CD1' HD12 ' A' ' 14' ' ' LEU . 39.7 p90 -102.0 160.34 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.109 0.481 . . . . 25.52 111.632 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -134.58 128.71 33.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.628 -0.715 . . . . 56.07 110.2 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 29.300000000000001 111.387 -179.517 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 9.2 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.7 0.286 . . . . 25.609999999999999 111.207 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.38 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 29.899999999999999 111.198 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -56.1 -20.31 16.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.178 -0.465 . . . . 39.039999999999999 112.195 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -86.56 -48.41 8.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.677 0.621 . . . . 45.600000000000001 112.677 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.55 -36.24 6.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.69 0.626 . . . . 28.23 112.69 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.28 -49.07 53.49 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.677 -0.409 . . . . 25.890000000000001 110.502 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -79.69 -56.58 4.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.477 . . . . 32.640000000000001 109.711 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -103.33 170.28 8.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.824 -0.626 . . . . 41.060000000000002 109.339 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -95.15 110.46 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 42.619999999999997 111.354 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.77 -169.2 1.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.23 -0.441 . . . . 28.050000000000001 110.804 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -108.51 168.04 9.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 46.350000000000001 110.828 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.4 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 6.6 mp -76.25 -30.49 57.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.447 . . . . 23.789999999999999 110.995 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -55.53 -26.76 44.87 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 74.930000000000007 111.712 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -64.5 -28.89 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.698 0.285 . . . . 64.420000000000002 111.005 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.24 -30.29 64.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.856 0.36 . . . . 32.640000000000001 111.4 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -31.2 70.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 41.859999999999999 111.433 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.7 mtm -61.32 -30.24 70.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 38.659999999999997 111.549 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 56.4 m-85 -83.68 -24.83 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 25.27 111.999 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -67.27 130.35 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 25.039999999999999 110.892 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.03 164.05 3.76 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.133 -0.485 . . . . 36.049999999999997 111.19 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.37 -28.67 10.16 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.92 1.746 . . . . 54.359999999999999 112.598 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 71.540000000000006 111.065 -179.977 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 41.9 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.868 0.366 . . . . 20.0 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.4 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 1.2 m-85 -81.75 66.79 7.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 20.0 110.777 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -127.92 -46.38 1.4 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 20.0 110.685 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -141.36 174.75 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 20.0 110.606 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 30.7 t -74.39 -30.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.37 . . . . 20.0 111.037 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.38 -39.93 89.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 20.0 111.042 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.56 82.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 20.0 111.214 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 20.0 111.36 -179.781 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.836 0.35 . . . . 75.5 110.747 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.2 p -118.2 176.17 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 31.379999999999999 110.65 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.0 tp -130.99 114.44 15.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 28.27 111.446 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.7 m -140.46 158.71 43.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.271 -0.422 . . . . 32.909999999999997 111.042 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.76 -145.45 41.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.929 -0.653 . . . . 20.0 113.083 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -30.34 65.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 21.73 111.461 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.21 -37.65 80.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 63.420000000000002 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.1 tp -73.18 -47.94 39.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 20.390000000000001 110.721 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.21 -30.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 20.0 111.19 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -45.65 78.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 31.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.57 -48.77 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 20.0 111.242 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.42 HD12 ' CD1' ' A' ' 23' ' ' PHE . 12.2 mt -59.48 -44.67 93.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 22.050000000000001 111.049 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -65.37 -32.27 73.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 32.759999999999998 110.821 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -76.54 -34.48 58.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 27.25 110.936 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.25 -66.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 25.510000000000002 111.048 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -77.42 -51.44 10.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 29.489999999999998 111.019 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.9 -121.25 24.38 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.913 -0.66 . . . . 40.609999999999999 113.286 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.06 -22.96 66.19 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.14 0.422 . . . . 79.049999999999997 112.14 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 mtm-85 -54.88 -25.62 30.1 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.992 0.367 . . . . 50.600000000000001 111.992 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 85.52 0.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.642 -0.79 . . . . 35.479999999999997 112.037 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' HD12 ' A' ' 14' ' ' LEU . 30.3 p90 -81.38 135.46 35.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.39 . . . . 25.52 111.51 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 1.6 p90 -105.74 151.6 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.945 -0.571 . . . . 56.07 110.335 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.38 . . . . 29.300000000000001 111.269 -179.607 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 4.1 tp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.862 0.363 . . . . 25.609999999999999 111.0 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.6 -59.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 29.899999999999999 111.657 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 7.5 m-20 -66.9 -24.0 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.424 . . . . 39.039999999999999 112.113 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.11 -21.78 22.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.634 0.605 . . . . 45.600000000000001 112.634 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -121.77 -47.8 2.18 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.326 0.491 . . . . 28.23 112.326 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.7 t -70.03 -44.18 69.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.885 -0.326 . . . . 25.890000000000001 111.018 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 14.5 m-85 -73.17 -38.19 66.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 32.640000000000001 110.56 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 41.060000000000002 110.705 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.9 p -58.87 153.39 17.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 42.619999999999997 111.185 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.4 p -151.14 -172.62 4.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 28.050000000000001 111.043 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -110.7 130.08 55.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 46.350000000000001 110.031 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.6 mt -55.58 -25.29 37.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 23.789999999999999 112.184 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -27.12 63.66 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 74.930000000000007 111.341 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -63.18 -28.36 69.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.632 -0.258 . . . . 64.420000000000002 111.298 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.9 mt -55.72 -28.25 54.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.557 -0.292 . . . . 32.640000000000001 111.754 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -70.37 -28.77 65.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.338 -0.392 . . . . 41.859999999999999 111.591 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.0 mtm -66.17 -51.97 52.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 38.659999999999997 111.298 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 82.5 m-85 -54.32 -22.76 12.93 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.86 -0.609 . . . . 25.27 112.234 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.3 m -67.92 145.47 54.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 25.039999999999999 110.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.16 175.23 5.0 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.341 -0.391 . . . . 36.049999999999997 111.145 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.82 -30.84 3.49 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.961 1.774 . . . . 54.359999999999999 112.697 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 71.540000000000006 111.092 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.598 0.237 . . . . 20.0 111.24 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -97.87 35.8 1.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 20.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.96 -51.37 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 20.0 110.481 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.3 p -146.72 173.33 12.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 20.0 110.515 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.7 t -58.03 -27.93 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.546 -0.297 . . . . 20.0 111.572 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.64 -39.04 67.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.957 0.408 . . . . 20.0 111.016 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.88 -50.95 67.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.047 -0.524 . . . . 20.0 112.115 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.736 0.303 . . . . 20.0 111.032 -179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.947 0.403 . . . . 75.5 111.101 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.1 p -137.96 -176.03 4.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 31.379999999999999 110.512 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.18 112.93 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 28.27 111.131 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.4 m -140.21 162.58 34.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 32.909999999999997 111.195 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.97 -145.78 49.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.92 -0.657 . . . . 20.0 113.166 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -29.46 65.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.298 . . . . 21.73 111.508 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.13 -38.6 83.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.398 -0.365 . . . . 63.420000000000002 110.961 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.17 -48.82 32.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 20.390000000000001 110.57 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.68 -31.71 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 20.0 110.972 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.82 -46.34 78.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 31.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.3 -47.59 84.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 20.0 110.998 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.438 ' CD1' ' CD2' ' A' ' 23' ' ' PHE . 14.9 mt -60.66 -41.0 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 22.050000000000001 110.77 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -70.73 -32.75 70.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 32.759999999999998 110.568 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.62 -32.67 53.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 27.25 110.624 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.3 t -86.43 -65.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 25.510000000000002 110.8 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -71.1 -51.46 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 29.489999999999998 111.008 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.0 -119.75 17.28 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.058 -0.592 . . . . 40.609999999999999 112.843 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.33 -27.38 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.579 0.228 . . . . 79.049999999999997 111.386 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.56 -67.28 0.32 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.826 0.346 . . . . 50.600000000000001 111.511 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.76 141.87 5.91 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.083 -0.58 . . . . 35.479999999999997 111.864 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.438 ' CD2' ' CD1' ' A' ' 14' ' ' LEU . 25.5 p90 -132.3 139.97 48.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 25.52 111.361 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -113.09 146.92 38.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 56.07 110.484 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.453 -0.34 . . . . 29.300000000000001 111.786 -179.755 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 1.1 tt . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.599 0.238 . . . . 25.609999999999999 111.51 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.89 -56.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.981 0.42 . . . . 29.899999999999999 111.3 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -21.41 64.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.075 -0.511 . . . . 39.039999999999999 111.933 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.02 -28.37 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.845 0.313 . . . . 45.600000000000001 111.845 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.0 -51.95 2.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.053 0.39 . . . . 28.23 112.053 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -65.36 -53.45 43.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.64 0.257 . . . . 25.890000000000001 111.182 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -66.01 -45.2 82.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 32.640000000000001 110.739 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 148.29 50.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 41.060000000000002 110.604 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 p -60.39 139.63 57.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 42.619999999999997 110.872 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.43 -173.81 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 28.050000000000001 111.017 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.58 132.21 54.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 46.350000000000001 110.208 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -28.1 62.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 23.789999999999999 111.704 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -59.15 -29.28 67.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.661 0.267 . . . . 74.930000000000007 111.323 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -61.12 -27.59 68.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.449 -0.342 . . . . 64.420000000000002 111.601 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 mt -57.02 -29.87 63.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.777 0.322 . . . . 32.640000000000001 111.555 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.84 -29.73 67.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 41.859999999999999 111.407 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.1 mtm -64.91 -47.54 77.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.433 -0.349 . . . . 38.659999999999997 111.323 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 97.8 m-85 -60.21 -30.68 69.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 25.27 111.501 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.5 m -60.16 129.51 42.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 25.039999999999999 110.873 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.28 151.84 34.89 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.18 -0.464 . . . . 36.049999999999997 111.346 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.41 -22.6 38.99 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.022 1.814 . . . . 54.359999999999999 112.979 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 120.929 0.395 . . . . 71.540000000000006 111.57 -179.726 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.685 0.279 . . . . 20.0 111.024 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -98.34 32.77 2.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 20.0 111.202 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -79.77 -33.5 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 20.0 110.424 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.8 t -157.08 174.36 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.861 -0.609 . . . . 20.0 110.391 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 32.1 t -68.06 -30.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.476 -0.329 . . . . 20.0 110.96 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.83 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 20.0 111.176 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.78 -42.65 97.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 20.0 111.473 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 20.0 111.279 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.734 0.302 . . . . 75.5 110.884 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 p -133.16 178.85 6.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 31.379999999999999 110.902 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 tp -136.6 109.48 7.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.375 . . . . 28.27 111.322 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.19 164.72 29.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 32.909999999999997 110.666 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.06 -146.83 43.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.759 -0.734 . . . . 20.0 112.742 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.94 -32.08 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 21.73 111.373 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.08 -37.42 77.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.233 -0.439 . . . . 63.420000000000002 111.14 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.2 tp -73.94 -51.22 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 20.390000000000001 110.974 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.87 -30.1 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 20.0 111.242 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.71 -48.78 65.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.4 . . . . 31.0 111.051 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.61 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 20.0 111.258 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.411 HD12 ' CD1' ' A' ' 23' ' ' PHE . 11.7 mt -60.65 -40.62 92.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 22.050000000000001 110.809 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -74.02 -32.84 63.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 32.759999999999998 110.434 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -41.97 88.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 27.25 110.515 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -86.8 -61.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 25.510000000000002 111.198 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.87 -51.35 12.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 29.489999999999998 111.224 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.9 -117.15 9.39 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 40.609999999999999 112.693 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.47 7.73 13.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.772 0.656 . . . . 79.049999999999997 112.772 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.83 -36.0 77.66 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.036 -0.415 . . . . 50.600000000000001 110.891 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.33 59.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 35.479999999999997 112.382 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CD1' HD12 ' A' ' 14' ' ' LEU . 29.8 p90 -58.71 133.88 56.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 25.52 111.422 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -86.47 142.37 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 56.07 110.779 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.391 . . . . 29.300000000000001 110.886 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 8.2 tp . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.876 0.369 . . . . 25.609999999999999 110.954 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.23 -65.72 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 29.899999999999999 110.958 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 19.1 m-20 -61.29 -21.07 63.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.226 -0.443 . . . . 39.039999999999999 111.791 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.58 -36.97 14.13 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.974 0.361 . . . . 45.600000000000001 111.974 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -106.44 -50.33 3.16 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.41 0.522 . . . . 28.23 112.41 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.2 t -60.42 -50.32 74.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.763 0.316 . . . . 25.890000000000001 111.071 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.0 m-85 -67.21 -56.22 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 32.640000000000001 110.219 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.22 145.99 44.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 41.060000000000002 110.354 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -57.36 136.51 56.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.207 -0.451 . . . . 42.619999999999997 111.77 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -126.47 -160.47 0.99 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.132 -0.485 . . . . 28.050000000000001 110.483 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -128.11 145.71 50.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.907 0.384 . . . . 46.350000000000001 110.578 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp -59.23 -26.38 64.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.168 -0.469 . . . . 23.789999999999999 111.535 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -57.82 -28.58 64.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.651 0.262 . . . . 74.930000000000007 111.442 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -68.75 -26.71 65.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 64.420000000000002 111.206 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.0 mt -55.45 -47.81 75.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.785 0.326 . . . . 32.640000000000001 111.78 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.49 -29.08 65.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 41.859999999999999 111.519 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.3 mtm -63.77 -50.01 70.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 38.659999999999997 111.465 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.446 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 93.2 m-85 -56.82 -28.26 61.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 25.27 111.813 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.1 m -60.35 127.15 30.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.369 . . . . 25.039999999999999 111.025 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.69 168.82 17.16 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.116 -0.493 . . . . 36.049999999999997 110.951 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.76 -30.62 3.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.832 1.688 . . . . 54.359999999999999 112.842 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 71.540000000000006 110.995 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.83 0.348 . . . . 20.0 111.028 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -82.05 67.02 7.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.246 0.546 . . . . 20.0 111.029 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -116.01 -41.0 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 20.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 20.2 t -142.96 178.3 7.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 20.0 110.543 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 t -73.9 -31.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 20.0 111.034 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.82 -39.58 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 20.0 111.057 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.6 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 20.0 111.47 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 20.0 111.332 -179.734 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.817 0.341 . . . . 75.5 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 p -128.43 176.1 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 31.379999999999999 111.048 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.6 tp -140.2 117.92 11.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 28.27 111.045 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 m -140.25 164.97 28.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.92 0.39 . . . . 32.909999999999997 110.963 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.64 -149.76 48.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.9 -0.667 . . . . 20.0 112.959 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.91 -29.83 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 21.73 111.475 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.78 -39.41 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 63.420000000000002 110.92 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.1 tp -72.69 -49.26 32.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 20.390000000000001 110.773 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.67 -31.9 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 20.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 -45.55 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 31.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.8 99.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 20.0 111.223 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.435 ' CD1' ' CD2' ' A' ' 23' ' ' PHE . 12.1 mt -60.53 -38.31 84.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.881 0.372 . . . . 22.050000000000001 110.551 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 1.5 mm-40 -76.5 -33.51 58.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 32.759999999999998 110.177 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -44.96 74.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 27.25 110.622 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 t -78.88 -65.62 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 25.510000000000002 111.289 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.7 m -64.6 -51.72 61.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 29.489999999999998 111.426 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.96 -109.07 1.29 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.96 -0.638 . . . . 40.609999999999999 113.18 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.79 -37.61 88.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 79.049999999999997 111.301 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -58.52 -28.97 65.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 50.600000000000001 111.446 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.86 174.56 46.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.555 -0.831 . . . . 35.479999999999997 111.721 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.435 ' CD2' ' CD1' ' A' ' 14' ' ' LEU . 13.6 p90 -150.37 156.0 40.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 25.52 111.546 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 112.45 14.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.646 -0.706 . . . . 56.07 110.285 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.466 0.354 0 CA-C-N 116.206 -0.452 . . . . 29.300000000000001 112.206 -179.264 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.451 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 1.1 tp . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.827 0.346 . . . . 25.609999999999999 110.353 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.05 -48.72 86.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 29.899999999999999 111.327 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -25.61 61.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 39.039999999999999 111.936 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -90.34 -26.18 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.867 0.321 . . . . 45.600000000000001 111.867 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -107.12 -41.09 5.24 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 28.23 112.016 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.9 t -80.72 -57.98 3.31 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.974 -0.29 . . . . 25.890000000000001 110.907 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -65.1 -37.43 87.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 32.640000000000001 110.488 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -126.91 158.87 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 41.060000000000002 110.253 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 p -82.2 113.19 19.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 42.619999999999997 110.99 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.7 p -99.21 -171.86 2.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 28.050000000000001 111.05 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -125.0 147.61 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 46.350000000000001 110.082 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.32 -28.72 55.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.207 -0.451 . . . . 23.789999999999999 111.824 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -59.63 -28.21 67.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 74.930000000000007 111.323 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -66.44 -32.18 73.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 64.420000000000002 111.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mt -55.1 -28.61 53.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.019 -0.537 . . . . 32.640000000000001 111.88 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.12 -35.95 71.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 41.859999999999999 111.287 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.7 mtm -59.02 -37.14 76.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 38.659999999999997 111.292 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 43' ' ' ILE . 84.8 m-85 -71.94 -29.59 64.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 25.27 111.324 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.66 128.85 37.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.377 . . . . 25.039999999999999 111.122 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.29 1.46 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.992 -0.549 . . . . 36.049999999999997 111.213 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -88.06 -21.75 1.56 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.312 2.008 . . . . 54.359999999999999 113.23 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.928 0.394 . . . . 71.540000000000006 111.872 -179.411 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 86.5 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.674 0.273 . . . . 20.0 110.921 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -86.08 57.49 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.46 0.648 . . . . 20.0 110.824 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -118.9 -42.82 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.764 -0.653 . . . . 20.0 110.495 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 44.1 p -143.63 175.02 10.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 20.0 110.586 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.34 -30.96 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 20.0 111.109 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.73 85.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 20.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.61 75.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 20.0 111.327 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 116.326 -0.397 . . . . 20.0 111.18 -179.829 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.841 0.353 . . . . 75.5 110.941 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.5 p -130.97 167.4 19.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.098 -0.501 . . . . 31.379999999999999 110.75 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 tp -122.05 113.25 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 28.27 111.095 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.3 m -140.22 162.74 34.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 32.909999999999997 111.216 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.68 -139.64 48.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.677 . . . . 20.0 112.949 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.62 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.665 0.269 . . . . 21.73 111.494 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.58 -38.53 87.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 63.420000000000002 110.841 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.63 -45.38 62.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 20.390000000000001 110.873 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.68 -30.79 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 20.0 111.241 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.59 -43.37 85.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 31.0 111.066 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.9 -48.52 65.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 20.0 111.393 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.411 HD12 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -59.65 -37.9 79.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 22.050000000000001 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.52 -32.09 60.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 32.759999999999998 110.725 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -79.29 -31.6 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 27.25 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.7 t -86.51 -63.25 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 25.510000000000002 110.928 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.0 m -74.26 -51.34 15.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 29.489999999999998 111.244 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.95 -112.51 4.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 40.609999999999999 112.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.74 7.49 17.55 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.758 0.651 . . . . 79.049999999999997 112.758 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -75.84 -33.59 60.06 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.974 -0.454 . . . . 50.600000000000001 111.123 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.32 80.85 1.37 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 35.479999999999997 112.19 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CD1' HD12 ' A' ' 14' ' ' LEU . 26.9 p90 -74.7 154.23 38.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.062 0.458 . . . . 25.52 111.396 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -130.95 120.78 24.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 56.07 110.423 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 29.300000000000001 111.544 -179.505 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.409 HD12 ' CE2' ' A' ' 60' ' ' TYR . 3.6 tp . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.844 0.354 . . . . 25.609999999999999 110.989 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.07 -57.28 11.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 29.899999999999999 111.415 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.99 -21.88 64.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.064 0.394 . . . . 39.039999999999999 112.064 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.4 -25.5 20.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.117 0.414 . . . . 45.600000000000001 112.117 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.3 m -112.66 -46.45 3.14 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.118 0.414 . . . . 28.23 112.118 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.0 t -71.67 -57.48 4.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.313 . . . . 25.890000000000001 110.987 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.54 -35.29 79.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 32.640000000000001 110.739 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -137.83 146.78 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 41.060000000000002 110.42 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -60.59 147.88 40.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 42.619999999999997 110.957 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.3 p -141.14 -173.84 3.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 28.050000000000001 111.047 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -111.24 128.71 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 46.350000000000001 110.137 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.76 -23.2 6.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.413 0.523 . . . . 23.789999999999999 112.413 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -61.47 -28.4 69.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.684 0.278 . . . . 74.930000000000007 111.296 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -64.73 -29.22 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.567 -0.288 . . . . 64.420000000000002 111.218 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 mt -56.22 -28.71 59.38 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.422 -0.354 . . . . 32.640000000000001 111.654 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.66 -29.94 66.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 41.859999999999999 111.256 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.7 mtm -63.86 -50.09 70.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 38.659999999999997 111.2 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' CE2' HD12 ' A' ' 43' ' ' ILE . 97.7 m-85 -57.22 -29.15 63.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 25.27 111.491 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.26 134.17 56.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 25.039999999999999 111.071 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.44 163.81 43.82 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.077 -0.51 . . . . 36.049999999999997 111.138 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.45 -23.12 4.33 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.136 1.891 . . . . 54.359999999999999 113.01 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.921 0.391 . . . . 71.540000000000006 111.538 -179.491 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.804 0.335 . . . . 20.0 111.062 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.64 32.74 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 20.0 110.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -89.24 -38.43 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 20.0 110.761 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t -155.8 174.96 14.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 20.0 110.756 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 46.0 t -67.24 -31.09 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 20.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.3 -42.71 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.399 . . . . 20.0 111.243 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.84 82.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 20.0 111.523 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.335 -0.393 . . . . 20.0 111.263 -179.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.803 0.335 . . . . 75.5 110.89 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.7 p -120.02 174.37 6.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 31.379999999999999 110.857 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.6 tp -140.12 116.57 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 28.27 111.146 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m -140.11 168.2 20.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 32.909999999999997 110.834 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.39 -150.11 49.43 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.748 -0.739 . . . . 20.0 112.856 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.74 -30.05 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.752 0.311 . . . . 21.73 111.319 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -59.19 -43.0 92.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 63.420000000000002 111.046 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -69.24 -43.52 73.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 20.390000000000001 110.595 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.75 -30.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 20.0 111.152 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -68.77 -37.53 79.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 31.0 111.057 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.43 71.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.471 -0.331 . . . . 20.0 111.002 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 12.2 mt -60.25 -42.16 94.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.854 0.359 . . . . 22.050000000000001 110.516 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -68.57 -32.52 72.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 32.759999999999998 110.325 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -43.3 68.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 27.25 110.737 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 t -81.76 -52.29 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.601 . . . . 25.510000000000002 111.413 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.9 m -83.23 -51.58 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 29.489999999999998 111.436 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.17 -109.83 2.34 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.752 -0.737 . . . . 40.609999999999999 112.797 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.87 7.3 13.22 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.889 0.7 . . . . 79.049999999999997 112.889 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -77.11 -39.82 48.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.05 0.386 . . . . 50.600000000000001 111.061 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.39 78.18 1.4 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.737 -0.744 . . . . 35.479999999999997 112.172 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 14' ' ' LEU . 27.5 p90 -72.06 163.17 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.079 0.466 . . . . 25.52 111.494 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.99 151.82 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.694 -0.684 . . . . 56.07 110.543 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CD2' HG23 ' A' ' 43' ' ' ILE . 73.9 m-85 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 29.300000000000001 111.258 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.415 HG23 ' CD2' ' A' ' 25' ' ' PHE . 1.5 tt . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 111.609 0.226 . . . . 25.609999999999999 111.609 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.6 -61.17 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.9 0.381 . . . . 29.899999999999999 111.449 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.26 -17.11 64.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.395 -0.366 . . . . 39.039999999999999 111.955 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -90.28 -32.74 16.4 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.807 0.669 . . . . 45.600000000000001 112.807 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.45 -29.05 5.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.805 0.668 . . . . 28.23 112.805 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -79.95 -46.13 17.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.871 -0.331 . . . . 25.890000000000001 110.698 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -74.53 -37.7 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.052 0.453 . . . . 32.640000000000001 110.212 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -130.11 159.23 37.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 41.060000000000002 109.865 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 p -78.74 127.12 31.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.788 0.328 . . . . 42.619999999999997 111.389 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.78 -160.86 0.94 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.3 -0.409 . . . . 28.050000000000001 110.46 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.9 175.06 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.47 -0.332 . . . . 46.350000000000001 110.403 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.11 -28.18 18.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.385 -0.37 . . . . 23.789999999999999 111.499 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -55.7 -26.01 42.9 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 111.706 0.262 . . . . 74.930000000000007 111.706 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -61.19 -29.16 69.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.663 0.268 . . . . 64.420000000000002 110.919 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 mt -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 32.640000000000001 111.567 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.22 -31.93 73.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 41.859999999999999 111.394 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.1 mtm -63.29 -53.08 58.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 38.659999999999997 111.217 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.41 ' CE2' HD11 ' A' ' 43' ' ' ILE . 86.7 m-85 -57.16 -26.12 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.189 -0.46 . . . . 25.27 111.721 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.43 130.39 46.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.84 0.353 . . . . 25.039999999999999 111.038 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.75 168.56 1.06 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.233 -0.44 . . . . 36.049999999999997 111.286 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.2 -30.11 1.72 Allowed 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.088 1.859 . . . . 54.359999999999999 112.813 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 71.540000000000006 111.093 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 111.624 0.231 . . . . 20.0 111.624 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -96.0 36.98 1.26 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.795 0.331 . . . . 20.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.63 -33.81 15.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 20.0 110.48 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 70.3 m -150.97 174.45 13.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.027 -0.533 . . . . 20.0 110.607 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 21.0 t -73.43 -29.32 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.422 -0.354 . . . . 20.0 111.337 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.82 76.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 20.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.0 86.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.114 -0.494 . . . . 20.0 111.417 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.4 . . . . 20.0 111.109 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.772 0.32 . . . . 75.5 110.826 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.5 p -135.68 166.78 22.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.169 -0.468 . . . . 31.379999999999999 110.783 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 tp -124.13 116.33 22.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.372 -0.376 . . . . 28.27 111.431 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 m -140.56 161.32 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 32.909999999999997 110.933 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.03 -147.67 44.96 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.77 -0.729 . . . . 20.0 113.047 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.15 66.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 21.73 111.475 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.63 -40.06 90.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 63.420000000000002 110.805 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.98 -43.58 74.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 20.390000000000001 110.587 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.94 -31.25 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 20.0 111.069 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.45 -31.0 67.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 31.0 111.008 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.1 -47.2 37.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 20.0 110.755 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 13.8 mt -60.46 -49.04 79.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 22.050000000000001 110.763 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -30.39 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 32.759999999999998 110.672 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -79.68 -35.16 39.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.427 -0.351 . . . . 27.25 110.937 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . 0.41 HG23 ' CZ ' ' B' ' 104' ' ' PHE . 34.3 t -85.01 -57.47 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 25.510000000000002 111.039 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.4 m -77.67 -51.26 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 29.489999999999998 111.442 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.37 -115.09 6.78 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.61 -0.805 . . . . 40.609999999999999 112.691 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -82.5 7.55 14.08 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.686 0.624 . . . . 79.049999999999997 112.686 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -75.57 -32.7 60.48 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.973 -0.455 . . . . 50.600000000000001 111.017 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.04 83.3 1.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.61 -0.805 . . . . 35.479999999999997 112.151 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 14' ' ' LEU . 35.6 p90 -76.96 157.88 31.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.972 0.415 . . . . 25.52 111.318 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -134.69 131.2 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 56.07 110.605 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 29.300000000000001 111.156 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 5.3 tp . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.7 0.286 . . . . 25.609999999999999 111.081 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.28 -52.46 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 29.899999999999999 111.293 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.412 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.2 m-20 -69.97 -24.71 63.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 39.039999999999999 111.811 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.51 -23.71 20.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.283 0.475 . . . . 45.600000000000001 112.283 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 55.8 m -116.0 -44.78 2.89 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.337 0.495 . . . . 28.23 112.337 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -75.02 -49.26 20.4 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.924 -0.311 . . . . 25.890000000000001 111.008 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 29.3 m-85 -72.15 -34.3 68.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.859 0.362 . . . . 32.640000000000001 110.577 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -134.68 149.86 50.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 41.060000000000002 110.273 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 p -67.41 136.54 54.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 42.619999999999997 110.821 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.4 p -130.1 -171.94 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 28.050000000000001 111.156 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.16 139.37 49.97 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.914 -0.585 . . . . 46.350000000000001 110.007 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.41 ' HB3' ' CE1' ' B' ' 104' ' ' PHE . 0.2 OUTLIER -58.18 -28.84 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 23.789999999999999 111.541 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp85 -58.47 -29.21 66.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.776 0.322 . . . . 74.930000000000007 111.282 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -66.12 -28.37 68.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.378 -0.374 . . . . 64.420000000000002 111.302 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.2 mt -56.93 -29.21 62.9 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.544 -0.298 . . . . 32.640000000000001 111.482 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.5 -31.37 69.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 41.859999999999999 111.047 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.8 mtm -61.36 -48.11 82.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 38.659999999999997 110.958 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 96.0 m-85 -59.15 -29.93 67.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 25.27 111.234 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.5 m -58.91 132.72 54.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 25.039999999999999 111.08 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.06 161.96 26.72 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.141 -0.481 . . . . 36.049999999999997 111.111 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.81 -27.16 6.18 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.964 1.776 . . . . 54.359999999999999 112.545 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 71.540000000000006 111.071 -179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.644 0.259 . . . . 20.0 111.256 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -97.68 33.19 2.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.779 0.323 . . . . 20.0 111.049 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.48 -34.12 11.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.001 0.429 . . . . 20.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 70.6 m -154.38 175.16 13.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 20.0 110.298 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 15.4 t -76.62 -30.91 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 20.0 111.193 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.62 90.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 20.0 110.893 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.84 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 20.0 111.337 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . 0.401 ' CD1' ' CD1' ' A' ' 54' ' ' LEU . 1.3 mt . . . . . 0 CA--C 1.531 0.212 0 CA-C-N 116.401 -0.363 . . . . 20.0 111.235 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.9 0.381 . . . . 75.5 111.04 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 p -119.91 174.2 6.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 31.379999999999999 110.775 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 tp -133.54 106.96 7.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 28.27 111.174 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.2 m -140.13 162.38 35.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.286 -0.415 . . . . 32.909999999999997 110.845 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.78 -143.35 38.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.713 -0.756 . . . . 20.0 112.634 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.79 -30.72 69.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.711 0.291 . . . . 21.73 111.218 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.42 -41.91 94.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 63.420000000000002 110.974 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.6 tp -70.46 -41.95 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 20.390000000000001 111.089 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -72.98 -33.47 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 20.0 111.142 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.54 -30.8 67.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 31.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.52 -47.27 42.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 20.0 110.902 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 12.6 mt -62.39 -50.26 72.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 22.050000000000001 110.647 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -61.33 -32.02 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 32.759999999999998 110.702 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -77.02 -36.4 56.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 27.25 110.91 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 t -85.15 -66.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 25.510000000000002 110.844 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.17 -51.39 21.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 29.489999999999998 110.96 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.97 -126.08 41.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.899 -0.667 . . . . 40.609999999999999 112.983 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.2 -25.02 45.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.941 0.348 . . . . 79.049999999999997 111.941 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 -55.33 -25.97 37.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.918 0.34 . . . . 50.600000000000001 111.918 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.31 94.03 0.4 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.558 -0.829 . . . . 35.479999999999997 112.12 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 14' ' ' LEU . 46.1 p90 -84.03 151.85 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.004 0.43 . . . . 25.52 111.552 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -131.41 134.64 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 56.07 110.386 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 29.300000000000001 111.176 -179.616 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.409 HD12 ' CE1' ' A' ' 60' ' ' TYR . 5.6 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.845 0.355 . . . . 25.609999999999999 111.202 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.9 t -64.97 -62.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 29.899999999999999 111.122 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -63.68 -24.03 67.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.251 -0.431 . . . . 39.039999999999999 111.976 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -90.77 -31.54 16.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.448 0.536 . . . . 45.600000000000001 112.448 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.21 -48.48 3.1 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.393 0.516 . . . . 28.23 112.393 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.9 t -63.41 -51.33 66.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.981 -0.287 . . . . 25.890000000000001 110.914 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.0 m-85 -65.38 -49.99 67.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 32.640000000000001 110.271 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -124.28 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 41.060000000000002 110.285 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 p -56.71 131.31 48.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.126 -0.488 . . . . 42.619999999999997 111.732 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -123.32 -163.29 1.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.329 -0.396 . . . . 28.050000000000001 110.844 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.63 134.84 54.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 46.350000000000001 110.128 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -27.28 48.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 23.789999999999999 112.005 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -58.26 -26.22 62.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.549 -0.296 . . . . 74.930000000000007 111.618 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -65.13 -26.85 68.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.55 0.214 . . . . 64.420000000000002 111.238 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mt -56.18 -30.84 62.8 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.777 0.323 . . . . 32.640000000000001 111.545 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -68.35 -30.34 69.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 41.859999999999999 111.524 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.9 mtm -66.13 -39.39 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.855 0.36 . . . . 38.659999999999997 111.451 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.409 ' CE1' HD12 ' A' ' 43' ' ' ILE . 70.9 m-85 -69.96 -24.61 63.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 25.27 112.045 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.11 138.45 58.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 25.039999999999999 110.789 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.61 173.76 1.83 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.165 -0.471 . . . . 36.049999999999997 110.915 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.06 -26.77 2.18 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.03 1.82 . . . . 54.359999999999999 112.731 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 71.540000000000006 111.224 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.851 0.357 . . . . 20.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -82.11 62.73 5.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.387 0.613 . . . . 20.0 110.949 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.44 -44.27 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 20.0 110.543 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 45.9 p -149.91 174.84 12.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.844 -0.616 . . . . 20.0 110.497 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 23.7 t -71.05 -35.57 59.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 20.0 111.009 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.3 -39.97 64.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 20.0 111.176 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.02 -42.33 85.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 20.0 111.594 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 20.0 110.848 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.883 0.373 . . . . 75.5 111.093 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.8 p -133.98 -178.33 4.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 31.379999999999999 110.74 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 tp -137.91 107.4 6.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.489 -0.323 . . . . 28.27 111.247 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.2 157.13 46.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 32.909999999999997 111.029 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.0 -142.88 36.99 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.926 -0.654 . . . . 20.0 112.878 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.69 63.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.691 0.281 . . . . 21.73 111.633 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.33 -40.82 92.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.386 . . . . 63.420000000000002 110.918 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.9 tp -71.94 -44.89 62.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 20.390000000000001 110.643 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.12 -29.91 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 20.0 111.238 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.54 -41.08 76.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.329 -0.396 . . . . 31.0 111.02 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.57 -48.93 70.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 20.0 111.194 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 13.4 mt -59.91 -46.08 90.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 22.050000000000001 110.919 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -66.44 -31.6 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 32.759999999999998 110.783 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -77.32 -31.96 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 27.25 110.808 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.48 -67.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 25.510000000000002 110.804 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.2 m -70.45 -51.64 27.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 29.489999999999998 111.173 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.63 -115.88 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 40.609999999999999 112.739 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.45 7.53 19.43 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.825 0.676 . . . . 79.049999999999997 112.825 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -69.11 -30.47 68.76 Favored 'General case' 0 C--O 1.231 0.09 0 O-C-N 122.032 -0.418 . . . . 50.600000000000001 111.052 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 60.63 1.29 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 35.479999999999997 111.906 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 14' ' ' LEU . 22.1 p90 -57.1 155.33 8.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 25.52 111.783 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.23 147.94 47.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.499 -0.773 . . . . 56.07 110.214 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.546 -0.297 . . . . 29.300000000000001 111.133 -179.618 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.778 0.323 . . . . 25.609999999999999 110.933 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.73 -65.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 29.899999999999999 111.073 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.17 -22.95 67.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.376 -0.375 . . . . 39.039999999999999 111.784 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -90.43 -30.65 17.22 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.263 0.468 . . . . 45.600000000000001 112.263 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.21 -51.12 2.9 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 28.23 112.274 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.24 -55.26 34.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.73 0.3 . . . . 25.890000000000001 110.92 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.98 -55.0 33.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.956 0.408 . . . . 32.640000000000001 110.216 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -122.87 147.15 46.89 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 116.004 -0.544 . . . . 41.060000000000002 109.967 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.6 p -58.73 133.98 56.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.78 0.324 . . . . 42.619999999999997 111.461 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.4 p -118.65 -164.47 1.04 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.892 0.377 . . . . 28.050000000000001 111.016 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.31 129.61 56.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.051 -0.522 . . . . 46.350000000000001 110.398 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.8 mt -54.08 -35.52 62.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.794 -0.639 . . . . 23.789999999999999 112.346 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -55.74 -26.43 45.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.779 0.289 . . . . 74.930000000000007 111.779 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.697 0.284 . . . . 64.420000000000002 111.115 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 mt -55.05 -29.28 57.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.28 -0.418 . . . . 32.640000000000001 111.799 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.56 -25.89 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 41.859999999999999 112.0 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.19 -45.54 55.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 38.659999999999997 110.906 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 55.9 m-85 -60.85 -26.26 67.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.164 -0.471 . . . . 25.27 111.312 -179.829 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.6 m -59.23 147.12 36.74 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.746 0.308 . . . . 25.039999999999999 110.902 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.47 160.71 66.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 36.049999999999997 110.929 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.9 -30.17 6.19 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.905 1.737 . . . . 54.359999999999999 112.499 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.414 -0.357 . . . . 71.540000000000006 111.058 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 29.3 t . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.621 0.248 . . . . 20.0 111.288 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.782 0.325 . . . . 20.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -79.43 -51.04 9.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 20.0 110.574 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 49.7 p -149.4 174.14 12.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.976 -0.556 . . . . 20.0 110.373 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -56.01 -29.72 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.871 0.367 . . . . 20.0 111.673 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.88 -39.08 83.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.126 -0.488 . . . . 20.0 110.957 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.25 43.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.035 -0.529 . . . . 20.0 112.025 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 20.0 110.728 -179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.855 0.36 . . . . 75.5 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.8 p -127.35 170.88 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 31.379999999999999 110.807 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.5 tp -133.05 109.82 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 28.27 111.265 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 m -140.07 163.24 33.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 32.909999999999997 110.902 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -146.15 42.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 20.0 112.867 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.22 -31.81 67.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.804 0.335 . . . . 21.73 111.533 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -59.61 -44.09 93.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 63.420000000000002 110.905 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.05 -44.97 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 20.390000000000001 110.697 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.25 -31.53 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 20.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.58 -49.24 74.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 31.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.44 -50.69 72.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 20.0 111.339 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . 0.418 HD12 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -58.61 -43.12 89.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.303 -0.408 . . . . 22.050000000000001 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -70.42 -32.03 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 32.759999999999998 110.667 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -79.04 -31.35 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 27.25 110.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.3 t -88.28 -68.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 25.510000000000002 111.112 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -71.22 -51.66 23.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 29.489999999999998 111.21 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.94 -112.87 3.48 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.995 -0.622 . . . . 40.609999999999999 113.089 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.89 -27.98 69.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 79.049999999999997 111.449 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.47 -27.31 47.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.796 0.295 . . . . 50.600000000000001 111.796 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.45 108.63 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 35.479999999999997 112.033 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' PHE . . . . . 0.418 ' CD1' HD12 ' A' ' 14' ' ' LEU . 29.2 p90 -95.82 150.06 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.448 . . . . 25.52 111.266 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -126.62 120.6 29.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 56.07 110.492 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 29.300000000000001 111.401 -179.773 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ILE . . . . . 0.432 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 4.6 tp . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.797 0.332 . . . . 25.609999999999999 111.094 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.59 -65.56 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 29.899999999999999 111.16 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.407 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.1 m-20 -60.86 -22.38 64.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.277 -0.419 . . . . 39.039999999999999 111.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.68 -38.04 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.115 0.413 . . . . 45.600000000000001 112.115 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.42 -49.73 3.38 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.362 0.504 . . . . 28.23 112.362 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.0 t -60.67 -50.77 72.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.728 0.299 . . . . 25.890000000000001 111.134 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PHE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 10.5 m-85 -66.99 -49.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 32.640000000000001 110.513 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 140.58 52.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.107 -0.497 . . . . 41.060000000000002 110.449 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -57.09 125.01 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.018 -0.537 . . . . 42.619999999999997 111.565 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.0 -163.06 0.89 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.327 -0.397 . . . . 28.050000000000001 110.937 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.34 141.22 46.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 46.350000000000001 110.149 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.59 -27.55 69.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 23.789999999999999 111.531 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.2 mtp-105 -58.13 -29.0 65.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.693 0.282 . . . . 74.930000000000007 111.314 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -61.23 -26.69 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 64.420000000000002 111.504 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.77 -29.23 59.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.719 0.295 . . . . 32.640000000000001 111.679 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -30.69 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 41.859999999999999 111.029 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -61.9 -49.47 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 38.659999999999997 111.186 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . 0.432 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 98.7 m-85 -58.44 -28.77 65.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.043 -0.526 . . . . 25.27 111.527 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 54.1 m -59.42 138.76 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.908 0.385 . . . . 25.039999999999999 111.241 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.44 166.14 47.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.016 -0.538 . . . . 36.049999999999997 111.165 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.63 -25.13 3.84 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.145 1.897 . . . . 54.359999999999999 112.869 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 71.540000000000006 111.368 -179.672 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.67 0.271 . . . . 20.0 111.215 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -92.62 47.9 1.33 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.154 0.502 . . . . 20.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -93.17 -34.18 13.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 20.0 110.527 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.2 t -160.12 174.67 13.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 20.0 110.599 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 33.1 t -67.14 -34.95 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 20.0 110.797 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.76 65.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 20.0 111.079 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.11 86.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 20.0 111.515 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.422 -0.354 . . . . 20.0 110.958 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 CA-C-O 119.739 -0.479 . . . . 20.0 112.457 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.22 161.5 44.34 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.97 1.78 . . . . 20.0 112.356 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -105.32 106.96 17.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 75.5 110.941 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 14.2 p -128.99 170.81 13.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 31.379999999999999 110.769 179.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.5 tp -130.87 110.08 11.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 28.27 111.164 -179.779 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.5 m -140.19 161.19 38.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 32.909999999999997 110.766 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -143.04 37.32 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.792 -0.718 . . . . 20.0 112.669 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.31 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.723 0.297 . . . . 21.73 111.201 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.14 -40.4 89.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 63.420000000000002 110.996 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 -46.64 62.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 20.390000000000001 110.828 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.25 -33.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 20.0 111.165 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.3 -42.34 96.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 31.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.17 -49.21 72.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 20.0 111.072 -179.941 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.26 -39.82 88.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 22.050000000000001 110.905 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -74.69 -31.75 61.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 32.759999999999998 110.701 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -77.9 -32.01 51.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 27.25 110.837 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 37.4 t -87.64 -67.68 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 25.510000000000002 110.831 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.4 m -70.41 -51.49 29.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 29.489999999999998 110.922 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.5 -113.31 5.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.772 . . . . 40.609999999999999 112.918 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.09 7.48 13.3 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.892 0.701 . . . . 79.049999999999997 112.892 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -76.11 -30.99 58.46 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.969 -0.457 . . . . 50.600000000000001 110.886 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.19 75.98 1.31 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.648 -0.787 . . . . 35.479999999999997 112.197 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CD1' HD12 ' A' ' 14' ' ' LEU . 31.0 p90 -69.86 150.35 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 25.52 111.333 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 3.0 p90 -124.78 138.91 54.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 56.07 110.462 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD2' ' CG2' ' A' ' 43' ' ' ILE . 14.7 m-85 -77.94 -42.85 31.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 29.300000000000001 111.278 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -99.48 120.64 39.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 38.350000000000001 111.259 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -150.61 150.04 27.5 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.996 -0.547 . . . . 42.350000000000001 110.822 179.574 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.42 160.91 33.3 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.957 1.771 . . . . 40.799999999999997 112.38 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.5 p -151.29 -47.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.956 -0.566 . . . . 55.75 110.759 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.41 -81.86 1.32 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.855 -0.688 . . . . 34.939999999999998 112.536 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -159.96 125.67 4.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.34 . . . . 34.259999999999998 110.865 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -119.27 50.9 0.79 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.876 -0.678 . . . . 36.130000000000003 112.473 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.7 t -150.06 -48.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 57.93 110.859 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.1 t -78.65 -38.83 38.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.849999999999994 110.876 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 m -87.7 124.18 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 20.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.3 ttp-105 -87.7 -58.58 2.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 20.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.04 111.84 7.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 20.0 110.906 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.73 133.89 6.64 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 20.0 111.019 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.66 171.46 12.04 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.005 1.803 . . . . 20.0 112.44 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -95.46 119.56 34.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 20.0 110.686 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -162.3 142.51 9.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 64.040000000000006 110.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.2 -90.86 0.12 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.773 -0.727 . . . . 35.079999999999998 112.37 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.424 ' CG2' ' CD2' ' A' ' 25' ' ' PHE . 4.5 tp -103.0 -30.95 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 25.609999999999999 110.823 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.24 -68.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.27 -0.423 . . . . 29.899999999999999 111.058 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.8 -17.6 37.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.101 0.408 . . . . 39.039999999999999 112.101 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.45 -38.48 13.24 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.936 0.717 . . . . 45.600000000000001 112.936 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.12 -27.69 7.93 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.993 0.738 . . . . 28.23 112.993 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.64 -45.2 22.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 25.890000000000001 110.633 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -79.86 -35.92 37.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 32.640000000000001 110.395 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mtp85 -123.92 156.32 36.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 41.060000000000002 110.071 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -82.41 111.58 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.795 0.331 . . . . 42.619999999999997 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.1 p -105.49 -163.05 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.849 0.357 . . . . 28.050000000000001 110.974 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -113.75 147.47 38.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 46.350000000000001 110.287 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 8.5 mp -63.49 -27.29 69.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 23.789999999999999 111.705 -179.388 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -58.32 -26.9 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.606 0.241 . . . . 74.930000000000007 111.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -60.76 -29.81 69.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.604 0.24 . . . . 64.420000000000002 111.07 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 mt -56.86 -30.96 64.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 32.640000000000001 111.619 -179.613 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -69.34 -34.11 74.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.449 -0.341 . . . . 41.859999999999999 111.413 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.2 mtm -58.66 -45.01 90.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.924 0.392 . . . . 38.659999999999997 111.305 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.419 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 79.5 m-85 -67.49 -27.74 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 25.27 111.586 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.6 m -60.53 130.76 48.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 25.039999999999999 110.775 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.02 162.24 55.64 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.212 -0.449 . . . . 36.049999999999997 111.184 -179.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 75.8 Cg_endo -76.18 -25.53 9.99 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.008 1.806 . . . . 54.359999999999999 112.713 -179.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 pp -58.34 170.95 0.64 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.825 0.345 . . . . 71.540000000000006 111.273 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -148.37 140.04 14.16 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.131 -0.486 . . . . 20.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.85 -169.18 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.895 1.73 . . . . 20.0 112.322 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.28 148.49 23.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 20.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -164.99 153.12 11.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 20.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 t -86.15 131.0 34.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 20.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.162 -0.923 . . . . 20.0 111.138 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.924 0.392 . . . . 20.0 111.147 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -65.13 133.97 52.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 20.0 111.003 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 4.7 m -82.98 -41.46 18.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 20.0 110.937 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 19.7 m-85 -82.01 72.24 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.08 0.467 . . . . 20.0 110.857 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -125.62 -45.38 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 20.0 110.625 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -144.82 174.62 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 20.0 110.797 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 33.0 t -68.64 -30.75 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 20.0 111.094 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.16 -39.56 65.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 20.0 111.267 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.93 -40.17 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 20.0 111.832 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -59.76 -43.74 94.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 20.0 110.992 -179.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -64.96 -51.24 62.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 20.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -59.66 -40.48 87.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 20.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 55.9 m -62.89 -47.28 84.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 20.0 110.981 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 29.9 ttp -72.86 -52.17 15.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 20.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -73.3 71.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 20.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.339 -1.256 . . . . 20.0 112.551 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 CA-C-O 119.682 -0.51 . . . . 20.0 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.9 -168.8 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.968 1.779 . . . . 20.0 112.454 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.91 108.17 18.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 75.5 110.974 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 27.0 p -129.96 176.29 8.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 31.379999999999999 110.823 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.2 tp -136.27 115.52 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 28.27 111.164 -179.692 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 m -140.23 159.79 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 32.909999999999997 111.013 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.32 -146.6 44.43 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.792 -0.718 . . . . 20.0 112.811 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.26 66.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.732 0.301 . . . . 21.73 111.32 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 63.420000000000002 110.748 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 tp -71.69 -49.69 37.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 20.390000000000001 110.516 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.08 -32.01 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 20.0 111.002 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.47 -44.36 87.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 31.0 110.846 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.79 -48.02 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 20.0 111.071 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 23' ' ' PHE . 14.2 mt -60.38 -41.74 94.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 22.050000000000001 110.764 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.99 -31.98 64.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 32.759999999999998 110.736 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -76.84 -30.9 56.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.506 . . . . 27.25 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.1 t -90.1 -56.78 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 25.510000000000002 110.939 -179.977 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.14 -51.34 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 29.489999999999998 111.178 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.49 -112.51 5.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 40.609999999999999 112.593 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.85 7.75 22.79 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.777 0.658 . . . . 79.049999999999997 112.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -81.76 -33.39 30.97 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 122.106 -0.371 . . . . 50.600000000000001 111.152 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.52 115.13 1.97 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.655 -0.783 . . . . 35.479999999999997 112.141 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.417 ' CD1' HD12 ' A' ' 14' ' ' LEU . 20.6 p90 -106.13 156.29 18.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 25.52 111.456 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.418 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 2.5 p90 -124.6 127.7 47.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 56.07 110.322 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -66.28 -27.37 67.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.372 -0.376 . . . . 29.300000000000001 111.665 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -88.87 138.86 31.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.399 . . . . 38.350000000000001 111.318 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 15.2 tptp -135.08 133.21 20.66 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.958 -0.564 . . . . 42.350000000000001 110.821 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -76.74 160.83 34.18 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.857 1.705 . . . . 40.799999999999997 112.318 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.2 t -172.58 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 55.75 110.924 179.98 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -99.36 -100.42 2.26 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 34.939999999999998 112.543 179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -85.23 -34.95 21.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 34.259999999999998 110.867 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.04 113.41 3.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.784 -0.722 . . . . 36.130000000000003 112.5 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -89.94 107.07 18.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.339 . . . . 57.93 111.011 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.5 p -157.8 -56.39 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 72.849999999999994 110.922 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 p -90.59 -52.22 5.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 20.0 110.828 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -87.39 159.93 18.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 20.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.7 139.34 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 20.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.25 165.26 18.99 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.179 -0.464 . . . . 20.0 111.115 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 44.3 Cg_endo -67.72 167.03 22.23 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.86 1.707 . . . . 20.0 112.227 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -101.12 128.54 47.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 20.0 110.931 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -177.56 127.77 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.056 -0.52 . . . . 64.040000000000006 110.719 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.95 -107.12 0.23 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 35.079999999999998 112.727 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 1.9 tp -72.05 -38.93 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 25.609999999999999 111.099 -179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.08 -59.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 29.899999999999999 111.49 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.43 -22.58 64.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.293 -0.412 . . . . 39.039999999999999 112.088 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.21 -23.71 21.19 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.437 0.532 . . . . 45.600000000000001 112.437 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.0 m -114.2 -43.63 3.2 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.067 0.395 . . . . 28.23 112.067 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -74.5 -54.04 8.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.74 0.305 . . . . 25.890000000000001 110.95 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.97 -32.61 67.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 32.640000000000001 110.652 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -133.0 150.86 52.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.515 . . . . 41.060000000000002 110.499 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.8 p -73.09 127.56 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 42.619999999999997 110.995 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.62 -173.25 2.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 28.050000000000001 111.132 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.88 54.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 46.350000000000001 109.824 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -51.02 -24.92 4.15 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 23.789999999999999 112.419 -179.03 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -63.35 -30.51 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 74.930000000000007 111.113 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.51 -30.04 62.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.327 -0.397 . . . . 64.420000000000002 111.703 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mt -56.39 -34.8 67.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 32.640000000000001 111.953 -179.519 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.28 -24.38 63.03 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.9 0.333 . . . . 41.859999999999999 111.9 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -68.13 -34.22 75.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 38.659999999999997 110.942 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.418 ' HA ' ' CE1' ' A' ' 24' ' ' TYR . 44.0 m-85 -78.75 -28.72 44.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 25.27 111.434 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.4 m -60.43 126.43 27.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 25.039999999999999 110.808 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.04 153.77 32.87 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.27 -0.423 . . . . 36.049999999999997 111.371 -179.845 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 -24.55 13.0 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.971 1.78 . . . . 54.359999999999999 112.728 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.16 -179.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.898 0.38 . . . . 71.540000000000006 111.366 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -145.89 161.97 37.78 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.053 -0.521 . . . . 20.0 110.725 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.42 113.13 2.34 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.882 1.721 . . . . 20.0 112.349 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.45 -68.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 20.0 111.09 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -160.61 145.69 14.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 20.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.1 p -83.19 151.66 25.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 20.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 20.0 111.061 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.848 0.356 . . . . 20.0 111.172 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -113.3 139.23 49.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 20.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.02 -30.61 27.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 20.0 111.101 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -97.92 36.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 20.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.35 -42.09 9.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 20.0 111.0 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 70.2 m -144.74 175.9 9.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 20.0 111.026 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 27.6 t -72.13 -30.11 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 20.0 111.138 -179.914 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.08 -39.96 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.375 -0.375 . . . . 20.0 111.041 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.78 84.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 20.0 111.298 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -63.12 -42.85 99.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.468 . . . . 20.0 111.419 -179.59 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.72 -53.8 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 20.0 111.585 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -56.83 -34.36 67.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.44 -0.345 . . . . 20.0 111.739 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 63.7 m -58.24 -44.99 88.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.598 -0.274 . . . . 20.0 111.649 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 4.5 ttp -76.54 -52.75 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.386 0.514 . . . . 20.0 112.386 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -74.91 -49.78 19.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.742 0.306 . . . . 20.0 111.746 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 118.453 -1.193 . . . . 20.0 112.519 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 CA-C-O 119.787 -0.452 . . . . 20.0 112.486 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.09 129.26 13.0 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.028 1.819 . . . . 20.0 112.431 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -146.24 110.77 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 75.5 110.964 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 p -134.22 161.84 33.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 31.379999999999999 110.456 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tp -119.98 115.62 24.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 28.27 111.165 -179.436 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.25 164.22 30.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 32.909999999999997 110.991 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.8 -143.6 46.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.84 -0.695 . . . . 20.0 112.848 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.8 68.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 21.73 111.283 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -60.82 -39.94 90.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 63.420000000000002 110.742 179.828 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.6 tp -67.76 -46.69 71.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 20.390000000000001 110.542 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.84 -31.86 49.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 20.0 110.878 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.97 -36.48 84.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 31.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -71.94 -46.47 57.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 20.0 111.025 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.41 HD12 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.31 -43.03 96.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 22.050000000000001 110.795 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -68.9 -31.76 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 32.759999999999998 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.17 -31.71 49.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 27.25 110.837 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 34.0 t -88.9 -67.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 25.510000000000002 110.881 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.25 -51.25 25.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 29.489999999999998 110.984 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.57 -115.12 6.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.668 -0.777 . . . . 40.609999999999999 112.731 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.81 7.37 15.33 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.729 0.64 . . . . 79.049999999999997 112.729 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -70.29 -35.92 74.03 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 118.097 0.408 . . . . 50.600000000000001 110.886 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.37 62.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 35.479999999999997 112.255 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.41 ' CD1' HD12 ' A' ' 14' ' ' LEU . 27.5 p90 -59.2 159.45 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 25.52 111.271 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.05 123.9 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 56.07 110.637 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -59.23 -75.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 29.300000000000001 111.074 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.39 126.45 27.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 38.350000000000001 110.941 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -102.63 91.67 2.92 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.148 -0.478 . . . . 42.350000000000001 110.753 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.13 -175.6 2.03 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.051 1.834 . . . . 40.799999999999997 112.45 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.1 p -133.61 95.69 3.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.474 . . . . 55.75 110.899 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.08 -89.66 1.13 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.72 -0.752 . . . . 34.939999999999998 112.525 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -97.5 -43.65 7.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 34.259999999999998 110.901 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.98 123.79 4.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.687 -0.768 . . . . 36.130000000000003 112.527 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.6 p -96.59 163.76 12.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 57.93 110.893 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.1 m -94.41 -65.24 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 72.849999999999994 110.91 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 p -158.9 103.17 1.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 20.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.32 -68.92 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 20.0 110.748 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -162.92 34.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 20.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.04 145.34 50.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.202 -0.454 . . . . 20.0 111.111 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.33 -168.64 0.45 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.94 1.76 . . . . 20.0 112.355 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -89.81 128.04 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 20.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.8 p -145.03 145.15 31.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 64.040000000000006 110.941 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.83 -120.23 0.86 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.752 -0.737 . . . . 35.079999999999998 112.534 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.403 HD12 ' CE2' ' A' ' 60' ' ' TYR . 3.3 tp -77.17 -39.88 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.796 0.331 . . . . 25.609999999999999 110.997 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.61 -54.13 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 29.899999999999999 111.466 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.407 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.1 m-20 -70.89 -23.3 62.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 39.039999999999999 111.954 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -90.06 -23.89 21.32 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.221 0.452 . . . . 45.600000000000001 112.221 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -115.66 -45.7 2.88 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.098 0.407 . . . . 28.23 112.098 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.0 t -73.1 -51.37 18.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.676 0.274 . . . . 25.890000000000001 111.117 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 26.5 m-85 -70.4 -32.47 70.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.895 0.378 . . . . 32.640000000000001 110.809 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -137.92 147.28 44.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 41.060000000000002 110.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -65.16 134.07 52.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 42.619999999999997 110.983 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -126.34 -172.51 2.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 28.050000000000001 111.066 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -116.68 142.98 46.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 46.350000000000001 110.088 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.405 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 2.1 mp -55.55 -27.57 49.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 23.789999999999999 111.937 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -60.59 -26.46 66.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.549 -0.296 . . . . 74.930000000000007 111.578 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.4 -30.55 70.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.806 0.336 . . . . 64.420000000000002 111.159 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.4 mt -57.1 -28.7 62.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 32.640000000000001 111.676 -179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -32.31 71.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 41.859999999999999 111.139 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.54 -43.81 96.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.394 -0.366 . . . . 38.659999999999997 111.094 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.403 ' CE2' HD12 ' A' ' 43' ' ' ILE . 96.3 m-85 -69.24 -27.61 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 25.27 111.546 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.5 m -59.58 132.23 53.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 25.039999999999999 110.954 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.83 162.81 26.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.151 -0.477 . . . . 36.049999999999997 111.244 -179.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.9 Cg_endo -79.1 -32.11 1.96 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.056 1.837 . . . . 54.359999999999999 112.581 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.88 157.33 12.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 71.540000000000006 111.077 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 158.0 44.32 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.116 -0.493 . . . . 20.0 110.886 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.64 -35.3 4.75 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.914 1.743 . . . . 20.0 112.349 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -135.19 121.67 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 20.0 111.149 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -112.06 155.81 23.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 20.0 110.973 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.4 p -89.6 -42.49 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 20.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.29 -0.862 . . . . 20.0 111.133 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.815 0.341 . . . . 20.0 111.257 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -116.39 124.95 51.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 20.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.9 t -82.93 -34.05 26.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 20.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.405 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 1.0 OUTLIER -94.63 46.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.468 0.651 . . . . 20.0 110.665 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -109.66 -30.8 7.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 20.0 110.966 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 66.0 m -156.37 -179.02 7.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 20.0 111.156 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 51.4 t -80.66 -28.75 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 20.0 111.121 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.63 -39.49 73.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.353 . . . . 20.0 111.478 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -36.91 66.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 20.0 111.997 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 4.6 mt -58.11 -44.73 87.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 20.0 111.256 -179.545 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -59.08 -45.46 90.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.458 -0.337 . . . . 20.0 111.189 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -34.77 76.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.44 . . . . 20.0 111.103 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 96.5 m -61.32 -49.07 78.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.308 -0.406 . . . . 20.0 111.699 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 4.0 mmt -76.31 -52.64 9.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.158 0.429 . . . . 20.0 112.158 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -77.54 -49.44 14.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 20.0 111.428 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.368 -1.24 . . . . 20.0 112.504 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 119.724 -0.486 . . . . 20.0 112.526 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.23 -179.66 3.29 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.932 1.755 . . . . 20.0 112.291 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -99.96 100.01 10.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 75.5 110.925 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.3 p -127.93 178.1 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 31.379999999999999 110.585 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.1 tp -135.48 108.99 7.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 28.27 111.099 -179.547 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.5 m -140.16 167.88 21.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.196 -0.456 . . . . 32.909999999999997 110.992 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.62 -137.19 50.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.879 -0.677 . . . . 20.0 112.778 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.91 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.638 0.256 . . . . 21.73 111.343 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.84 -42.53 97.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.385 -0.37 . . . . 63.420000000000002 110.989 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 47.7 tp -68.72 -42.68 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 20.390000000000001 110.936 179.952 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.67 -34.58 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 20.0 110.928 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.23 -35.04 79.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 31.0 110.967 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -72.99 -49.38 29.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 20.0 111.363 -179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.419 HD12 ' CD1' ' A' ' 23' ' ' PHE . 11.8 mt -57.9 -30.41 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 22.050000000000001 111.171 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -80.78 -31.48 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 32.759999999999998 110.609 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.402 ' CE2' ' HB3' ' B' ' 113' ' ' CYS . 34.7 t80 -76.6 -33.88 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 27.25 110.81 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.3 t -89.48 -40.36 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 25.510000000000002 111.406 -179.627 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 m -100.27 -51.93 3.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 29.489999999999998 111.315 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.18 -110.38 3.17 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.655 -0.783 . . . . 40.609999999999999 112.723 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.19 7.62 37.14 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.846 0.684 . . . . 79.049999999999997 112.846 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -66.67 -38.45 86.84 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.029 -0.419 . . . . 50.600000000000001 110.844 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.88 60.41 0.88 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 35.479999999999997 112.233 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CD1' HD12 ' A' ' 14' ' ' LEU . 27.0 p90 -58.07 140.56 52.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 25.52 111.345 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.414 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 8.0 p90 -123.96 127.69 48.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 56.07 110.501 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -58.03 -67.42 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 29.300000000000001 111.509 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -80.22 104.26 10.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 38.350000000000001 111.329 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -90.71 -47.26 0.37 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.238 -0.437 . . . . 42.350000000000001 111.451 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . 0.404 ' CD ' ' N ' ' A' ' 27' ' ' LYS . 62.6 Cg_endo -87.43 -170.05 0.55 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.245 1.963 . . . . 40.799999999999997 112.658 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.0 p -164.42 32.22 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.948 -0.569 . . . . 55.75 110.676 179.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.29 -145.39 0.13 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.878 -0.677 . . . . 34.939999999999998 112.677 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -103.32 -175.09 2.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 34.259999999999998 110.988 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.92 -113.42 4.45 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 36.130000000000003 112.483 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.7 p -90.45 -43.69 10.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 57.93 110.917 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -91.86 107.68 19.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 72.849999999999994 110.9 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.6 p -148.8 -65.54 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 20.0 110.94 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.86 161.26 19.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 20.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -91.09 97.93 11.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 20.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -168.94 -64.17 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 20.0 111.089 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_endo -71.07 -171.21 0.56 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.847 1.698 . . . . 20.0 112.334 -179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.81 124.94 22.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 20.0 110.905 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 38.6 p -157.78 150.5 22.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 64.040000000000006 110.859 179.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.26 -101.33 0.22 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.748 -0.739 . . . . 35.079999999999998 112.626 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.414 HD12 ' CE1' ' A' ' 60' ' ' TYR . 2.9 tp -72.51 -35.89 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.724 0.297 . . . . 25.609999999999999 111.05 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.98 -58.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 29.899999999999999 111.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.59 -22.58 63.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 39.039999999999999 112.027 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.17 -19.76 23.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.562 0.578 . . . . 45.600000000000001 112.562 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.8 m -121.81 -41.74 2.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.192 0.441 . . . . 28.23 112.192 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.7 t -73.97 -53.9 9.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 25.890000000000001 110.963 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -65.67 -34.05 77.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 32.640000000000001 110.617 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -139.01 148.31 43.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 41.060000000000002 110.717 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 p -65.73 131.88 47.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 42.619999999999997 110.989 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.0 p -122.17 -171.92 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 28.050000000000001 110.883 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -111.53 132.78 54.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 46.350000000000001 110.131 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.422 ' HB2' ' CG ' ' B' ' 104' ' ' PHE . 0.3 OUTLIER -53.43 -24.28 12.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.332 0.493 . . . . 23.789999999999999 112.332 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.65 -26.96 67.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.477 0.177 . . . . 74.930000000000007 111.477 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 20.9 mmm180 -68.58 -28.83 67.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.649 0.261 . . . . 64.420000000000002 111.271 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.8 mt -56.08 -28.84 59.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.447 -0.342 . . . . 32.640000000000001 111.788 -179.552 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -68.66 -32.22 71.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 41.859999999999999 111.193 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.3 mtm -62.64 -49.77 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 38.659999999999997 111.148 -179.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.419 ' CE2' ' HD2' ' A' ' 27' ' ' LYS . 84.6 m-85 -56.83 -28.56 61.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 25.27 111.675 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -59.23 141.73 53.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 25.039999999999999 111.197 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -78.43 176.59 3.49 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.235 -0.438 . . . . 36.049999999999997 110.985 179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 93.5 Cg_endo -83.21 -34.81 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.018 1.812 . . . . 54.359999999999999 112.701 -179.692 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.49 148.38 33.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 71.540000000000006 111.058 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.19 159.94 31.94 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.126 -0.488 . . . . 20.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.22 -179.04 4.87 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.957 1.772 . . . . 20.0 112.374 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.08 170.76 7.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 20.0 111.153 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.81 -48.83 4.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 20.0 110.975 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -67.72 158.95 31.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 20.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.183 -0.913 . . . . 20.0 111.077 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.821 0.344 . . . . 20.0 111.178 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.7 137.91 38.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 20.0 110.826 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.85 -26.23 40.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 20.0 111.421 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.422 ' CG ' ' HB2' ' A' ' 54' ' ' LEU . 2.8 m-30 -96.52 32.84 1.93 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.718 0.295 . . . . 20.0 111.353 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -88.51 -33.49 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.892 0.377 . . . . 20.0 110.447 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 50.8 p -155.86 174.82 14.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 20.0 110.407 179.801 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -74.08 -30.87 28.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.41 -0.359 . . . . 20.0 111.131 -179.905 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.19 96.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 20.0 111.09 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.83 83.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 20.0 111.078 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 26.6 tp -58.68 -43.21 89.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 20.0 111.157 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -64.84 -43.02 94.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 20.0 110.968 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -60.8 -37.27 81.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.312 -0.404 . . . . 20.0 111.027 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . 0.402 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 3.7 m -59.36 -46.93 87.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 20.0 111.056 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 8.9 tpt -67.56 -51.7 47.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 20.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -80.25 71.24 7.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 20.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.418 -1.212 . . . . 20.0 112.454 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 CA-C-O 119.789 -0.45 . . . . 20.0 112.562 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.84 -168.71 0.38 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.926 1.751 . . . . 20.0 112.342 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.06 101.61 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 75.5 110.896 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 13.0 p -129.33 -171.39 2.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 31.379999999999999 110.607 179.834 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 tp -140.28 111.84 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.494 -0.321 . . . . 28.27 111.195 -179.513 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.4 m -140.15 162.95 34.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 32.909999999999997 111.148 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.91 -139.53 48.37 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.815 -0.707 . . . . 20.0 113.052 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.34 64.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.625 0.25 . . . . 21.73 111.485 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.0 -39.79 91.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.439 -0.346 . . . . 63.420000000000002 110.855 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 32.6 tp -71.81 -45.38 61.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 20.390000000000001 110.737 179.894 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.12 -31.41 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 20.0 111.019 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.62 -45.01 84.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 31.0 111.008 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -64.19 -47.33 80.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 20.0 111.155 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.417 HD12 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -60.74 -36.25 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 22.050000000000001 110.798 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -79.1 -31.58 44.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 32.759999999999998 110.794 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -79.0 -31.7 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 27.25 110.869 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -88.14 -68.1 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 25.510000000000002 110.945 -179.819 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.8 m -67.99 -51.32 48.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 29.489999999999998 111.053 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.35 -114.3 5.37 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.767 . . . . 40.609999999999999 112.835 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -84.41 7.55 19.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.805 0.668 . . . . 79.049999999999997 112.805 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -71.95 -30.74 65.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.036 0.38 . . . . 50.600000000000001 110.936 179.942 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.34 67.72 1.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 35.479999999999997 112.082 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.417 ' CD1' HD12 ' A' ' 14' ' ' LEU . 30.6 p90 -60.46 164.85 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 25.52 111.501 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.42 ' CD1' ' HB3' ' A' ' 27' ' ' LYS . 3.5 p90 -144.32 125.25 14.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.72 -0.673 . . . . 56.07 110.465 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -58.23 -69.88 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 29.300000000000001 111.428 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -83.34 127.43 33.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.427 -0.351 . . . . 38.350000000000001 111.189 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB3' ' CD1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -139.7 148.8 57.17 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.143 -0.48 . . . . 42.350000000000001 110.776 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.95 142.5 31.51 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.88 1.72 . . . . 40.799999999999997 112.351 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.7 p -117.6 135.7 53.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 55.75 110.866 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.41 87.3 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.748 . . . . 34.939999999999998 112.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -89.79 148.85 22.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 34.259999999999998 110.927 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.36 66.52 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 36.130000000000003 112.586 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.2 m -93.91 -58.56 2.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 57.93 110.855 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.2 p -147.55 -63.37 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 72.849999999999994 110.928 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.8 m -159.45 -74.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 20.0 110.836 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -90.11 128.71 36.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 20.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 tpt85 -131.36 157.03 44.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 20.0 110.947 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -66.16 162.15 49.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 20.0 111.135 179.9 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.1 Cg_endo -68.49 140.92 49.17 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.958 1.772 . . . . 20.0 112.367 -179.867 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -107.32 142.53 36.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.035 -0.529 . . . . 20.0 110.81 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.5 p -128.32 -172.94 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 64.040000000000006 111.027 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.25 -130.75 5.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 35.079999999999998 112.663 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -97.67 -32.07 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.786 0.327 . . . . 25.609999999999999 111.009 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.69 -64.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 29.899999999999999 111.682 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.404 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 12.0 m-20 -67.47 -19.73 65.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.276 -0.42 . . . . 39.039999999999999 112.116 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.29 -25.56 20.46 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 111.961 0.356 . . . . 45.600000000000001 111.961 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 96.9 m -117.25 -51.52 2.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.108 0.41 . . . . 28.23 112.108 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 t -63.43 -44.04 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 25.890000000000001 111.153 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.404 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.4 m-85 -74.96 -49.23 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.443 -0.344 . . . . 32.640000000000001 110.604 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.84 150.0 45.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 41.060000000000002 110.364 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 143.39 56.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.899 0.38 . . . . 42.619999999999997 111.02 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 p -138.03 -166.36 1.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.132 -0.485 . . . . 28.050000000000001 110.932 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -113.55 138.79 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 46.350000000000001 109.851 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.405 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 3.3 mm? -61.32 -27.03 68.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.564 -0.289 . . . . 23.789999999999999 111.524 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -55.81 -26.51 46.73 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.736 0.273 . . . . 74.930000000000007 111.736 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -63.1 -28.07 69.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.68 0.276 . . . . 64.420000000000002 111.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . 0.419 HD11 ' CZ ' ' B' ' 104' ' ' PHE . 6.9 mt -56.26 -31.34 63.49 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.792 0.33 . . . . 32.640000000000001 111.426 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -67.02 -33.58 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 41.859999999999999 111.334 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.8 mtm -59.41 -54.07 50.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 38.659999999999997 111.064 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.42 ' CE2' HD12 ' A' ' 43' ' ' ILE . 78.9 m-85 -57.83 -26.96 62.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.974 -0.557 . . . . 25.27 111.614 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.3 m -60.19 130.3 45.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.836 0.35 . . . . 25.039999999999999 110.806 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.0 156.28 80.99 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.286 -0.415 . . . . 36.049999999999997 111.129 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.84 -26.49 9.57 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.033 1.822 . . . . 54.359999999999999 112.527 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.22 176.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 71.540000000000006 111.178 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.54 156.74 52.87 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.03 -0.532 . . . . 20.0 110.717 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.47 83.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.87 1.713 . . . . 20.0 112.194 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -175.58 -176.21 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 20.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -91.54 89.43 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.425 . . . . 20.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 t -102.52 158.07 16.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 20.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 20.0 111.113 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.824 0.345 . . . . 20.0 111.298 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -75.08 118.15 17.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 20.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 7.0 m -83.11 -30.27 28.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 20.0 111.011 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.419 ' CZ ' HD11 ' A' ' 57' ' ' LEU . 2.2 m-30 -87.87 55.77 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.26 0.552 . . . . 20.0 111.079 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.48 -35.62 6.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 20.0 110.165 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.1 m -160.28 174.72 13.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 20.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 23.5 t -72.44 -31.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 20.0 110.818 -179.979 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.95 90.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 20.0 111.062 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.88 78.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 20.0 111.213 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 67.4 tp -58.36 -42.78 87.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 20.0 111.151 179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -65.1 -49.31 70.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 20.0 111.068 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -59.32 -41.29 88.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 20.0 111.116 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 93.9 m -59.53 -45.31 92.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 20.0 111.059 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -51.08 19.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.343 -0.39 . . . . 20.0 110.947 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -86.3 71.23 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.152 0.501 . . . . 20.0 110.833 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 118.324 -1.264 . . . . 20.0 112.426 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 CA-C-O 119.829 -0.429 . . . . 20.0 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -90.52 21.94 0.8 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.406 2.071 . . . . 20.0 113.201 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -83.08 97.87 9.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.309 . . . . 75.5 110.854 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 17.0 p -124.9 175.96 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 31.379999999999999 110.73 179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.6 tp -129.52 110.25 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 28.27 111.213 -179.602 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.9 m -140.22 161.7 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 32.909999999999997 110.933 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.36 -139.3 45.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.802 -0.713 . . . . 20.0 112.843 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.09 66.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.343 . . . . 21.73 111.454 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.39 -41.29 93.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 63.420000000000002 110.942 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.18 -43.87 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 20.390000000000001 110.73 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.42 -31.78 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 20.0 110.968 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.42 -42.12 92.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 31.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -66.01 -48.51 70.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 20.0 111.168 179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.436 ' CD1' ' CD2' ' A' ' 23' ' ' PHE . 17.6 mt -60.12 -38.47 83.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 22.050000000000001 110.827 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -73.26 -32.38 64.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 32.759999999999998 110.594 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -79.35 -32.08 43.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.047 -0.524 . . . . 27.25 110.755 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -87.32 -44.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.042 -0.526 . . . . 25.510000000000002 110.905 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -100.43 -51.63 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 29.489999999999998 111.233 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.09 -95.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.967 -0.635 . . . . 40.609999999999999 112.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.58 -28.42 26.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 79.049999999999997 111.459 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 19.8 mtm-85 -57.7 -34.28 69.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.799 0.333 . . . . 50.600000000000001 111.365 -179.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.75 150.93 27.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 35.479999999999997 112.214 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.436 ' CD2' ' CD1' ' A' ' 14' ' ' LEU . 15.5 p90 -141.33 145.02 34.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.965 0.412 . . . . 25.52 111.143 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -109.52 127.67 54.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 56.07 110.771 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -65.77 -31.36 72.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 29.300000000000001 110.827 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -125.21 104.86 8.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 38.350000000000001 110.957 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -67.83 137.37 92.56 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.261 -0.427 . . . . 42.350000000000001 110.742 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -76.56 124.81 7.86 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.945 1.763 . . . . 40.799999999999997 112.366 -179.996 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 33.4 p -158.34 100.32 1.66 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 55.75 110.914 -179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.71 99.73 0.34 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.829 -0.7 . . . . 34.939999999999998 112.535 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -84.43 -67.56 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 34.259999999999998 110.876 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.89 -98.21 0.86 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.672 -0.775 . . . . 36.130000000000003 112.516 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -147.64 -174.89 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 57.93 110.911 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.6 t -69.91 112.49 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 72.849999999999994 110.911 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.6 m -96.24 117.9 31.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 20.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -84.58 -34.13 23.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 20.0 110.923 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -147.56 114.14 6.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.119 -0.491 . . . . 20.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -161.76 160.69 22.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 20.0 111.142 179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.99 107.94 2.34 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.89 1.726 . . . . 20.0 112.295 179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -105.64 132.67 51.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 20.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.0 p -150.01 169.01 22.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 64.040000000000006 110.861 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.67 -100.34 0.15 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 35.079999999999998 112.6 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.421 HD11 ' CE1' ' A' ' 60' ' ' TYR . 3.1 tp -106.78 -35.41 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 25.609999999999999 110.991 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.8 t -58.27 -57.97 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 29.899999999999999 111.446 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.4 m-20 -68.32 -22.22 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 39.039999999999999 111.932 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.31 -23.87 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.276 0.473 . . . . 45.600000000000001 112.276 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.8 m -117.22 -46.68 2.69 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.238 0.459 . . . . 28.23 112.238 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.7 t -71.26 -52.47 18.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.312 . . . . 25.890000000000001 111.072 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 15.1 m-85 -64.44 -37.09 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 32.640000000000001 110.798 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -140.31 149.85 43.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 41.060000000000002 110.913 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -60.06 140.65 56.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 42.619999999999997 111.11 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -133.12 -174.63 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 28.050000000000001 110.817 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.89 127.63 53.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.995 -0.548 . . . . 46.350000000000001 109.929 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -53.81 -26.56 24.61 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.173 -0.467 . . . . 23.789999999999999 111.979 -179.117 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -58.11 -22.71 51.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.606 -0.27 . . . . 74.930000000000007 111.498 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.5 mmt180 -81.21 7.04 12.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.883 0.698 . . . . 64.420000000000002 112.883 -179.856 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.1 mt -90.06 -39.21 13.05 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.032 -0.417 . . . . 32.640000000000001 111.333 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.05 67.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 41.859999999999999 111.52 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.2 ptp -63.84 -31.8 73.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.466 -0.334 . . . . 38.659999999999997 111.466 -179.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.421 ' CE1' HD11 ' A' ' 43' ' ' ILE . 65.6 m-85 -70.52 -29.07 65.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 25.27 111.445 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.7 m -61.18 130.28 45.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 25.039999999999999 111.12 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.44 157.37 13.39 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.095 -0.502 . . . . 36.049999999999997 111.191 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.99 -24.78 38.95 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.888 1.726 . . . . 54.359999999999999 112.785 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.68 171.8 1.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 71.540000000000006 111.044 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -150.88 157.18 35.8 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.071 -0.513 . . . . 20.0 110.784 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.29 148.14 60.98 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.99 1.793 . . . . 20.0 112.243 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.45 -51.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 20.0 111.058 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -139.25 -48.16 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 20.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.2 t -158.72 32.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 20.0 110.781 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.326 -0.845 . . . . 20.0 111.036 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.889 0.375 . . . . 20.0 111.18 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -95.57 109.6 21.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 20.0 111.007 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 90.8 m -82.79 -27.31 31.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.5 . . . . 20.0 111.242 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -96.04 37.89 1.21 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.853 0.359 . . . . 20.0 111.256 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.13 -51.07 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 20.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 54.3 p -142.11 174.96 10.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 20.0 110.801 179.907 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 21.3 t -67.67 -36.49 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 20.0 111.093 179.941 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.8 82.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 20.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.78 92.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 20.0 111.147 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -42.86 87.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 20.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 27.2 ttp85 -60.25 -45.01 94.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 20.0 110.807 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -69.92 -35.83 74.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 20.0 110.802 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 16.6 t -59.19 -38.94 81.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.047 -0.524 . . . . 20.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 12.9 tpt -75.74 -51.72 12.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 20.0 110.939 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -80.12 71.05 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.159 0.504 . . . . 20.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.312 -1.271 . . . . 20.0 112.571 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 CA-C-O 119.71 -0.494 . . . . 20.0 112.551 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.98 144.96 48.88 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.91 1.74 . . . . 20.0 112.235 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.22 93.49 4.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 75.5 111.044 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 p -136.19 147.77 47.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 31.379999999999999 110.451 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tp -109.49 114.31 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 28.27 111.148 -179.379 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.2 m -140.37 162.06 36.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 32.909999999999997 110.999 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.49 -145.86 46.37 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.874 -0.679 . . . . 20.0 113.048 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.57 65.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.794 0.33 . . . . 21.73 111.461 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.15 -43.11 96.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 63.420000000000002 110.898 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.61 -43.7 84.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 20.390000000000001 110.499 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.37 -33.35 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 20.0 111.006 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.0 -48.82 80.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 31.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -60.9 -47.45 86.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 20.0 111.172 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.405 HD12 ' CD1' ' A' ' 23' ' ' PHE . 24.2 mt -60.0 -39.61 86.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 22.050000000000001 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -75.79 -31.38 59.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 32.759999999999998 110.84 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -79.3 -30.75 43.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 27.25 111.085 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.9 t -89.28 -48.22 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 25.510000000000002 111.023 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 m -86.9 -51.27 6.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.392 -0.367 . . . . 29.489999999999998 111.191 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.86 -109.41 2.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.671 -0.776 . . . . 40.609999999999999 112.492 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.85 7.77 35.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.611 0.597 . . . . 79.049999999999997 112.611 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.8 mmm180 -72.52 -30.12 64.19 Favored 'General case' 0 C--O 1.231 0.092 0 O-C-N 122.041 -0.412 . . . . 50.600000000000001 111.044 -179.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.15 84.39 0.8 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 35.479999999999997 112.136 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.405 ' CD1' HD12 ' A' ' 14' ' ' LEU . 38.3 p90 -84.47 171.56 12.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.127 0.489 . . . . 25.52 111.389 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 12.7 p90 -145.27 124.3 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.63 . . . . 56.07 110.47 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -57.27 -63.54 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 29.300000000000001 111.491 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -59.12 125.54 24.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 38.350000000000001 111.206 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.416 ' HG3' ' CE1' ' A' ' 60' ' ' TYR . 10.2 mmtt -129.02 117.57 19.22 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.089 -0.505 . . . . 42.350000000000001 110.424 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.63 139.1 33.41 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.838 1.692 . . . . 40.799999999999997 112.295 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.6 p -112.98 -48.97 2.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.192 -0.458 . . . . 55.75 110.817 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.24 79.58 1.08 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.778 -0.725 . . . . 34.939999999999998 112.508 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -158.63 124.28 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 34.259999999999998 110.954 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.33 71.19 1.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 36.130000000000003 112.47 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.3 t -102.55 100.64 10.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 57.93 110.936 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -163.48 -65.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 72.849999999999994 110.927 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.4 m -87.8 -169.96 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 20.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.2 mtm-85 -60.29 142.96 53.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 20.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -77.35 165.9 23.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 20.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -90.19 166.47 19.96 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.165 -0.471 . . . . 20.0 111.053 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 38.0 Cg_endo -65.74 -168.17 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.938 1.759 . . . . 20.0 112.243 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -70.59 123.73 22.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 20.0 111.018 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.9 p -152.47 119.97 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 64.040000000000006 110.871 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.87 -94.64 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 35.079999999999998 112.529 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.439 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 2.3 tp -81.53 -36.96 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.87 0.367 . . . . 25.609999999999999 111.076 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.1 -59.53 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 29.899999999999999 111.537 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.414 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.43 -21.56 63.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.06 0.393 . . . . 39.039999999999999 112.06 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.14 -24.11 21.16 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 112.258 0.466 . . . . 45.600000000000001 112.258 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 75.9 m -116.49 -45.57 2.81 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.13 0.419 . . . . 28.23 112.13 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.2 t -71.88 -53.03 14.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 25.890000000000001 110.995 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.414 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 22.5 m-85 -67.45 -37.16 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 32.640000000000001 110.57 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -134.01 145.86 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 41.060000000000002 110.347 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 p -66.87 124.24 22.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.287 -0.415 . . . . 42.619999999999997 111.038 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -111.99 -174.92 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 28.050000000000001 111.278 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.88 138.64 45.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 46.350000000000001 109.951 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.402 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 3.2 mp -53.55 -31.45 46.49 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.134 0.42 . . . . 23.789999999999999 112.134 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -57.66 -28.45 63.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 74.930000000000007 111.424 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.2 mmm-85 -68.87 -22.5 64.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.515 -0.311 . . . . 64.420000000000002 111.609 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.54 -40.53 87.53 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.871 0.367 . . . . 32.640000000000001 110.592 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -62.5 -32.95 73.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 41.859999999999999 109.887 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.69 -31.37 57.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.711 -0.677 . . . . 38.659999999999997 111.335 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.439 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 96.3 m-85 -85.37 -29.15 24.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 25.27 111.569 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 65.4 m -58.34 130.39 46.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 25.039999999999999 111.258 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -62.36 163.42 14.55 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.538 . . . . 36.049999999999997 111.313 -179.953 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.8 Cg_endo -80.64 -24.89 4.8 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.101 1.867 . . . . 54.359999999999999 112.872 -179.821 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.75 163.86 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.36 . . . . 71.540000000000006 111.151 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.91 167.23 13.81 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.043 -0.526 . . . . 20.0 110.612 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.35 152.15 79.48 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.876 1.717 . . . . 20.0 112.271 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.86 -70.99 0.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.221 -0.445 . . . . 20.0 111.159 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -134.67 35.29 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 20.0 110.869 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.9 t -144.23 106.55 4.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 20.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.225 -0.893 . . . . 20.0 111.081 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.838 0.352 . . . . 20.0 111.21 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -93.98 124.59 38.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 20.0 110.859 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.5 m -82.9 -41.7 18.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 20.0 110.911 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.402 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 1.7 m-85 -83.34 66.28 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 20.0 110.947 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -124.33 -45.07 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 20.0 110.611 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 17.0 p -147.0 174.94 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 20.0 110.58 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.92 -31.02 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 20.0 111.004 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.46 70.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 20.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.55 68.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 20.0 111.79 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -56.46 -48.04 77.91 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.291 -0.413 . . . . 20.0 111.372 -179.786 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -65.06 -45.65 84.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 20.0 111.16 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -59.38 -36.69 76.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 20.0 111.175 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 88.3 m -63.88 -59.12 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 20.0 111.104 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 11.3 tpt -63.87 -51.92 62.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 20.0 111.039 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -82.59 71.19 9.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.094 0.473 . . . . 20.0 110.779 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.409 -1.217 . . . . 20.0 112.493 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 119.67 -0.517 . . . . 20.0 112.545 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.95 144.95 49.05 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.984 1.789 . . . . 20.0 112.242 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -112.27 106.39 14.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 75.5 110.967 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 54.2 p -137.64 176.5 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 31.379999999999999 110.596 179.679 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.9 tp -135.93 110.08 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 28.27 111.251 -179.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -140.22 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 32.909999999999997 110.963 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.04 -144.79 40.26 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.854 -0.688 . . . . 20.0 112.915 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.75 64.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.785 0.326 . . . . 21.73 111.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.67 -46.52 90.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 63.420000000000002 110.805 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.7 tp -64.37 -44.94 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.052 -0.522 . . . . 20.390000000000001 110.766 179.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.77 -33.96 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 20.0 111.139 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.69 -31.02 71.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 31.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.66 -47.49 31.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 20.0 110.966 179.749 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.419 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 14.8 mt -61.73 -47.09 86.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.209 -0.451 . . . . 22.050000000000001 110.871 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -32.29 73.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 32.759999999999998 110.665 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.68 -34.38 58.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 27.25 110.971 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.6 t -86.71 -61.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 25.510000000000002 110.96 -179.833 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.1 m -76.78 -51.58 11.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 29.489999999999998 111.139 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.22 -122.46 29.13 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.895 -0.669 . . . . 40.609999999999999 113.059 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -58.71 -25.71 63.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.855 0.317 . . . . 79.049999999999997 111.855 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 -56.02 -30.03 61.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.75 0.31 . . . . 50.600000000000001 111.751 -179.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.01 104.99 0.4 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.686 -0.769 . . . . 35.479999999999997 111.955 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.419 ' CD2' ' HB3' ' A' ' 14' ' ' LEU . 41.4 p90 -93.21 153.37 18.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 25.52 111.554 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.6 139.74 46.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.783 -0.644 . . . . 56.07 110.469 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.38 -30.5 25.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.37 -0.377 . . . . 29.300000000000001 110.862 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -120.9 92.05 3.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.394 -0.366 . . . . 38.350000000000001 111.038 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -59.99 139.38 90.76 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.245 -0.434 . . . . 42.350000000000001 110.775 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.26 135.56 31.98 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.915 1.743 . . . . 40.799999999999997 112.257 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -169.94 124.09 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 55.75 110.922 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.16 -75.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 34.939999999999998 112.458 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -74.55 138.44 43.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.739 0.304 . . . . 34.259999999999998 111.026 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.23 139.79 3.16 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.739 -0.743 . . . . 36.130000000000003 112.55 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.3 m -94.36 -51.72 4.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 57.93 110.86 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -73.49 167.14 21.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 72.849999999999994 110.894 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 m -153.5 33.4 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 20.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -79.83 -31.77 40.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 20.0 110.961 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 -176.3 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 20.0 110.814 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.71 156.97 15.77 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.325 -0.398 . . . . 20.0 111.411 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.01 -168.83 0.55 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.978 1.785 . . . . 20.0 112.555 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -86.59 90.8 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 20.0 110.382 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -151.66 146.11 25.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.266 -0.424 . . . . 64.040000000000006 111.01 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.76 -146.28 2.09 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.82 -0.705 . . . . 35.079999999999998 112.606 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.418 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 4.2 tp -93.27 -36.46 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 25.609999999999999 110.941 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.22 -66.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 29.899999999999999 111.104 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.406 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.9 m-20 -61.06 -20.73 62.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.11 0.411 . . . . 39.039999999999999 112.11 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.96 -28.79 17.81 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.261 0.837 . . . . 45.600000000000001 113.261 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -33.95 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.937 0.717 . . . . 28.23 112.937 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 45.5 t -73.67 -33.66 64.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 25.890000000000001 110.478 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.406 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.9 m-85 -84.84 -47.75 10.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 32.640000000000001 110.342 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 160.71 22.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.805 -0.634 . . . . 41.060000000000002 109.957 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 p -79.25 116.4 19.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.735 0.303 . . . . 42.619999999999997 111.059 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.59 -171.06 1.77 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.799 0.333 . . . . 28.050000000000001 110.911 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.28 134.6 45.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 46.350000000000001 110.338 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -57.6 -27.39 62.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.005 -0.543 . . . . 23.789999999999999 111.759 -179.105 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -26.21 62.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.636 0.236 . . . . 74.930000000000007 111.636 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -62.31 -28.4 69.71 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.601 0.238 . . . . 64.420000000000002 111.192 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 mt -56.1 -29.15 60.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.745 0.307 . . . . 32.640000000000001 111.627 -179.909 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -69.71 -29.74 67.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 41.859999999999999 111.396 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.3 mtm -65.23 -49.84 68.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.841 0.353 . . . . 38.659999999999997 111.265 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.418 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 87.7 m-85 -56.52 -25.59 52.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 25.27 111.855 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.2 m -64.64 134.66 54.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.398 . . . . 25.039999999999999 111.055 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -64.61 158.67 66.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 36.049999999999997 111.024 179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 -30.33 56.83 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.897 1.731 . . . . 54.359999999999999 112.757 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.51 174.46 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.387 . . . . 71.540000000000006 110.875 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -142.13 162.71 44.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 20.0 110.954 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.67 115.79 3.27 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.88 1.72 . . . . 20.0 112.268 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.87 175.76 2.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 20.0 110.998 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 85.87 3.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 20.0 110.94 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.2 m -163.25 175.07 11.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 20.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.278 -0.868 . . . . 20.0 111.153 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.81 0.338 . . . . 20.0 111.22 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -63.18 145.04 56.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 20.0 110.753 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t -75.27 -35.3 61.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 20.0 111.231 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 20.3 m-85 -98.6 32.86 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.456 -0.338 . . . . 20.0 111.041 -179.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -86.47 -33.08 20.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 20.0 110.54 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.1 t -158.58 174.84 14.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 20.0 110.528 179.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.0 t -65.02 -31.06 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 20.0 111.162 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.35 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 20.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.52 -50.2 70.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 20.0 111.888 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.08 -42.65 95.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 20.0 111.051 -179.947 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -56.38 -42.81 78.5 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.929 0.395 . . . . 20.0 111.348 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -67.01 -35.75 80.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 20.0 110.685 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.86 -46.76 83.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.117 -0.492 . . . . 20.0 110.828 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 16.5 ptp -73.97 -45.36 50.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 20.0 110.989 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -91.02 71.2 6.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.196 0.522 . . . . 20.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.338 -1.257 . . . . 20.0 112.416 -179.911 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 CA-C-O 119.807 -0.441 . . . . 20.0 112.556 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.33 122.09 6.84 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.989 1.793 . . . . 20.0 112.228 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -127.37 97.6 4.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 75.5 110.978 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 10.9 p -122.1 171.05 9.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 31.379999999999999 110.609 179.729 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 8.1 tp -128.66 113.32 15.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.386 -0.37 . . . . 28.27 111.035 -179.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.18 164.09 31.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.915 0.388 . . . . 32.909999999999997 111.234 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 57.5 -137.86 48.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.016 -0.612 . . . . 20.0 113.003 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.86 66.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.687 0.279 . . . . 21.73 111.664 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.03 -38.97 77.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.823 0.344 . . . . 63.420000000000002 111.278 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 tp -72.33 -39.92 67.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 20.390000000000001 110.493 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -33.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.518 . . . . 20.0 111.143 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.67 -50.13 70.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 31.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.69 -50.78 72.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 20.0 111.147 179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.413 HD12 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -60.28 -42.21 94.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 22.050000000000001 110.875 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -71.84 -31.8 66.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 32.759999999999998 110.69 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -78.09 -31.28 50.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 27.25 110.871 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.5 t -89.13 -60.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 25.510000000000002 111.038 -179.859 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 m -78.61 -51.54 9.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 29.489999999999998 111.033 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.88 -103.67 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 40.609999999999999 113.14 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.93 -5.28 56.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.074 0.768 . . . . 79.049999999999997 113.074 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.25 -42.51 91.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.205 0.457 . . . . 50.600000000000001 111.113 -179.929 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.24 65.78 0.81 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 35.479999999999997 112.342 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.413 ' CD1' HD12 ' A' ' 14' ' ' LEU . 26.6 p90 -58.87 156.36 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.921 0.391 . . . . 25.52 111.411 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 117.07 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 56.07 110.212 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -57.68 -42.33 83.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.421 -0.354 . . . . 29.300000000000001 111.493 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -81.77 142.53 32.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.011 0.434 . . . . 38.350000000000001 111.093 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 5.6 tttp -134.66 106.94 10.78 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.945 -0.57 . . . . 42.350000000000001 110.629 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.41 156.62 61.25 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.865 1.71 . . . . 40.799999999999997 112.638 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.8 p -112.01 135.06 53.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 55.75 110.778 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.27 -43.24 10.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 34.939999999999998 112.575 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -68.3 148.56 50.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 34.259999999999998 110.996 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.85 113.39 3.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 36.130000000000003 112.449 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 p -133.72 34.66 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 57.93 110.848 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.9 p -99.21 35.96 1.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 72.849999999999994 110.941 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.1 m -91.3 -51.78 5.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.112 -0.494 . . . . 20.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.1 ttp-105 -88.61 -67.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 20.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 -176.68 155.78 1.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 20.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -174.75 94.88 0.29 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 20.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.14 -178.92 3.51 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.796 1.664 . . . . 20.0 112.31 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.68 107.05 18.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 20.0 110.94 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -142.11 172.91 12.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 64.040000000000006 110.832 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.6 -125.74 1.77 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.651 -0.785 . . . . 35.079999999999998 112.698 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.451 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 1.7 tt -78.5 -24.25 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 111.755 0.28 . . . . 25.609999999999999 111.755 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -56.34 -55.4 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.939 0.4 . . . . 29.899999999999999 111.582 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.407 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.11 -21.75 64.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 39.039999999999999 111.906 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -90.39 -25.11 20.57 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.192 0.441 . . . . 45.600000000000001 112.192 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -114.36 -45.03 3.05 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.265 0.469 . . . . 28.23 112.265 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.3 t -73.25 -55.14 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 25.890000000000001 111.167 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 20.7 m-85 -63.81 -33.81 76.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.884 0.373 . . . . 32.640000000000001 110.873 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 ptm85 -142.05 150.69 41.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 41.060000000000002 110.854 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 p -62.87 137.29 58.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.594 . . . . 42.619999999999997 110.949 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -128.12 175.09 8.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 28.050000000000001 110.904 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.84 128.06 45.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 46.350000000000001 110.291 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 86.0 mt -54.12 -25.72 23.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 23.789999999999999 112.274 -179.091 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -59.53 -30.02 68.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 74.930000000000007 111.011 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.5 mmm-85 -65.96 -26.87 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 64.420000000000002 111.393 179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.51 -30.95 63.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.869 0.366 . . . . 32.640000000000001 111.491 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.28 -26.63 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 41.859999999999999 111.809 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 57.4 mtm -67.56 -52.2 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 38.659999999999997 111.545 -179.672 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 93.0 m-85 -54.48 -25.45 25.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 25.27 112.222 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.0 m -61.74 131.11 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 25.039999999999999 110.979 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.65 169.87 0.94 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.155 -0.475 . . . . 36.049999999999997 111.079 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -76.7 -33.2 3.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.847 1.698 . . . . 54.359999999999999 112.488 -179.799 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -60.01 179.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 71.540000000000006 110.986 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -142.35 159.41 58.22 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 20.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.21 -167.8 0.11 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.867 1.712 . . . . 20.0 112.241 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.71 -52.25 66.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 20.0 111.126 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -136.31 149.83 48.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 20.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.4 m -98.56 131.55 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 20.0 110.987 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.219 -0.896 . . . . 20.0 111.115 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.831 0.348 . . . . 20.0 111.27 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -109.08 130.67 55.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 20.0 110.75 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 24.7 t -83.13 -31.12 27.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 20.0 111.451 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 18.6 m-85 -97.27 32.82 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.448 -0.342 . . . . 20.0 111.099 -179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -80.03 -51.12 9.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 20.0 110.459 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 34.4 p -143.44 173.92 11.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.94 -0.573 . . . . 20.0 110.425 179.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.4 t -61.74 -30.45 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 20.0 111.308 -179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.46 -39.47 70.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 20.0 111.412 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.37 74.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 20.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -59.01 -49.71 76.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.532 -0.304 . . . . 20.0 111.115 -179.599 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 ttp-105 -60.07 -42.8 95.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 20.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -35.05 79.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 20.0 111.288 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 65.4 m -56.81 -46.01 81.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.333 -0.394 . . . . 20.0 111.908 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 9.5 ttt -76.06 -52.43 10.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.061 0.393 . . . . 20.0 112.061 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -67.67 -49.27 63.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 20.0 111.47 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.311 -1.272 . . . . 20.0 112.502 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 CA-C-O 119.784 -0.453 . . . . 20.0 112.524 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.79 121.33 6.22 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.989 1.792 . . . . 20.0 112.411 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -101.33 106.96 18.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.5 110.787 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 44.8 p -133.46 177.1 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 31.379999999999999 111.156 -179.836 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.3 tp -140.22 118.74 12.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.272 -0.422 . . . . 28.27 111.318 -179.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.0 m -140.44 159.52 42.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.354 -0.385 . . . . 32.909999999999997 111.072 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.1 -149.53 47.61 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.953 -0.642 . . . . 20.0 113.017 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.87 62.16 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.748 0.309 . . . . 21.73 111.65 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -60.07 -39.5 86.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 63.420000000000002 110.685 179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.0 tp -71.11 -47.5 57.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 20.390000000000001 110.314 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.89 -31.61 54.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.958 -0.565 . . . . 20.0 110.948 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.72 -42.64 90.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 31.0 110.782 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -62.28 -46.49 88.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 20.0 111.087 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.408 HD12 ' CD1' ' A' ' 23' ' ' PHE . 13.4 mt -59.7 -42.59 93.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 22.050000000000001 110.939 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.32 -31.33 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 32.759999999999998 110.876 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -76.84 -31.77 57.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 27.25 110.943 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 28.9 t -90.07 -59.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 25.510000000000002 110.927 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.4 m -77.86 -51.59 10.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 29.489999999999998 110.949 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.79 -121.89 26.55 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.939 -0.648 . . . . 40.609999999999999 113.108 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.25 -24.58 66.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.845 0.313 . . . . 79.049999999999997 111.845 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 12.0 mtm-85 -55.46 -27.31 47.39 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.897 0.332 . . . . 50.600000000000001 111.897 -179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 109.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.563 -0.827 . . . . 35.479999999999997 111.973 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.408 ' CD1' HD12 ' A' ' 14' ' ' LEU . 39.7 p90 -102.0 160.34 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.109 0.481 . . . . 25.52 111.632 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.42 ' CE1' ' HB3' ' A' ' 27' ' ' LYS . 5.8 p90 -134.58 128.71 33.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.628 -0.715 . . . . 56.07 110.2 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -63.37 -68.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 29.300000000000001 111.387 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -88.85 117.16 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 38.350000000000001 111.16 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 10.6 pttp -114.02 152.39 45.71 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.135 -0.484 . . . . 42.350000000000001 110.71 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.69 136.56 63.22 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.924 1.749 . . . . 40.799999999999997 112.358 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 p -126.41 -58.08 1.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 55.75 110.847 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.34 -129.62 6.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 34.939999999999998 112.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -158.5 179.09 9.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.813 0.34 . . . . 34.259999999999998 111.001 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.36 147.24 21.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 36.130000000000003 112.546 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -90.12 140.78 29.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 57.93 110.876 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -95.75 148.33 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 72.849999999999994 110.89 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.3 p -91.35 -64.06 1.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 20.0 110.841 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -128.75 -47.32 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 20.0 110.837 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -135.84 153.95 51.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 20.0 110.895 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.04 166.25 16.78 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.103 -0.498 . . . . 20.0 111.105 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 27.8 Cg_endo -62.12 101.26 0.23 Allowed 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.937 1.758 . . . . 20.0 112.194 -179.98 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -106.47 126.53 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 20.0 110.924 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -158.13 130.63 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 64.040000000000006 110.705 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.99 -126.04 2.74 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.803 -0.713 . . . . 35.079999999999998 112.791 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.444 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 9.2 tp -81.78 -36.95 14.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.7 0.286 . . . . 25.609999999999999 111.207 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.38 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 29.899999999999999 111.198 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -56.1 -20.31 16.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.178 -0.465 . . . . 39.039999999999999 112.195 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -86.56 -48.41 8.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.677 0.621 . . . . 45.600000000000001 112.677 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.55 -36.24 6.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.69 0.626 . . . . 28.23 112.69 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.28 -49.07 53.49 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.677 -0.409 . . . . 25.890000000000001 110.502 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -79.69 -56.58 4.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.477 . . . . 32.640000000000001 109.711 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -103.33 170.28 8.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.824 -0.626 . . . . 41.060000000000002 109.339 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -95.15 110.46 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 42.619999999999997 111.354 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.77 -169.2 1.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.23 -0.441 . . . . 28.050000000000001 110.804 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -108.51 168.04 9.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 46.350000000000001 110.828 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.4 ' O ' ' CE2' ' B' ' 104' ' ' PHE . 6.6 mp -76.25 -30.49 57.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.447 . . . . 23.789999999999999 110.995 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -55.53 -26.76 44.87 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 74.930000000000007 111.712 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -64.5 -28.89 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.698 0.285 . . . . 64.420000000000002 111.005 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.1 mt -57.24 -30.29 64.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.856 0.36 . . . . 32.640000000000001 111.4 -179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -31.2 70.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 41.859999999999999 111.433 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.7 mtm -61.32 -30.24 70.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 38.659999999999997 111.549 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.444 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 56.4 m-85 -83.68 -24.83 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 25.27 111.999 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -67.27 130.35 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 25.039999999999999 110.892 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -58.03 164.05 3.76 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.133 -0.485 . . . . 36.049999999999997 111.19 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_endo -74.37 -28.67 10.16 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.92 1.746 . . . . 54.359999999999999 112.598 -179.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.48 169.83 1.17 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 71.540000000000006 111.065 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -148.85 159.76 37.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.165 -0.47 . . . . 20.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.39 -170.03 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.945 1.763 . . . . 20.0 112.308 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.2 -173.16 4.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 20.0 111.185 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -67.9 -69.44 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 20.0 110.824 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 88.2 p -84.21 127.84 34.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 20.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.287 -0.863 . . . . 20.0 111.148 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.812 0.339 . . . . 20.0 111.25 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -115.68 115.11 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 20.0 110.797 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 41.9 m -82.63 -38.65 23.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 20.0 110.987 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.4 ' CE2' ' O ' ' A' ' 54' ' ' LEU . 1.2 m-85 -81.75 66.79 7.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 20.0 110.777 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -127.92 -46.38 1.4 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 20.0 110.685 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -141.36 174.75 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 20.0 110.606 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 30.7 t -74.39 -30.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.37 . . . . 20.0 111.037 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.38 -39.93 89.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 20.0 111.042 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.56 82.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 20.0 111.214 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -56.94 -45.4 82.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 20.0 111.36 -179.781 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -65.05 -56.83 10.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 20.0 111.372 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -43.96 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 20.0 111.266 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 22.6 m -59.5 -49.62 77.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 20.0 111.163 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 32.5 ttm -71.09 -51.66 23.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 20.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -81.65 71.08 8.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.166 0.508 . . . . 20.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.375 -1.236 . . . . 20.0 112.56 -179.889 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 CA-C-O 119.772 -0.46 . . . . 20.0 112.521 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -90.25 43.53 0.55 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.313 2.009 . . . . 20.0 112.873 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -99.26 92.7 5.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.35 . . . . 75.5 110.747 179.801 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 11.2 p -118.2 176.17 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 31.379999999999999 110.65 -179.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.0 tp -130.99 114.44 15.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 28.27 111.446 -179.415 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.7 m -140.46 158.71 43.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.271 -0.422 . . . . 32.909999999999997 111.042 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.76 -145.45 41.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.929 -0.653 . . . . 20.0 113.083 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -30.34 65.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 21.73 111.461 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.21 -37.65 80.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 63.420000000000002 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 63.1 tp -73.18 -47.94 39.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 20.390000000000001 110.721 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.21 -30.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 20.0 111.19 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -45.65 78.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 31.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.57 -48.77 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 20.0 111.242 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.42 HD12 ' CD1' ' A' ' 23' ' ' PHE . 12.2 mt -59.48 -44.67 93.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 22.050000000000001 111.049 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -65.37 -32.27 73.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 32.759999999999998 110.821 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CZ ' ' HE1' ' B' ' 114' ' ' MET . 30.0 t80 -76.54 -34.48 58.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 27.25 110.936 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 26.1 t -88.25 -66.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 25.510000000000002 111.048 -179.733 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -77.42 -51.44 10.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 29.489999999999998 111.019 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.9 -121.25 24.38 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.913 -0.66 . . . . 40.609999999999999 113.286 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.06 -22.96 66.19 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.14 0.422 . . . . 79.049999999999997 112.14 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 8.3 mtm-85 -54.88 -25.62 30.1 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.992 0.367 . . . . 50.600000000000001 111.992 -179.556 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 85.52 0.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.642 -0.79 . . . . 35.479999999999997 112.037 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' HD12 ' A' ' 14' ' ' LEU . 30.3 p90 -81.38 135.46 35.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.39 . . . . 25.52 111.51 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.413 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 1.6 p90 -105.74 151.6 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.945 -0.571 . . . . 56.07 110.335 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -93.08 -39.26 11.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.38 . . . . 29.300000000000001 111.269 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -97.51 123.65 41.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 38.350000000000001 111.105 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HD3' ' CD1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -96.72 150.44 36.95 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.273 -0.421 . . . . 42.350000000000001 110.789 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.38 -61.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.543 1.495 . . . . 40.799999999999997 112.382 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.1 t -179.2 -50.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.853 0.358 . . . . 55.75 110.757 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.02 -96.81 0.14 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.84 -0.695 . . . . 34.939999999999998 112.499 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -148.57 -52.64 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 34.259999999999998 110.908 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.18 136.07 8.18 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.7 -0.762 . . . . 36.130000000000003 112.556 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -102.88 170.83 7.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.742 0.306 . . . . 57.93 110.952 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.3 p -155.18 -70.67 0.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 72.849999999999994 110.877 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 t -170.17 34.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 20.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -102.49 170.56 7.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 20.0 110.898 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.0 ttp-105 -78.27 148.96 33.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.481 . . . . 20.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -162.75 83.52 1.54 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.165 -0.47 . . . . 20.0 111.194 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.21 -168.46 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.932 1.754 . . . . 20.0 112.206 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -100.6 98.91 9.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 20.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.0 p -148.95 136.2 20.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 64.040000000000006 110.906 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.71 -140.05 7.44 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.905 -0.664 . . . . 35.079999999999998 112.347 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.438 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 4.1 tp -78.79 -40.33 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 25.609999999999999 111.0 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.6 -59.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 29.899999999999999 111.657 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 7.5 m-20 -66.9 -24.0 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.424 . . . . 39.039999999999999 112.113 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.11 -21.78 22.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.634 0.605 . . . . 45.600000000000001 112.634 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -121.77 -47.8 2.18 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.326 0.491 . . . . 28.23 112.326 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.7 t -70.03 -44.18 69.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.885 -0.326 . . . . 25.890000000000001 111.018 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 14.5 m-85 -73.17 -38.19 66.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 32.640000000000001 110.56 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 41.060000000000002 110.705 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.9 p -58.87 153.39 17.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 42.619999999999997 111.185 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.4 p -151.14 -172.62 4.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 28.050000000000001 111.043 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -110.7 130.08 55.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 46.350000000000001 110.031 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 47.6 mt -55.58 -25.29 37.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 23.789999999999999 112.184 -178.811 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -27.12 63.66 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 74.930000000000007 111.341 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -63.18 -28.36 69.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.632 -0.258 . . . . 64.420000000000002 111.298 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.9 mt -55.72 -28.25 54.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.557 -0.292 . . . . 32.640000000000001 111.754 -179.777 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -70.37 -28.77 65.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.338 -0.392 . . . . 41.859999999999999 111.591 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 71.0 mtm -66.17 -51.97 52.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 38.659999999999997 111.298 -179.757 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.438 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 82.5 m-85 -54.32 -22.76 12.93 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.86 -0.609 . . . . 25.27 112.234 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.3 m -67.92 145.47 54.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 25.039999999999999 110.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.16 175.23 5.0 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.341 -0.391 . . . . 36.049999999999997 111.145 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_endo -77.82 -30.84 3.49 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.961 1.774 . . . . 54.359999999999999 112.697 -179.764 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.97 178.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 71.540000000000006 111.092 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -131.03 163.69 47.4 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 20.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.8 137.83 55.44 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.014 1.809 . . . . 20.0 112.287 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.89 118.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 20.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -77.29 118.05 19.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 20.0 110.884 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.2 m -96.14 -50.47 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 20.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.212 -0.899 . . . . 20.0 111.112 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.828 0.347 . . . . 20.0 111.093 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -107.45 145.0 33.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 20.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t -80.95 -28.03 35.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 20.0 111.24 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -97.87 35.8 1.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 20.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.96 -51.37 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 20.0 110.481 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 13.3 p -146.72 173.33 12.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 20.0 110.515 179.431 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.7 t -58.03 -27.93 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.546 -0.297 . . . . 20.0 111.572 -179.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.64 -39.04 67.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.957 0.408 . . . . 20.0 111.016 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.88 -50.95 67.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.047 -0.524 . . . . 20.0 112.115 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -58.98 -45.26 91.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.736 0.303 . . . . 20.0 111.032 -179.754 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -65.04 -45.02 87.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 20.0 110.608 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -64.21 -35.59 81.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 20.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 19.4 m -58.0 -51.96 67.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 20.0 111.203 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.416 ' HE1' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -75.91 -51.96 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 20.0 110.901 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -82.85 71.34 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 20.0 110.843 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.348 -1.251 . . . . 20.0 112.494 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 CA-C-O 119.788 -0.451 . . . . 20.0 112.492 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.78 150.07 49.29 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.02 1.813 . . . . 20.0 112.337 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 4.2 mm-40 -144.61 115.1 7.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.5 111.101 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.1 p -137.96 -176.03 4.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 31.379999999999999 110.512 179.738 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.18 112.93 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 28.27 111.131 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.4 m -140.21 162.58 34.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 32.909999999999997 111.195 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.97 -145.78 49.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.92 -0.657 . . . . 20.0 113.166 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -29.46 65.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.298 . . . . 21.73 111.508 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.13 -38.6 83.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.398 -0.365 . . . . 63.420000000000002 110.961 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.17 -48.82 32.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 20.390000000000001 110.57 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.68 -31.71 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 20.0 110.972 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.82 -46.34 78.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 31.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.3 -47.59 84.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 20.0 110.998 179.874 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.438 ' CD1' ' CD2' ' A' ' 23' ' ' PHE . 14.9 mt -60.66 -41.0 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 22.050000000000001 110.77 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -70.73 -32.75 70.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 32.759999999999998 110.568 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.62 -32.67 53.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 27.25 110.624 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 36.3 t -86.43 -65.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 25.510000000000002 110.8 179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -71.1 -51.46 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 29.489999999999998 111.008 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.0 -119.75 17.28 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.058 -0.592 . . . . 40.609999999999999 112.843 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.33 -27.38 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.579 0.228 . . . . 79.049999999999997 111.386 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.56 -67.28 0.32 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.826 0.346 . . . . 50.600000000000001 111.511 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.76 141.87 5.91 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.083 -0.58 . . . . 35.479999999999997 111.864 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.438 ' CD2' ' CD1' ' A' ' 14' ' ' LEU . 25.5 p90 -132.3 139.97 48.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 25.52 111.361 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -113.09 146.92 38.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 56.07 110.484 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -94.41 24.2 4.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.453 -0.34 . . . . 29.300000000000001 111.786 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -158.74 93.53 1.18 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.836 0.35 . . . . 38.350000000000001 110.614 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -57.82 -48.14 97.69 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.254 -0.43 . . . . 42.350000000000001 111.389 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.39 -168.53 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.925 1.75 . . . . 40.799999999999997 112.244 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 10.0 t -160.04 115.17 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 55.75 110.821 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.04 -50.76 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 34.939999999999998 112.501 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -78.89 121.22 24.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 34.259999999999998 110.915 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.29 59.9 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.716 . . . . 36.130000000000003 112.508 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 t -102.49 33.78 3.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.391 . . . . 57.93 110.902 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.0 p -142.39 155.98 45.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 72.849999999999994 110.921 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -96.37 -55.48 2.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 20.0 110.911 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -71.29 -49.99 37.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 20.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -78.35 127.94 32.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 20.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -164.58 96.97 0.9 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 20.0 111.109 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.44 167.33 27.29 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.864 1.709 . . . . 20.0 112.332 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.69 131.21 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 20.0 110.954 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.5 p -157.09 -178.23 7.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 64.040000000000006 110.911 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.66 -103.73 1.39 Allowed Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.929 -0.653 . . . . 35.079999999999998 112.473 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.45 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 1.1 tt -84.47 -26.85 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.599 0.238 . . . . 25.609999999999999 111.51 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.89 -56.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.981 0.42 . . . . 29.899999999999999 111.3 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -21.41 64.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.075 -0.511 . . . . 39.039999999999999 111.933 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.02 -28.37 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.845 0.313 . . . . 45.600000000000001 111.845 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.0 -51.95 2.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.053 0.39 . . . . 28.23 112.053 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -65.36 -53.45 43.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.64 0.257 . . . . 25.890000000000001 111.182 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -66.01 -45.2 82.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 32.640000000000001 110.739 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 148.29 50.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 41.060000000000002 110.604 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 p -60.39 139.63 57.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 42.619999999999997 110.872 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.43 -173.81 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 28.050000000000001 111.017 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.58 132.21 54.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 46.350000000000001 110.208 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -57.27 -28.1 62.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 23.789999999999999 111.704 -179.031 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -59.15 -29.28 67.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.661 0.267 . . . . 74.930000000000007 111.323 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -61.12 -27.59 68.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.449 -0.342 . . . . 64.420000000000002 111.601 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.7 mt -57.02 -29.87 63.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.777 0.322 . . . . 32.640000000000001 111.555 -179.805 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.84 -29.73 67.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 41.859999999999999 111.407 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.1 mtm -64.91 -47.54 77.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.433 -0.349 . . . . 38.659999999999997 111.323 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.45 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 97.8 m-85 -60.21 -30.68 69.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 25.27 111.501 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.5 m -60.16 129.51 42.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 25.039999999999999 110.873 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.28 151.84 34.89 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.18 -0.464 . . . . 36.049999999999997 111.346 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.41 -22.6 38.99 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.022 1.814 . . . . 54.359999999999999 112.979 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -55.94 179.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.929 0.395 . . . . 71.540000000000006 111.57 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.62 136.27 4.07 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.039 -0.528 . . . . 20.0 110.708 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.96 -179.75 4.14 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.807 1.671 . . . . 20.0 112.339 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.28 163.83 12.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 20.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -99.39 121.6 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 20.0 110.975 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.1 p -157.5 130.4 7.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 20.0 110.867 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.153 -0.927 . . . . 20.0 111.153 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.805 0.335 . . . . 20.0 111.308 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -105.42 135.3 47.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 20.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.99 -30.85 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 20.0 111.024 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -98.34 32.77 2.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 20.0 111.202 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -79.77 -33.5 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 20.0 110.424 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 24.8 t -157.08 174.36 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.861 -0.609 . . . . 20.0 110.391 179.594 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 32.1 t -68.06 -30.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.476 -0.329 . . . . 20.0 110.96 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.51 -39.83 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 20.0 111.176 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.78 -42.65 97.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 20.0 111.473 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.21 -42.5 86.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 20.0 111.279 -179.794 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -56.85 -62.42 1.75 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.183 -0.462 . . . . 20.0 111.273 -179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -35.04 73.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 20.0 111.025 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 19.4 t -61.12 -53.92 50.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 20.0 111.514 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.412 ' HE1' ' CE2' ' B' ' 115' ' ' TYR . 11.1 ptt? -76.17 -48.66 19.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.81 0.3 . . . . 20.0 111.81 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . 0.412 ' CE2' ' HE1' ' B' ' 114' ' ' MET . 42.9 m-85 -69.47 -49.14 57.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.806 0.336 . . . . 20.0 111.222 -179.625 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.36 -1.245 . . . . 20.0 112.524 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 119.759 -0.467 . . . . 20.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.71 121.57 6.77 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.992 1.795 . . . . 20.0 112.33 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -107.89 102.84 12.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 75.5 110.884 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 p -133.16 178.85 6.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 31.379999999999999 110.902 179.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 tp -136.6 109.48 7.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.375 . . . . 28.27 111.322 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.19 164.72 29.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 32.909999999999997 110.666 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.06 -146.83 43.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.759 -0.734 . . . . 20.0 112.742 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.94 -32.08 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 21.73 111.373 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.08 -37.42 77.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.233 -0.439 . . . . 63.420000000000002 111.14 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 31.2 tp -73.94 -51.22 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 20.390000000000001 110.974 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.87 -30.1 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 20.0 111.242 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.71 -48.78 65.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.4 . . . . 31.0 111.051 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.55 -45.61 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 20.0 111.258 -179.858 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.411 HD12 ' CD1' ' A' ' 23' ' ' PHE . 11.7 mt -60.65 -40.62 92.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 22.050000000000001 110.809 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -74.02 -32.84 63.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 32.759999999999998 110.434 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.419 ' CE2' ' HG3' ' B' ' 114' ' ' MET . 0.1 OUTLIER -66.31 -41.97 88.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 27.25 110.515 179.748 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 25.4 t -86.8 -61.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 25.510000000000002 111.198 -179.653 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.87 -51.35 12.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 29.489999999999998 111.224 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.9 -117.15 9.39 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 40.609999999999999 112.693 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.47 7.73 13.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.772 0.656 . . . . 79.049999999999997 112.772 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.83 -36.0 77.66 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.036 -0.415 . . . . 50.600000000000001 110.891 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.33 59.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 35.479999999999997 112.382 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CD1' HD12 ' A' ' 14' ' ' LEU . 29.8 p90 -58.71 133.88 56.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 25.52 111.422 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -86.47 142.37 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 56.07 110.779 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -29.13 17.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.391 . . . . 29.300000000000001 110.886 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.79 67.88 1.4 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.219 0.533 . . . . 38.350000000000001 110.733 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.42 ' HE3' ' CD1' ' A' ' 60' ' ' TYR . 5.1 ptpp? -67.63 -177.23 0.3 Allowed Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.933 -0.576 . . . . 42.350000000000001 109.802 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -84.72 -169.87 0.71 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.75 1.633 . . . . 40.799999999999997 112.39 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 77.5 p -58.83 -75.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 55.75 111.192 -179.675 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.05 -135.66 2.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 34.939999999999998 112.538 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -150.06 157.99 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 34.259999999999998 110.934 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.22 -172.15 35.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.7 -0.762 . . . . 36.130000000000003 112.408 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 76.7 p -93.64 -30.86 14.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.759 0.314 . . . . 57.93 110.972 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 p -153.67 134.15 13.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 72.849999999999994 111.003 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.3 m -152.16 157.13 41.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 20.0 110.755 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.21 -70.93 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 20.0 110.477 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -178.45 152.63 0.67 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.173 -0.467 . . . . 20.0 110.705 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -124.16 145.93 49.92 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 20.0 110.933 179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.82 173.41 10.16 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.9 1.733 . . . . 20.0 112.254 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 23.8 tt0 -80.74 105.17 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 20.0 111.013 -179.96 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 24.1 p -158.11 -179.55 8.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 64.040000000000006 110.834 179.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.17 -110.61 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.663 -0.78 . . . . 35.079999999999998 112.548 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.446 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 8.2 tp -101.55 -36.74 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 25.609999999999999 110.954 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.23 -65.72 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 29.899999999999999 110.958 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.408 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 19.1 m-20 -61.29 -21.07 63.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.226 -0.443 . . . . 39.039999999999999 111.791 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.58 -36.97 14.13 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.974 0.361 . . . . 45.600000000000001 111.974 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -106.44 -50.33 3.16 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.41 0.522 . . . . 28.23 112.41 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.2 t -60.42 -50.32 74.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.763 0.316 . . . . 25.890000000000001 111.071 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.408 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.0 m-85 -67.21 -56.22 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 32.640000000000001 110.219 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.22 145.99 44.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 41.060000000000002 110.354 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -57.36 136.51 56.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.207 -0.451 . . . . 42.619999999999997 111.77 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -126.47 -160.47 0.99 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.132 -0.485 . . . . 28.050000000000001 110.483 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -128.11 145.71 50.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.907 0.384 . . . . 46.350000000000001 110.578 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 1.6 mp -59.23 -26.38 64.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.168 -0.469 . . . . 23.789999999999999 111.535 -179.645 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -57.82 -28.58 64.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.651 0.262 . . . . 74.930000000000007 111.442 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -68.75 -26.71 65.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 64.420000000000002 111.206 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.0 mt -55.45 -47.81 75.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.785 0.326 . . . . 32.640000000000001 111.78 -179.728 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.49 -29.08 65.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 41.859999999999999 111.519 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.3 mtm -63.77 -50.01 70.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 38.659999999999997 111.465 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.446 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 93.2 m-85 -56.82 -28.26 61.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 25.27 111.813 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.1 m -60.35 127.15 30.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.369 . . . . 25.039999999999999 111.025 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -70.69 168.82 17.16 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.116 -0.493 . . . . 36.049999999999997 110.951 -179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 82.7 Cg_endo -77.76 -30.62 3.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.832 1.688 . . . . 54.359999999999999 112.842 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.02 155.13 17.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 71.540000000000006 110.995 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -158.34 153.81 22.4 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.113 -0.494 . . . . 20.0 110.823 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 129.29 9.83 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.917 1.744 . . . . 20.0 112.383 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.86 165.13 23.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 20.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -90.18 -40.03 12.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 20.0 110.791 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.0 t -75.1 -58.51 3.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 20.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.258 -0.877 . . . . 20.0 111.125 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.833 0.349 . . . . 20.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -113.81 100.56 8.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 20.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 11.5 m -82.52 -35.44 27.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 20.0 111.028 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 14.5 m-30 -82.05 67.02 7.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.246 0.546 . . . . 20.0 111.029 179.975 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -116.01 -41.0 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 20.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 20.2 t -142.96 178.3 7.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 20.0 110.543 179.746 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 23.8 t -73.9 -31.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 20.0 111.034 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.82 -39.58 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 20.0 111.057 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.6 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 20.0 111.47 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -57.23 -53.25 60.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 20.0 111.332 -179.734 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.412 ' HG3' ' CD1' ' B' ' 115' ' ' TYR . 4.7 ttt-85 -62.49 -49.06 76.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 20.0 111.119 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -59.9 -44.65 94.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.387 . . . . 20.0 111.235 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 18.4 m -69.55 -45.02 69.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.331 -0.395 . . . . 20.0 111.547 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.419 ' HG3' ' CE2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -70.45 -52.35 22.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 20.0 111.674 -179.306 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . 0.412 ' CD1' ' HG3' ' B' ' 111' ' ' ARG . 74.5 m-85 -79.78 -49.08 12.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.745 0.307 . . . . 20.0 111.173 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.395 -1.225 . . . . 20.0 112.464 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 CA-C-O 119.788 -0.451 . . . . 20.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.97 124.7 9.32 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.028 1.819 . . . . 20.0 112.298 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -132.56 103.45 6.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.5 110.863 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 60.9 p -128.43 176.1 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 31.379999999999999 111.048 -179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.6 tp -140.2 117.92 11.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 28.27 111.045 -179.746 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 m -140.25 164.97 28.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.92 0.39 . . . . 32.909999999999997 110.963 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.64 -149.76 48.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.9 -0.667 . . . . 20.0 112.959 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.91 -29.83 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 21.73 111.475 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 -59.78 -39.41 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 63.420000000000002 110.92 -179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 58.1 tp -72.69 -49.26 32.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 20.390000000000001 110.773 179.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.67 -31.9 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 20.0 110.952 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 -45.55 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 31.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -61.43 -42.8 99.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 20.0 111.223 -179.834 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.435 ' CD1' ' CD2' ' A' ' 23' ' ' PHE . 12.1 mt -60.53 -38.31 84.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.881 0.372 . . . . 22.050000000000001 110.551 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . 0.407 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 1.5 mm-40 -76.5 -33.51 58.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 32.759999999999998 110.177 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CD2' ' CG ' ' B' ' 114' ' ' MET . 0.1 OUTLIER -68.34 -44.96 74.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 27.25 110.622 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.5 t -78.88 -65.62 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 25.510000000000002 111.289 -179.706 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.7 m -64.6 -51.72 61.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 29.489999999999998 111.426 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.96 -109.07 1.29 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.96 -0.638 . . . . 40.609999999999999 113.18 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.79 -37.61 88.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 79.049999999999997 111.301 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.6 mtm180 -58.52 -28.97 65.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 50.600000000000001 111.446 -179.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.86 174.56 46.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.555 -0.831 . . . . 35.479999999999997 111.721 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.435 ' CD2' ' CD1' ' A' ' 14' ' ' LEU . 13.6 p90 -150.37 156.0 40.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 25.52 111.546 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 112.45 14.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.646 -0.706 . . . . 56.07 110.285 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -52.68 -42.11 64.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.206 -0.452 . . . . 29.300000000000001 112.206 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -83.79 137.75 33.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 38.350000000000001 111.358 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.418 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 25.6 mtpp -154.8 159.7 31.61 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 115.991 -0.549 . . . . 42.350000000000001 110.811 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.41 120.45 6.97 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 121.986 1.791 . . . . 40.799999999999997 112.403 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.8 p -138.21 122.77 18.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 55.75 110.913 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.65 174.55 44.43 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 34.939999999999998 112.583 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -82.06 -73.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.745 0.307 . . . . 34.259999999999998 110.854 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.81 -167.99 10.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 36.130000000000003 112.652 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.6 t -149.3 -63.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 57.93 110.896 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -161.09 146.8 14.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 72.849999999999994 110.857 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.8 m -143.36 148.0 35.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 20.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -86.21 -49.21 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 20.0 110.928 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -90.56 136.35 33.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 20.0 110.978 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.84 102.7 8.46 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 20.0 110.983 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.56 170.86 17.5 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.82 1.68 . . . . 20.0 112.416 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -108.66 91.61 3.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 20.0 110.175 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -150.99 156.77 41.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 64.040000000000006 111.377 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.05 -95.56 0.12 Allowed Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.922 -0.581 . . . . 35.079999999999998 112.023 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.451 ' CD1' ' CE1' ' A' ' 60' ' ' TYR . 1.1 tp -84.91 -35.46 10.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 25.609999999999999 110.353 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.05 -48.72 86.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 29.899999999999999 111.327 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -25.61 61.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 39.039999999999999 111.936 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -90.34 -26.18 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.867 0.321 . . . . 45.600000000000001 111.867 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -107.12 -41.09 5.24 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 28.23 112.016 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.9 t -80.72 -57.98 3.31 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.974 -0.29 . . . . 25.890000000000001 110.907 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -65.1 -37.43 87.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 32.640000000000001 110.488 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -126.91 158.87 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 41.060000000000002 110.253 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 p -82.2 113.19 19.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 42.619999999999997 110.99 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.7 p -99.21 -171.86 2.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 28.050000000000001 111.05 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -125.0 147.61 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 46.350000000000001 110.082 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 2.1 mp -55.32 -28.72 55.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.207 -0.451 . . . . 23.789999999999999 111.824 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -59.63 -28.21 67.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 74.930000000000007 111.323 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -66.44 -32.18 73.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 64.420000000000002 111.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.5 mt -55.1 -28.61 53.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.019 -0.537 . . . . 32.640000000000001 111.88 -179.345 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.12 -35.95 71.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 41.859999999999999 111.287 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.7 mtm -59.02 -37.14 76.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 38.659999999999997 111.292 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 43' ' ' ILE . 84.8 m-85 -71.94 -29.59 64.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 25.27 111.324 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.66 128.85 37.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.377 . . . . 25.039999999999999 111.122 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -61.71 171.29 1.46 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.992 -0.549 . . . . 36.049999999999997 111.213 -179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 83.5 Cg_endo -88.06 -21.75 1.56 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.312 2.008 . . . . 54.359999999999999 113.23 -179.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -54.8 153.86 5.68 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.928 0.394 . . . . 71.540000000000006 111.872 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -144.97 158.25 52.81 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.021 -0.536 . . . . 20.0 110.807 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.97 -167.99 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.933 1.755 . . . . 20.0 112.232 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.52 -76.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 20.0 111.16 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -145.77 109.57 4.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 20.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.4 m -163.13 33.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 20.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.277 -0.868 . . . . 20.0 111.123 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.77 0.319 . . . . 20.0 111.166 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.55 124.55 34.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 20.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 86.5 m -83.05 -40.9 19.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 20.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 1.5 m-85 -86.08 57.49 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.46 0.648 . . . . 20.0 110.824 -179.866 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -118.9 -42.82 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.764 -0.653 . . . . 20.0 110.495 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 44.1 p -143.63 175.02 10.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 20.0 110.586 179.619 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.0 t -74.34 -30.96 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 20.0 111.109 -179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.73 85.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 20.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.61 75.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 20.0 111.327 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -57.59 -43.72 84.83 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.326 -0.397 . . . . 20.0 111.18 -179.829 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -65.21 -53.23 47.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 20.0 111.275 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -62.57 -47.32 84.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 20.0 111.37 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 13.2 m -58.98 -59.27 5.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 20.0 111.415 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.45 ' CG ' ' CD2' ' A' ' 16' ' ' PHE . 0.0 OUTLIER -63.12 -52.59 61.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.384 -0.371 . . . . 20.0 110.989 -179.615 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -92.17 71.12 5.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.091 0.472 . . . . 20.0 110.935 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.431 -1.205 . . . . 20.0 112.593 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.139 0 CA-C-O 119.752 -0.471 . . . . 20.0 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.31 117.1 4.84 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.913 1.742 . . . . 20.0 112.251 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.5 mm-40 -145.8 112.67 6.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 75.5 110.941 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.5 p -130.97 167.4 19.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.098 -0.501 . . . . 31.379999999999999 110.75 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 tp -122.05 113.25 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 28.27 111.095 -179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.3 m -140.22 162.74 34.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 32.909999999999997 111.216 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.68 -139.64 48.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.677 . . . . 20.0 112.949 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.62 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.665 0.269 . . . . 21.73 111.494 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.58 -38.53 87.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 63.420000000000002 110.841 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.63 -45.38 62.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 20.390000000000001 110.873 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.68 -30.79 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 20.0 111.241 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.59 -43.37 85.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 31.0 111.066 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -67.9 -48.52 65.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 20.0 111.393 -179.85 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.411 HD12 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -59.65 -37.9 79.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 22.050000000000001 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.52 -32.09 60.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 32.759999999999998 110.725 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -79.29 -31.6 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 27.25 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.7 t -86.51 -63.25 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 25.510000000000002 110.928 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.0 m -74.26 -51.34 15.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 29.489999999999998 111.244 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.95 -112.51 4.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 40.609999999999999 112.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.74 7.49 17.55 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.758 0.651 . . . . 79.049999999999997 112.758 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.5 mmm180 -75.84 -33.59 60.06 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.974 -0.454 . . . . 50.600000000000001 111.123 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.32 80.85 1.37 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 35.479999999999997 112.19 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.411 ' CD1' HD12 ' A' ' 14' ' ' LEU . 26.9 p90 -74.7 154.23 38.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.062 0.458 . . . . 25.52 111.396 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -130.95 120.78 24.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 56.07 110.423 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -57.32 -71.92 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 29.300000000000001 111.544 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.8 113.52 2.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.392 . . . . 38.350000000000001 111.094 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -105.39 137.89 19.4 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 42.350000000000001 110.686 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.07 155.93 60.71 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.902 1.735 . . . . 40.799999999999997 112.247 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -153.31 129.61 10.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 55.75 110.924 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.78 -49.62 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 34.939999999999998 112.476 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -71.55 139.92 49.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 34.259999999999998 110.935 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.34 160.6 10.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 36.130000000000003 112.476 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.7 m -149.95 -55.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.78 0.324 . . . . 57.93 110.908 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.2 p -151.87 131.5 13.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 72.849999999999994 110.804 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.9 t -165.93 169.96 14.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 20.0 110.977 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -51.32 12.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 20.0 110.713 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -130.27 108.94 10.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 20.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.28 48.93 0.28 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.151 -0.477 . . . . 20.0 111.158 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.64 177.26 9.04 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.899 1.733 . . . . 20.0 112.328 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 34.4 tt0 -90.13 93.31 9.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 20.0 110.88 179.935 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 16.8 p -160.18 177.22 10.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 64.040000000000006 110.909 -179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.4 -119.63 4.46 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 35.079999999999998 112.49 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.409 HD12 ' CE2' ' A' ' 60' ' ' TYR . 3.6 tp -106.8 -41.78 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 25.609999999999999 110.989 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.07 -57.28 11.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 29.899999999999999 111.415 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.99 -21.88 64.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.064 0.394 . . . . 39.039999999999999 112.064 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.4 -25.5 20.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.117 0.414 . . . . 45.600000000000001 112.117 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.3 m -112.66 -46.45 3.14 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.118 0.414 . . . . 28.23 112.118 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.0 t -71.67 -57.48 4.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.313 . . . . 25.890000000000001 110.987 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.54 -35.29 79.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 32.640000000000001 110.739 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -137.83 146.78 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 41.060000000000002 110.42 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -60.59 147.88 40.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 42.619999999999997 110.957 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.3 p -141.14 -173.84 3.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 28.050000000000001 111.047 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -111.24 128.71 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 46.350000000000001 110.137 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -52.76 -23.2 6.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.413 0.523 . . . . 23.789999999999999 112.413 -178.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -61.47 -28.4 69.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.684 0.278 . . . . 74.930000000000007 111.296 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -64.73 -29.22 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.567 -0.288 . . . . 64.420000000000002 111.218 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.5 mt -56.22 -28.71 59.38 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.422 -0.354 . . . . 32.640000000000001 111.654 -179.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.66 -29.94 66.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 41.859999999999999 111.256 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.7 mtm -63.86 -50.09 70.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 38.659999999999997 111.2 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.409 ' CE2' HD12 ' A' ' 43' ' ' ILE . 97.7 m-85 -57.22 -29.15 63.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 25.27 111.491 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.26 134.17 56.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 25.039999999999999 111.071 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -67.44 163.81 43.82 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.077 -0.51 . . . . 36.049999999999997 111.138 -179.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 94.5 Cg_endo -82.45 -23.12 4.33 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.136 1.891 . . . . 54.359999999999999 113.01 -179.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.59 148.44 24.15 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.921 0.391 . . . . 71.540000000000006 111.538 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.6 mtpt -162.7 170.93 7.0 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.889 -0.596 . . . . 20.0 110.578 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.66 -28.87 11.31 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.864 1.709 . . . . 20.0 112.372 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.56 137.77 57.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 20.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -106.25 -176.69 3.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 20.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.1 m -90.35 122.87 33.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 20.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.217 -0.897 . . . . 20.0 111.113 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 16.5 tpt85 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.817 0.342 . . . . 20.0 111.266 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -75.26 145.0 42.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 20.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.98 -32.16 66.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 20.0 111.062 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.64 32.74 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 20.0 110.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -89.24 -38.43 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 20.0 110.761 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 33.2 t -155.8 174.96 14.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 20.0 110.756 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 46.0 t -67.24 -31.09 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 20.0 110.987 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.3 -42.71 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.399 . . . . 20.0 111.243 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.84 82.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 20.0 111.523 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -68.5 -42.55 78.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.335 -0.393 . . . . 20.0 111.263 -179.778 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -56.99 -49.1 76.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 20.0 111.64 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -57.75 -34.55 69.67 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.482 -0.326 . . . . 20.0 111.439 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 81.5 m -58.41 -47.66 83.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.759 0.314 . . . . 20.0 111.468 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 11.8 tpt -76.15 -48.81 19.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 20.0 111.902 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -67.53 -49.13 64.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.669 0.271 . . . . 20.0 111.313 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.455 -1.192 . . . . 20.0 112.491 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 CA-C-O 119.769 -0.462 . . . . 20.0 112.531 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.99 152.0 50.97 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.0 1.8 . . . . 20.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -112.09 100.99 9.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 75.5 110.89 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 28.7 p -120.02 174.37 6.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 31.379999999999999 110.857 -179.908 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.6 tp -140.12 116.57 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 28.27 111.146 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m -140.11 168.2 20.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 32.909999999999997 110.834 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.39 -150.11 49.43 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.748 -0.739 . . . . 20.0 112.856 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.74 -30.05 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.752 0.311 . . . . 21.73 111.319 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.8 mt-10 -59.19 -43.0 92.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 63.420000000000002 111.046 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -69.24 -43.52 73.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 20.390000000000001 110.595 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.75 -30.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 20.0 111.152 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -68.77 -37.53 79.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 31.0 111.057 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -70.31 -42.43 71.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.471 -0.331 . . . . 20.0 111.002 179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.417 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 12.2 mt -60.25 -42.16 94.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.854 0.359 . . . . 22.050000000000001 110.516 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -68.57 -32.52 72.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 32.759999999999998 110.325 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -43.3 68.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 27.25 110.737 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 22.6 t -81.76 -52.29 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.601 . . . . 25.510000000000002 111.413 -179.369 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.9 m -83.23 -51.58 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 29.489999999999998 111.436 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.17 -109.83 2.34 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.752 -0.737 . . . . 40.609999999999999 112.797 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.87 7.3 13.22 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.889 0.7 . . . . 79.049999999999997 112.889 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 3.0 mmm180 -77.11 -39.82 48.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.05 0.386 . . . . 50.600000000000001 111.061 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.39 78.18 1.4 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.737 -0.744 . . . . 35.479999999999997 112.172 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.417 ' CD2' ' HB3' ' A' ' 14' ' ' LEU . 27.5 p90 -72.06 163.17 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.079 0.466 . . . . 25.52 111.494 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . 0.421 ' CE1' ' HB3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -143.99 151.82 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.694 -0.684 . . . . 56.07 110.543 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . 0.415 ' CD2' HG23 ' A' ' 43' ' ' ILE . 73.9 m-85 -97.37 35.56 1.6 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 29.300000000000001 111.258 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -176.36 126.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.377 -0.374 . . . . 38.350000000000001 110.907 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.421 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 20.3 pttp -148.67 149.52 31.1 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.167 -0.469 . . . . 42.350000000000001 110.97 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.0 170.24 19.39 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.883 1.722 . . . . 40.799999999999997 112.313 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 t -158.19 140.53 14.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 55.75 110.853 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.21 -33.98 6.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.76 . . . . 34.939999999999998 112.466 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -80.47 -59.09 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 34.259999999999998 110.987 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.12 71.92 2.88 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.767 -0.73 . . . . 36.130000000000003 112.54 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 t -127.64 103.57 7.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 57.93 110.924 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 m -158.25 151.78 23.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 72.849999999999994 110.921 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -107.86 -33.39 7.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 20.0 110.918 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -60.46 -45.55 93.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 20.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -66.86 -168.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 20.0 110.618 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -56.77 159.47 7.05 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.635 -0.257 . . . . 20.0 111.473 -179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -68.64 160.11 50.8 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.969 1.78 . . . . 20.0 112.381 -179.804 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -88.11 129.21 35.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.028 -0.533 . . . . 20.0 110.828 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -136.08 -178.28 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 64.040000000000006 110.916 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.21 -118.17 1.64 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 35.079999999999998 112.766 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.415 HG23 ' CD2' ' A' ' 25' ' ' PHE . 1.5 tt -103.9 -25.05 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 111.609 0.226 . . . . 25.609999999999999 111.609 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.6 -61.17 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.9 0.381 . . . . 29.899999999999999 111.449 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.26 -17.11 64.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.395 -0.366 . . . . 39.039999999999999 111.955 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -90.28 -32.74 16.4 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.807 0.669 . . . . 45.600000000000001 112.807 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.45 -29.05 5.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.805 0.668 . . . . 28.23 112.805 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -79.95 -46.13 17.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.871 -0.331 . . . . 25.890000000000001 110.698 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -74.53 -37.7 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.052 0.453 . . . . 32.640000000000001 110.212 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -130.11 159.23 37.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 41.060000000000002 109.865 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 p -78.74 127.12 31.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.788 0.328 . . . . 42.619999999999997 111.389 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.78 -160.86 0.94 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.3 -0.409 . . . . 28.050000000000001 110.46 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.9 175.06 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.47 -0.332 . . . . 46.350000000000001 110.403 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -91.11 -28.18 18.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.385 -0.37 . . . . 23.789999999999999 111.499 -179.529 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -55.7 -26.01 42.9 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 111.706 0.262 . . . . 74.930000000000007 111.706 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -61.19 -29.16 69.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.663 0.268 . . . . 64.420000000000002 110.919 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.4 mt -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 32.640000000000001 111.567 -179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.22 -31.93 73.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 41.859999999999999 111.394 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.1 mtm -63.29 -53.08 58.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 38.659999999999997 111.217 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.41 ' CE2' HD11 ' A' ' 43' ' ' ILE . 86.7 m-85 -57.16 -26.12 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.189 -0.46 . . . . 25.27 111.721 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.43 130.39 46.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.84 0.353 . . . . 25.039999999999999 111.038 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -57.75 168.56 1.06 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.233 -0.44 . . . . 36.049999999999997 111.286 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 84.2 Cg_endo -81.2 -30.11 1.72 Allowed 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.088 1.859 . . . . 54.359999999999999 112.813 -179.643 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 149.56 29.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 71.540000000000006 111.093 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -150.26 157.93 36.74 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.043 -0.526 . . . . 20.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.21 134.55 17.61 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.866 1.711 . . . . 20.0 112.331 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -161.25 -53.41 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 20.0 111.079 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -147.41 -47.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 20.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.4 m -96.58 145.83 25.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 20.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.209 -0.901 . . . . 20.0 111.053 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.858 0.361 . . . . 20.0 111.215 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -78.58 125.06 28.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 20.0 110.823 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.0 -24.13 33.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 20.0 111.624 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 13.6 m-85 -96.0 36.98 1.26 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.795 0.331 . . . . 20.0 111.335 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.63 -33.81 15.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 20.0 110.48 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 70.3 m -150.97 174.45 13.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.027 -0.533 . . . . 20.0 110.607 179.723 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 21.0 t -73.43 -29.32 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.422 -0.354 . . . . 20.0 111.337 -179.881 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.82 76.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 20.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.0 86.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.114 -0.494 . . . . 20.0 111.417 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -60.02 -42.01 93.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.4 . . . . 20.0 111.109 -179.858 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -54.78 -42.67 72.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.389 -0.368 . . . . 20.0 111.636 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 4.2 ttp-105 -60.37 -52.44 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 20.0 110.976 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 5.8 m -67.76 -41.8 82.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.281 -0.418 . . . . 20.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.442 ' CE ' ' CE2' ' B' ' 115' ' ' TYR . 50.6 ttp -62.12 -53.14 59.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.935 -0.575 . . . . 20.0 111.223 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . 0.442 ' CE2' ' CE ' ' B' ' 114' ' ' MET . 84.0 m-85 -93.38 71.09 4.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 20.0 111.082 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.367 -1.241 . . . . 20.0 112.43 179.939 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 CA-C-O 119.731 -0.483 . . . . 20.0 112.547 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.63 152.58 48.28 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.937 1.758 . . . . 20.0 112.506 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.88 110.47 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 75.5 110.826 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.5 p -135.68 166.78 22.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.169 -0.468 . . . . 31.379999999999999 110.783 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 tp -124.13 116.33 22.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.372 -0.376 . . . . 28.27 111.431 -179.412 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 m -140.56 161.32 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 32.909999999999997 110.933 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.03 -147.67 44.96 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.77 -0.729 . . . . 20.0 113.047 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.15 66.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 21.73 111.475 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 48.8 mt-10 -60.63 -40.06 90.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 63.420000000000002 110.805 179.933 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.98 -43.58 74.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 20.390000000000001 110.587 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.94 -31.25 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 20.0 111.069 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.45 -31.0 67.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 31.0 111.008 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -74.1 -47.2 37.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 20.0 110.755 179.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.412 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 13.8 mt -60.46 -49.04 79.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 22.050000000000001 110.763 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -30.39 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 32.759999999999998 110.672 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . 0.452 ' CE2' ' CE ' ' B' ' 114' ' ' MET . 48.2 t80 -79.68 -35.16 39.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.427 -0.351 . . . . 27.25 110.937 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . 0.41 HG23 ' CZ ' ' B' ' 104' ' ' PHE . 34.3 t -85.01 -57.47 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 25.510000000000002 111.039 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.4 m -77.67 -51.26 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 29.489999999999998 111.442 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.37 -115.09 6.78 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.61 -0.805 . . . . 40.609999999999999 112.691 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -82.5 7.55 14.08 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.686 0.624 . . . . 79.049999999999997 112.686 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.9 mmm180 -75.57 -32.7 60.48 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.973 -0.455 . . . . 50.600000000000001 111.017 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.04 83.3 1.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.61 -0.805 . . . . 35.479999999999997 112.151 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.412 ' CD2' ' HB3' ' A' ' 14' ' ' LEU . 35.6 p90 -76.96 157.88 31.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.972 0.415 . . . . 25.52 111.318 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -134.69 131.2 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 56.07 110.605 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -67.19 -52.02 46.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 29.300000000000001 111.156 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -75.87 116.49 16.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 38.350000000000001 110.955 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -112.37 96.91 37.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.22 -0.445 . . . . 42.350000000000001 110.888 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.62 171.85 15.52 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.854 1.703 . . . . 40.799999999999997 112.359 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.5 p -153.4 -54.32 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 55.75 110.901 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.17 139.41 48.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 34.939999999999998 112.567 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.7 -169.21 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.881 0.372 . . . . 34.259999999999998 110.626 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.17 79.12 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.818 -0.706 . . . . 36.130000000000003 112.53 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.9 p -149.27 -47.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 57.93 110.962 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.8 m -72.1 176.87 4.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 72.849999999999994 110.829 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 t -78.64 177.3 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 20.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.3 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.159 0.504 . . . . 20.0 111.849 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -159.53 122.4 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 20.0 110.984 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.52 135.98 11.16 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.159 -0.473 . . . . 20.0 110.961 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.0 112.86 2.66 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.988 1.792 . . . . 20.0 112.382 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -77.35 104.3 7.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 20.0 110.884 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -176.75 150.23 0.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 64.040000000000006 110.923 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.18 -128.41 1.86 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 35.079999999999998 112.475 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.437 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 5.3 tp -87.4 -42.63 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.7 0.286 . . . . 25.609999999999999 111.081 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.28 -52.46 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 29.899999999999999 111.293 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.412 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.2 m-20 -69.97 -24.71 63.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 39.039999999999999 111.811 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.51 -23.71 20.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.283 0.475 . . . . 45.600000000000001 112.283 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 55.8 m -116.0 -44.78 2.89 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.337 0.495 . . . . 28.23 112.337 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -75.02 -49.26 20.4 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.924 -0.311 . . . . 25.890000000000001 111.008 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.412 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 29.3 m-85 -72.15 -34.3 68.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.859 0.362 . . . . 32.640000000000001 110.577 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -134.68 149.86 50.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 41.060000000000002 110.273 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 p -67.41 136.54 54.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 42.619999999999997 110.821 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.4 p -130.1 -171.94 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 28.050000000000001 111.156 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.16 139.37 49.97 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.914 -0.585 . . . . 46.350000000000001 110.007 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.41 ' HB3' ' CE1' ' B' ' 104' ' ' PHE . 0.2 OUTLIER -58.18 -28.84 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 23.789999999999999 111.541 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp85 -58.47 -29.21 66.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.776 0.322 . . . . 74.930000000000007 111.282 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -66.12 -28.37 68.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.378 -0.374 . . . . 64.420000000000002 111.302 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 6.2 mt -56.93 -29.21 62.9 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.544 -0.298 . . . . 32.640000000000001 111.482 -179.642 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.5 -31.37 69.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 41.859999999999999 111.047 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.8 mtm -61.36 -48.11 82.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 38.659999999999997 110.958 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.437 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 96.0 m-85 -59.15 -29.93 67.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 25.27 111.234 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.5 m -58.91 132.72 54.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 25.039999999999999 111.08 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -63.06 161.96 26.72 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.141 -0.481 . . . . 36.049999999999997 111.111 179.993 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 89.1 Cg_endo -77.81 -27.16 6.18 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.964 1.776 . . . . 54.359999999999999 112.545 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.54 161.01 6.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 71.540000000000006 111.071 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -140.14 157.61 68.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.069 -0.514 . . . . 20.0 110.812 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.92 132.56 17.1 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.928 1.752 . . . . 20.0 112.242 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.39 -54.13 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 20.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.09 31.31 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 20.0 110.889 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.1 m -141.53 32.95 1.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.429 . . . . 20.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.186 -0.911 . . . . 20.0 111.118 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 35.0 ttp85 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.812 0.339 . . . . 20.0 111.221 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -81.72 110.91 17.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 20.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.9 m -82.96 -28.76 29.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 20.0 111.256 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . 0.41 ' CE1' ' HB3' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -97.68 33.19 2.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.779 0.323 . . . . 20.0 111.049 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.48 -34.12 11.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.001 0.429 . . . . 20.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 70.6 m -154.38 175.16 13.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 20.0 110.298 179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 15.4 t -76.62 -30.91 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 20.0 111.193 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.62 90.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 20.0 110.893 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.84 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 20.0 111.337 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . 0.401 ' CD1' ' CD1' ' A' ' 54' ' ' LEU . 1.3 mt -57.65 -44.71 85.83 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.401 -0.363 . . . . 20.0 111.235 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -64.8 -51.11 63.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.393 -0.367 . . . . 20.0 110.975 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -61.64 -37.88 85.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 20.0 111.026 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 58.6 m -64.29 -58.55 6.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 20.0 110.795 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 114' ' ' MET . . . . . 0.452 ' CE ' ' CE2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -61.98 -51.57 67.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 20.0 110.839 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.1 71.17 10.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.174 0.512 . . . . 20.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.423 -1.209 . . . . 20.0 112.509 -179.921 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 CA-C-O 119.744 -0.476 . . . . 20.0 112.589 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.61 -168.97 0.59 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.959 1.773 . . . . 20.0 112.433 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -82.21 102.09 10.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.5 111.04 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.0 p -119.91 174.2 6.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 31.379999999999999 110.775 179.901 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 7.2 tp -133.54 106.96 7.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 28.27 111.174 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.2 m -140.13 162.38 35.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.286 -0.415 . . . . 32.909999999999997 110.845 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.78 -143.35 38.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.713 -0.756 . . . . 20.0 112.634 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.79 -30.72 69.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.711 0.291 . . . . 21.73 111.218 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.42 -41.91 94.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 63.420000000000002 110.974 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 29.6 tp -70.46 -41.95 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 20.390000000000001 111.089 -179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -72.98 -33.47 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 20.0 111.142 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.54 -30.8 67.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 31.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -73.52 -47.27 42.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 20.0 110.902 179.861 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.422 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 12.6 mt -62.39 -50.26 72.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 22.050000000000001 110.647 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -61.33 -32.02 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 32.759999999999998 110.702 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -77.02 -36.4 56.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 27.25 110.91 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 33.9 t -85.15 -66.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 25.510000000000002 110.844 -179.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.17 -51.39 21.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 29.489999999999998 110.96 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.97 -126.08 41.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.899 -0.667 . . . . 40.609999999999999 112.983 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.2 -25.02 45.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.941 0.348 . . . . 79.049999999999997 111.941 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 9.5 mtm-85 -55.33 -25.97 37.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.918 0.34 . . . . 50.600000000000001 111.918 -179.628 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.31 94.03 0.4 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.558 -0.829 . . . . 35.479999999999997 112.12 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.422 ' CD2' ' HB3' ' A' ' 14' ' ' LEU . 46.1 p90 -84.03 151.85 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.004 0.43 . . . . 25.52 111.552 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -131.41 134.64 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 56.07 110.386 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -71.07 -65.9 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 29.300000000000001 111.176 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -68.18 128.21 35.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 38.350000000000001 111.163 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -101.32 157.1 34.3 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.075 -0.511 . . . . 42.350000000000001 110.659 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.19 143.87 99.6 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.936 1.757 . . . . 40.799999999999997 112.201 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.9 t -86.71 -43.22 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 55.75 110.963 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.43 -172.01 41.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 34.939999999999998 112.562 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -97.6 -57.05 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.716 0.293 . . . . 34.259999999999998 110.92 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.03 80.95 0.69 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 36.130000000000003 112.499 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.3 m -150.01 114.32 5.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 57.93 110.861 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.7 p -102.94 -39.26 7.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 72.849999999999994 110.993 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.0 m -78.58 112.5 15.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 20.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.22 159.8 24.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 20.0 111.003 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.14 -177.96 6.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 20.0 110.82 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.88 73.78 4.81 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.348 -0.387 . . . . 20.0 111.256 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.17 170.98 14.43 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.049 1.832 . . . . 20.0 112.189 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -158.44 93.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.384 . . . . 20.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -177.6 125.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 64.040000000000006 110.83 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.24 -128.33 0.94 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.668 -0.777 . . . . 35.079999999999998 112.546 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.409 HD12 ' CE1' ' A' ' 60' ' ' TYR . 5.6 tp -58.57 -34.93 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.845 0.355 . . . . 25.609999999999999 111.202 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.9 t -64.97 -62.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 29.899999999999999 111.122 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -63.68 -24.03 67.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.251 -0.431 . . . . 39.039999999999999 111.976 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -90.77 -31.54 16.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.448 0.536 . . . . 45.600000000000001 112.448 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.21 -48.48 3.1 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.393 0.516 . . . . 28.23 112.393 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.9 t -63.41 -51.33 66.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.981 -0.287 . . . . 25.890000000000001 110.914 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.0 m-85 -65.38 -49.99 67.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 32.640000000000001 110.271 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -124.28 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 41.060000000000002 110.285 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 p -56.71 131.31 48.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.126 -0.488 . . . . 42.619999999999997 111.732 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -123.32 -163.29 1.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.329 -0.396 . . . . 28.050000000000001 110.844 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.63 134.84 54.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 46.350000000000001 110.128 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -55.64 -27.28 48.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 23.789999999999999 112.005 -179.085 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -58.26 -26.22 62.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.549 -0.296 . . . . 74.930000000000007 111.618 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -65.13 -26.85 68.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.55 0.214 . . . . 64.420000000000002 111.238 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 5.2 mt -56.18 -30.84 62.8 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.777 0.323 . . . . 32.640000000000001 111.545 -179.831 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -68.35 -30.34 69.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 41.859999999999999 111.524 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.9 mtm -66.13 -39.39 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.855 0.36 . . . . 38.659999999999997 111.451 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.409 ' CE1' HD12 ' A' ' 43' ' ' ILE . 70.9 m-85 -69.96 -24.61 63.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 25.27 112.045 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.11 138.45 58.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 25.039999999999999 110.789 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -65.61 173.76 1.83 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.165 -0.471 . . . . 36.049999999999997 110.915 179.95 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 92.6 Cg_endo -83.06 -26.77 2.18 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.03 1.82 . . . . 54.359999999999999 112.731 -179.838 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.98 174.4 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 71.540000000000006 111.224 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.13 161.93 58.44 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.969 -0.559 . . . . 20.0 110.713 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.08 132.94 6.36 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.985 1.79 . . . . 20.0 112.534 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.3 155.14 39.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 20.0 111.146 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -178.04 94.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 20.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.0 t -77.44 143.88 38.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 20.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.236 -0.888 . . . . 20.0 111.063 -179.972 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.769 0.319 . . . . 20.0 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -78.26 115.92 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 20.0 110.837 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.5 m -83.0 -41.92 18.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 20.0 111.12 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -82.11 62.73 5.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.387 0.613 . . . . 20.0 110.949 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.44 -44.27 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 20.0 110.543 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 45.9 p -149.91 174.84 12.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.844 -0.616 . . . . 20.0 110.497 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 23.7 t -71.05 -35.57 59.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 20.0 111.009 179.944 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.3 -39.97 64.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 20.0 111.176 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.02 -42.33 85.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 20.0 111.594 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -42.99 97.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 20.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -61.3 -42.96 99.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 20.0 110.86 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -63.12 -35.96 82.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 20.0 110.935 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 65.9 m -60.62 -47.7 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 20.0 110.889 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 72.6 mtm -75.43 -51.66 12.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 20.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -82.55 71.17 9.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.165 0.507 . . . . 20.0 110.829 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.388 -1.229 . . . . 20.0 112.511 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 CA-C-O 119.745 -0.475 . . . . 20.0 112.546 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.26 172.49 13.03 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.975 1.784 . . . . 20.0 112.276 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -104.28 97.88 7.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 75.5 111.093 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 37.8 p -133.98 -178.33 4.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 31.379999999999999 110.74 179.813 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 tp -137.91 107.4 6.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.489 -0.323 . . . . 28.27 111.247 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.2 157.13 46.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 32.909999999999997 111.029 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.0 -142.88 36.99 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.926 -0.654 . . . . 20.0 112.878 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.69 63.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.691 0.281 . . . . 21.73 111.633 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.33 -40.82 92.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.386 . . . . 63.420000000000002 110.918 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 21.9 tp -71.94 -44.89 62.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 20.390000000000001 110.643 179.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.12 -29.91 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 20.0 111.238 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.54 -41.08 76.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.329 -0.396 . . . . 31.0 111.02 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -65.57 -48.93 70.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 20.0 111.194 179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.416 ' HB3' ' CD2' ' A' ' 23' ' ' PHE . 13.4 mt -59.91 -46.08 90.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 22.050000000000001 110.919 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -66.44 -31.6 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 32.759999999999998 110.783 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -77.32 -31.96 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 27.25 110.808 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 39.4 t -89.48 -67.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 25.510000000000002 110.804 179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.2 m -70.45 -51.64 27.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 29.489999999999998 111.173 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.63 -115.88 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 40.609999999999999 112.739 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.45 7.53 19.43 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.825 0.676 . . . . 79.049999999999997 112.825 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 1.2 mmm180 -69.11 -30.47 68.76 Favored 'General case' 0 C--O 1.231 0.09 0 O-C-N 122.032 -0.418 . . . . 50.600000000000001 111.052 179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 60.63 1.29 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 35.479999999999997 111.906 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.416 ' CD2' ' HB3' ' A' ' 14' ' ' LEU . 22.1 p90 -57.1 155.33 8.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 25.52 111.783 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.23 147.94 47.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.499 -0.773 . . . . 56.07 110.214 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -78.81 -57.49 3.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.546 -0.297 . . . . 29.300000000000001 111.133 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -87.88 121.7 30.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.371 -0.377 . . . . 38.350000000000001 111.039 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HE3' ' CE2' ' A' ' 60' ' ' TYR . 22.1 pttp -143.09 143.56 25.3 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.225 -0.443 . . . . 42.350000000000001 110.823 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.07 127.62 11.52 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.843 1.695 . . . . 40.799999999999997 112.463 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 t -112.38 -35.65 5.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 55.75 110.738 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.0 91.45 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 34.939999999999998 112.456 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -86.78 123.01 31.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 34.259999999999998 110.886 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.96 60.84 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.774 -0.727 . . . . 36.130000000000003 112.514 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 t -150.03 -54.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.87 0.367 . . . . 57.93 110.947 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 m -148.23 118.17 7.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.849999999999994 110.834 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 t -105.85 31.04 5.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 20.0 111.015 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -80.31 -38.91 29.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 20.0 110.842 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -149.62 155.84 40.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 20.0 110.759 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.28 99.59 7.48 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.248 -0.433 . . . . 20.0 111.276 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.16 144.65 29.99 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.886 1.724 . . . . 20.0 112.306 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -97.54 104.84 16.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 20.0 110.852 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.5 p -148.54 138.81 22.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 64.040000000000006 110.892 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.85 -105.4 0.24 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.73 . . . . 35.079999999999998 112.403 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . . . . . . . . . 2.6 tp -105.29 -30.71 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.778 0.323 . . . . 25.609999999999999 110.933 179.944 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.73 -65.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 29.899999999999999 111.073 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.17 -22.95 67.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.376 -0.375 . . . . 39.039999999999999 111.784 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -90.43 -30.65 17.22 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.263 0.468 . . . . 45.600000000000001 112.263 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.21 -51.12 2.9 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 28.23 112.274 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.24 -55.26 34.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.73 0.3 . . . . 25.890000000000001 110.92 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.98 -55.0 33.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.956 0.408 . . . . 32.640000000000001 110.216 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -122.87 147.15 46.89 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 116.004 -0.544 . . . . 41.060000000000002 109.967 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.6 p -58.73 133.98 56.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.78 0.324 . . . . 42.619999999999997 111.461 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.4 p -118.65 -164.47 1.04 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.892 0.377 . . . . 28.050000000000001 111.016 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.31 129.61 56.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.051 -0.522 . . . . 46.350000000000001 110.398 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 92.8 mt -54.08 -35.52 62.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.794 -0.639 . . . . 23.789999999999999 112.346 -178.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -55.74 -26.43 45.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.779 0.289 . . . . 74.930000000000007 111.779 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.697 0.284 . . . . 64.420000000000002 111.115 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 4.6 mt -55.05 -29.28 57.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.28 -0.418 . . . . 32.640000000000001 111.799 -179.839 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.56 -25.89 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 41.859999999999999 112.0 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.19 -45.54 55.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 38.659999999999997 110.906 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.41 ' CE2' ' HE3' ' A' ' 27' ' ' LYS . 55.9 m-85 -60.85 -26.26 67.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.164 -0.471 . . . . 25.27 111.312 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.6 m -59.23 147.12 36.74 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.746 0.308 . . . . 25.039999999999999 110.902 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -80.47 160.71 66.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 36.049999999999997 110.929 179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.9 -30.17 6.19 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.905 1.737 . . . . 54.359999999999999 112.499 -179.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.16 172.56 1.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.414 -0.357 . . . . 71.540000000000006 111.058 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -150.18 155.84 37.33 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.187 -0.461 . . . . 20.0 110.79 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.58 86.61 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.86 1.707 . . . . 20.0 112.363 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.43 32.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 20.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -101.93 -169.63 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 20.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -57.15 -49.88 74.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.531 -0.304 . . . . 20.0 111.346 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.335 -0.841 . . . . 20.0 111.115 179.949 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 120.811 0.338 . . . . 20.0 111.183 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -101.18 145.26 29.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.31 -0.404 . . . . 20.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 29.3 t -76.76 -28.5 55.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.265 -0.425 . . . . 20.0 111.288 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 18.8 m-85 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.782 0.325 . . . . 20.0 111.125 179.972 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -79.43 -51.04 9.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 20.0 110.574 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 49.7 p -149.4 174.14 12.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.976 -0.556 . . . . 20.0 110.373 179.363 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 21.2 t -56.01 -29.72 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.871 0.367 . . . . 20.0 111.673 -179.851 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.88 -39.08 83.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.126 -0.488 . . . . 20.0 110.957 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.25 43.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.035 -0.529 . . . . 20.0 112.025 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -59.63 -42.67 93.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 20.0 110.728 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . 0.412 ' HG3' ' CD2' ' B' ' 115' ' ' TYR . 1.1 tpp85 -58.85 -46.28 88.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.275 -0.42 . . . . 20.0 110.86 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.17 -35.7 74.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 20.0 110.711 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 10.4 m -58.84 -59.1 5.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.516 . . . . 20.0 111.278 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -52.35 51.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 20.0 111.15 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . 0.412 ' CD2' ' HG3' ' B' ' 111' ' ' ARG . 3.3 m-85 -86.53 71.18 10.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.096 0.474 . . . . 20.0 110.822 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.33 -1.261 . . . . 20.0 112.554 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 CA-C-O 119.77 -0.461 . . . . 20.0 112.486 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.46 -169.08 0.49 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.985 1.79 . . . . 20.0 112.421 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -72.1 101.83 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 75.5 110.96 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 43.8 p -127.35 170.88 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 31.379999999999999 110.807 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 11.5 tp -133.05 109.82 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 28.27 111.265 -179.72 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 m -140.07 163.24 33.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 32.909999999999997 110.902 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -146.15 42.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 20.0 112.867 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.22 -31.81 67.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.804 0.335 . . . . 21.73 111.533 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -59.61 -44.09 93.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 63.420000000000002 110.905 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.05 -44.97 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 20.390000000000001 110.697 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.25 -31.53 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 20.0 111.101 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.58 -49.24 74.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 31.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' ALA . . . . . . . . . . . . . . . -59.44 -50.69 72.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 20.0 111.339 -179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . 0.418 HD12 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -58.61 -43.12 89.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.303 -0.408 . . . . 22.050000000000001 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -70.42 -32.03 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 32.759999999999998 110.667 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -79.04 -31.35 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 27.25 110.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' VAL . . . . . . . . . . . . . 38.3 t -88.28 -68.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 25.510000000000002 111.112 -179.685 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -71.22 -51.66 23.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 29.489999999999998 111.21 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.94 -112.87 3.48 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.995 -0.622 . . . . 40.609999999999999 113.089 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.89 -27.98 69.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 79.049999999999997 111.449 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -55.47 -27.31 47.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.796 0.295 . . . . 50.600000000000001 111.796 -179.789 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.45 108.63 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 35.479999999999997 112.033 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' PHE . . . . . 0.418 ' CD1' HD12 ' A' ' 14' ' ' LEU . 29.2 p90 -95.82 150.06 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.448 . . . . 25.52 111.266 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -126.62 120.6 29.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 56.07 110.492 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -57.84 -49.67 75.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 29.300000000000001 111.401 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -71.16 121.74 18.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 38.350000000000001 111.0 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' ' CE1' ' A' ' 60' ' ' TYR . 11.2 tptp -101.72 131.96 22.26 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.22 -0.446 . . . . 42.350000000000001 110.654 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.72 109.73 2.37 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.866 1.711 . . . . 40.799999999999997 112.334 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.9 t -149.28 91.79 1.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 55.75 110.892 179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.37 -110.19 0.61 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 34.939999999999998 112.482 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 32' ' ' GLY . 42.1 p90 -99.63 -46.43 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.843 0.354 . . . . 34.259999999999998 110.925 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' N ' ' CD2' ' A' ' 31' ' ' TYR . . . -172.4 -101.51 0.15 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.758 -0.734 . . . . 36.130000000000003 112.518 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.0 m -139.86 164.95 28.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 57.93 110.942 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.3 p -75.9 153.41 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 72.849999999999994 110.921 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -153.0 -64.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 20.0 110.773 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -90.56 -60.21 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 20.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -161.65 111.16 1.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 20.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -155.01 160.34 31.0 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.1 -0.5 . . . . 20.0 111.069 179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.3 Cg_endo -71.49 121.04 7.37 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 121.846 1.698 . . . . 20.0 112.335 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -102.06 134.52 45.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 20.0 110.925 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -177.6 107.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 64.040000000000006 110.777 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.79 -104.92 2.18 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.851 -0.69 . . . . 35.079999999999998 112.623 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ILE . . . . . 0.432 ' CD1' ' CE2' ' A' ' 60' ' ' TYR . 4.6 tp -87.51 -32.31 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.797 0.332 . . . . 25.609999999999999 111.094 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.59 -65.56 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 29.899999999999999 111.16 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.407 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.1 m-20 -60.86 -22.38 64.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.277 -0.419 . . . . 39.039999999999999 111.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.68 -38.04 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.115 0.413 . . . . 45.600000000000001 112.115 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.42 -49.73 3.38 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.362 0.504 . . . . 28.23 112.362 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.0 t -60.67 -50.77 72.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.728 0.299 . . . . 25.890000000000001 111.134 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PHE . . . . . 0.407 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 10.5 m-85 -66.99 -49.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 32.640000000000001 110.513 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 140.58 52.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.107 -0.497 . . . . 41.060000000000002 110.449 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -57.09 125.01 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.018 -0.537 . . . . 42.619999999999997 111.565 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.0 -163.06 0.89 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.327 -0.397 . . . . 28.050000000000001 110.937 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.34 141.22 46.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 46.350000000000001 110.149 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -64.59 -27.55 69.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 23.789999999999999 111.531 -179.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.2 mtp-105 -58.13 -29.0 65.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.693 0.282 . . . . 74.930000000000007 111.314 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -61.23 -26.69 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 64.420000000000002 111.504 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.8 mt -55.77 -29.23 59.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.719 0.295 . . . . 32.640000000000001 111.679 -179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -30.69 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 41.859999999999999 111.029 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -61.9 -49.47 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 38.659999999999997 111.186 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . 0.432 ' CE2' ' CD1' ' A' ' 43' ' ' ILE . 98.7 m-85 -58.44 -28.77 65.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.043 -0.526 . . . . 25.27 111.527 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 54.1 m -59.42 138.76 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.908 0.385 . . . . 25.039999999999999 111.241 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ALA . . . . . . . . . . . . . . . -74.44 166.14 47.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.016 -0.538 . . . . 36.049999999999997 111.165 -179.978 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 87.6 Cg_endo -81.63 -25.13 3.84 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.145 1.897 . . . . 54.359999999999999 112.869 -179.79 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -58.31 173.27 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 71.540000000000006 111.368 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -141.28 161.3 53.73 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.041 -0.527 . . . . 20.0 110.796 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.45 -32.29 93.6 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.013 1.809 . . . . 20.0 112.226 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.07 121.68 38.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 20.0 111.16 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.23 103.3 12.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 20.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.1 t -96.41 -42.36 8.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 20.0 110.9 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.26 -0.876 . . . . 20.0 111.002 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.787 0.327 . . . . 20.0 111.24 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -87.34 113.28 22.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 20.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 49.6 t -82.86 -28.76 29.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 20.0 111.215 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -92.62 47.9 1.33 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.154 0.502 . . . . 20.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -93.17 -34.18 13.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 20.0 110.527 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.2 t -160.12 174.67 13.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 20.0 110.599 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 33.1 t -67.14 -34.95 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 20.0 110.797 179.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.76 65.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 20.0 111.079 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.11 86.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 20.0 111.515 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.79 -43.12 94.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.422 -0.354 . . . . 20.0 110.958 -179.853 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.0 ttp180 -64.08 -42.71 96.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 20.0 110.748 179.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 13.7 mtp-105 -58.61 -35.6 72.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 20.0 111.146 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 91.5 m -58.57 -53.18 61.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 20.0 111.188 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 7.6 tpt -74.96 -42.04 58.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 20.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 10.0 m-85 -69.13 71.17 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.149 0.499 . . . . 20.0 110.976 179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.384 -1.231 . . . . 20.0 112.499 -179.901 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.798 0.332 . . . . 75.5 110.941 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.75 ' O ' HG11 ' B' ' 107' ' ' VAL . 14.2 p -128.99 170.81 13.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 31.38 110.769 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.784 HD13 HG13 ' B' ' 107' ' ' VAL . 8.5 tp -130.87 110.08 11.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 28.27 111.164 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.5 m -140.19 161.19 38.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 32.91 110.766 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -143.04 37.32 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.792 -0.718 . . . . 19.09 112.669 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.31 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.723 0.297 . . . . 21.73 111.201 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.14 -40.4 89.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 63.42 110.996 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 -46.64 62.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 20.39 110.828 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.25 -33.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 19.22 111.165 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.3 -42.34 96.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 31.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.79 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -64.17 -49.21 72.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 18.28 111.072 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.642 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.26 -39.82 88.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 22.05 110.905 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -74.69 -31.75 61.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 32.76 110.701 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -77.9 -32.01 51.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 27.25 110.837 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 13' ' ' ALA . 37.4 t -87.64 -67.68 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 25.51 110.831 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.4 m -70.41 -51.49 29.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 29.49 110.922 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.5 -113.31 5.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.772 . . . . 40.61 112.918 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.09 7.48 13.3 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.892 0.701 . . . . 79.05 112.892 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -76.11 -30.99 58.46 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.969 -0.457 . . . . 50.6 110.886 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.19 75.98 1.31 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.648 -0.787 . . . . 35.48 112.197 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.642 ' CD1' HD13 ' A' ' 14' ' ' LEU . 31.0 p90 -69.86 150.35 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 25.52 111.333 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.431 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 3.0 p90 -124.78 138.91 54.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 56.07 110.462 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD2' ' CG2' ' A' ' 43' ' ' ILE . 14.7 m-85 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 29.3 111.278 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.764 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.5 tp . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.747 0.308 . . . . 25.61 110.823 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.24 -68.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.27 -0.423 . . . . 29.9 111.058 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.8 -17.6 37.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.101 0.408 . . . . 39.04 112.101 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.45 -38.48 13.24 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.936 0.717 . . . . 45.6 112.936 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.12 -27.69 7.93 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.993 0.738 . . . . 28.23 112.993 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.64 -45.2 22.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 25.89 110.633 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -79.86 -35.92 37.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 32.64 110.395 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mtp85 -123.92 156.32 36.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 41.06 110.071 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -82.41 111.58 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.795 0.331 . . . . 42.62 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.1 p -105.49 -163.05 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.849 0.357 . . . . 28.05 110.974 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -113.75 147.47 38.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 46.35 110.287 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.784 ' CD2' HD12 ' B' ' 110' ' ' LEU . 8.5 mp -63.49 -27.29 69.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 23.79 111.705 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -58.32 -26.9 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.606 0.241 . . . . 74.93 111.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -60.76 -29.81 69.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.604 0.24 . . . . 64.42 111.07 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.4 mt -56.86 -30.96 64.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 32.64 111.619 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -69.34 -34.11 74.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.449 -0.341 . . . . 41.86 111.413 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.2 mtm -58.66 -45.01 90.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.924 0.392 . . . . 38.66 111.305 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.764 ' CE2' HD13 ' A' ' 43' ' ' ILE . 79.5 m-85 -67.49 -27.74 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 25.27 111.586 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.6 m -60.53 130.76 48.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 25.04 110.775 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.02 162.24 55.64 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.212 -0.449 . . . . 36.05 111.184 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 75.8 Cg_endo -76.18 -25.53 9.99 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.008 1.806 . . . . 54.36 112.713 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.825 0.345 . . . . 71.54 111.273 -179.853 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.416 ' HA ' HD22 ' A' ' 54' ' ' LEU . 19.7 m-85 -82.01 72.24 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.08 0.467 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -125.62 -45.38 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.625 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -144.82 174.62 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.797 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 5' ' ' LEU . 33.0 t -68.64 -30.75 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.094 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.16 -39.56 65.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.267 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.93 -40.17 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.832 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.784 HD12 ' CD2' ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 0.0 110.992 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.861 0.362 . . . . 75.5 110.974 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.57 ' O ' HG11 ' B' ' 107' ' ' VAL . 27.0 p -129.96 176.29 8.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 31.38 110.823 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.464 HD13 HG13 ' B' ' 107' ' ' VAL . 10.2 tp -136.27 115.52 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 28.27 111.164 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 m -140.23 159.79 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 32.91 111.013 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.32 -146.6 44.43 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.792 -0.718 . . . . 19.09 112.811 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.26 66.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.732 0.301 . . . . 21.73 111.32 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 63.42 110.748 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 tp -71.69 -49.69 37.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 20.39 110.516 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.08 -32.01 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 19.22 111.002 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.47 -44.36 87.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 31.0 110.846 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.765 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.79 -48.02 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 18.28 111.071 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.724 HD13 ' CD1' ' A' ' 23' ' ' PHE . 14.2 mt -60.38 -41.74 94.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 22.05 110.764 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.99 -31.98 64.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 32.76 110.736 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -76.84 -30.9 56.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.506 . . . . 27.25 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.1 t -90.1 -56.78 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 25.51 110.939 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.14 -51.34 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 29.49 111.178 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.49 -112.51 5.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 40.61 112.593 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.85 7.75 22.79 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.777 0.658 . . . . 79.05 112.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.677 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.6 mtm180 -81.76 -33.39 30.97 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 122.106 -0.371 . . . . 50.6 111.152 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.52 115.13 1.97 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.655 -0.783 . . . . 35.48 112.141 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.724 ' CD1' HD13 ' A' ' 14' ' ' LEU . 20.6 p90 -106.13 156.29 18.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 25.52 111.456 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 2.5 p90 -124.6 127.7 47.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 56.07 110.322 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.372 -0.376 . . . . 29.3 111.665 -179.182 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.431 HD13 ' CE1' ' A' ' 60' ' ' TYR . 1.9 tp . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 120.814 0.34 . . . . 25.61 111.099 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.08 -59.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 29.9 111.49 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.43 -22.58 64.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.293 -0.412 . . . . 39.04 112.088 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.21 -23.71 21.19 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.437 0.532 . . . . 45.6 112.437 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.0 m -114.2 -43.63 3.2 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.067 0.395 . . . . 28.23 112.067 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -74.5 -54.04 8.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.74 0.305 . . . . 25.89 110.95 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.97 -32.61 67.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 32.64 110.652 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -133.0 150.86 52.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.515 . . . . 41.06 110.499 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.8 p -73.09 127.56 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 42.62 110.995 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.62 -173.25 2.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 28.05 111.132 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.88 54.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 46.35 109.824 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.697 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -51.02 -24.92 4.15 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 23.79 112.419 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -63.35 -30.51 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 74.93 111.113 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.51 -30.04 62.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.327 -0.397 . . . . 64.42 111.703 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.2 mt -56.39 -34.8 67.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 32.64 111.953 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.28 -24.38 63.03 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.9 0.333 . . . . 41.86 111.9 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -68.13 -34.22 75.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 38.66 110.942 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CE1' HD13 ' A' ' 43' ' ' ILE . 44.0 m-85 -78.75 -28.72 44.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 25.27 111.434 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.4 m -60.43 126.43 27.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 25.04 110.808 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.721 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -58.04 153.77 32.87 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.27 -0.423 . . . . 36.05 111.371 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 -24.55 13.0 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.971 1.78 . . . . 54.36 112.728 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.721 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.898 0.38 . . . . 71.54 111.366 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.757 0.313 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -97.92 36.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.35 -42.09 9.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.0 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.565 ' CA ' HD21 ' A' ' 54' ' ' LEU . 70.2 m -144.74 175.9 9.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 4' ' ' THR . 27.6 t -72.13 -30.11 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.138 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.08 -39.96 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.041 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.78 84.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.298 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.54 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.419 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.939 0.399 . . . . 75.5 110.964 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 p -134.22 161.84 33.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 31.38 110.456 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 5' ' ' LEU . 9.9 tp -119.98 115.62 24.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 28.27 111.165 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.25 164.22 30.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 32.91 110.991 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.8 -143.6 46.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.84 -0.695 . . . . 19.09 112.848 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.8 68.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 21.73 111.283 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HB3' HD11 ' A' ' 5' ' ' LEU . 45.4 mt-10 -60.82 -39.94 90.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 63.42 110.742 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.6 tp -67.76 -46.69 71.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 20.39 110.542 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.84 -31.86 49.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 19.22 110.878 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.97 -36.48 84.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 31.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.776 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -71.94 -46.47 57.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 18.28 111.025 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.31 -43.03 96.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 22.05 110.795 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -68.9 -31.76 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 32.76 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.17 -31.71 49.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 27.25 110.837 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 13' ' ' ALA . 34.0 t -88.9 -67.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 25.51 110.881 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.25 -51.25 25.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 29.49 110.984 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.57 -115.12 6.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.668 -0.777 . . . . 40.61 112.731 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.81 7.37 15.33 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.729 0.64 . . . . 79.05 112.729 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -70.29 -35.92 74.03 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 118.097 0.408 . . . . 50.6 110.886 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.37 62.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 35.48 112.255 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.506 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.5 p90 -59.2 159.45 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 25.52 111.271 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.05 123.9 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 56.07 110.637 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 29.3 111.074 -179.838 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.574 HD13 ' CE2' ' A' ' 60' ' ' TYR . 3.3 tp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 25.61 110.997 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.61 -54.13 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 29.9 111.466 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.411 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.1 m-20 -70.89 -23.3 62.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 39.04 111.954 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -90.06 -23.89 21.32 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.221 0.452 . . . . 45.6 112.221 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -115.66 -45.7 2.88 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.098 0.407 . . . . 28.23 112.098 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.0 t -73.1 -51.37 18.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.676 0.274 . . . . 25.89 111.117 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 26.5 m-85 -70.4 -32.47 70.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.895 0.378 . . . . 32.64 110.809 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -137.92 147.28 44.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 41.06 110.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -65.16 134.07 52.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 42.62 110.983 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -126.34 -172.51 2.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 28.05 111.066 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -116.68 142.98 46.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 46.35 110.088 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.756 HD23 ' CD1' ' B' ' 110' ' ' LEU . 2.1 mp -55.55 -27.57 49.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 23.79 111.937 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -60.59 -26.46 66.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.549 -0.296 . . . . 74.93 111.578 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.4 -30.55 70.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.806 0.336 . . . . 64.42 111.159 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.4 mt -57.1 -28.7 62.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 32.64 111.676 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -32.31 71.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 41.86 111.139 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.54 -43.81 96.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.394 -0.366 . . . . 38.66 111.094 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.3 m-85 -69.24 -27.61 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 25.27 111.546 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.5 m -59.58 132.23 53.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 25.04 110.954 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -63.83 162.81 26.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.151 -0.477 . . . . 36.05 111.244 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 94.9 Cg_endo -79.1 -32.11 1.96 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.056 1.837 . . . . 54.36 112.581 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 71.54 111.077 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.76 0.314 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.538 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -94.63 46.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.468 0.651 . . . . 0.0 110.665 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -109.66 -30.8 7.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.966 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.653 ' O ' HD21 ' A' ' 54' ' ' LEU . 66.0 m -156.37 -179.02 7.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.156 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.401 HG13 HD13 ' A' ' 5' ' ' LEU . 51.4 t -80.66 -28.75 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.121 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.63 -39.49 73.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.353 . . . . 0.0 111.478 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -36.91 66.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.997 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.756 ' CD1' HD23 ' A' ' 54' ' ' LEU . 4.6 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.256 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.856 0.36 . . . . 75.5 110.925 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.565 ' O ' HG11 ' B' ' 107' ' ' VAL . 44.3 p -127.93 178.1 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 31.38 110.585 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.642 HD13 HG13 ' B' ' 107' ' ' VAL . 8.1 tp -135.48 108.99 7.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 28.27 111.099 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.5 m -140.16 167.88 21.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.196 -0.456 . . . . 32.91 110.992 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.62 -137.19 50.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.879 -0.677 . . . . 19.09 112.778 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.91 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.638 0.256 . . . . 21.73 111.343 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.84 -42.53 97.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.385 -0.37 . . . . 63.42 110.989 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.434 HD11 HG12 ' A' ' 43' ' ' ILE . 47.7 tp -68.72 -42.68 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 20.39 110.936 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.67 -34.58 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 19.22 110.928 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.23 -35.04 79.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 31.0 110.967 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' B' ' 110' ' ' LEU . . . -72.99 -49.38 29.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 18.28 111.363 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.7 HD13 ' CD1' ' A' ' 23' ' ' PHE . 11.8 mt -57.9 -30.41 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 22.05 111.171 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -80.78 -31.48 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 32.76 110.609 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -76.6 -33.88 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 27.25 110.81 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 13' ' ' ALA . 25.3 t -89.48 -40.36 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 25.51 111.406 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 m -100.27 -51.93 3.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 29.49 111.315 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.18 -110.38 3.17 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.655 -0.783 . . . . 40.61 112.723 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.19 7.62 37.14 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.846 0.684 . . . . 79.05 112.846 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.559 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -66.67 -38.45 86.84 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.029 -0.419 . . . . 50.6 110.844 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.88 60.41 0.88 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 35.48 112.233 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.0 p90 -58.07 140.56 52.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 25.52 111.345 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -123.96 127.69 48.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 56.07 110.501 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 29.3 111.509 -179.478 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.582 HD13 ' CE1' ' A' ' 60' ' ' TYR . 2.9 tp . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.724 0.297 . . . . 25.61 111.05 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.98 -58.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 29.9 111.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.59 -22.58 63.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 39.04 112.027 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.17 -19.76 23.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.562 0.578 . . . . 45.6 112.562 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.8 m -121.81 -41.74 2.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.192 0.441 . . . . 28.23 112.192 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.7 t -73.97 -53.9 9.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 25.89 110.963 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -65.67 -34.05 77.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 32.64 110.617 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -139.01 148.31 43.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 41.06 110.717 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 p -65.73 131.88 47.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 42.62 110.989 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.0 p -122.17 -171.92 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 28.05 110.883 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -111.53 132.78 54.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 46.35 110.131 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.556 HD23 ' C ' ' B' ' 104' ' ' PHE . 0.3 OUTLIER -53.43 -24.28 12.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.332 0.493 . . . . 23.79 112.332 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.65 -26.96 67.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.477 0.177 . . . . 74.93 111.477 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.456 ' NE ' ' HE2' ' A' ' 59' ' ' MET . 20.9 mmm180 -68.58 -28.83 67.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.649 0.261 . . . . 64.42 111.271 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.8 mt -56.08 -28.84 59.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.447 -0.342 . . . . 32.64 111.788 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -68.66 -32.22 71.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 41.86 111.193 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.456 ' HE2' ' NE ' ' A' ' 56' ' ' ARG . 71.3 mtm -62.64 -49.77 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 38.66 111.148 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.582 ' CE1' HD13 ' A' ' 43' ' ' ILE . 84.6 m-85 -56.83 -28.56 61.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 25.27 111.675 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -59.23 141.73 53.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 25.04 111.197 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.772 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -78.43 176.59 3.49 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.235 -0.438 . . . . 36.05 110.985 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.772 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 93.5 Cg_endo -83.21 -34.81 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.018 1.812 . . . . 54.36 112.701 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.451 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 71.54 111.058 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.496 0.188 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.556 ' C ' HD23 ' A' ' 54' ' ' LEU . 2.8 m-30 -96.52 32.84 1.93 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.718 0.295 . . . . 0.0 111.353 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -88.51 -33.49 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.892 0.377 . . . . 0.0 110.447 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.54 ' C ' HD21 ' A' ' 54' ' ' LEU . 50.8 p -155.86 174.82 14.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.407 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 5' ' ' LEU . 21.2 t -74.08 -30.87 28.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.131 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.19 96.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.83 83.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.078 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.531 HD21 ' CB ' ' A' ' 13' ' ' ALA . 26.6 tp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.157 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.743 0.306 . . . . 75.5 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.703 ' O ' HG11 ' B' ' 107' ' ' VAL . 13.0 p -129.33 -171.39 2.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 31.38 110.607 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.418 HD13 HG13 ' B' ' 107' ' ' VAL . 9.1 tp -140.28 111.84 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.494 -0.321 . . . . 28.27 111.195 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.4 m -140.15 162.95 34.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 32.91 111.148 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.91 -139.53 48.37 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.815 -0.707 . . . . 19.09 113.052 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.34 64.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.625 0.25 . . . . 21.73 111.485 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.0 -39.79 91.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.439 -0.346 . . . . 63.42 110.855 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.477 HD11 HG12 ' A' ' 43' ' ' ILE . 32.6 tp -71.81 -45.38 61.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 20.39 110.737 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.12 -31.41 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 19.22 111.019 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.62 -45.01 84.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 31.0 111.008 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.971 ' HB2' HD21 ' B' ' 110' ' ' LEU . . . -64.19 -47.33 80.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 18.28 111.155 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -60.74 -36.25 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 22.05 110.798 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -79.1 -31.58 44.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 32.76 110.794 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -79.0 -31.7 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 27.25 110.869 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.4 t -88.14 -68.1 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 25.51 110.945 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.8 m -67.99 -51.32 48.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 29.49 111.053 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.35 -114.3 5.37 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.767 . . . . 40.61 112.835 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -84.41 7.55 19.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.805 0.668 . . . . 79.05 112.805 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.5 mmm180 -71.95 -30.74 65.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.036 0.38 . . . . 50.6 110.936 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.34 67.72 1.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 35.48 112.082 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.674 ' CD1' HD13 ' A' ' 14' ' ' LEU . 30.6 p90 -60.46 164.85 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 25.52 111.501 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -144.32 125.25 14.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.72 -0.673 . . . . 56.07 110.465 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 29.3 111.428 -179.555 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.579 HD13 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.786 0.327 . . . . 25.61 111.009 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.69 -64.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 29.9 111.682 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 12.0 m-20 -67.47 -19.73 65.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.276 -0.42 . . . . 39.04 112.116 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.29 -25.56 20.46 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 111.961 0.356 . . . . 45.6 111.961 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 96.9 m -117.25 -51.52 2.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.108 0.41 . . . . 28.23 112.108 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 t -63.43 -44.04 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 25.89 111.153 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.4 m-85 -74.96 -49.23 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.443 -0.344 . . . . 32.64 110.604 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.84 150.0 45.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 41.06 110.364 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 143.39 56.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.899 0.38 . . . . 42.62 111.02 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 p -138.03 -166.36 1.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.132 -0.485 . . . . 28.05 110.932 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -113.55 138.79 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 46.35 109.851 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.729 HD12 HD22 ' B' ' 110' ' ' LEU . 3.3 mm? -61.32 -27.03 68.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.564 -0.289 . . . . 23.79 111.524 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -55.81 -26.51 46.73 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.736 0.273 . . . . 74.93 111.736 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -63.1 -28.07 69.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.68 0.276 . . . . 64.42 111.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.572 HD11 HD12 ' A' ' 54' ' ' LEU . 6.9 mt -56.26 -31.34 63.49 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.792 0.33 . . . . 32.64 111.426 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -67.02 -33.58 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 41.86 111.334 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.8 mtm -59.41 -54.07 50.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 38.66 111.064 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.579 ' CE2' HD13 ' A' ' 43' ' ' ILE . 78.9 m-85 -57.83 -26.96 62.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.974 -0.557 . . . . 25.27 111.614 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.3 m -60.19 130.3 45.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.836 0.35 . . . . 25.04 110.806 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -65.0 156.28 80.99 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.286 -0.415 . . . . 36.05 111.129 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.84 -26.49 9.57 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.033 1.822 . . . . 54.36 112.527 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.689 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 71.54 111.178 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.718 0.294 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.508 ' HZ ' HG21 ' A' ' 17' ' ' VAL . 2.2 m-30 -87.87 55.77 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.26 0.552 . . . . 0.0 111.079 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.48 -35.62 6.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.165 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.1 m -160.28 174.72 13.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.703 HG11 ' O ' ' A' ' 4' ' ' THR . 23.5 t -72.44 -31.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.95 90.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.062 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.88 78.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.213 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.971 HD21 ' HB2' ' A' ' 13' ' ' ALA . 67.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.151 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.748 0.309 . . . . 75.5 110.854 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.651 ' O ' HG11 ' B' ' 107' ' ' VAL . 17.0 p -124.9 175.96 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 31.38 110.73 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.677 HD13 HG13 ' B' ' 107' ' ' VAL . 8.6 tp -129.52 110.25 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 28.27 111.213 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.9 m -140.22 161.7 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 32.91 110.933 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.36 -139.3 45.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.802 -0.713 . . . . 19.09 112.843 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.09 66.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.343 . . . . 21.73 111.454 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.39 -41.29 93.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 63.42 110.942 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.18 -43.87 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 20.39 110.73 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.42 -31.78 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 19.22 110.968 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.42 -42.12 92.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 31.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.787 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -66.01 -48.51 70.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 18.28 111.168 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.908 HD13 ' CD2' ' A' ' 23' ' ' PHE . 17.6 mt -60.12 -38.47 83.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 22.05 110.827 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -73.26 -32.38 64.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 32.76 110.594 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -79.35 -32.08 43.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.047 -0.524 . . . . 27.25 110.755 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.6 t -87.32 -44.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.042 -0.526 . . . . 25.51 110.905 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -100.43 -51.63 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 29.49 111.233 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.09 -95.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.967 -0.635 . . . . 40.61 112.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.58 -28.42 26.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 79.05 111.459 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 19.8 mtm-85 -57.7 -34.28 69.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.799 0.333 . . . . 50.6 111.365 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.75 150.93 27.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 35.48 112.214 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.908 ' CD2' HD13 ' A' ' 14' ' ' LEU . 15.5 p90 -141.33 145.02 34.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.965 0.412 . . . . 25.52 111.143 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -109.52 127.67 54.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 56.07 110.771 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 29.3 110.827 179.923 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 ' CE1' ' A' ' 60' ' ' TYR . 3.1 tp . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.759 0.314 . . . . 25.61 110.991 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.8 t -58.27 -57.97 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 29.9 111.446 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.4 m-20 -68.32 -22.22 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 39.04 111.932 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.31 -23.87 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.276 0.473 . . . . 45.6 112.276 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.8 m -117.22 -46.68 2.69 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.238 0.459 . . . . 28.23 112.238 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.7 t -71.26 -52.47 18.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.312 . . . . 25.89 111.072 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 15.1 m-85 -64.44 -37.09 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 32.64 110.798 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -140.31 149.85 43.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 41.06 110.913 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -60.06 140.65 56.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 42.62 111.11 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -133.12 -174.63 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 28.05 110.817 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.89 127.63 53.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.995 -0.548 . . . . 46.35 109.929 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.561 HD21 ' CA ' ' B' ' 106' ' ' SER . 0.1 OUTLIER -53.81 -26.56 24.61 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.173 -0.467 . . . . 23.79 111.979 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -58.11 -22.71 51.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.606 -0.27 . . . . 74.93 111.498 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HB3' ' HE3' ' A' ' 59' ' ' MET . 1.5 mmt180 -81.21 7.04 12.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.883 0.698 . . . . 64.42 112.883 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.1 mt -90.06 -39.21 13.05 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.032 -0.417 . . . . 32.64 111.333 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.05 67.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 41.86 111.52 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.42 ' HE3' ' HB3' ' A' ' 56' ' ' ARG . 1.2 ptp -63.84 -31.8 73.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.466 -0.334 . . . . 38.66 111.466 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.414 ' CE1' HD13 ' A' ' 43' ' ' ILE . 65.6 m-85 -70.52 -29.07 65.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 25.27 111.445 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.7 m -61.18 130.28 45.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 25.04 111.12 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.603 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -57.44 157.37 13.39 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.095 -0.502 . . . . 36.05 111.191 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.99 -24.78 38.95 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.888 1.726 . . . . 54.36 112.785 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.603 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 71.54 111.044 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 90.8 m . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.596 0.236 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -96.04 37.89 1.21 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.853 0.359 . . . . 0.0 111.256 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.13 -51.07 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.561 ' CA ' HD21 ' A' ' 54' ' ' LEU . 54.3 p -142.11 174.96 10.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.801 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.677 HG13 HD13 ' A' ' 5' ' ' LEU . 21.3 t -67.67 -36.49 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.093 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.8 82.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.78 92.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.916 0.389 . . . . 75.5 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 p -136.19 147.77 47.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 31.38 110.451 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 5' ' ' LEU . 9.9 tp -109.49 114.31 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 28.27 111.148 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.2 m -140.37 162.06 36.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 32.91 110.999 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.49 -145.86 46.37 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.874 -0.679 . . . . 19.09 113.048 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.57 65.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.794 0.33 . . . . 21.73 111.461 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.15 -43.11 96.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 63.42 110.898 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.61 -43.7 84.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 20.39 110.499 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.37 -33.35 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 19.22 111.006 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.0 -48.82 80.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 31.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.775 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.9 -47.45 86.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 18.28 111.172 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 23' ' ' PHE . 24.2 mt -60.0 -39.61 86.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 22.05 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -75.79 -31.38 59.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 32.76 110.84 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -79.3 -30.75 43.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 27.25 111.085 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 13' ' ' ALA . 36.9 t -89.28 -48.22 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 25.51 111.023 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 m -86.9 -51.27 6.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.392 -0.367 . . . . 29.49 111.191 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.86 -109.41 2.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.671 -0.776 . . . . 40.61 112.492 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.85 7.77 35.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.611 0.597 . . . . 79.05 112.611 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.684 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.8 mmm180 -72.52 -30.12 64.19 Favored 'General case' 0 C--O 1.231 0.092 0 O-C-N 122.041 -0.412 . . . . 50.6 111.044 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.15 84.39 0.8 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 35.48 112.136 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 14' ' ' LEU . 38.3 p90 -84.47 171.56 12.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.127 0.489 . . . . 25.52 111.389 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -145.27 124.3 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.63 . . . . 56.07 110.47 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 29.3 111.491 -179.605 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.517 HD13 ' CE2' ' A' ' 60' ' ' TYR . 2.3 tp . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.87 0.367 . . . . 25.61 111.076 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.1 -59.53 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 29.9 111.537 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.43 -21.56 63.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.06 0.393 . . . . 39.04 112.06 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.14 -24.11 21.16 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 112.258 0.466 . . . . 45.6 112.258 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 75.9 m -116.49 -45.57 2.81 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.13 0.419 . . . . 28.23 112.13 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.2 t -71.88 -53.03 14.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 25.89 110.995 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 22.5 m-85 -67.45 -37.16 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 32.64 110.57 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -134.01 145.86 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 41.06 110.347 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 p -66.87 124.24 22.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.287 -0.415 . . . . 42.62 111.038 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -111.99 -174.92 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 28.05 111.278 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.88 138.64 45.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 46.35 109.951 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.75 HD23 ' CD1' ' B' ' 110' ' ' LEU . 3.2 mp -53.55 -31.45 46.49 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.134 0.42 . . . . 23.79 112.134 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -57.66 -28.45 63.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 74.93 111.424 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.2 mmm-85 -68.87 -22.5 64.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.515 -0.311 . . . . 64.42 111.609 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.54 -40.53 87.53 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.871 0.367 . . . . 32.64 110.592 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -62.5 -32.95 73.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 41.86 109.887 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.69 -31.37 57.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.711 -0.677 . . . . 38.66 111.335 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.517 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.3 m-85 -85.37 -29.15 24.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 25.27 111.569 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 65.4 m -58.34 130.39 46.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 25.04 111.258 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -62.36 163.42 14.55 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.538 . . . . 36.05 111.313 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 83.8 Cg_endo -80.64 -24.89 4.8 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.101 1.867 . . . . 54.36 112.872 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.562 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.36 . . . . 71.54 111.151 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.747 0.308 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.561 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.7 m-85 -83.34 66.28 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 110.947 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -124.33 -45.07 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.611 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 17.0 p -147.0 174.94 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.58 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.92 -31.02 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.004 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.46 70.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.55 68.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.79 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.75 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.372 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.795 0.331 . . . . 75.5 110.967 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.682 ' O ' HG11 ' B' ' 107' ' ' VAL . 54.2 p -137.64 176.5 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 31.38 110.596 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.549 HD13 HG13 ' B' ' 107' ' ' VAL . 9.9 tp -135.93 110.08 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 28.27 111.251 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -140.22 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 32.91 110.963 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.04 -144.79 40.26 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.854 -0.688 . . . . 19.09 112.915 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.75 64.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.785 0.326 . . . . 21.73 111.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.67 -46.52 90.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 63.42 110.805 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 43' ' ' ILE . 58.7 tp -64.37 -44.94 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.052 -0.522 . . . . 20.39 110.766 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.77 -33.96 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 19.22 111.139 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.69 -31.02 71.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 31.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -74.66 -47.49 31.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 18.28 110.966 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.749 HD13 ' CD1' ' A' ' 23' ' ' PHE . 14.8 mt -61.73 -47.09 86.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.209 -0.451 . . . . 22.05 110.871 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -32.29 73.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 32.76 110.665 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.68 -34.38 58.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 27.25 110.971 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.6 t -86.71 -61.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 25.51 110.96 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.1 m -76.78 -51.58 11.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 29.49 111.139 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.22 -122.46 29.13 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.895 -0.669 . . . . 40.61 113.059 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -58.71 -25.71 63.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.855 0.317 . . . . 79.05 111.855 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.592 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 mtm-85 -56.02 -30.03 61.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.75 0.31 . . . . 50.6 111.751 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.01 104.99 0.4 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.686 -0.769 . . . . 35.48 111.955 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.749 ' CD1' HD13 ' A' ' 14' ' ' LEU . 41.4 p90 -93.21 153.37 18.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 25.52 111.554 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.6 139.74 46.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.783 -0.644 . . . . 56.07 110.469 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.37 -0.377 . . . . 29.3 110.862 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.759 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.2 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.875 0.369 . . . . 25.61 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.22 -66.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 29.9 111.104 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.418 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.9 m-20 -61.06 -20.73 62.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.11 0.411 . . . . 39.04 112.11 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.96 -28.79 17.81 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.261 0.837 . . . . 45.6 113.261 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -33.95 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.937 0.717 . . . . 28.23 112.937 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 45.5 t -73.67 -33.66 64.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 25.89 110.478 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.9 m-85 -84.84 -47.75 10.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 32.64 110.342 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 160.71 22.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.805 -0.634 . . . . 41.06 109.957 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 p -79.25 116.4 19.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.735 0.303 . . . . 42.62 111.059 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.59 -171.06 1.77 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.799 0.333 . . . . 28.05 110.911 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.28 134.6 45.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 46.35 110.338 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -57.6 -27.39 62.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.005 -0.543 . . . . 23.79 111.759 -179.105 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -26.21 62.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.636 0.236 . . . . 74.93 111.636 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -62.31 -28.4 69.71 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.601 0.238 . . . . 64.42 111.192 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.6 mt -56.1 -29.15 60.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.745 0.307 . . . . 32.64 111.627 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -69.71 -29.74 67.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 41.86 111.396 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.3 mtm -65.23 -49.84 68.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.841 0.353 . . . . 38.66 111.265 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.759 ' CE2' HD13 ' A' ' 43' ' ' ILE . 87.7 m-85 -56.52 -25.59 52.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 25.27 111.855 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.2 m -64.64 134.66 54.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.398 . . . . 25.04 111.055 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -64.61 158.67 66.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 36.05 111.024 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 -30.33 56.83 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.897 1.731 . . . . 54.36 112.757 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.521 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.387 . . . . 71.54 110.875 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.699 0.285 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.595 ' C ' HD13 ' A' ' 54' ' ' LEU . 20.3 m-85 -98.6 32.86 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.041 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -86.47 -33.08 20.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.54 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.437 ' O ' HD21 ' A' ' 54' ' ' LEU . 13.1 t -158.58 174.84 14.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.528 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 4' ' ' THR . 22.0 t -65.02 -31.06 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.162 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.35 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.52 -50.2 70.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.888 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.513 HD12 HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.051 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.922 0.392 . . . . 75.5 110.978 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.549 ' O ' HG11 ' B' ' 107' ' ' VAL . 10.9 p -122.1 171.05 9.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 31.38 110.609 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.814 HD13 HG13 ' B' ' 107' ' ' VAL . 8.1 tp -128.66 113.32 15.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.386 -0.37 . . . . 28.27 111.035 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.18 164.09 31.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.915 0.388 . . . . 32.91 111.234 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 57.5 -137.86 48.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.016 -0.612 . . . . 19.09 113.003 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.86 66.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.687 0.279 . . . . 21.73 111.664 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.03 -38.97 77.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.823 0.344 . . . . 63.42 111.278 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 tp -72.33 -39.92 67.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 20.39 110.493 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -33.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.518 . . . . 19.22 111.143 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.67 -50.13 70.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 31.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.776 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.69 -50.78 72.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 18.28 111.147 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.549 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -60.28 -42.21 94.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 22.05 110.875 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -71.84 -31.8 66.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 32.76 110.69 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -78.09 -31.28 50.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 27.25 110.871 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.5 t -89.13 -60.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 25.51 111.038 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 m -78.61 -51.54 9.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 29.49 111.033 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.88 -103.67 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 40.61 113.14 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.93 -5.28 56.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.074 0.768 . . . . 79.05 113.074 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -59.25 -42.51 91.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.205 0.457 . . . . 50.6 111.113 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.24 65.78 0.81 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 35.48 112.342 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CD1' HD13 ' A' ' 14' ' ' LEU . 26.6 p90 -58.87 156.36 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.921 0.391 . . . . 25.52 111.411 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 117.07 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 56.07 110.212 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.421 -0.354 . . . . 29.3 111.493 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.86 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.7 tt . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 111.755 0.28 . . . . 25.61 111.755 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -56.34 -55.4 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.939 0.4 . . . . 29.9 111.582 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.11 -21.75 64.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 39.04 111.906 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -90.39 -25.11 20.57 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.192 0.441 . . . . 45.6 112.192 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -114.36 -45.03 3.05 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.265 0.469 . . . . 28.23 112.265 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.3 t -73.25 -55.14 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 25.89 111.167 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 20.7 m-85 -63.81 -33.81 76.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.884 0.373 . . . . 32.64 110.873 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 ptm85 -142.05 150.69 41.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 41.06 110.854 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 p -62.87 137.29 58.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.594 . . . . 42.62 110.949 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -128.12 175.09 8.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 28.05 110.904 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.84 128.06 45.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 46.35 110.291 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.731 HD11 ' O ' ' B' ' 106' ' ' SER . 86.0 mt -54.12 -25.72 23.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 23.79 112.274 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -59.53 -30.02 68.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 74.93 111.011 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HB3' ' HE2' ' A' ' 59' ' ' MET . 11.5 mmm-85 -65.96 -26.87 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 64.42 111.393 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.51 -30.95 63.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.869 0.366 . . . . 32.64 111.491 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.28 -26.63 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 41.86 111.809 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.491 ' HE2' ' HB3' ' A' ' 56' ' ' ARG . 57.4 mtm -67.56 -52.2 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 38.66 111.545 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.86 ' CE2' HD12 ' A' ' 43' ' ' ILE . 93.0 m-85 -54.48 -25.45 25.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 25.27 112.222 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.0 m -61.74 131.11 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 25.04 110.979 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -58.65 169.87 0.94 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.155 -0.475 . . . . 36.05 111.079 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.6 Cg_endo -76.7 -33.2 3.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.847 1.698 . . . . 54.36 112.488 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 71.54 110.986 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 24.7 t . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.655 0.264 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.429 ' HA ' HD12 ' A' ' 54' ' ' LEU . 18.6 m-85 -97.27 32.82 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.099 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -80.03 -51.12 9.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 110.459 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.731 ' O ' HD11 ' A' ' 54' ' ' LEU . 34.4 p -143.44 173.92 11.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.425 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.814 HG13 HD13 ' A' ' 5' ' ' LEU . 22.4 t -61.74 -30.45 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.308 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.46 -39.47 70.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.412 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.37 74.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.681 HD12 HD13 ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.115 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.757 0.313 . . . . 75.5 110.787 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' HG11 ' B' ' 107' ' ' VAL . 44.8 p -133.46 177.1 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 31.38 111.156 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 9' ' ' GLU . 10.3 tp -140.22 118.74 12.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.272 -0.422 . . . . 28.27 111.318 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.0 m -140.44 159.52 42.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.354 -0.385 . . . . 32.91 111.072 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.1 -149.53 47.61 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.953 -0.642 . . . . 19.09 113.017 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.87 62.16 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.748 0.309 . . . . 21.73 111.65 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HB3' HD11 ' A' ' 5' ' ' LEU . 46.7 mt-10 -60.07 -39.5 86.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 63.42 110.685 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.0 tp -71.11 -47.5 57.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 20.39 110.314 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.89 -31.61 54.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.958 -0.565 . . . . 19.22 110.948 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.72 -42.64 90.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 31.0 110.782 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -62.28 -46.49 88.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 18.28 111.087 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.589 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.4 mt -59.7 -42.59 93.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 22.05 110.939 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.32 -31.33 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 32.76 110.876 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -76.84 -31.77 57.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 27.25 110.943 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 13' ' ' ALA . 28.9 t -90.07 -59.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 25.51 110.927 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.4 m -77.86 -51.59 10.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 29.49 110.949 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.79 -121.89 26.55 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.939 -0.648 . . . . 40.61 113.108 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.25 -24.58 66.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.845 0.313 . . . . 79.05 111.845 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.598 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 12.0 mtm-85 -55.46 -27.31 47.39 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.897 0.332 . . . . 50.6 111.897 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 109.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.563 -0.827 . . . . 35.48 111.973 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.589 ' CD1' HD13 ' A' ' 14' ' ' LEU . 39.7 p90 -102.0 160.34 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.109 0.481 . . . . 25.52 111.632 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -134.58 128.71 33.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.628 -0.715 . . . . 56.07 110.2 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 29.3 111.387 -179.517 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.965 HD13 ' CE2' ' A' ' 60' ' ' TYR . 9.2 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.7 0.286 . . . . 25.61 111.207 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.38 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 29.9 111.198 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -56.1 -20.31 16.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.178 -0.465 . . . . 39.04 112.195 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -86.56 -48.41 8.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.677 0.621 . . . . 45.6 112.677 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.55 -36.24 6.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.69 0.626 . . . . 28.23 112.69 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.28 -49.07 53.49 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.677 -0.409 . . . . 25.89 110.502 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -79.69 -56.58 4.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.477 . . . . 32.64 109.711 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -103.33 170.28 8.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.824 -0.626 . . . . 41.06 109.339 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -95.15 110.46 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 42.62 111.354 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.77 -169.2 1.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.23 -0.441 . . . . 28.05 110.804 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -108.51 168.04 9.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 46.35 110.828 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' B' ' 104' ' ' PHE . 6.6 mp -76.25 -30.49 57.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.447 . . . . 23.79 110.995 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -55.53 -26.76 44.87 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 74.93 111.712 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -64.5 -28.89 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.698 0.285 . . . . 64.42 111.005 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.1 mt -57.24 -30.29 64.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.856 0.36 . . . . 32.64 111.4 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -31.2 70.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 41.86 111.433 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.7 mtm -61.32 -30.24 70.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 38.66 111.549 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.965 ' CE2' HD13 ' A' ' 43' ' ' ILE . 56.4 m-85 -83.68 -24.83 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 25.27 111.999 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -67.27 130.35 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 25.04 110.892 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -58.03 164.05 3.76 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.133 -0.485 . . . . 36.05 111.19 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.1 Cg_endo -74.37 -28.67 10.16 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.92 1.746 . . . . 54.36 112.598 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.49 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 71.54 111.065 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 41.9 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.868 0.366 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.622 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.2 m-85 -81.75 66.79 7.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.777 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -127.92 -46.38 1.4 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.685 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -141.36 174.75 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.606 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 4' ' ' THR . 30.7 t -74.39 -30.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.037 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.38 -39.93 89.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.042 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.56 82.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.214 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.612 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.36 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.409 ' O ' HG21 ' B' ' 107' ' ' VAL . 2.7 mp0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.836 0.35 . . . . 75.5 110.747 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.442 ' O ' HG11 ' B' ' 107' ' ' VAL . 11.2 p -118.2 176.17 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 31.38 110.65 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.556 HD13 HG13 ' B' ' 107' ' ' VAL . 10.0 tp -130.99 114.44 15.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 28.27 111.446 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.7 m -140.46 158.71 43.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.271 -0.422 . . . . 32.91 111.042 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.76 -145.45 41.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.929 -0.653 . . . . 19.09 113.083 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -30.34 65.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 21.73 111.461 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.21 -37.65 80.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 63.42 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.441 HD11 HG12 ' A' ' 43' ' ' ILE . 63.1 tp -73.18 -47.94 39.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 20.39 110.721 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.21 -30.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 19.22 111.19 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -45.65 78.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 31.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -61.57 -48.77 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 18.28 111.242 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.748 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.2 mt -59.48 -44.67 93.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 22.05 111.049 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -65.37 -32.27 73.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 32.76 110.821 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -76.54 -34.48 58.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 27.25 110.936 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 13' ' ' ALA . 26.1 t -88.25 -66.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 25.51 111.048 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -77.42 -51.44 10.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 29.49 111.019 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.9 -121.25 24.38 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.913 -0.66 . . . . 40.61 113.286 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.06 -22.96 66.19 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.14 0.422 . . . . 79.05 112.14 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 8.3 mtm-85 -54.88 -25.62 30.1 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.992 0.367 . . . . 50.6 111.992 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 85.52 0.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.642 -0.79 . . . . 35.48 112.037 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.748 ' CD1' HD13 ' A' ' 14' ' ' LEU . 30.3 p90 -81.38 135.46 35.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.39 . . . . 25.52 111.51 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 1.6 p90 -105.74 151.6 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.945 -0.571 . . . . 56.07 110.335 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.38 . . . . 29.3 111.269 -179.607 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.772 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.1 tp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.862 0.363 . . . . 25.61 111.0 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.6 -59.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 29.9 111.657 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 7.5 m-20 -66.9 -24.0 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.424 . . . . 39.04 112.113 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.11 -21.78 22.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.634 0.605 . . . . 45.6 112.634 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -121.77 -47.8 2.18 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.326 0.491 . . . . 28.23 112.326 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.7 t -70.03 -44.18 69.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.885 -0.326 . . . . 25.89 111.018 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 14.5 m-85 -73.17 -38.19 66.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 32.64 110.56 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 41.06 110.705 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.9 p -58.87 153.39 17.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 42.62 111.185 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.4 p -151.14 -172.62 4.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 28.05 111.043 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -110.7 130.08 55.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 46.35 110.031 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.74 HD11 ' O ' ' B' ' 106' ' ' SER . 47.6 mt -55.58 -25.29 37.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 23.79 112.184 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -27.12 63.66 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 74.93 111.341 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' ARG . . . . . 0.439 ' NE ' ' HE1' ' A' ' 59' ' ' MET . 12.6 mmm180 -63.18 -28.36 69.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.632 -0.258 . . . . 64.42 111.298 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.9 mt -55.72 -28.25 54.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.557 -0.292 . . . . 32.64 111.754 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -70.37 -28.77 65.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.338 -0.392 . . . . 41.86 111.591 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' MET . . . . . 0.439 ' HE1' ' NE ' ' A' ' 56' ' ' ARG . 71.0 mtm -66.17 -51.97 52.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 38.66 111.298 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.772 ' CE2' HD13 ' A' ' 43' ' ' ILE . 82.5 m-85 -54.32 -22.76 12.93 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.86 -0.609 . . . . 25.27 112.234 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.3 m -67.92 145.47 54.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 25.04 110.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.813 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -80.16 175.23 5.0 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.341 -0.391 . . . . 36.05 111.145 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.813 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 85.8 Cg_endo -77.82 -30.84 3.49 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.961 1.774 . . . . 54.36 112.697 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 71.54 111.092 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.598 0.237 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -97.87 35.8 1.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.96 -51.37 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 110.481 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.74 ' O ' HD11 ' A' ' 54' ' ' LEU . 13.3 p -146.72 173.33 12.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.515 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 5' ' ' LEU . 22.7 t -58.03 -27.93 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.572 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.64 -39.04 67.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.957 0.408 . . . . 0.0 111.016 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.88 -50.95 67.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.115 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.622 HD12 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.736 0.303 . . . . 0.0 111.032 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.514 ' OE2' ' HB2' ' B' ' 108' ' ' ALA . 4.2 mm-40 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.947 0.403 . . . . 75.5 111.101 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.69 ' O ' HG11 ' B' ' 107' ' ' VAL . 16.1 p -137.96 -176.03 4.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 31.38 110.512 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.18 112.93 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 28.27 111.131 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.4 m -140.21 162.58 34.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 32.91 111.195 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.97 -145.78 49.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.92 -0.657 . . . . 19.09 113.166 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -29.46 65.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.298 . . . . 21.73 111.508 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.13 -38.6 83.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.398 -0.365 . . . . 63.42 110.961 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.17 -48.82 32.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 20.39 110.57 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.68 -31.71 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 19.22 110.972 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.82 -46.34 78.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 31.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.806 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.3 -47.59 84.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 18.28 110.998 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.921 HD13 ' CD2' ' A' ' 23' ' ' PHE . 14.9 mt -60.66 -41.0 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 22.05 110.77 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -70.73 -32.75 70.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 32.76 110.568 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.62 -32.67 53.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 27.25 110.624 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 13' ' ' ALA . 36.3 t -86.43 -65.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 25.51 110.8 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -71.1 -51.46 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 29.49 111.008 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.0 -119.75 17.28 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.058 -0.592 . . . . 40.61 112.843 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.33 -27.38 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.579 0.228 . . . . 79.05 111.386 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.56 -67.28 0.32 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.826 0.346 . . . . 50.6 111.511 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.76 141.87 5.91 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.083 -0.58 . . . . 35.48 111.864 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.921 ' CD2' HD13 ' A' ' 14' ' ' LEU . 25.5 p90 -132.3 139.97 48.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 25.52 111.361 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -113.09 146.92 38.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 56.07 110.484 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.453 -0.34 . . . . 29.3 111.786 -179.755 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.1 tt . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.599 0.238 . . . . 25.61 111.51 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.89 -56.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.981 0.42 . . . . 29.9 111.3 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -21.41 64.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.075 -0.511 . . . . 39.04 111.933 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.02 -28.37 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.845 0.313 . . . . 45.6 111.845 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.0 -51.95 2.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.053 0.39 . . . . 28.23 112.053 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -65.36 -53.45 43.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.64 0.257 . . . . 25.89 111.182 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -66.01 -45.2 82.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 32.64 110.739 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 148.29 50.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 41.06 110.604 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 p -60.39 139.63 57.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 42.62 110.872 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.43 -173.81 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 28.05 111.017 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.58 132.21 54.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 46.35 110.208 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.704 ' HG ' HD12 ' B' ' 110' ' ' LEU . 0.7 OUTLIER -57.27 -28.1 62.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 23.79 111.704 -179.031 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -59.15 -29.28 67.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.661 0.267 . . . . 74.93 111.323 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -61.12 -27.59 68.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.449 -0.342 . . . . 64.42 111.601 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.7 mt -57.02 -29.87 63.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.777 0.322 . . . . 32.64 111.555 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.84 -29.73 67.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 41.86 111.407 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.1 mtm -64.91 -47.54 77.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.433 -0.349 . . . . 38.66 111.323 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.764 ' CE2' HD12 ' A' ' 43' ' ' ILE . 97.8 m-85 -60.21 -30.68 69.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 25.27 111.501 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.5 m -60.16 129.51 42.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 25.04 110.873 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.58 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -57.28 151.84 34.89 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.18 -0.464 . . . . 36.05 111.346 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.41 -22.6 38.99 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.022 1.814 . . . . 54.36 112.979 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 120.929 0.395 . . . . 71.54 111.57 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.685 0.279 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -98.34 32.77 2.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.202 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -79.77 -33.5 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.424 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.691 ' C ' HD21 ' A' ' 54' ' ' LEU . 24.8 t -157.08 174.36 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.391 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 4' ' ' THR . 32.1 t -68.06 -30.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.96 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 108' ' ' ALA . . . . . 0.514 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . . . -69.51 -39.83 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.176 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.78 -42.65 97.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.473 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.704 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.279 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.734 0.302 . . . . 75.5 110.884 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.662 ' O ' HG11 ' B' ' 107' ' ' VAL . 31.1 p -133.16 178.85 6.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 31.38 110.902 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.481 HD13 HG13 ' B' ' 107' ' ' VAL . 10.1 tp -136.6 109.48 7.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.375 . . . . 28.27 111.322 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.19 164.72 29.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 32.91 110.666 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.06 -146.83 43.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.759 -0.734 . . . . 19.09 112.742 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.94 -32.08 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 21.73 111.373 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.08 -37.42 77.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.233 -0.439 . . . . 63.42 111.14 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.419 HD11 ' CG1' ' A' ' 43' ' ' ILE . 31.2 tp -73.94 -51.22 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 20.39 110.974 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.87 -30.1 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 19.22 111.242 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.71 -48.78 65.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.4 . . . . 31.0 111.051 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.55 -45.61 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 18.28 111.258 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.751 HD13 ' CD1' ' A' ' 23' ' ' PHE . 11.7 mt -60.65 -40.62 92.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 22.05 110.809 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -74.02 -32.84 63.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 32.76 110.434 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -41.97 88.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 27.25 110.515 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.448 HG22 ' HZ ' ' B' ' 104' ' ' PHE . 25.4 t -86.8 -61.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 25.51 111.198 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.87 -51.35 12.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 29.49 111.224 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.9 -117.15 9.39 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 40.61 112.693 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.47 7.73 13.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.772 0.656 . . . . 79.05 112.772 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.83 -36.0 77.66 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.036 -0.415 . . . . 50.6 110.891 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.33 59.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 35.48 112.382 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.751 ' CD1' HD13 ' A' ' 14' ' ' LEU . 29.8 p90 -58.71 133.88 56.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 25.52 111.422 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -86.47 142.37 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 56.07 110.779 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.391 . . . . 29.3 110.886 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.916 HD13 ' CE2' ' A' ' 60' ' ' TYR . 8.2 tp . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.876 0.369 . . . . 25.61 110.954 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.23 -65.72 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 29.9 110.958 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 19.1 m-20 -61.29 -21.07 63.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.226 -0.443 . . . . 39.04 111.791 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.58 -36.97 14.13 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.974 0.361 . . . . 45.6 111.974 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -106.44 -50.33 3.16 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.41 0.522 . . . . 28.23 112.41 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.2 t -60.42 -50.32 74.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.763 0.316 . . . . 25.89 111.071 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.0 m-85 -67.21 -56.22 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 32.64 110.219 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.22 145.99 44.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 41.06 110.354 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -57.36 136.51 56.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.207 -0.451 . . . . 42.62 111.77 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -126.47 -160.47 0.99 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.132 -0.485 . . . . 28.05 110.483 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -128.11 145.71 50.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.907 0.384 . . . . 46.35 110.578 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 1.021 HD23 HD12 ' B' ' 110' ' ' LEU . 1.6 mp -59.23 -26.38 64.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.168 -0.469 . . . . 23.79 111.535 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -57.82 -28.58 64.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.651 0.262 . . . . 74.93 111.442 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -68.75 -26.71 65.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 64.42 111.206 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.0 mt -55.45 -47.81 75.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.785 0.326 . . . . 32.64 111.78 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.49 -29.08 65.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 41.86 111.519 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.3 mtm -63.77 -50.01 70.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 38.66 111.465 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.916 ' CE2' HD13 ' A' ' 43' ' ' ILE . 93.2 m-85 -56.82 -28.26 61.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 25.27 111.813 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.1 m -60.35 127.15 30.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.369 . . . . 25.04 111.025 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -70.69 168.82 17.16 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.116 -0.493 . . . . 36.05 110.951 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 82.7 Cg_endo -77.76 -30.62 3.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.832 1.688 . . . . 54.36 112.842 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 71.54 110.995 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.83 0.348 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.618 ' C ' HD13 ' A' ' 54' ' ' LEU . 14.5 m-30 -82.05 67.02 7.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.246 0.546 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -116.01 -41.0 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 54' ' ' LEU . 20.2 t -142.96 178.3 7.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.543 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.662 HG11 ' O ' ' A' ' 4' ' ' THR . 23.8 t -73.9 -31.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.034 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.82 -39.58 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.6 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.47 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 1.021 HD12 HD23 ' A' ' 54' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.332 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.817 0.341 . . . . 75.5 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.575 ' O ' HG11 ' B' ' 107' ' ' VAL . 60.9 p -128.43 176.1 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 31.38 111.048 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 9' ' ' GLU . 11.6 tp -140.2 117.92 11.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 28.27 111.045 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 m -140.25 164.97 28.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.92 0.39 . . . . 32.91 110.963 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.64 -149.76 48.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.9 -0.667 . . . . 19.09 112.959 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.91 -29.83 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 21.73 111.475 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HB3' HD11 ' A' ' 5' ' ' LEU . 34.0 mt-10 -59.78 -39.41 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 63.42 110.92 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.518 HD11 HG12 ' A' ' 43' ' ' ILE . 58.1 tp -72.69 -49.26 32.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 20.39 110.773 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.67 -31.9 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 19.22 110.952 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 -45.55 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 31.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -61.43 -42.8 99.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 18.28 111.223 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 23' ' ' PHE . 12.1 mt -60.53 -38.31 84.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.881 0.372 . . . . 22.05 110.551 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' GLN . . . . . 0.405 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 1.5 mm-40 -76.5 -33.51 58.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 32.76 110.177 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -44.96 74.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 27.25 110.622 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 13' ' ' ALA . 33.5 t -78.88 -65.62 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 25.51 111.289 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.7 m -64.6 -51.72 61.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 29.49 111.426 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.96 -109.07 1.29 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.96 -0.638 . . . . 40.61 113.18 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.79 -37.61 88.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 79.05 111.301 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.646 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.6 mtm180 -58.52 -28.97 65.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 50.6 111.446 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.86 174.56 46.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.555 -0.831 . . . . 35.48 111.721 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.901 ' CD2' HD13 ' A' ' 14' ' ' LEU . 13.6 p90 -150.37 156.0 40.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 25.52 111.546 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 112.45 14.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.646 -0.706 . . . . 56.07 110.285 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.466 0.354 0 CA-C-N 116.206 -0.452 . . . . 29.3 112.206 -179.264 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 10' ' ' LEU . 1.1 tp . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.827 0.346 . . . . 25.61 110.353 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.05 -48.72 86.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 29.9 111.327 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -25.61 61.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 39.04 111.936 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -90.34 -26.18 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.867 0.321 . . . . 45.6 111.867 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -107.12 -41.09 5.24 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 28.23 112.016 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.9 t -80.72 -57.98 3.31 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.974 -0.29 . . . . 25.89 110.907 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -65.1 -37.43 87.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 32.64 110.488 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -126.91 158.87 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 41.06 110.253 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 p -82.2 113.19 19.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 42.62 110.99 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.7 p -99.21 -171.86 2.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 28.05 111.05 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -125.0 147.61 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 46.35 110.082 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.788 HD23 ' CD1' ' B' ' 110' ' ' LEU . 2.1 mp -55.32 -28.72 55.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.207 -0.451 . . . . 23.79 111.824 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -59.63 -28.21 67.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 74.93 111.323 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -66.44 -32.18 73.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 64.42 111.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.5 mt -55.1 -28.61 53.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.019 -0.537 . . . . 32.64 111.88 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.12 -35.95 71.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 41.86 111.287 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.7 mtm -59.02 -37.14 76.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 38.66 111.292 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 43' ' ' ILE . 84.8 m-85 -71.94 -29.59 64.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 25.27 111.324 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.66 128.85 37.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.377 . . . . 25.04 111.122 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.71 171.29 1.46 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.992 -0.549 . . . . 36.05 111.213 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.57 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 83.5 Cg_endo -88.06 -21.75 1.56 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.312 2.008 . . . . 54.36 113.23 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.465 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.928 0.394 . . . . 71.54 111.872 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 86.5 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.674 0.273 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.506 ' C ' HD13 ' A' ' 54' ' ' LEU . 1.5 m-85 -86.08 57.49 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.46 0.648 . . . . 0.0 110.824 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -118.9 -42.82 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.495 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.434 ' O ' HD11 ' A' ' 54' ' ' LEU . 44.1 p -143.63 175.02 10.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.586 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 4' ' ' THR . 22.0 t -74.34 -30.96 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.73 85.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.61 75.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.327 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.788 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.18 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLU . . . . . 0.572 ' OE2' ' HB2' ' B' ' 108' ' ' ALA . 3.5 mm-40 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.841 0.353 . . . . 75.5 110.941 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.52 ' O ' HG11 ' B' ' 107' ' ' VAL . 16.5 p -130.97 167.4 19.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.098 -0.501 . . . . 31.38 110.75 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.537 HD13 HG13 ' B' ' 107' ' ' VAL . 9.1 tp -122.05 113.25 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 28.27 111.095 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.3 m -140.22 162.74 34.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 32.91 111.216 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.68 -139.64 48.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.677 . . . . 19.09 112.949 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.62 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.665 0.269 . . . . 21.73 111.494 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.58 -38.53 87.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 63.42 110.841 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.63 -45.38 62.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 20.39 110.873 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.68 -30.79 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 19.22 111.241 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.59 -43.37 85.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 31.0 111.066 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.778 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -67.9 -48.52 65.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 18.28 111.393 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.55 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -59.65 -37.9 79.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 22.05 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.52 -32.09 60.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 32.76 110.725 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -79.29 -31.6 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 27.25 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.7 t -86.51 -63.25 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 25.51 110.928 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.0 m -74.26 -51.34 15.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 29.49 111.244 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.95 -112.51 4.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 40.61 112.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.74 7.49 17.55 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.758 0.651 . . . . 79.05 112.758 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.5 mmm180 -75.84 -33.59 60.06 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.974 -0.454 . . . . 50.6 111.123 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.32 80.85 1.37 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 35.48 112.19 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.55 ' CD1' HD13 ' A' ' 14' ' ' LEU . 26.9 p90 -74.7 154.23 38.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.062 0.458 . . . . 25.52 111.396 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -130.95 120.78 24.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 56.07 110.423 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 29.3 111.544 -179.505 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.732 HD13 ' CE2' ' A' ' 60' ' ' TYR . 3.6 tp . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.844 0.354 . . . . 25.61 110.989 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.07 -57.28 11.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 29.9 111.415 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.99 -21.88 64.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.064 0.394 . . . . 39.04 112.064 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.4 -25.5 20.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.117 0.414 . . . . 45.6 112.117 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.3 m -112.66 -46.45 3.14 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.118 0.414 . . . . 28.23 112.118 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.0 t -71.67 -57.48 4.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.313 . . . . 25.89 110.987 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.54 -35.29 79.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 32.64 110.739 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -137.83 146.78 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 41.06 110.42 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -60.59 147.88 40.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 42.62 110.957 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.3 p -141.14 -173.84 3.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 28.05 111.047 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -111.24 128.71 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 46.35 110.137 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.701 HD21 ' C ' ' B' ' 106' ' ' SER . 0.2 OUTLIER -52.76 -23.2 6.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.413 0.523 . . . . 23.79 112.413 -178.996 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -61.47 -28.4 69.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.684 0.278 . . . . 74.93 111.296 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -64.73 -29.22 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.567 -0.288 . . . . 64.42 111.218 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 54' ' ' LEU . 6.5 mt -56.22 -28.71 59.38 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.422 -0.354 . . . . 32.64 111.654 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.66 -29.94 66.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 41.86 111.256 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.7 mtm -63.86 -50.09 70.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 38.66 111.2 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 43' ' ' ILE . 97.7 m-85 -57.22 -29.15 63.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 25.27 111.491 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.26 134.17 56.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 25.04 111.071 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.44 163.81 43.82 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.077 -0.51 . . . . 36.05 111.138 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 94.5 Cg_endo -82.45 -23.12 4.33 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.136 1.891 . . . . 54.36 113.01 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.57 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.921 0.391 . . . . 71.54 111.538 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.804 0.335 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.64 32.74 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -89.24 -38.43 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.761 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.701 ' C ' HD21 ' A' ' 54' ' ' LEU . 33.2 t -155.8 174.96 14.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.756 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.537 HG13 HD13 ' A' ' 5' ' ' LEU . 46.0 t -67.24 -31.09 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.987 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 108' ' ' ALA . . . . . 0.572 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . . . -73.3 -42.71 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.243 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.84 82.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.523 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.493 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.263 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.803 0.335 . . . . 75.5 110.89 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.461 ' O ' HG11 ' B' ' 107' ' ' VAL . 28.7 p -120.02 174.37 6.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 31.38 110.857 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 9' ' ' GLU . 11.6 tp -140.12 116.57 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 28.27 111.146 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m -140.11 168.2 20.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 32.91 110.834 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.39 -150.11 49.43 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.748 -0.739 . . . . 19.09 112.856 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.74 -30.05 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.752 0.311 . . . . 21.73 111.319 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.475 ' HB3' HD11 ' A' ' 5' ' ' LEU . 32.8 mt-10 -59.19 -43.0 92.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 63.42 111.046 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -69.24 -43.52 73.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 20.39 110.595 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.75 -30.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 19.22 111.152 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -68.77 -37.53 79.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 31.0 111.057 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -70.31 -42.43 71.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.471 -0.331 . . . . 18.28 111.002 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.453 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.2 mt -60.25 -42.16 94.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.854 0.359 . . . . 22.05 110.516 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -68.57 -32.52 72.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 32.76 110.325 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -43.3 68.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 27.25 110.737 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 13' ' ' ALA . 22.6 t -81.76 -52.29 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.601 . . . . 25.51 111.413 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.9 m -83.23 -51.58 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 29.49 111.436 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.17 -109.83 2.34 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.752 -0.737 . . . . 40.61 112.797 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.87 7.3 13.22 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.889 0.7 . . . . 79.05 112.889 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.614 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.0 mmm180 -77.11 -39.82 48.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.05 0.386 . . . . 50.6 111.061 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.39 78.18 1.4 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.737 -0.744 . . . . 35.48 112.172 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.5 p90 -72.06 163.17 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.079 0.466 . . . . 25.52 111.494 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.99 151.82 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.694 -0.684 . . . . 56.07 110.543 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CD2' HG22 ' A' ' 43' ' ' ILE . 73.9 m-85 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 29.3 111.258 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.792 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.5 tt . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 111.609 0.226 . . . . 25.61 111.609 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.6 -61.17 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.9 0.381 . . . . 29.9 111.449 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.26 -17.11 64.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.395 -0.366 . . . . 39.04 111.955 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -90.28 -32.74 16.4 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.807 0.669 . . . . 45.6 112.807 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.45 -29.05 5.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.805 0.668 . . . . 28.23 112.805 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -79.95 -46.13 17.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.871 -0.331 . . . . 25.89 110.698 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -74.53 -37.7 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.052 0.453 . . . . 32.64 110.212 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -130.11 159.23 37.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 41.06 109.865 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 p -78.74 127.12 31.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.788 0.328 . . . . 42.62 111.389 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.78 -160.86 0.94 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.3 -0.409 . . . . 28.05 110.46 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.9 175.06 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.47 -0.332 . . . . 46.35 110.403 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.745 ' HG ' HD12 ' B' ' 110' ' ' LEU . 0.3 OUTLIER -91.11 -28.18 18.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.385 -0.37 . . . . 23.79 111.499 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -55.7 -26.01 42.9 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 111.706 0.262 . . . . 74.93 111.706 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -61.19 -29.16 69.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.663 0.268 . . . . 64.42 110.919 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.4 mt -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 32.64 111.567 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.22 -31.93 73.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 41.86 111.394 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.1 mtm -63.29 -53.08 58.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 38.66 111.217 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.792 ' CE2' HD12 ' A' ' 43' ' ' ILE . 86.7 m-85 -57.16 -26.12 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.189 -0.46 . . . . 25.27 111.721 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.43 130.39 46.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.84 0.353 . . . . 25.04 111.038 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -57.75 168.56 1.06 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.233 -0.44 . . . . 36.05 111.286 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 84.2 Cg_endo -81.2 -30.11 1.72 Allowed 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.088 1.859 . . . . 54.36 112.813 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 71.54 111.093 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.519 ' C ' HD23 ' A' ' 54' ' ' LEU . 13.6 m-85 -96.0 36.98 1.26 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.795 0.331 . . . . 0.0 111.335 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.63 -33.81 15.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 0.0 110.48 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.473 ' C ' HD21 ' A' ' 54' ' ' LEU . 70.3 m -150.97 174.45 13.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.607 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 4' ' ' THR . 21.0 t -73.43 -29.32 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.337 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.82 76.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.0 86.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.417 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.745 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.109 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.772 0.32 . . . . 75.5 110.826 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.5 p -135.68 166.78 22.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.169 -0.468 . . . . 31.38 110.783 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 9' ' ' GLU . 10.1 tp -124.13 116.33 22.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.372 -0.376 . . . . 28.27 111.431 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 m -140.56 161.32 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 32.91 110.933 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.03 -147.67 44.96 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.77 -0.729 . . . . 19.09 113.047 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.15 66.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 21.73 111.475 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HB3' HD11 ' A' ' 5' ' ' LEU . 48.8 mt-10 -60.63 -40.06 90.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 63.42 110.805 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.98 -43.58 74.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 20.39 110.587 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.94 -31.25 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 19.22 111.069 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.45 -31.0 67.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 31.0 111.008 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.819 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -74.1 -47.2 37.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 18.28 110.755 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.8 mt -60.46 -49.04 79.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 22.05 110.763 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -30.39 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 32.76 110.672 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -79.68 -35.16 39.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.427 -0.351 . . . . 27.25 110.937 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 13' ' ' ALA . 34.3 t -85.01 -57.47 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 25.51 111.039 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.4 m -77.67 -51.26 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 29.49 111.442 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.37 -115.09 6.78 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.61 -0.805 . . . . 40.61 112.691 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -82.5 7.55 14.08 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.686 0.624 . . . . 79.05 112.686 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.9 mmm180 -75.57 -32.7 60.48 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.973 -0.455 . . . . 50.6 111.017 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.04 83.3 1.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.61 -0.805 . . . . 35.48 112.151 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.62 ' CD1' HD13 ' A' ' 14' ' ' LEU . 35.6 p90 -76.96 157.88 31.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.972 0.415 . . . . 25.52 111.318 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -134.69 131.2 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 56.07 110.605 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 29.3 111.156 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.691 HD13 ' CE2' ' A' ' 60' ' ' TYR . 5.3 tp . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.7 0.286 . . . . 25.61 111.081 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.28 -52.46 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 29.9 111.293 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.2 m-20 -69.97 -24.71 63.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 39.04 111.811 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.51 -23.71 20.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.283 0.475 . . . . 45.6 112.283 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 55.8 m -116.0 -44.78 2.89 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.337 0.495 . . . . 28.23 112.337 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -75.02 -49.26 20.4 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.924 -0.311 . . . . 25.89 111.008 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 29.3 m-85 -72.15 -34.3 68.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.859 0.362 . . . . 32.64 110.577 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -134.68 149.86 50.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 41.06 110.273 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 p -67.41 136.54 54.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 42.62 110.821 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.4 p -130.1 -171.94 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 28.05 111.156 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.16 139.37 49.97 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.914 -0.585 . . . . 46.35 110.007 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.18 -28.84 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 23.79 111.541 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp85 -58.47 -29.21 66.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.776 0.322 . . . . 74.93 111.282 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -66.12 -28.37 68.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.378 -0.374 . . . . 64.42 111.302 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 54' ' ' LEU . 6.2 mt -56.93 -29.21 62.9 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.544 -0.298 . . . . 32.64 111.482 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.5 -31.37 69.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 41.86 111.047 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.8 mtm -61.36 -48.11 82.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 38.66 110.958 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.691 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.0 m-85 -59.15 -29.93 67.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 25.27 111.234 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.5 m -58.91 132.72 54.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 25.04 111.08 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -63.06 161.96 26.72 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.141 -0.481 . . . . 36.05 111.111 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 89.1 Cg_endo -77.81 -27.16 6.18 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.964 1.776 . . . . 54.36 112.545 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.608 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 71.54 111.071 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.644 0.259 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.449 ' C ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -97.68 33.19 2.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.779 0.323 . . . . 0.0 111.049 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.48 -34.12 11.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.001 0.429 . . . . 0.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.536 ' C ' HD21 ' A' ' 54' ' ' LEU . 70.6 m -154.38 175.16 13.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.298 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 15.4 t -76.62 -30.91 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 111.193 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.62 90.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.84 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.337 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.481 ' CD1' HD12 ' A' ' 54' ' ' LEU . 1.3 mt . . . . . 0 CA--C 1.531 0.212 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.235 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.9 0.381 . . . . 75.5 111.04 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.749 ' O ' HG11 ' B' ' 107' ' ' VAL . 43.0 p -119.91 174.2 6.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 31.38 110.775 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.823 HD13 HG13 ' B' ' 107' ' ' VAL . 7.2 tp -133.54 106.96 7.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 28.27 111.174 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.2 m -140.13 162.38 35.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.286 -0.415 . . . . 32.91 110.845 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.78 -143.35 38.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.713 -0.756 . . . . 19.09 112.634 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.79 -30.72 69.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.711 0.291 . . . . 21.73 111.218 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.42 -41.91 94.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 63.42 110.974 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.548 HD12 HD23 ' A' ' 5' ' ' LEU . 29.6 tp -70.46 -41.95 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 20.39 111.089 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -72.98 -33.47 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 19.22 111.142 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.54 -30.8 67.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 31.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -73.52 -47.27 42.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 18.28 110.902 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.758 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.6 mt -62.39 -50.26 72.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 22.05 110.647 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -61.33 -32.02 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 32.76 110.702 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -77.02 -36.4 56.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 27.25 110.91 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 13' ' ' ALA . 33.9 t -85.15 -66.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 25.51 110.844 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.17 -51.39 21.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 29.49 110.96 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.97 -126.08 41.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.899 -0.667 . . . . 40.61 112.983 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.2 -25.02 45.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.941 0.348 . . . . 79.05 111.941 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 mtm-85 -55.33 -25.97 37.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.918 0.34 . . . . 50.6 111.918 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.31 94.03 0.4 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.558 -0.829 . . . . 35.48 112.12 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.758 ' CD1' HD13 ' A' ' 14' ' ' LEU . 46.1 p90 -84.03 151.85 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.004 0.43 . . . . 25.52 111.552 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -131.41 134.64 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 56.07 110.386 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 29.3 111.176 -179.616 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.472 HD13 ' CE1' ' A' ' 60' ' ' TYR . 5.6 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.845 0.355 . . . . 25.61 111.202 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.9 t -64.97 -62.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 29.9 111.122 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.43 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -63.68 -24.03 67.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.251 -0.431 . . . . 39.04 111.976 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -90.77 -31.54 16.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.448 0.536 . . . . 45.6 112.448 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.21 -48.48 3.1 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.393 0.516 . . . . 28.23 112.393 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.9 t -63.41 -51.33 66.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.981 -0.287 . . . . 25.89 110.914 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.0 m-85 -65.38 -49.99 67.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 32.64 110.271 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -124.28 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 41.06 110.285 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 p -56.71 131.31 48.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.126 -0.488 . . . . 42.62 111.732 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -123.32 -163.29 1.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.329 -0.396 . . . . 28.05 110.844 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.63 134.84 54.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 46.35 110.128 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.624 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -55.64 -27.28 48.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 23.79 112.005 -179.085 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -58.26 -26.22 62.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.549 -0.296 . . . . 74.93 111.618 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -65.13 -26.85 68.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.55 0.214 . . . . 64.42 111.238 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.624 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.2 mt -56.18 -30.84 62.8 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.777 0.323 . . . . 32.64 111.545 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -68.35 -30.34 69.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 41.86 111.524 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.9 mtm -66.13 -39.39 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.855 0.36 . . . . 38.66 111.451 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 43' ' ' ILE . 70.9 m-85 -69.96 -24.61 63.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 25.27 112.045 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.11 138.45 58.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 25.04 110.789 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -65.61 173.76 1.83 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.165 -0.471 . . . . 36.05 110.915 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 92.6 Cg_endo -83.06 -26.77 2.18 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.03 1.82 . . . . 54.36 112.731 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 71.54 111.224 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.851 0.357 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -82.11 62.73 5.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.387 0.613 . . . . 0.0 110.949 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.44 -44.27 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.543 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 45.9 p -149.91 174.84 12.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.497 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.823 HG13 HD13 ' A' ' 5' ' ' LEU . 23.7 t -71.05 -35.57 59.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.009 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.3 -39.97 64.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.176 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.02 -42.33 85.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.594 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.848 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.883 0.373 . . . . 75.5 111.093 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' HG11 ' B' ' 107' ' ' VAL . 37.8 p -133.98 -178.33 4.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 31.38 110.74 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 tp -137.91 107.4 6.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.489 -0.323 . . . . 28.27 111.247 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.2 157.13 46.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 32.91 111.029 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.0 -142.88 36.99 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.926 -0.654 . . . . 19.09 112.878 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.69 63.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.691 0.281 . . . . 21.73 111.633 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.33 -40.82 92.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.386 . . . . 63.42 110.918 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.551 HD11 HG12 ' A' ' 43' ' ' ILE . 21.9 tp -71.94 -44.89 62.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 20.39 110.643 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.12 -29.91 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 19.22 111.238 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.54 -41.08 76.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.329 -0.396 . . . . 31.0 111.02 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.721 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -65.57 -48.93 70.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 18.28 111.194 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.4 mt -59.91 -46.08 90.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 22.05 110.919 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -66.44 -31.6 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 32.76 110.783 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -77.32 -31.96 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 27.25 110.808 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.4 t -89.48 -67.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 25.51 110.804 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.2 m -70.45 -51.64 27.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 29.49 111.173 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.63 -115.88 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 40.61 112.739 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.45 7.53 19.43 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.825 0.676 . . . . 79.05 112.825 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 1.2 mmm180 -69.11 -30.47 68.76 Favored 'General case' 0 C--O 1.231 0.09 0 O-C-N 122.032 -0.418 . . . . 50.6 111.052 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 60.63 1.29 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 35.48 111.906 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.583 ' CD1' HD13 ' A' ' 14' ' ' LEU . 22.1 p90 -57.1 155.33 8.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 25.52 111.783 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.23 147.94 47.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.499 -0.773 . . . . 56.07 110.214 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.546 -0.297 . . . . 29.3 111.133 -179.618 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.551 HG12 HD11 ' A' ' 10' ' ' LEU . 2.6 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.778 0.323 . . . . 25.61 110.933 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.73 -65.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 29.9 111.073 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.17 -22.95 67.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.376 -0.375 . . . . 39.04 111.784 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -90.43 -30.65 17.22 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.263 0.468 . . . . 45.6 112.263 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.21 -51.12 2.9 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 28.23 112.274 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.24 -55.26 34.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.73 0.3 . . . . 25.89 110.92 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.98 -55.0 33.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.956 0.408 . . . . 32.64 110.216 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -122.87 147.15 46.89 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 116.004 -0.544 . . . . 41.06 109.967 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.6 p -58.73 133.98 56.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.78 0.324 . . . . 42.62 111.461 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.4 p -118.65 -164.47 1.04 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.892 0.377 . . . . 28.05 111.016 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.31 129.61 56.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.051 -0.522 . . . . 46.35 110.398 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.789 HD22 ' CD1' ' B' ' 110' ' ' LEU . 92.8 mt -54.08 -35.52 62.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.794 -0.639 . . . . 23.79 112.346 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -55.74 -26.43 45.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.779 0.289 . . . . 74.93 111.779 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.697 0.284 . . . . 64.42 111.115 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.6 mt -55.05 -29.28 57.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.28 -0.418 . . . . 32.64 111.799 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.56 -25.89 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 41.86 112.0 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.19 -45.54 55.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 38.66 110.906 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CE1' HD13 ' A' ' 43' ' ' ILE . 55.9 m-85 -60.85 -26.26 67.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.164 -0.471 . . . . 25.27 111.312 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.6 m -59.23 147.12 36.74 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.746 0.308 . . . . 25.04 110.902 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -80.47 160.71 66.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 36.05 110.929 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.5 Cg_endo -75.9 -30.17 6.19 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.905 1.737 . . . . 54.36 112.499 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.414 -0.357 . . . . 71.54 111.058 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 29.3 t . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.621 0.248 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' B' B ' 104' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 54' ' ' LEU . 18.8 m-85 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.782 0.325 . . . . 0.0 111.125 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -79.43 -51.04 9.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 110.574 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 106' ' ' SER . . . . . 0.724 ' O ' HD11 ' A' ' 54' ' ' LEU . 49.7 p -149.4 174.14 12.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 4' ' ' THR . 21.2 t -56.01 -29.72 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.871 0.367 . . . . 0.0 111.673 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.88 -39.08 83.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.957 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.25 43.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.025 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.789 ' CD1' HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 0.0 110.728 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.855 0.36 . . . . 75.5 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' THR . . . . . 0.678 ' O ' HG11 ' B' ' 107' ' ' VAL . 43.8 p -127.35 170.88 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 31.38 110.807 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' LEU . . . . . 0.588 HD13 HG13 ' B' ' 107' ' ' VAL . 11.5 tp -133.05 109.82 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 28.27 111.265 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 m -140.07 163.24 33.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 32.91 110.902 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -146.15 42.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 19.09 112.867 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.22 -31.81 67.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.804 0.335 . . . . 21.73 111.533 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -59.61 -44.09 93.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 63.42 110.905 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.05 -44.97 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 20.39 110.697 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.25 -31.53 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 19.22 111.101 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.58 -49.24 74.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 31.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' ALA . . . . . 0.799 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.44 -50.69 72.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 18.28 111.339 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.661 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -58.61 -43.12 89.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.303 -0.408 . . . . 22.05 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -70.42 -32.03 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 32.76 110.667 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -79.04 -31.35 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 27.25 110.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.3 t -88.28 -68.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 25.51 111.112 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -71.22 -51.66 23.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 29.49 111.21 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.94 -112.87 3.48 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.995 -0.622 . . . . 40.61 113.089 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.89 -27.98 69.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 79.05 111.449 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ARG . . . . . 0.696 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.7 OUTLIER -55.47 -27.31 47.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.796 0.295 . . . . 50.6 111.796 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.45 108.63 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 35.48 112.033 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' PHE . . . . . 0.661 ' CD1' HD13 ' A' ' 14' ' ' LEU . 29.2 p90 -95.82 150.06 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.448 . . . . 25.52 111.266 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -126.62 120.6 29.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 56.07 110.492 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 29.3 111.401 -179.773 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ILE . . . . . 0.785 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.6 tp . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.797 0.332 . . . . 25.61 111.094 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.59 -65.56 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 29.9 111.16 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.1 m-20 -60.86 -22.38 64.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.277 -0.419 . . . . 39.04 111.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.68 -38.04 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.115 0.413 . . . . 45.6 112.115 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.42 -49.73 3.38 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.362 0.504 . . . . 28.23 112.362 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.0 t -60.67 -50.77 72.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.728 0.299 . . . . 25.89 111.134 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 10.5 m-85 -66.99 -49.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 32.64 110.513 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 140.58 52.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.107 -0.497 . . . . 41.06 110.449 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -57.09 125.01 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.018 -0.537 . . . . 42.62 111.565 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.0 -163.06 0.89 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.327 -0.397 . . . . 28.05 110.937 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.34 141.22 46.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 46.35 110.149 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.73 HD12 ' CD1' ' B' ' 110' ' ' LEU . 3.4 mm? -64.59 -27.55 69.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 23.79 111.531 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.2 mtp-105 -58.13 -29.0 65.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.693 0.282 . . . . 74.93 111.314 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -61.23 -26.69 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 64.42 111.504 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 54' ' ' LEU . 9.8 mt -55.77 -29.23 59.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.719 0.295 . . . . 32.64 111.679 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -30.69 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 41.86 111.029 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -61.9 -49.47 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 38.66 111.186 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . 0.785 ' CE2' HD13 ' A' ' 43' ' ' ILE . 98.7 m-85 -58.44 -28.77 65.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.043 -0.526 . . . . 25.27 111.527 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 54.1 m -59.42 138.76 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.908 0.385 . . . . 25.04 111.241 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -74.44 166.14 47.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.016 -0.538 . . . . 36.05 111.165 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 87.6 Cg_endo -81.63 -25.13 3.84 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.145 1.897 . . . . 54.36 112.869 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 64' ' ' LEU . . . . . 0.566 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 71.54 111.368 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.67 0.271 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -92.62 47.9 1.33 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.154 0.502 . . . . 0.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -93.17 -34.18 13.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.527 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.2 t -160.12 174.67 13.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.599 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 107' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 4' ' ' THR . 33.1 t -67.14 -34.95 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.797 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.76 65.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.11 86.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.515 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' B' B ' 110' ' ' LEU . . . . . 0.73 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.958 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 CA-C-O 119.739 -0.479 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.22 161.5 44.34 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.97 1.78 . . . . 0.0 112.356 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -105.32 106.96 17.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 75.5 110.941 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.75 ' O ' HG11 ' B' ' 107' ' ' VAL . 14.2 p -128.99 170.81 13.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 31.38 110.769 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.784 HD13 HG13 ' B' ' 107' ' ' VAL . 8.5 tp -130.87 110.08 11.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 28.27 111.164 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.5 m -140.19 161.19 38.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 32.91 110.766 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -143.04 37.32 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.792 -0.718 . . . . 19.09 112.669 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.31 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.723 0.297 . . . . 21.73 111.201 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.14 -40.4 89.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 63.42 110.996 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 -46.64 62.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 20.39 110.828 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.25 -33.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 19.22 111.165 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.3 -42.34 96.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 31.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.79 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -64.17 -49.21 72.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 18.28 111.072 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.642 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.26 -39.82 88.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 22.05 110.905 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -74.69 -31.75 61.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 32.76 110.701 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -77.9 -32.01 51.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 27.25 110.837 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 13' ' ' ALA . 37.4 t -87.64 -67.68 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 25.51 110.831 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.4 m -70.41 -51.49 29.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 29.49 110.922 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.5 -113.31 5.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.772 . . . . 40.61 112.918 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.09 7.48 13.3 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.892 0.701 . . . . 79.05 112.892 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -76.11 -30.99 58.46 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.969 -0.457 . . . . 50.6 110.886 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.19 75.98 1.31 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.648 -0.787 . . . . 35.48 112.197 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.642 ' CD1' HD13 ' A' ' 14' ' ' LEU . 31.0 p90 -69.86 150.35 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 25.52 111.333 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.431 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 3.0 p90 -124.78 138.91 54.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 56.07 110.462 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD2' ' CG2' ' A' ' 43' ' ' ILE . 14.7 m-85 -77.94 -42.85 31.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 29.3 111.278 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -99.48 120.64 39.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 38.35 111.259 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -150.61 150.04 27.5 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.996 -0.547 . . . . 42.35 110.822 179.574 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.42 160.91 33.3 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.957 1.771 . . . . 40.8 112.38 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.5 p -151.29 -47.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.956 -0.566 . . . . 55.75 110.759 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.41 -81.86 1.32 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.855 -0.688 . . . . 34.94 112.536 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -159.96 125.67 4.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.34 . . . . 34.26 110.865 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -119.27 50.9 0.79 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.876 -0.678 . . . . 36.13 112.473 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.7 t -150.06 -48.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 57.93 110.859 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.1 t -78.65 -38.83 38.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.85 110.876 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 m -87.7 124.18 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.3 ttp-105 -87.7 -58.58 2.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.04 111.84 7.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.73 133.89 6.64 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.019 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.66 171.46 12.04 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.005 1.803 . . . . 0.0 112.44 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -95.46 119.56 34.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -162.3 142.51 9.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 64.04 110.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.2 -90.86 0.12 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.773 -0.727 . . . . 35.08 112.37 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.764 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.5 tp -103.0 -30.95 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 25.61 110.823 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.24 -68.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.27 -0.423 . . . . 29.9 111.058 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.8 -17.6 37.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.101 0.408 . . . . 39.04 112.101 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.45 -38.48 13.24 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.936 0.717 . . . . 45.6 112.936 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.12 -27.69 7.93 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.993 0.738 . . . . 28.23 112.993 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.64 -45.2 22.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 25.89 110.633 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -79.86 -35.92 37.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 32.64 110.395 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mtp85 -123.92 156.32 36.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 41.06 110.071 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -82.41 111.58 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.795 0.331 . . . . 42.62 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.1 p -105.49 -163.05 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.849 0.357 . . . . 28.05 110.974 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -113.75 147.47 38.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 46.35 110.287 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.784 ' CD2' HD12 ' B' ' 110' ' ' LEU . 8.5 mp -63.49 -27.29 69.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 23.79 111.705 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -58.32 -26.9 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.606 0.241 . . . . 74.93 111.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -60.76 -29.81 69.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.604 0.24 . . . . 64.42 111.07 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.4 mt -56.86 -30.96 64.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 32.64 111.619 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -69.34 -34.11 74.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.449 -0.341 . . . . 41.86 111.413 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.2 mtm -58.66 -45.01 90.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.924 0.392 . . . . 38.66 111.305 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.764 ' CE2' HD13 ' A' ' 43' ' ' ILE . 79.5 m-85 -67.49 -27.74 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 25.27 111.586 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.6 m -60.53 130.76 48.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 25.04 110.775 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.02 162.24 55.64 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.212 -0.449 . . . . 36.05 111.184 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 75.8 Cg_endo -76.18 -25.53 9.99 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.008 1.806 . . . . 54.36 112.713 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 pp -58.34 170.95 0.64 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.825 0.345 . . . . 71.54 111.273 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -148.37 140.04 14.16 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.85 -169.18 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.895 1.73 . . . . 0.0 112.322 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.28 148.49 23.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -164.99 153.12 11.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 t -86.15 131.0 34.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.162 -0.923 . . . . 20.0 111.138 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.924 0.392 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -65.13 133.97 52.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.003 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 4.7 m -82.98 -41.46 18.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.937 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.416 ' HA ' HD22 ' A' ' 54' ' ' LEU . 19.7 m-85 -82.01 72.24 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.08 0.467 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -125.62 -45.38 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.625 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -144.82 174.62 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.797 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 5' ' ' LEU . 33.0 t -68.64 -30.75 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.094 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.16 -39.56 65.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.267 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.93 -40.17 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.832 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.784 HD12 ' CD2' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -59.76 -43.74 94.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 0.0 110.992 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -64.96 -51.24 62.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -59.66 -40.48 87.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 55.9 m -62.89 -47.28 84.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 29.9 ttp -72.86 -52.17 15.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -73.3 71.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.339 -1.256 . . . . 20.0 112.551 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 CA-C-O 119.682 -0.51 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.9 -168.8 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.968 1.779 . . . . 0.0 112.454 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.91 108.17 18.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 75.5 110.974 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.57 ' O ' HG11 ' B' ' 107' ' ' VAL . 27.0 p -129.96 176.29 8.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 31.38 110.823 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.464 HD13 HG13 ' B' ' 107' ' ' VAL . 10.2 tp -136.27 115.52 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 28.27 111.164 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 m -140.23 159.79 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 32.91 111.013 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.32 -146.6 44.43 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.792 -0.718 . . . . 19.09 112.811 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.26 66.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.732 0.301 . . . . 21.73 111.32 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 63.42 110.748 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 tp -71.69 -49.69 37.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 20.39 110.516 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.08 -32.01 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 19.22 111.002 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.47 -44.36 87.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 31.0 110.846 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.765 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.79 -48.02 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 18.28 111.071 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.724 HD13 ' CD1' ' A' ' 23' ' ' PHE . 14.2 mt -60.38 -41.74 94.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 22.05 110.764 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.99 -31.98 64.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 32.76 110.736 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -76.84 -30.9 56.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.506 . . . . 27.25 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.1 t -90.1 -56.78 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 25.51 110.939 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.14 -51.34 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 29.49 111.178 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.49 -112.51 5.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 40.61 112.593 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.85 7.75 22.79 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.777 0.658 . . . . 79.05 112.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.677 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.6 mtm180 -81.76 -33.39 30.97 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 122.106 -0.371 . . . . 50.6 111.152 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.52 115.13 1.97 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.655 -0.783 . . . . 35.48 112.141 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.724 ' CD1' HD13 ' A' ' 14' ' ' LEU . 20.6 p90 -106.13 156.29 18.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 25.52 111.456 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 2.5 p90 -124.6 127.7 47.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 56.07 110.322 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -66.28 -27.37 67.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.372 -0.376 . . . . 29.3 111.665 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -88.87 138.86 31.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.399 . . . . 38.35 111.318 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 15.2 tptp -135.08 133.21 20.66 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.958 -0.564 . . . . 42.35 110.821 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -76.74 160.83 34.18 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.857 1.705 . . . . 40.8 112.318 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 30' ' ' GLY . 9.2 t -172.58 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 55.75 110.924 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' N ' HG23 ' A' ' 29' ' ' THR . . . -99.36 -100.42 2.26 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 34.94 112.543 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -85.23 -34.95 21.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 34.26 110.867 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.04 113.41 3.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.784 -0.722 . . . . 36.13 112.5 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -89.94 107.07 18.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.339 . . . . 57.93 111.011 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.5 p -157.8 -56.39 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 72.85 110.922 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 p -90.59 -52.22 5.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -87.39 159.93 18.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.7 139.34 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -156.25 165.26 18.99 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.605 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 44.3 Cg_endo -67.72 167.03 22.23 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.86 1.707 . . . . 0.0 112.227 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -101.12 128.54 47.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -177.56 127.77 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.056 -0.52 . . . . 64.04 110.719 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.95 -107.12 0.23 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 35.08 112.727 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.431 HD13 ' CE1' ' A' ' 60' ' ' TYR . 1.9 tp -72.05 -38.93 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 25.61 111.099 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.08 -59.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 29.9 111.49 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.43 -22.58 64.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.293 -0.412 . . . . 39.04 112.088 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.21 -23.71 21.19 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.437 0.532 . . . . 45.6 112.437 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.0 m -114.2 -43.63 3.2 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.067 0.395 . . . . 28.23 112.067 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -74.5 -54.04 8.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.74 0.305 . . . . 25.89 110.95 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.97 -32.61 67.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 32.64 110.652 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -133.0 150.86 52.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.515 . . . . 41.06 110.499 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.8 p -73.09 127.56 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 42.62 110.995 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.62 -173.25 2.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 28.05 111.132 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.88 54.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 46.35 109.824 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.697 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -51.02 -24.92 4.15 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 23.79 112.419 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -63.35 -30.51 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 74.93 111.113 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.51 -30.04 62.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.327 -0.397 . . . . 64.42 111.703 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.2 mt -56.39 -34.8 67.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 32.64 111.953 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.28 -24.38 63.03 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.9 0.333 . . . . 41.86 111.9 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -68.13 -34.22 75.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 38.66 110.942 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CE1' HD13 ' A' ' 43' ' ' ILE . 44.0 m-85 -78.75 -28.72 44.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 25.27 111.434 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.4 m -60.43 126.43 27.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 25.04 110.808 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.721 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -58.04 153.77 32.87 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.27 -0.423 . . . . 36.05 111.371 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 -24.55 13.0 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.971 1.78 . . . . 54.36 112.728 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.721 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -58.16 -179.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.898 0.38 . . . . 71.54 111.366 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -145.89 161.97 37.78 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.725 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.42 113.13 2.34 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.882 1.721 . . . . 0.0 112.349 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.45 -68.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -160.61 145.69 14.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.1 p -83.19 151.66 25.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 20.0 111.061 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.848 0.356 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -113.3 139.23 49.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.02 -30.61 27.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -97.92 36.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.35 -42.09 9.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.0 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.565 ' CA ' HD21 ' A' ' 54' ' ' LEU . 70.2 m -144.74 175.9 9.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 4' ' ' THR . 27.6 t -72.13 -30.11 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.138 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.08 -39.96 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.041 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.78 84.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.298 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.54 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -63.12 -42.85 99.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.419 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.72 -53.8 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.585 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -56.83 -34.36 67.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.739 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 63.7 m -58.24 -44.99 88.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.649 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 4.5 ttp -76.54 -52.75 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -74.91 -49.78 19.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 111.746 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 118.453 -1.193 . . . . 20.0 112.519 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.09 129.26 13.0 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.028 1.819 . . . . 0.0 112.431 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -146.24 110.77 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 75.5 110.964 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 p -134.22 161.84 33.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 31.38 110.456 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 5' ' ' LEU . 9.9 tp -119.98 115.62 24.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 28.27 111.165 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.25 164.22 30.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 32.91 110.991 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.8 -143.6 46.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.84 -0.695 . . . . 19.09 112.848 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.8 68.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 21.73 111.283 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HB3' HD11 ' A' ' 5' ' ' LEU . 45.4 mt-10 -60.82 -39.94 90.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 63.42 110.742 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.6 tp -67.76 -46.69 71.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 20.39 110.542 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.84 -31.86 49.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 19.22 110.878 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.97 -36.48 84.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 31.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.776 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -71.94 -46.47 57.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 18.28 111.025 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.31 -43.03 96.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 22.05 110.795 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -68.9 -31.76 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 32.76 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.17 -31.71 49.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 27.25 110.837 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 13' ' ' ALA . 34.0 t -88.9 -67.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 25.51 110.881 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.25 -51.25 25.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 29.49 110.984 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.57 -115.12 6.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.668 -0.777 . . . . 40.61 112.731 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.81 7.37 15.33 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.729 0.64 . . . . 79.05 112.729 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -70.29 -35.92 74.03 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 118.097 0.408 . . . . 50.6 110.886 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.37 62.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 35.48 112.255 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.506 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.5 p90 -59.2 159.45 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 25.52 111.271 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.05 123.9 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 56.07 110.637 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -59.23 -75.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 29.3 111.074 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.39 126.45 27.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 38.35 110.941 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -102.63 91.67 2.92 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.148 -0.478 . . . . 42.35 110.753 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.13 -175.6 2.03 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.051 1.834 . . . . 40.8 112.45 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.1 p -133.61 95.69 3.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.474 . . . . 55.75 110.899 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.08 -89.66 1.13 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.72 -0.752 . . . . 34.94 112.525 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -97.5 -43.65 7.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 34.26 110.901 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.98 123.79 4.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.687 -0.768 . . . . 36.13 112.527 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.6 p -96.59 163.76 12.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 57.93 110.893 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.1 m -94.41 -65.24 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 72.85 110.91 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 p -158.9 103.17 1.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.32 -68.92 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.748 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -162.92 34.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.04 145.34 50.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.33 -168.64 0.45 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.94 1.76 . . . . 0.0 112.355 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -89.81 128.04 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.8 p -145.03 145.15 31.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 64.04 110.941 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.83 -120.23 0.86 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.752 -0.737 . . . . 35.08 112.534 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.574 HD13 ' CE2' ' A' ' 60' ' ' TYR . 3.3 tp -77.17 -39.88 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.796 0.331 . . . . 25.61 110.997 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.61 -54.13 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 29.9 111.466 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.411 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.1 m-20 -70.89 -23.3 62.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 39.04 111.954 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -90.06 -23.89 21.32 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.221 0.452 . . . . 45.6 112.221 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -115.66 -45.7 2.88 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.098 0.407 . . . . 28.23 112.098 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.0 t -73.1 -51.37 18.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.676 0.274 . . . . 25.89 111.117 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 26.5 m-85 -70.4 -32.47 70.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.895 0.378 . . . . 32.64 110.809 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -137.92 147.28 44.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 41.06 110.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -65.16 134.07 52.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 42.62 110.983 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -126.34 -172.51 2.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 28.05 111.066 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -116.68 142.98 46.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 46.35 110.088 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.756 HD23 ' CD1' ' B' ' 110' ' ' LEU . 2.1 mp -55.55 -27.57 49.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 23.79 111.937 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -60.59 -26.46 66.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.549 -0.296 . . . . 74.93 111.578 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.4 -30.55 70.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.806 0.336 . . . . 64.42 111.159 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.4 mt -57.1 -28.7 62.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 32.64 111.676 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -32.31 71.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 41.86 111.139 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.54 -43.81 96.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.394 -0.366 . . . . 38.66 111.094 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.3 m-85 -69.24 -27.61 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 25.27 111.546 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.5 m -59.58 132.23 53.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 25.04 110.954 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -63.83 162.81 26.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.151 -0.477 . . . . 36.05 111.244 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 94.9 Cg_endo -79.1 -32.11 1.96 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.056 1.837 . . . . 54.36 112.581 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -59.88 157.33 12.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 71.54 111.077 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 158.0 44.32 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.64 -35.3 4.75 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.914 1.743 . . . . 0.0 112.349 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -135.19 121.67 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.149 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -112.06 155.81 23.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.973 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.4 p -89.6 -42.49 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.29 -0.862 . . . . 20.0 111.133 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.815 0.341 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -116.39 124.95 51.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.9 t -82.93 -34.05 26.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.538 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -94.63 46.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.468 0.651 . . . . 0.0 110.665 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -109.66 -30.8 7.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.966 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.653 ' O ' HD21 ' A' ' 54' ' ' LEU . 66.0 m -156.37 -179.02 7.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.156 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.401 HG13 HD13 ' A' ' 5' ' ' LEU . 51.4 t -80.66 -28.75 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.121 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.63 -39.49 73.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.353 . . . . 0.0 111.478 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -36.91 66.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.997 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.756 ' CD1' HD23 ' A' ' 54' ' ' LEU . 4.6 mt -58.11 -44.73 87.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.256 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -59.08 -45.46 90.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.189 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -34.77 76.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.103 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 96.5 m -61.32 -49.07 78.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.699 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 4.0 mmt -76.31 -52.64 9.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -77.54 -49.44 14.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 111.428 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.368 -1.24 . . . . 20.0 112.504 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 119.724 -0.486 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.23 -179.66 3.29 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.932 1.755 . . . . 0.0 112.291 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -99.96 100.01 10.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 75.5 110.925 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.565 ' O ' HG11 ' B' ' 107' ' ' VAL . 44.3 p -127.93 178.1 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 31.38 110.585 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.642 HD13 HG13 ' B' ' 107' ' ' VAL . 8.1 tp -135.48 108.99 7.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 28.27 111.099 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.5 m -140.16 167.88 21.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.196 -0.456 . . . . 32.91 110.992 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.62 -137.19 50.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.879 -0.677 . . . . 19.09 112.778 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.91 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.638 0.256 . . . . 21.73 111.343 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.84 -42.53 97.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.385 -0.37 . . . . 63.42 110.989 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.434 HD11 HG12 ' A' ' 43' ' ' ILE . 47.7 tp -68.72 -42.68 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 20.39 110.936 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.67 -34.58 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 19.22 110.928 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.23 -35.04 79.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 31.0 110.967 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' B' ' 110' ' ' LEU . . . -72.99 -49.38 29.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 18.28 111.363 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.7 HD13 ' CD1' ' A' ' 23' ' ' PHE . 11.8 mt -57.9 -30.41 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 22.05 111.171 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -80.78 -31.48 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 32.76 110.609 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' B' ' 113' ' ' CYS . 34.7 t80 -76.6 -33.88 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 27.25 110.81 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 13' ' ' ALA . 25.3 t -89.48 -40.36 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 25.51 111.406 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 m -100.27 -51.93 3.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 29.49 111.315 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.18 -110.38 3.17 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.655 -0.783 . . . . 40.61 112.723 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.19 7.62 37.14 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.846 0.684 . . . . 79.05 112.846 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.559 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -66.67 -38.45 86.84 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.029 -0.419 . . . . 50.6 110.844 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.88 60.41 0.88 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 35.48 112.233 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.0 p90 -58.07 140.56 52.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 25.52 111.345 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.415 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 8.0 p90 -123.96 127.69 48.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 56.07 110.501 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -58.03 -67.42 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 29.3 111.509 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -80.22 104.26 10.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 38.35 111.329 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -90.71 -47.26 0.37 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.238 -0.437 . . . . 42.35 111.451 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.641 ' O ' HG23 ' A' ' 29' ' ' THR . 62.6 Cg_endo -87.43 -170.05 0.55 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.245 1.963 . . . . 40.8 112.658 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 28' ' ' PRO . 2.0 p -164.42 32.22 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.948 -0.569 . . . . 55.75 110.676 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.29 -145.39 0.13 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.878 -0.677 . . . . 34.94 112.677 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -103.32 -175.09 2.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 34.26 110.988 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.92 -113.42 4.45 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 36.13 112.483 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.7 p -90.45 -43.69 10.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 57.93 110.917 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -91.86 107.68 19.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 72.85 110.9 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.6 p -148.8 -65.54 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.94 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.86 161.26 19.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -91.09 97.93 11.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -168.94 -64.17 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.089 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 59.1 Cg_endo -71.07 -171.21 0.56 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.847 1.698 . . . . 0.0 112.334 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -136.81 124.94 22.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 40' ' ' GLN . 38.6 p -157.78 150.5 22.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 64.04 110.859 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.26 -101.33 0.22 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.748 -0.739 . . . . 35.08 112.626 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.582 HD13 ' CE1' ' A' ' 60' ' ' TYR . 2.9 tp -72.51 -35.89 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.724 0.297 . . . . 25.61 111.05 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.98 -58.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 29.9 111.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.59 -22.58 63.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 39.04 112.027 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.17 -19.76 23.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.562 0.578 . . . . 45.6 112.562 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.8 m -121.81 -41.74 2.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.192 0.441 . . . . 28.23 112.192 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.7 t -73.97 -53.9 9.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 25.89 110.963 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -65.67 -34.05 77.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 32.64 110.617 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -139.01 148.31 43.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 41.06 110.717 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 p -65.73 131.88 47.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 42.62 110.989 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.0 p -122.17 -171.92 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 28.05 110.883 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -111.53 132.78 54.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 46.35 110.131 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.556 HD23 ' C ' ' B' ' 104' ' ' PHE . 0.3 OUTLIER -53.43 -24.28 12.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.332 0.493 . . . . 23.79 112.332 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.65 -26.96 67.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.477 0.177 . . . . 74.93 111.477 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.456 ' NE ' ' HE2' ' A' ' 59' ' ' MET . 20.9 mmm180 -68.58 -28.83 67.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.649 0.261 . . . . 64.42 111.271 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.8 mt -56.08 -28.84 59.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.447 -0.342 . . . . 32.64 111.788 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -68.66 -32.22 71.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 41.86 111.193 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.456 ' HE2' ' NE ' ' A' ' 56' ' ' ARG . 71.3 mtm -62.64 -49.77 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 38.66 111.148 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.582 ' CE1' HD13 ' A' ' 43' ' ' ILE . 84.6 m-85 -56.83 -28.56 61.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 25.27 111.675 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -59.23 141.73 53.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 25.04 111.197 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.772 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -78.43 176.59 3.49 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.235 -0.438 . . . . 36.05 110.985 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.772 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 93.5 Cg_endo -83.21 -34.81 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.018 1.812 . . . . 54.36 112.701 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.451 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -59.49 148.38 33.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 71.54 111.058 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.19 159.94 31.94 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.22 -179.04 4.87 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.957 1.772 . . . . 0.0 112.374 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.08 170.76 7.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.81 -48.83 4.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.975 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -67.72 158.95 31.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.183 -0.913 . . . . 20.0 111.077 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.821 0.344 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.7 137.91 38.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.85 -26.23 40.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.421 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.556 ' C ' HD23 ' A' ' 54' ' ' LEU . 2.8 m-30 -96.52 32.84 1.93 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.718 0.295 . . . . 0.0 111.353 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -88.51 -33.49 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.892 0.377 . . . . 0.0 110.447 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.54 ' C ' HD21 ' A' ' 54' ' ' LEU . 50.8 p -155.86 174.82 14.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.407 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 5' ' ' LEU . 21.2 t -74.08 -30.87 28.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.131 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.19 96.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.83 83.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.078 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.531 HD21 ' CB ' ' A' ' 13' ' ' ALA . 26.6 tp -58.68 -43.21 89.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.157 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -64.84 -43.02 94.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.968 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -60.8 -37.27 81.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.027 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 113' ' ' CYS . . . . . 0.416 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 3.7 m -59.36 -46.93 87.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.056 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 8.9 tpt -67.56 -51.7 47.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -80.25 71.24 7.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.418 -1.212 . . . . 20.0 112.454 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 CA-C-O 119.789 -0.45 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.84 -168.71 0.38 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.926 1.751 . . . . 0.0 112.342 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.06 101.61 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 75.5 110.896 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.703 ' O ' HG11 ' B' ' 107' ' ' VAL . 13.0 p -129.33 -171.39 2.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 31.38 110.607 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.418 HD13 HG13 ' B' ' 107' ' ' VAL . 9.1 tp -140.28 111.84 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.494 -0.321 . . . . 28.27 111.195 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.4 m -140.15 162.95 34.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 32.91 111.148 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.91 -139.53 48.37 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.815 -0.707 . . . . 19.09 113.052 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.34 64.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.625 0.25 . . . . 21.73 111.485 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.0 -39.79 91.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.439 -0.346 . . . . 63.42 110.855 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.477 HD11 HG12 ' A' ' 43' ' ' ILE . 32.6 tp -71.81 -45.38 61.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 20.39 110.737 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.12 -31.41 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 19.22 111.019 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.62 -45.01 84.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 31.0 111.008 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.971 ' HB2' HD21 ' B' ' 110' ' ' LEU . . . -64.19 -47.33 80.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 18.28 111.155 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -60.74 -36.25 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 22.05 110.798 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -79.1 -31.58 44.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 32.76 110.794 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -79.0 -31.7 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 27.25 110.869 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.4 t -88.14 -68.1 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 25.51 110.945 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.8 m -67.99 -51.32 48.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 29.49 111.053 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.35 -114.3 5.37 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.767 . . . . 40.61 112.835 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -84.41 7.55 19.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.805 0.668 . . . . 79.05 112.805 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.5 mmm180 -71.95 -30.74 65.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.036 0.38 . . . . 50.6 110.936 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.34 67.72 1.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 35.48 112.082 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.674 ' CD1' HD13 ' A' ' 14' ' ' LEU . 30.6 p90 -60.46 164.85 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 25.52 111.501 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 27' ' ' LYS . 3.5 p90 -144.32 125.25 14.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.72 -0.673 . . . . 56.07 110.465 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -58.23 -69.88 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 29.3 111.428 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -83.34 127.43 33.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.427 -0.351 . . . . 38.35 111.189 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -139.7 148.8 57.17 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.143 -0.48 . . . . 42.35 110.776 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.95 142.5 31.51 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.88 1.72 . . . . 40.8 112.351 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.7 p -117.6 135.7 53.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 55.75 110.866 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.41 87.3 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.748 . . . . 34.94 112.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -89.79 148.85 22.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 34.26 110.927 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.36 66.52 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 36.13 112.586 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.2 m -93.91 -58.56 2.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 57.93 110.855 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.2 p -147.55 -63.37 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 72.85 110.928 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.8 m -159.45 -74.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -90.11 128.71 36.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 tpt85 -131.36 157.03 44.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -66.16 162.15 49.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 48.1 Cg_endo -68.49 140.92 49.17 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.958 1.772 . . . . 0.0 112.367 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -107.32 142.53 36.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.81 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.5 p -128.32 -172.94 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 64.04 111.027 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.25 -130.75 5.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 35.08 112.663 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.579 HD13 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -97.67 -32.07 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.786 0.327 . . . . 25.61 111.009 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.69 -64.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 29.9 111.682 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 12.0 m-20 -67.47 -19.73 65.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.276 -0.42 . . . . 39.04 112.116 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.29 -25.56 20.46 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 111.961 0.356 . . . . 45.6 111.961 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 96.9 m -117.25 -51.52 2.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.108 0.41 . . . . 28.23 112.108 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 t -63.43 -44.04 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 25.89 111.153 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.4 m-85 -74.96 -49.23 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.443 -0.344 . . . . 32.64 110.604 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.84 150.0 45.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 41.06 110.364 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 143.39 56.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.899 0.38 . . . . 42.62 111.02 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 p -138.03 -166.36 1.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.132 -0.485 . . . . 28.05 110.932 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -113.55 138.79 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 46.35 109.851 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.729 HD12 HD22 ' B' ' 110' ' ' LEU . 3.3 mm? -61.32 -27.03 68.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.564 -0.289 . . . . 23.79 111.524 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -55.81 -26.51 46.73 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.736 0.273 . . . . 74.93 111.736 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -63.1 -28.07 69.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.68 0.276 . . . . 64.42 111.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.572 HD11 HD12 ' A' ' 54' ' ' LEU . 6.9 mt -56.26 -31.34 63.49 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.792 0.33 . . . . 32.64 111.426 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -67.02 -33.58 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 41.86 111.334 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.8 mtm -59.41 -54.07 50.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 38.66 111.064 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.579 ' CE2' HD13 ' A' ' 43' ' ' ILE . 78.9 m-85 -57.83 -26.96 62.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.974 -0.557 . . . . 25.27 111.614 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.3 m -60.19 130.3 45.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.836 0.35 . . . . 25.04 110.806 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -65.0 156.28 80.99 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.286 -0.415 . . . . 36.05 111.129 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.84 -26.49 9.57 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.033 1.822 . . . . 54.36 112.527 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.689 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -59.22 176.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 71.54 111.178 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.54 156.74 52.87 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.717 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.47 83.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.87 1.713 . . . . 0.0 112.194 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -175.58 -176.21 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -91.54 89.43 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 t -102.52 158.07 16.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 20.0 111.113 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.824 0.345 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -75.08 118.15 17.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 7.0 m -83.11 -30.27 28.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.011 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.508 ' HZ ' HG21 ' A' ' 17' ' ' VAL . 2.2 m-30 -87.87 55.77 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.26 0.552 . . . . 0.0 111.079 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.48 -35.62 6.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.165 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.1 m -160.28 174.72 13.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.703 HG11 ' O ' ' A' ' 4' ' ' THR . 23.5 t -72.44 -31.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.95 90.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.062 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.88 78.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.213 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.971 HD21 ' HB2' ' A' ' 13' ' ' ALA . 67.4 tp -58.36 -42.78 87.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.151 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -65.1 -49.31 70.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -59.32 -41.29 88.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.116 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 93.9 m -59.53 -45.31 92.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.059 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -51.08 19.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.947 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -86.3 71.23 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.152 0.501 . . . . 0.0 110.833 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 118.324 -1.264 . . . . 20.0 112.426 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 CA-C-O 119.829 -0.429 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -90.52 21.94 0.8 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.406 2.071 . . . . 0.0 113.201 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -83.08 97.87 9.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.309 . . . . 75.5 110.854 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.651 ' O ' HG11 ' B' ' 107' ' ' VAL . 17.0 p -124.9 175.96 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 31.38 110.73 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.677 HD13 HG13 ' B' ' 107' ' ' VAL . 8.6 tp -129.52 110.25 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 28.27 111.213 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.9 m -140.22 161.7 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 32.91 110.933 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.36 -139.3 45.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.802 -0.713 . . . . 19.09 112.843 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.09 66.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.343 . . . . 21.73 111.454 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.39 -41.29 93.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 63.42 110.942 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.18 -43.87 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 20.39 110.73 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.42 -31.78 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 19.22 110.968 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.42 -42.12 92.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 31.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.787 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -66.01 -48.51 70.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 18.28 111.168 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.908 HD13 ' CD2' ' A' ' 23' ' ' PHE . 17.6 mt -60.12 -38.47 83.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 22.05 110.827 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -73.26 -32.38 64.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 32.76 110.594 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -79.35 -32.08 43.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.047 -0.524 . . . . 27.25 110.755 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.6 t -87.32 -44.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.042 -0.526 . . . . 25.51 110.905 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -100.43 -51.63 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 29.49 111.233 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.09 -95.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.967 -0.635 . . . . 40.61 112.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.58 -28.42 26.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 79.05 111.459 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 19.8 mtm-85 -57.7 -34.28 69.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.799 0.333 . . . . 50.6 111.365 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.75 150.93 27.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 35.48 112.214 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.908 ' CD2' HD13 ' A' ' 14' ' ' LEU . 15.5 p90 -141.33 145.02 34.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.965 0.412 . . . . 25.52 111.143 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -109.52 127.67 54.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 56.07 110.771 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -65.77 -31.36 72.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 29.3 110.827 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -125.21 104.86 8.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 38.35 110.957 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -67.83 137.37 92.56 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.261 -0.427 . . . . 42.35 110.742 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' HG23 ' A' ' 29' ' ' THR . 73.6 Cg_endo -76.56 124.81 7.86 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.945 1.763 . . . . 40.8 112.366 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 28' ' ' PRO . 33.4 p -158.34 100.32 1.66 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 55.75 110.914 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.71 99.73 0.34 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.829 -0.7 . . . . 34.94 112.535 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -84.43 -67.56 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 34.26 110.876 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.89 -98.21 0.86 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.672 -0.775 . . . . 36.13 112.516 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -147.64 -174.89 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 57.93 110.911 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.6 t -69.91 112.49 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 72.85 110.911 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.6 m -96.24 117.9 31.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -84.58 -34.13 23.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -147.56 114.14 6.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -161.76 160.69 22.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.439 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 60.4 Cg_endo -71.99 107.94 2.34 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.89 1.726 . . . . 0.0 112.295 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -105.64 132.67 51.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.0 p -150.01 169.01 22.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 64.04 110.861 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.67 -100.34 0.15 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 35.08 112.6 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 ' CE1' ' A' ' 60' ' ' TYR . 3.1 tp -106.78 -35.41 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 25.61 110.991 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.8 t -58.27 -57.97 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 29.9 111.446 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.4 m-20 -68.32 -22.22 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 39.04 111.932 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.31 -23.87 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.276 0.473 . . . . 45.6 112.276 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.8 m -117.22 -46.68 2.69 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.238 0.459 . . . . 28.23 112.238 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.7 t -71.26 -52.47 18.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.312 . . . . 25.89 111.072 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 15.1 m-85 -64.44 -37.09 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 32.64 110.798 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -140.31 149.85 43.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 41.06 110.913 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -60.06 140.65 56.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 42.62 111.11 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -133.12 -174.63 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 28.05 110.817 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.89 127.63 53.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.995 -0.548 . . . . 46.35 109.929 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.561 HD21 ' CA ' ' B' ' 106' ' ' SER . 0.1 OUTLIER -53.81 -26.56 24.61 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.173 -0.467 . . . . 23.79 111.979 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -58.11 -22.71 51.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.606 -0.27 . . . . 74.93 111.498 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HB3' ' HE3' ' A' ' 59' ' ' MET . 1.5 mmt180 -81.21 7.04 12.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.883 0.698 . . . . 64.42 112.883 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.1 mt -90.06 -39.21 13.05 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.032 -0.417 . . . . 32.64 111.333 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.05 67.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 41.86 111.52 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.42 ' HE3' ' HB3' ' A' ' 56' ' ' ARG . 1.2 ptp -63.84 -31.8 73.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.466 -0.334 . . . . 38.66 111.466 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.414 ' CE1' HD13 ' A' ' 43' ' ' ILE . 65.6 m-85 -70.52 -29.07 65.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 25.27 111.445 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.7 m -61.18 130.28 45.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 25.04 111.12 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.603 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -57.44 157.37 13.39 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.095 -0.502 . . . . 36.05 111.191 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.99 -24.78 38.95 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.888 1.726 . . . . 54.36 112.785 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.603 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -60.68 171.8 1.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 71.54 111.044 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -150.88 157.18 35.8 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.784 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.29 148.14 60.98 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.99 1.793 . . . . 0.0 112.243 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.45 -51.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.058 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -139.25 -48.16 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.2 t -158.72 32.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.781 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.326 -0.845 . . . . 20.0 111.036 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.889 0.375 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -95.57 109.6 21.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.007 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 90.8 m -82.79 -27.31 31.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.242 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -96.04 37.89 1.21 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.853 0.359 . . . . 0.0 111.256 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.13 -51.07 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.561 ' CA ' HD21 ' A' ' 54' ' ' LEU . 54.3 p -142.11 174.96 10.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.801 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.677 HG13 HD13 ' A' ' 5' ' ' LEU . 21.3 t -67.67 -36.49 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.093 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.8 82.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.78 92.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -42.86 87.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 27.2 ttp85 -60.25 -45.01 94.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.807 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -69.92 -35.83 74.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.802 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 16.6 t -59.19 -38.94 81.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 12.9 tpt -75.74 -51.72 12.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -80.12 71.05 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.159 0.504 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.312 -1.271 . . . . 20.0 112.571 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.98 144.96 48.88 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.91 1.74 . . . . 0.0 112.235 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.22 93.49 4.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 75.5 111.044 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 p -136.19 147.77 47.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 31.38 110.451 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 5' ' ' LEU . 9.9 tp -109.49 114.31 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 28.27 111.148 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.2 m -140.37 162.06 36.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 32.91 110.999 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.49 -145.86 46.37 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.874 -0.679 . . . . 19.09 113.048 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.57 65.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.794 0.33 . . . . 21.73 111.461 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.15 -43.11 96.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 63.42 110.898 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.61 -43.7 84.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 20.39 110.499 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.37 -33.35 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 19.22 111.006 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.0 -48.82 80.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 31.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.775 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.9 -47.45 86.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 18.28 111.172 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 23' ' ' PHE . 24.2 mt -60.0 -39.61 86.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 22.05 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -75.79 -31.38 59.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 32.76 110.84 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -79.3 -30.75 43.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 27.25 111.085 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 13' ' ' ALA . 36.9 t -89.28 -48.22 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 25.51 111.023 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 m -86.9 -51.27 6.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.392 -0.367 . . . . 29.49 111.191 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.86 -109.41 2.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.671 -0.776 . . . . 40.61 112.492 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.85 7.77 35.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.611 0.597 . . . . 79.05 112.611 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.684 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.8 mmm180 -72.52 -30.12 64.19 Favored 'General case' 0 C--O 1.231 0.092 0 O-C-N 122.041 -0.412 . . . . 50.6 111.044 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.15 84.39 0.8 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 35.48 112.136 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 14' ' ' LEU . 38.3 p90 -84.47 171.56 12.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.127 0.489 . . . . 25.52 111.389 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.401 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 12.7 p90 -145.27 124.3 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.63 . . . . 56.07 110.47 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -57.27 -63.54 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 29.3 111.491 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -59.12 125.54 24.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 38.35 111.206 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HG3' ' CE1' ' A' ' 60' ' ' TYR . 10.2 mmtt -129.02 117.57 19.22 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.089 -0.505 . . . . 42.35 110.424 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.63 139.1 33.41 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.838 1.692 . . . . 40.8 112.295 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.6 p -112.98 -48.97 2.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.192 -0.458 . . . . 55.75 110.817 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.24 79.58 1.08 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.778 -0.725 . . . . 34.94 112.508 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -158.63 124.28 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 34.26 110.954 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.33 71.19 1.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 36.13 112.47 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.3 t -102.55 100.64 10.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 57.93 110.936 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -163.48 -65.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 72.85 110.927 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.4 m -87.8 -169.96 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.2 mtm-85 -60.29 142.96 53.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -77.35 165.9 23.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -90.19 166.47 19.96 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.053 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 38.0 Cg_endo -65.74 -168.17 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.938 1.759 . . . . 0.0 112.243 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -70.59 123.73 22.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.018 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.9 p -152.47 119.97 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 64.04 110.871 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.87 -94.64 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 35.08 112.529 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.517 HD13 ' CE2' ' A' ' 60' ' ' TYR . 2.3 tp -81.53 -36.96 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.87 0.367 . . . . 25.61 111.076 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.1 -59.53 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 29.9 111.537 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.43 -21.56 63.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.06 0.393 . . . . 39.04 112.06 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.14 -24.11 21.16 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 112.258 0.466 . . . . 45.6 112.258 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 75.9 m -116.49 -45.57 2.81 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.13 0.419 . . . . 28.23 112.13 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.2 t -71.88 -53.03 14.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 25.89 110.995 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 22.5 m-85 -67.45 -37.16 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 32.64 110.57 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -134.01 145.86 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 41.06 110.347 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 p -66.87 124.24 22.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.287 -0.415 . . . . 42.62 111.038 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -111.99 -174.92 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 28.05 111.278 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.88 138.64 45.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 46.35 109.951 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.75 HD23 ' CD1' ' B' ' 110' ' ' LEU . 3.2 mp -53.55 -31.45 46.49 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.134 0.42 . . . . 23.79 112.134 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -57.66 -28.45 63.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 74.93 111.424 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.2 mmm-85 -68.87 -22.5 64.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.515 -0.311 . . . . 64.42 111.609 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.54 -40.53 87.53 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.871 0.367 . . . . 32.64 110.592 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -62.5 -32.95 73.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 41.86 109.887 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.69 -31.37 57.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.711 -0.677 . . . . 38.66 111.335 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.517 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.3 m-85 -85.37 -29.15 24.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 25.27 111.569 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 65.4 m -58.34 130.39 46.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 25.04 111.258 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -62.36 163.42 14.55 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.538 . . . . 36.05 111.313 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 83.8 Cg_endo -80.64 -24.89 4.8 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.101 1.867 . . . . 54.36 112.872 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.562 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -60.75 163.86 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.36 . . . . 71.54 111.151 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.91 167.23 13.81 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.612 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.35 152.15 79.48 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.876 1.717 . . . . 0.0 112.271 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.86 -70.99 0.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -134.67 35.29 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.9 t -144.23 106.55 4.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.225 -0.893 . . . . 20.0 111.081 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.838 0.352 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -93.98 124.59 38.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.859 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.5 m -82.9 -41.7 18.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.561 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.7 m-85 -83.34 66.28 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 110.947 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -124.33 -45.07 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.611 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 17.0 p -147.0 174.94 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.58 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.92 -31.02 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.004 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.46 70.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.55 68.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.79 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.75 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -56.46 -48.04 77.91 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.372 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -65.06 -45.65 84.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.16 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -59.38 -36.69 76.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.175 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 88.3 m -63.88 -59.12 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.104 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 11.3 tpt -63.87 -51.92 62.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.039 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -82.59 71.19 9.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.094 0.473 . . . . 0.0 110.779 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.409 -1.217 . . . . 20.0 112.493 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.95 144.95 49.05 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.984 1.789 . . . . 0.0 112.242 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -112.27 106.39 14.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 75.5 110.967 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.682 ' O ' HG11 ' B' ' 107' ' ' VAL . 54.2 p -137.64 176.5 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 31.38 110.596 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.549 HD13 HG13 ' B' ' 107' ' ' VAL . 9.9 tp -135.93 110.08 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 28.27 111.251 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -140.22 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 32.91 110.963 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.04 -144.79 40.26 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.854 -0.688 . . . . 19.09 112.915 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.75 64.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.785 0.326 . . . . 21.73 111.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.67 -46.52 90.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 63.42 110.805 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 43' ' ' ILE . 58.7 tp -64.37 -44.94 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.052 -0.522 . . . . 20.39 110.766 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.77 -33.96 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 19.22 111.139 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.69 -31.02 71.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 31.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -74.66 -47.49 31.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 18.28 110.966 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.749 HD13 ' CD1' ' A' ' 23' ' ' PHE . 14.8 mt -61.73 -47.09 86.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.209 -0.451 . . . . 22.05 110.871 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -32.29 73.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 32.76 110.665 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.68 -34.38 58.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 27.25 110.971 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.6 t -86.71 -61.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 25.51 110.96 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.1 m -76.78 -51.58 11.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 29.49 111.139 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.22 -122.46 29.13 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.895 -0.669 . . . . 40.61 113.059 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -58.71 -25.71 63.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.855 0.317 . . . . 79.05 111.855 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.592 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 mtm-85 -56.02 -30.03 61.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.75 0.31 . . . . 50.6 111.751 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.01 104.99 0.4 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.686 -0.769 . . . . 35.48 111.955 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.749 ' CD1' HD13 ' A' ' 14' ' ' LEU . 41.4 p90 -93.21 153.37 18.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 25.52 111.554 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.6 139.74 46.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.783 -0.644 . . . . 56.07 110.469 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.38 -30.5 25.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.37 -0.377 . . . . 29.3 110.862 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -120.9 92.05 3.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.394 -0.366 . . . . 38.35 111.038 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -59.99 139.38 90.76 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.245 -0.434 . . . . 42.35 110.775 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.26 135.56 31.98 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.915 1.743 . . . . 40.8 112.257 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -169.94 124.09 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 55.75 110.922 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.16 -75.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 34.94 112.458 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -74.55 138.44 43.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.739 0.304 . . . . 34.26 111.026 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.23 139.79 3.16 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.739 -0.743 . . . . 36.13 112.55 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.3 m -94.36 -51.72 4.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 57.93 110.86 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -73.49 167.14 21.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 72.85 110.894 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 m -153.5 33.4 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -79.83 -31.77 40.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.961 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 -176.3 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.814 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.71 156.97 15.77 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.411 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.01 -168.83 0.55 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.978 1.785 . . . . 0.0 112.555 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -86.59 90.8 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.382 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -151.66 146.11 25.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.266 -0.424 . . . . 64.04 111.01 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.76 -146.28 2.09 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.82 -0.705 . . . . 35.08 112.606 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.759 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.2 tp -93.27 -36.46 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 25.61 110.941 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.22 -66.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 29.9 111.104 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.418 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.9 m-20 -61.06 -20.73 62.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.11 0.411 . . . . 39.04 112.11 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.96 -28.79 17.81 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.261 0.837 . . . . 45.6 113.261 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -33.95 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.937 0.717 . . . . 28.23 112.937 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 45.5 t -73.67 -33.66 64.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 25.89 110.478 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.9 m-85 -84.84 -47.75 10.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 32.64 110.342 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 160.71 22.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.805 -0.634 . . . . 41.06 109.957 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 p -79.25 116.4 19.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.735 0.303 . . . . 42.62 111.059 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.59 -171.06 1.77 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.799 0.333 . . . . 28.05 110.911 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.28 134.6 45.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 46.35 110.338 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -57.6 -27.39 62.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.005 -0.543 . . . . 23.79 111.759 -179.105 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -26.21 62.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.636 0.236 . . . . 74.93 111.636 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -62.31 -28.4 69.71 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.601 0.238 . . . . 64.42 111.192 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.6 mt -56.1 -29.15 60.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.745 0.307 . . . . 32.64 111.627 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -69.71 -29.74 67.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 41.86 111.396 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.3 mtm -65.23 -49.84 68.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.841 0.353 . . . . 38.66 111.265 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.759 ' CE2' HD13 ' A' ' 43' ' ' ILE . 87.7 m-85 -56.52 -25.59 52.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 25.27 111.855 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.2 m -64.64 134.66 54.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.398 . . . . 25.04 111.055 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -64.61 158.67 66.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 36.05 111.024 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 -30.33 56.83 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.897 1.731 . . . . 54.36 112.757 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.521 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -60.51 174.46 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.387 . . . . 71.54 110.875 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -142.13 162.71 44.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.954 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.67 115.79 3.27 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.88 1.72 . . . . 0.0 112.268 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.87 175.76 2.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.998 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 85.87 3.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.2 m -163.25 175.07 11.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.278 -0.868 . . . . 20.0 111.153 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -63.18 145.04 56.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.753 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t -75.27 -35.3 61.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.231 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.595 ' C ' HD13 ' A' ' 54' ' ' LEU . 20.3 m-85 -98.6 32.86 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.041 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -86.47 -33.08 20.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.54 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.437 ' O ' HD21 ' A' ' 54' ' ' LEU . 13.1 t -158.58 174.84 14.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.528 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 4' ' ' THR . 22.0 t -65.02 -31.06 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.162 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.35 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.52 -50.2 70.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.888 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.513 HD12 HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -60.08 -42.65 95.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.051 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -56.38 -42.81 78.5 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -67.01 -35.75 80.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.685 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.86 -46.76 83.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.464 ' HE2' HD23 ' B' ' 110' ' ' LEU . 16.5 ptp -73.97 -45.36 50.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -91.02 71.2 6.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.196 0.522 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.338 -1.257 . . . . 20.0 112.416 -179.911 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 CA-C-O 119.807 -0.441 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.33 122.09 6.84 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.989 1.793 . . . . 0.0 112.228 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -127.37 97.6 4.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 75.5 110.978 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.549 ' O ' HG11 ' B' ' 107' ' ' VAL . 10.9 p -122.1 171.05 9.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 31.38 110.609 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.814 HD13 HG13 ' B' ' 107' ' ' VAL . 8.1 tp -128.66 113.32 15.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.386 -0.37 . . . . 28.27 111.035 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.18 164.09 31.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.915 0.388 . . . . 32.91 111.234 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 57.5 -137.86 48.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.016 -0.612 . . . . 19.09 113.003 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.86 66.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.687 0.279 . . . . 21.73 111.664 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.03 -38.97 77.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.823 0.344 . . . . 63.42 111.278 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 tp -72.33 -39.92 67.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 20.39 110.493 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -33.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.518 . . . . 19.22 111.143 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.67 -50.13 70.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 31.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.776 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.69 -50.78 72.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 18.28 111.147 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.549 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -60.28 -42.21 94.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 22.05 110.875 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -71.84 -31.8 66.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 32.76 110.69 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -78.09 -31.28 50.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 27.25 110.871 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.5 t -89.13 -60.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 25.51 111.038 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 m -78.61 -51.54 9.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 29.49 111.033 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.88 -103.67 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 40.61 113.14 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.93 -5.28 56.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.074 0.768 . . . . 79.05 113.074 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -59.25 -42.51 91.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.205 0.457 . . . . 50.6 111.113 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.24 65.78 0.81 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 35.48 112.342 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CD1' HD13 ' A' ' 14' ' ' LEU . 26.6 p90 -58.87 156.36 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.921 0.391 . . . . 25.52 111.411 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 117.07 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 56.07 110.212 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -57.68 -42.33 83.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.421 -0.354 . . . . 29.3 111.493 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -81.77 142.53 32.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.011 0.434 . . . . 38.35 111.093 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 60' ' ' TYR . 5.6 tttp -134.66 106.94 10.78 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.945 -0.57 . . . . 42.35 110.629 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.41 156.62 61.25 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.865 1.71 . . . . 40.8 112.638 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.8 p -112.01 135.06 53.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 55.75 110.778 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.27 -43.24 10.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 34.94 112.575 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -68.3 148.56 50.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 34.26 110.996 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.85 113.39 3.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 36.13 112.449 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 p -133.72 34.66 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 57.93 110.848 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.9 p -99.21 35.96 1.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 72.85 110.941 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.1 m -91.3 -51.78 5.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.1 ttp-105 -88.61 -67.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 -176.68 155.78 1.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -174.75 94.88 0.29 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.14 -178.92 3.51 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.796 1.664 . . . . 0.0 112.31 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.68 107.05 18.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -142.11 172.91 12.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 64.04 110.832 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.6 -125.74 1.77 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.651 -0.785 . . . . 35.08 112.698 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.86 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.7 tt -78.5 -24.25 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 111.755 0.28 . . . . 25.61 111.755 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -56.34 -55.4 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.939 0.4 . . . . 29.9 111.582 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.11 -21.75 64.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 39.04 111.906 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -90.39 -25.11 20.57 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.192 0.441 . . . . 45.6 112.192 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -114.36 -45.03 3.05 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.265 0.469 . . . . 28.23 112.265 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.3 t -73.25 -55.14 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 25.89 111.167 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 20.7 m-85 -63.81 -33.81 76.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.884 0.373 . . . . 32.64 110.873 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 ptm85 -142.05 150.69 41.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 41.06 110.854 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 p -62.87 137.29 58.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.594 . . . . 42.62 110.949 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -128.12 175.09 8.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 28.05 110.904 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.84 128.06 45.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 46.35 110.291 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.731 HD11 ' O ' ' B' ' 106' ' ' SER . 86.0 mt -54.12 -25.72 23.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 23.79 112.274 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -59.53 -30.02 68.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 74.93 111.011 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HB3' ' HE2' ' A' ' 59' ' ' MET . 11.5 mmm-85 -65.96 -26.87 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 64.42 111.393 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.51 -30.95 63.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.869 0.366 . . . . 32.64 111.491 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.28 -26.63 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 41.86 111.809 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HE2' ' HB3' ' A' ' 56' ' ' ARG . 57.4 mtm -67.56 -52.2 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 38.66 111.545 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.86 ' CE2' HD12 ' A' ' 43' ' ' ILE . 93.0 m-85 -54.48 -25.45 25.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 25.27 112.222 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.0 m -61.74 131.11 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 25.04 110.979 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -58.65 169.87 0.94 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.155 -0.475 . . . . 36.05 111.079 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.6 Cg_endo -76.7 -33.2 3.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.847 1.698 . . . . 54.36 112.488 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -60.01 179.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 71.54 110.986 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -142.35 159.41 58.22 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.21 -167.8 0.11 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.867 1.712 . . . . 0.0 112.241 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.71 -52.25 66.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.126 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -136.31 149.83 48.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.4 m -98.56 131.55 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.987 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.219 -0.896 . . . . 20.0 111.115 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.831 0.348 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -109.08 130.67 55.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.75 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 24.7 t -83.13 -31.12 27.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.451 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.429 ' HA ' HD12 ' A' ' 54' ' ' LEU . 18.6 m-85 -97.27 32.82 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.099 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -80.03 -51.12 9.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 110.459 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.731 ' O ' HD11 ' A' ' 54' ' ' LEU . 34.4 p -143.44 173.92 11.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.425 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.814 HG13 HD13 ' A' ' 5' ' ' LEU . 22.4 t -61.74 -30.45 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.308 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.46 -39.47 70.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.412 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.37 74.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.681 HD12 HD13 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -59.01 -49.71 76.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.115 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 ttp-105 -60.07 -42.8 95.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -35.05 79.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.288 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 65.4 m -56.81 -46.01 81.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.908 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 9.5 ttt -76.06 -52.43 10.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -67.67 -49.27 63.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.47 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.311 -1.272 . . . . 20.0 112.502 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 CA-C-O 119.784 -0.453 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.79 121.33 6.22 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.989 1.792 . . . . 0.0 112.411 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -101.33 106.96 18.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.5 110.787 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' HG11 ' B' ' 107' ' ' VAL . 44.8 p -133.46 177.1 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 31.38 111.156 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 9' ' ' GLU . 10.3 tp -140.22 118.74 12.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.272 -0.422 . . . . 28.27 111.318 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.0 m -140.44 159.52 42.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.354 -0.385 . . . . 32.91 111.072 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.1 -149.53 47.61 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.953 -0.642 . . . . 19.09 113.017 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.87 62.16 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.748 0.309 . . . . 21.73 111.65 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HB3' HD11 ' A' ' 5' ' ' LEU . 46.7 mt-10 -60.07 -39.5 86.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 63.42 110.685 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.0 tp -71.11 -47.5 57.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 20.39 110.314 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.89 -31.61 54.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.958 -0.565 . . . . 19.22 110.948 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.72 -42.64 90.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 31.0 110.782 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -62.28 -46.49 88.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 18.28 111.087 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.589 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.4 mt -59.7 -42.59 93.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 22.05 110.939 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.32 -31.33 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 32.76 110.876 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -76.84 -31.77 57.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 27.25 110.943 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 13' ' ' ALA . 28.9 t -90.07 -59.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 25.51 110.927 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.4 m -77.86 -51.59 10.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 29.49 110.949 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.79 -121.89 26.55 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.939 -0.648 . . . . 40.61 113.108 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.25 -24.58 66.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.845 0.313 . . . . 79.05 111.845 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.598 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 12.0 mtm-85 -55.46 -27.31 47.39 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.897 0.332 . . . . 50.6 111.897 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 109.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.563 -0.827 . . . . 35.48 111.973 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.589 ' CD1' HD13 ' A' ' 14' ' ' LEU . 39.7 p90 -102.0 160.34 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.109 0.481 . . . . 25.52 111.632 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 27' ' ' LYS . 5.8 p90 -134.58 128.71 33.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.628 -0.715 . . . . 56.07 110.2 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -63.37 -68.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 29.3 111.387 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -88.85 117.16 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 38.35 111.16 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 10.6 pttp -114.02 152.39 45.71 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.135 -0.484 . . . . 42.35 110.71 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.69 136.56 63.22 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.924 1.749 . . . . 40.8 112.358 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 p -126.41 -58.08 1.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 55.75 110.847 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.34 -129.62 6.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 34.94 112.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -158.5 179.09 9.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.813 0.34 . . . . 34.26 111.001 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.36 147.24 21.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 36.13 112.546 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -90.12 140.78 29.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 57.93 110.876 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -95.75 148.33 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 72.85 110.89 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.3 p -91.35 -64.06 1.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.841 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -128.75 -47.32 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -135.84 153.95 51.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -159.04 166.25 16.78 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.105 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 27.8 Cg_endo -62.12 101.26 0.23 Allowed 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.937 1.758 . . . . 0.0 112.194 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -106.47 126.53 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -158.13 130.63 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 64.04 110.705 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.99 -126.04 2.74 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.803 -0.713 . . . . 35.08 112.791 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.965 HD13 ' CE2' ' A' ' 60' ' ' TYR . 9.2 tp -81.78 -36.95 14.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.7 0.286 . . . . 25.61 111.207 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.38 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 29.9 111.198 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -56.1 -20.31 16.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.178 -0.465 . . . . 39.04 112.195 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -86.56 -48.41 8.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.677 0.621 . . . . 45.6 112.677 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.55 -36.24 6.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.69 0.626 . . . . 28.23 112.69 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.28 -49.07 53.49 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.677 -0.409 . . . . 25.89 110.502 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -79.69 -56.58 4.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.477 . . . . 32.64 109.711 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -103.33 170.28 8.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.824 -0.626 . . . . 41.06 109.339 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -95.15 110.46 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 42.62 111.354 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.77 -169.2 1.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.23 -0.441 . . . . 28.05 110.804 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -108.51 168.04 9.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 46.35 110.828 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' B' ' 104' ' ' PHE . 6.6 mp -76.25 -30.49 57.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.447 . . . . 23.79 110.995 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -55.53 -26.76 44.87 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 74.93 111.712 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -64.5 -28.89 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.698 0.285 . . . . 64.42 111.005 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.1 mt -57.24 -30.29 64.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.856 0.36 . . . . 32.64 111.4 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -31.2 70.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 41.86 111.433 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.7 mtm -61.32 -30.24 70.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 38.66 111.549 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.965 ' CE2' HD13 ' A' ' 43' ' ' ILE . 56.4 m-85 -83.68 -24.83 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 25.27 111.999 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -67.27 130.35 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 25.04 110.892 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -58.03 164.05 3.76 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.133 -0.485 . . . . 36.05 111.19 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.1 Cg_endo -74.37 -28.67 10.16 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.92 1.746 . . . . 54.36 112.598 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.49 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -59.48 169.83 1.17 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 71.54 111.065 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -148.85 159.76 37.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.39 -170.03 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.945 1.763 . . . . 0.0 112.308 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.2 -173.16 4.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.185 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -67.9 -69.44 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 88.2 p -84.21 127.84 34.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.287 -0.863 . . . . 20.0 111.148 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.812 0.339 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -115.68 115.11 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.797 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 41.9 m -82.63 -38.65 23.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.987 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.622 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.2 m-85 -81.75 66.79 7.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.777 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -127.92 -46.38 1.4 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.685 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -141.36 174.75 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.606 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 4' ' ' THR . 30.7 t -74.39 -30.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.037 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.38 -39.93 89.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.042 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.56 82.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.214 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.612 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -56.94 -45.4 82.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.36 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -65.05 -56.83 10.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.372 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -43.96 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.266 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 22.6 m -59.5 -49.62 77.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 32.5 ttm -71.09 -51.66 23.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -81.65 71.08 8.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.166 0.508 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.375 -1.236 . . . . 20.0 112.56 -179.889 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -90.25 43.53 0.55 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.313 2.009 . . . . 0.0 112.873 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.409 ' O ' HG21 ' B' ' 107' ' ' VAL . 2.7 mp0 -99.26 92.7 5.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.35 . . . . 75.5 110.747 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.442 ' O ' HG11 ' B' ' 107' ' ' VAL . 11.2 p -118.2 176.17 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 31.38 110.65 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.556 HD13 HG13 ' B' ' 107' ' ' VAL . 10.0 tp -130.99 114.44 15.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 28.27 111.446 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.7 m -140.46 158.71 43.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.271 -0.422 . . . . 32.91 111.042 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.76 -145.45 41.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.929 -0.653 . . . . 19.09 113.083 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -30.34 65.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 21.73 111.461 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.21 -37.65 80.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 63.42 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.441 HD11 HG12 ' A' ' 43' ' ' ILE . 63.1 tp -73.18 -47.94 39.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 20.39 110.721 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.21 -30.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 19.22 111.19 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -45.65 78.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 31.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -61.57 -48.77 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 18.28 111.242 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.748 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.2 mt -59.48 -44.67 93.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 22.05 111.049 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -65.37 -32.27 73.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 32.76 110.821 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.466 ' CZ ' ' HE2' ' B' ' 114' ' ' MET . 30.0 t80 -76.54 -34.48 58.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 27.25 110.936 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 13' ' ' ALA . 26.1 t -88.25 -66.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 25.51 111.048 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -77.42 -51.44 10.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 29.49 111.019 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.9 -121.25 24.38 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.913 -0.66 . . . . 40.61 113.286 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.06 -22.96 66.19 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.14 0.422 . . . . 79.05 112.14 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 8.3 mtm-85 -54.88 -25.62 30.1 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.992 0.367 . . . . 50.6 111.992 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 85.52 0.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.642 -0.79 . . . . 35.48 112.037 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.748 ' CD1' HD13 ' A' ' 14' ' ' LEU . 30.3 p90 -81.38 135.46 35.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.39 . . . . 25.52 111.51 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 1.6 p90 -105.74 151.6 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.945 -0.571 . . . . 56.07 110.335 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -93.08 -39.26 11.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.38 . . . . 29.3 111.269 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -97.51 123.65 41.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 38.35 111.105 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' ' CD1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -96.72 150.44 36.95 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.273 -0.421 . . . . 42.35 110.789 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.38 -61.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.543 1.495 . . . . 40.8 112.382 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.1 t -179.2 -50.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.853 0.358 . . . . 55.75 110.757 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.02 -96.81 0.14 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.84 -0.695 . . . . 34.94 112.499 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -148.57 -52.64 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 34.26 110.908 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.18 136.07 8.18 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.7 -0.762 . . . . 36.13 112.556 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -102.88 170.83 7.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.742 0.306 . . . . 57.93 110.952 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.3 p -155.18 -70.67 0.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 72.85 110.877 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 t -170.17 34.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -102.49 170.56 7.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.0 ttp-105 -78.27 148.96 33.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -162.75 83.52 1.54 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.21 -168.46 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.932 1.754 . . . . 0.0 112.206 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -100.6 98.91 9.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.0 p -148.95 136.2 20.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 64.04 110.906 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.71 -140.05 7.44 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.905 -0.664 . . . . 35.08 112.347 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.772 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.1 tp -78.79 -40.33 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 25.61 111.0 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.6 -59.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 29.9 111.657 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 7.5 m-20 -66.9 -24.0 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.424 . . . . 39.04 112.113 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.11 -21.78 22.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.634 0.605 . . . . 45.6 112.634 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -121.77 -47.8 2.18 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.326 0.491 . . . . 28.23 112.326 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.7 t -70.03 -44.18 69.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.885 -0.326 . . . . 25.89 111.018 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 14.5 m-85 -73.17 -38.19 66.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 32.64 110.56 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 41.06 110.705 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.9 p -58.87 153.39 17.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 42.62 111.185 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.4 p -151.14 -172.62 4.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 28.05 111.043 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -110.7 130.08 55.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 46.35 110.031 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.74 HD11 ' O ' ' B' ' 106' ' ' SER . 47.6 mt -55.58 -25.29 37.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 23.79 112.184 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -27.12 63.66 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 74.93 111.341 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' CD ' ' HE2' ' A' ' 59' ' ' MET . 12.6 mmm180 -63.18 -28.36 69.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.632 -0.258 . . . . 64.42 111.298 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.9 mt -55.72 -28.25 54.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.557 -0.292 . . . . 32.64 111.754 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -70.37 -28.77 65.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.338 -0.392 . . . . 41.86 111.591 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.435 ' HE2' ' CD ' ' A' ' 56' ' ' ARG . 71.0 mtm -66.17 -51.97 52.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 38.66 111.298 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.772 ' CE2' HD13 ' A' ' 43' ' ' ILE . 82.5 m-85 -54.32 -22.76 12.93 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.86 -0.609 . . . . 25.27 112.234 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.3 m -67.92 145.47 54.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 25.04 110.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.813 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -80.16 175.23 5.0 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.341 -0.391 . . . . 36.05 111.145 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.813 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 85.8 Cg_endo -77.82 -30.84 3.49 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.961 1.774 . . . . 54.36 112.697 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.97 178.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 71.54 111.092 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -131.03 163.69 47.4 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.8 137.83 55.44 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.014 1.809 . . . . 0.0 112.287 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.89 118.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -77.29 118.05 19.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.2 m -96.14 -50.47 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.212 -0.899 . . . . 20.0 111.112 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.828 0.347 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -107.45 145.0 33.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t -80.95 -28.03 35.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.24 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -97.87 35.8 1.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.96 -51.37 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 110.481 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.74 ' O ' HD11 ' A' ' 54' ' ' LEU . 13.3 p -146.72 173.33 12.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.515 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 5' ' ' LEU . 22.7 t -58.03 -27.93 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.572 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.64 -39.04 67.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.957 0.408 . . . . 0.0 111.016 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.88 -50.95 67.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.115 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.622 HD12 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.98 -45.26 91.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.736 0.303 . . . . 0.0 111.032 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -65.04 -45.02 87.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.608 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -64.21 -35.59 81.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 19.4 m -58.0 -51.96 67.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.203 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.466 ' HE2' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -75.91 -51.96 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -82.85 71.34 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.843 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.348 -1.251 . . . . 20.0 112.494 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 CA-C-O 119.788 -0.451 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.78 150.07 49.29 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.02 1.813 . . . . 0.0 112.337 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.514 ' OE2' ' HB2' ' B' ' 108' ' ' ALA . 4.2 mm-40 -144.61 115.1 7.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.5 111.101 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.69 ' O ' HG11 ' B' ' 107' ' ' VAL . 16.1 p -137.96 -176.03 4.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 31.38 110.512 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.18 112.93 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 28.27 111.131 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.4 m -140.21 162.58 34.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 32.91 111.195 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.97 -145.78 49.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.92 -0.657 . . . . 19.09 113.166 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -29.46 65.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.298 . . . . 21.73 111.508 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.13 -38.6 83.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.398 -0.365 . . . . 63.42 110.961 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.17 -48.82 32.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 20.39 110.57 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.68 -31.71 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 19.22 110.972 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.82 -46.34 78.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 31.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.806 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.3 -47.59 84.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 18.28 110.998 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.921 HD13 ' CD2' ' A' ' 23' ' ' PHE . 14.9 mt -60.66 -41.0 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 22.05 110.77 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -70.73 -32.75 70.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 32.76 110.568 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.62 -32.67 53.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 27.25 110.624 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 13' ' ' ALA . 36.3 t -86.43 -65.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 25.51 110.8 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -71.1 -51.46 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 29.49 111.008 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.0 -119.75 17.28 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.058 -0.592 . . . . 40.61 112.843 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.33 -27.38 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.579 0.228 . . . . 79.05 111.386 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.56 -67.28 0.32 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.826 0.346 . . . . 50.6 111.511 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.76 141.87 5.91 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.083 -0.58 . . . . 35.48 111.864 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.921 ' CD2' HD13 ' A' ' 14' ' ' LEU . 25.5 p90 -132.3 139.97 48.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 25.52 111.361 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -113.09 146.92 38.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 56.07 110.484 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -94.41 24.2 4.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.453 -0.34 . . . . 29.3 111.786 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 77.0 m-20 -158.74 93.53 1.18 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.836 0.35 . . . . 38.35 110.614 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -57.82 -48.14 97.69 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.254 -0.43 . . . . 42.35 111.389 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.39 -168.53 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.925 1.75 . . . . 40.8 112.244 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 29' ' ' THR . 10.0 t -160.04 115.17 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 55.75 110.821 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.04 -50.76 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 34.94 112.501 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -78.89 121.22 24.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 34.26 110.915 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.29 59.9 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.716 . . . . 36.13 112.508 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 t -102.49 33.78 3.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.391 . . . . 57.93 110.902 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.0 p -142.39 155.98 45.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 72.85 110.921 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -96.37 -55.48 2.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -71.29 -49.99 37.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -78.35 127.94 32.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -164.58 96.97 0.9 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.109 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.44 167.33 27.29 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.864 1.709 . . . . 0.0 112.332 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.69 131.21 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.5 p -157.09 -178.23 7.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 64.04 110.911 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.66 -103.73 1.39 Allowed Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.929 -0.653 . . . . 35.08 112.473 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.1 tt -84.47 -26.85 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.599 0.238 . . . . 25.61 111.51 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.89 -56.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.981 0.42 . . . . 29.9 111.3 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -21.41 64.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.075 -0.511 . . . . 39.04 111.933 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.02 -28.37 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.845 0.313 . . . . 45.6 111.845 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.0 -51.95 2.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.053 0.39 . . . . 28.23 112.053 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -65.36 -53.45 43.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.64 0.257 . . . . 25.89 111.182 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -66.01 -45.2 82.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 32.64 110.739 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 148.29 50.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 41.06 110.604 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 p -60.39 139.63 57.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 42.62 110.872 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.43 -173.81 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 28.05 111.017 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.58 132.21 54.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 46.35 110.208 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.704 ' HG ' HD12 ' B' ' 110' ' ' LEU . 0.7 OUTLIER -57.27 -28.1 62.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 23.79 111.704 -179.031 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -59.15 -29.28 67.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.661 0.267 . . . . 74.93 111.323 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.498 ' HD2' ' HE1' ' A' ' 59' ' ' MET . 3.5 mmt85 -61.12 -27.59 68.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.449 -0.342 . . . . 64.42 111.601 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.7 mt -57.02 -29.87 63.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.777 0.322 . . . . 32.64 111.555 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.84 -29.73 67.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 41.86 111.407 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.498 ' HE1' ' HD2' ' A' ' 56' ' ' ARG . 38.1 mtm -64.91 -47.54 77.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.433 -0.349 . . . . 38.66 111.323 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.764 ' CE2' HD12 ' A' ' 43' ' ' ILE . 97.8 m-85 -60.21 -30.68 69.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 25.27 111.501 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.5 m -60.16 129.51 42.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 25.04 110.873 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.58 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -57.28 151.84 34.89 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.18 -0.464 . . . . 36.05 111.346 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.41 -22.6 38.99 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.022 1.814 . . . . 54.36 112.979 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -55.94 179.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.929 0.395 . . . . 71.54 111.57 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.62 136.27 4.07 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.708 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.96 -179.75 4.14 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.807 1.671 . . . . 0.0 112.339 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.28 163.83 12.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -99.39 121.6 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.975 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.1 p -157.5 130.4 7.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.153 -0.927 . . . . 20.0 111.153 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.805 0.335 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -105.42 135.3 47.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.99 -30.85 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.024 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -98.34 32.77 2.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.202 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -79.77 -33.5 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.424 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.691 ' C ' HD21 ' A' ' 54' ' ' LEU . 24.8 t -157.08 174.36 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.391 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 4' ' ' THR . 32.1 t -68.06 -30.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.96 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 108' ' ' ALA . . . . . 0.514 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . . . -69.51 -39.83 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.176 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.78 -42.65 97.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.473 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.704 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -58.21 -42.5 86.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.279 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.556 ' HA ' ' HE3' ' B' ' 114' ' ' MET . 0.0 OUTLIER -56.85 -62.42 1.75 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.273 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -35.04 73.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.025 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 19.4 t -61.12 -53.92 50.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.514 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.556 ' HE3' ' HA ' ' B' ' 111' ' ' ARG . 11.1 ptt? -76.17 -48.66 19.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -69.47 -49.14 57.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.806 0.336 . . . . 0.0 111.222 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.36 -1.245 . . . . 20.0 112.524 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.71 121.57 6.77 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.992 1.795 . . . . 0.0 112.33 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -107.89 102.84 12.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 75.5 110.884 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.662 ' O ' HG11 ' B' ' 107' ' ' VAL . 31.1 p -133.16 178.85 6.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 31.38 110.902 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.481 HD13 HG13 ' B' ' 107' ' ' VAL . 10.1 tp -136.6 109.48 7.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.375 . . . . 28.27 111.322 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.19 164.72 29.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 32.91 110.666 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.06 -146.83 43.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.759 -0.734 . . . . 19.09 112.742 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.94 -32.08 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 21.73 111.373 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.08 -37.42 77.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.233 -0.439 . . . . 63.42 111.14 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.419 HD11 ' CG1' ' A' ' 43' ' ' ILE . 31.2 tp -73.94 -51.22 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 20.39 110.974 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.87 -30.1 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 19.22 111.242 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.71 -48.78 65.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.4 . . . . 31.0 111.051 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.55 -45.61 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 18.28 111.258 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.751 HD13 ' CD1' ' A' ' 23' ' ' PHE . 11.7 mt -60.65 -40.62 92.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 22.05 110.809 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -74.02 -32.84 63.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 32.76 110.434 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' B' ' 114' ' ' MET . 0.1 OUTLIER -66.31 -41.97 88.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 27.25 110.515 179.748 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.448 HG22 ' HZ ' ' B' ' 104' ' ' PHE . 25.4 t -86.8 -61.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 25.51 111.198 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.87 -51.35 12.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 29.49 111.224 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.9 -117.15 9.39 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 40.61 112.693 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.47 7.73 13.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.772 0.656 . . . . 79.05 112.772 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.83 -36.0 77.66 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.036 -0.415 . . . . 50.6 110.891 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.33 59.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 35.48 112.382 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.751 ' CD1' HD13 ' A' ' 14' ' ' LEU . 29.8 p90 -58.71 133.88 56.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 25.52 111.422 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -86.47 142.37 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 56.07 110.779 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -29.13 17.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.391 . . . . 29.3 110.886 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.79 67.88 1.4 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.219 0.533 . . . . 38.35 110.733 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HE3' ' CD1' ' A' ' 60' ' ' TYR . 5.1 ptpp? -67.63 -177.23 0.3 Allowed Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.933 -0.576 . . . . 42.35 109.802 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -84.72 -169.87 0.71 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.75 1.633 . . . . 40.8 112.39 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.833 HG22 ' HB3' ' A' ' 38' ' ' ALA . 77.5 p -58.83 -75.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 55.75 111.192 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.05 -135.66 2.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 34.94 112.538 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -150.06 157.99 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 34.26 110.934 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.22 -172.15 35.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.7 -0.762 . . . . 36.13 112.408 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 76.7 p -93.64 -30.86 14.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.759 0.314 . . . . 57.93 110.972 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 p -153.67 134.15 13.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 72.85 111.003 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.3 m -152.16 157.13 41.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.755 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.21 -70.93 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.477 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -178.45 152.63 0.67 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.833 ' HB3' HG22 ' A' ' 29' ' ' THR . . . -124.16 145.93 49.92 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.933 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.82 173.41 10.16 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.9 1.733 . . . . 0.0 112.254 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.453 ' O ' HG23 ' A' ' 41' ' ' THR . 23.8 tt0 -80.74 105.17 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 40' ' ' GLN . 24.1 p -158.11 -179.55 8.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 64.04 110.834 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.17 -110.61 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.663 -0.78 . . . . 35.08 112.548 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.916 HD13 ' CE2' ' A' ' 60' ' ' TYR . 8.2 tp -101.55 -36.74 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 25.61 110.954 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.23 -65.72 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 29.9 110.958 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 19.1 m-20 -61.29 -21.07 63.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.226 -0.443 . . . . 39.04 111.791 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.58 -36.97 14.13 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.974 0.361 . . . . 45.6 111.974 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -106.44 -50.33 3.16 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.41 0.522 . . . . 28.23 112.41 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.2 t -60.42 -50.32 74.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.763 0.316 . . . . 25.89 111.071 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.0 m-85 -67.21 -56.22 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 32.64 110.219 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.22 145.99 44.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 41.06 110.354 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -57.36 136.51 56.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.207 -0.451 . . . . 42.62 111.77 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -126.47 -160.47 0.99 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.132 -0.485 . . . . 28.05 110.483 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -128.11 145.71 50.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.907 0.384 . . . . 46.35 110.578 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 1.021 HD23 HD12 ' B' ' 110' ' ' LEU . 1.6 mp -59.23 -26.38 64.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.168 -0.469 . . . . 23.79 111.535 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -57.82 -28.58 64.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.651 0.262 . . . . 74.93 111.442 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' ARG . . . . . 0.462 ' NE ' ' HE1' ' A' ' 59' ' ' MET . 8.4 mmm180 -68.75 -26.71 65.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 64.42 111.206 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.0 mt -55.45 -47.81 75.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.785 0.326 . . . . 32.64 111.78 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.49 -29.08 65.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 41.86 111.519 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' MET . . . . . 0.462 ' HE1' ' NE ' ' A' ' 56' ' ' ARG . 30.3 mtm -63.77 -50.01 70.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 38.66 111.465 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.916 ' CE2' HD13 ' A' ' 43' ' ' ILE . 93.2 m-85 -56.82 -28.26 61.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 25.27 111.813 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.1 m -60.35 127.15 30.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.369 . . . . 25.04 111.025 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -70.69 168.82 17.16 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.116 -0.493 . . . . 36.05 110.951 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 82.7 Cg_endo -77.76 -30.62 3.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.832 1.688 . . . . 54.36 112.842 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.02 155.13 17.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 71.54 110.995 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -158.34 153.81 22.4 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 129.29 9.83 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.917 1.744 . . . . 0.0 112.383 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.86 165.13 23.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -90.18 -40.03 12.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.791 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.0 t -75.1 -58.51 3.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.258 -0.877 . . . . 20.0 111.125 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.833 0.349 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -113.81 100.56 8.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 11.5 m -82.52 -35.44 27.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.028 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.618 ' C ' HD13 ' A' ' 54' ' ' LEU . 14.5 m-30 -82.05 67.02 7.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.246 0.546 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -116.01 -41.0 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 54' ' ' LEU . 20.2 t -142.96 178.3 7.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.543 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.662 HG11 ' O ' ' A' ' 4' ' ' THR . 23.8 t -73.9 -31.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.034 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.82 -39.58 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.6 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.47 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 1.021 HD12 HD23 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -57.23 -53.25 60.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.332 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.421 ' HG3' ' CD1' ' B' ' 115' ' ' TYR . 4.7 ttt-85 -62.49 -49.06 76.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.119 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -59.9 -44.65 94.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.235 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 18.4 m -69.55 -45.02 69.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.547 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.542 ' SD ' HD23 ' B' ' 110' ' ' LEU . 0.0 OUTLIER -70.45 -52.35 22.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.674 -179.306 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' B' B ' 115' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' B' ' 111' ' ' ARG . 74.5 m-85 -79.78 -49.08 12.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 111.173 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.395 -1.225 . . . . 20.0 112.464 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 CA-C-O 119.788 -0.451 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.97 124.7 9.32 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.028 1.819 . . . . 0.0 112.298 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -132.56 103.45 6.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.5 110.863 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.575 ' O ' HG11 ' B' ' 107' ' ' VAL . 60.9 p -128.43 176.1 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 31.38 111.048 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 9' ' ' GLU . 11.6 tp -140.2 117.92 11.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 28.27 111.045 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 m -140.25 164.97 28.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.92 0.39 . . . . 32.91 110.963 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.64 -149.76 48.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.9 -0.667 . . . . 19.09 112.959 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.91 -29.83 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 21.73 111.475 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HB3' HD11 ' A' ' 5' ' ' LEU . 34.0 mt-10 -59.78 -39.41 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 63.42 110.92 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.518 HD11 HG12 ' A' ' 43' ' ' ILE . 58.1 tp -72.69 -49.26 32.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 20.39 110.773 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.67 -31.9 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 19.22 110.952 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 -45.55 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 31.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -61.43 -42.8 99.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 18.28 111.223 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 23' ' ' PHE . 12.1 mt -60.53 -38.31 84.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.881 0.372 . . . . 22.05 110.551 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' GLN . . . . . 0.405 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 1.5 mm-40 -76.5 -33.51 58.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 32.76 110.177 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CD2' ' CG ' ' B' ' 114' ' ' MET . 0.1 OUTLIER -68.34 -44.96 74.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 27.25 110.622 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 13' ' ' ALA . 33.5 t -78.88 -65.62 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 25.51 111.289 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.7 m -64.6 -51.72 61.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 29.49 111.426 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.96 -109.07 1.29 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.96 -0.638 . . . . 40.61 113.18 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.79 -37.61 88.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 79.05 111.301 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.646 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.6 mtm180 -58.52 -28.97 65.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 50.6 111.446 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.86 174.56 46.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.555 -0.831 . . . . 35.48 111.721 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.901 ' CD2' HD13 ' A' ' 14' ' ' LEU . 13.6 p90 -150.37 156.0 40.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 25.52 111.546 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 112.45 14.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.646 -0.706 . . . . 56.07 110.285 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -52.68 -42.11 64.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.206 -0.452 . . . . 29.3 112.206 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -83.79 137.75 33.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 38.35 111.358 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 25.6 mtpp -154.8 159.7 31.61 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 115.991 -0.549 . . . . 42.35 110.811 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.41 120.45 6.97 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 121.986 1.791 . . . . 40.8 112.403 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.8 p -138.21 122.77 18.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 55.75 110.913 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.65 174.55 44.43 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 34.94 112.583 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -82.06 -73.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.745 0.307 . . . . 34.26 110.854 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.81 -167.99 10.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 36.13 112.652 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.6 t -149.3 -63.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 57.93 110.896 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -161.09 146.8 14.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 72.85 110.857 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.8 m -143.36 148.0 35.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -86.21 -49.21 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.928 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -90.56 136.35 33.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.978 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.84 102.7 8.46 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.56 170.86 17.5 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.82 1.68 . . . . 0.0 112.416 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -108.66 91.61 3.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.175 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -150.99 156.77 41.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 64.04 111.377 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.05 -95.56 0.12 Allowed Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.922 -0.581 . . . . 35.08 112.023 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 10' ' ' LEU . 1.1 tp -84.91 -35.46 10.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 25.61 110.353 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.05 -48.72 86.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 29.9 111.327 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -25.61 61.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 39.04 111.936 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -90.34 -26.18 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.867 0.321 . . . . 45.6 111.867 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -107.12 -41.09 5.24 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 28.23 112.016 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.9 t -80.72 -57.98 3.31 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.974 -0.29 . . . . 25.89 110.907 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -65.1 -37.43 87.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 32.64 110.488 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -126.91 158.87 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 41.06 110.253 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 p -82.2 113.19 19.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 42.62 110.99 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.7 p -99.21 -171.86 2.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 28.05 111.05 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -125.0 147.61 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 46.35 110.082 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.788 HD23 ' CD1' ' B' ' 110' ' ' LEU . 2.1 mp -55.32 -28.72 55.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.207 -0.451 . . . . 23.79 111.824 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -59.63 -28.21 67.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 74.93 111.323 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -66.44 -32.18 73.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 64.42 111.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.5 mt -55.1 -28.61 53.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.019 -0.537 . . . . 32.64 111.88 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.12 -35.95 71.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 41.86 111.287 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.7 mtm -59.02 -37.14 76.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 38.66 111.292 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 43' ' ' ILE . 84.8 m-85 -71.94 -29.59 64.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 25.27 111.324 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.66 128.85 37.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.377 . . . . 25.04 111.122 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.71 171.29 1.46 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.992 -0.549 . . . . 36.05 111.213 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.57 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 83.5 Cg_endo -88.06 -21.75 1.56 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.312 2.008 . . . . 54.36 113.23 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.465 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -54.8 153.86 5.68 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.928 0.394 . . . . 71.54 111.872 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -144.97 158.25 52.81 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.807 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.97 -167.99 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.933 1.755 . . . . 0.0 112.232 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.52 -76.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.16 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -145.77 109.57 4.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.4 m -163.13 33.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.277 -0.868 . . . . 20.0 111.123 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.77 0.319 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.55 124.55 34.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 86.5 m -83.05 -40.9 19.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.506 ' C ' HD13 ' A' ' 54' ' ' LEU . 1.5 m-85 -86.08 57.49 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.46 0.648 . . . . 0.0 110.824 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -118.9 -42.82 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.495 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.434 ' O ' HD11 ' A' ' 54' ' ' LEU . 44.1 p -143.63 175.02 10.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.586 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 4' ' ' THR . 22.0 t -74.34 -30.96 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.73 85.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.61 75.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.327 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.788 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -57.59 -43.72 84.83 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.18 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -65.21 -53.23 47.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.275 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -62.57 -47.32 84.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.37 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 13.2 m -58.98 -59.27 5.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.415 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.683 ' SD ' HD23 ' B' ' 110' ' ' LEU . 0.0 OUTLIER -63.12 -52.59 61.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.989 -179.615 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -92.17 71.12 5.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.091 0.472 . . . . 0.0 110.935 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.431 -1.205 . . . . 20.0 112.593 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.139 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.31 117.1 4.84 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.913 1.742 . . . . 0.0 112.251 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLU . . . . . 0.572 ' OE2' ' HB2' ' B' ' 108' ' ' ALA . 3.5 mm-40 -145.8 112.67 6.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 75.5 110.941 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.52 ' O ' HG11 ' B' ' 107' ' ' VAL . 16.5 p -130.97 167.4 19.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.098 -0.501 . . . . 31.38 110.75 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.537 HD13 HG13 ' B' ' 107' ' ' VAL . 9.1 tp -122.05 113.25 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 28.27 111.095 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.3 m -140.22 162.74 34.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 32.91 111.216 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.68 -139.64 48.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.677 . . . . 19.09 112.949 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.62 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.665 0.269 . . . . 21.73 111.494 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.58 -38.53 87.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 63.42 110.841 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.63 -45.38 62.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 20.39 110.873 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.68 -30.79 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 19.22 111.241 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.59 -43.37 85.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 31.0 111.066 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.778 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -67.9 -48.52 65.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 18.28 111.393 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.55 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -59.65 -37.9 79.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 22.05 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.52 -32.09 60.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 32.76 110.725 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -79.29 -31.6 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 27.25 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.7 t -86.51 -63.25 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 25.51 110.928 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.0 m -74.26 -51.34 15.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 29.49 111.244 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.95 -112.51 4.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 40.61 112.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.74 7.49 17.55 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.758 0.651 . . . . 79.05 112.758 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.5 mmm180 -75.84 -33.59 60.06 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.974 -0.454 . . . . 50.6 111.123 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.32 80.85 1.37 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 35.48 112.19 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.55 ' CD1' HD13 ' A' ' 14' ' ' LEU . 26.9 p90 -74.7 154.23 38.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.062 0.458 . . . . 25.52 111.396 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -130.95 120.78 24.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 56.07 110.423 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -57.32 -71.92 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 29.3 111.544 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.8 113.52 2.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.392 . . . . 38.35 111.094 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -105.39 137.89 19.4 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 42.35 110.686 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.07 155.93 60.71 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.902 1.735 . . . . 40.8 112.247 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -153.31 129.61 10.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 55.75 110.924 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.78 -49.62 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 34.94 112.476 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -71.55 139.92 49.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 34.26 110.935 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.34 160.6 10.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 36.13 112.476 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.7 m -149.95 -55.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.78 0.324 . . . . 57.93 110.908 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.2 p -151.87 131.5 13.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 72.85 110.804 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.9 t -165.93 169.96 14.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.977 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -51.32 12.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.713 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -130.27 108.94 10.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.28 48.93 0.28 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.158 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.64 177.26 9.04 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.899 1.733 . . . . 0.0 112.328 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' GLN . . . . . 0.537 ' O ' HG23 ' A' ' 41' ' ' THR . 34.4 tt0 -90.13 93.31 9.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 40' ' ' GLN . 16.8 p -160.18 177.22 10.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 64.04 110.909 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.4 -119.63 4.46 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 35.08 112.49 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.732 HD13 ' CE2' ' A' ' 60' ' ' TYR . 3.6 tp -106.8 -41.78 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 25.61 110.989 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.07 -57.28 11.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 29.9 111.415 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.99 -21.88 64.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.064 0.394 . . . . 39.04 112.064 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.4 -25.5 20.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.117 0.414 . . . . 45.6 112.117 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.3 m -112.66 -46.45 3.14 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.118 0.414 . . . . 28.23 112.118 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.0 t -71.67 -57.48 4.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.313 . . . . 25.89 110.987 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.54 -35.29 79.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 32.64 110.739 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -137.83 146.78 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 41.06 110.42 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -60.59 147.88 40.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 42.62 110.957 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.3 p -141.14 -173.84 3.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 28.05 111.047 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -111.24 128.71 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 46.35 110.137 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.701 HD21 ' C ' ' B' ' 106' ' ' SER . 0.2 OUTLIER -52.76 -23.2 6.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.413 0.523 . . . . 23.79 112.413 -178.996 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -61.47 -28.4 69.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.684 0.278 . . . . 74.93 111.296 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -64.73 -29.22 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.567 -0.288 . . . . 64.42 111.218 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 54' ' ' LEU . 6.5 mt -56.22 -28.71 59.38 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.422 -0.354 . . . . 32.64 111.654 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.66 -29.94 66.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 41.86 111.256 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.7 mtm -63.86 -50.09 70.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 38.66 111.2 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 43' ' ' ILE . 97.7 m-85 -57.22 -29.15 63.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 25.27 111.491 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.26 134.17 56.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 25.04 111.071 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.44 163.81 43.82 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.077 -0.51 . . . . 36.05 111.138 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 94.5 Cg_endo -82.45 -23.12 4.33 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.136 1.891 . . . . 54.36 113.01 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.57 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -57.59 148.44 24.15 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.921 0.391 . . . . 71.54 111.538 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.6 mtpt -162.7 170.93 7.0 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.578 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.66 -28.87 11.31 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.864 1.709 . . . . 0.0 112.372 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.56 137.77 57.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -106.25 -176.69 3.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.1 m -90.35 122.87 33.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.217 -0.897 . . . . 20.0 111.113 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 16.5 tpt85 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -75.26 145.0 42.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.98 -32.16 66.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.062 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.64 32.74 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -89.24 -38.43 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.761 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.701 ' C ' HD21 ' A' ' 54' ' ' LEU . 33.2 t -155.8 174.96 14.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.756 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.537 HG13 HD13 ' A' ' 5' ' ' LEU . 46.0 t -67.24 -31.09 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.987 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 108' ' ' ALA . . . . . 0.572 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . . . -73.3 -42.71 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.243 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.84 82.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.523 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.493 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -68.5 -42.55 78.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.263 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -56.99 -49.1 76.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.64 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -57.75 -34.55 69.67 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.439 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 81.5 m -58.41 -47.66 83.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 111.468 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 11.8 tpt -76.15 -48.81 19.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.902 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -67.53 -49.13 64.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.669 0.271 . . . . 0.0 111.313 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.455 -1.192 . . . . 20.0 112.491 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.99 152.0 50.97 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.0 1.8 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -112.09 100.99 9.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 75.5 110.89 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.461 ' O ' HG11 ' B' ' 107' ' ' VAL . 28.7 p -120.02 174.37 6.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 31.38 110.857 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 9' ' ' GLU . 11.6 tp -140.12 116.57 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 28.27 111.146 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m -140.11 168.2 20.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 32.91 110.834 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.39 -150.11 49.43 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.748 -0.739 . . . . 19.09 112.856 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.74 -30.05 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.752 0.311 . . . . 21.73 111.319 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.475 ' HB3' HD11 ' A' ' 5' ' ' LEU . 32.8 mt-10 -59.19 -43.0 92.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 63.42 111.046 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -69.24 -43.52 73.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 20.39 110.595 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.75 -30.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 19.22 111.152 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -68.77 -37.53 79.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 31.0 111.057 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -70.31 -42.43 71.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.471 -0.331 . . . . 18.28 111.002 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.453 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.2 mt -60.25 -42.16 94.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.854 0.359 . . . . 22.05 110.516 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -68.57 -32.52 72.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 32.76 110.325 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' ' HA ' ' B' ' 114' ' ' MET . 0.1 OUTLIER -71.07 -43.3 68.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 27.25 110.737 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 13' ' ' ALA . 22.6 t -81.76 -52.29 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.601 . . . . 25.51 111.413 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.9 m -83.23 -51.58 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 29.49 111.436 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.17 -109.83 2.34 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.752 -0.737 . . . . 40.61 112.797 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.87 7.3 13.22 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.889 0.7 . . . . 79.05 112.889 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.614 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.0 mmm180 -77.11 -39.82 48.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.05 0.386 . . . . 50.6 111.061 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.39 78.18 1.4 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.737 -0.744 . . . . 35.48 112.172 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.5 p90 -72.06 163.17 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.079 0.466 . . . . 25.52 111.494 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -143.99 151.82 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.694 -0.684 . . . . 56.07 110.543 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CD2' HG22 ' A' ' 43' ' ' ILE . 73.9 m-85 -97.37 35.56 1.6 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 29.3 111.258 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -176.36 126.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.377 -0.374 . . . . 38.35 110.907 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 20.3 pttp -148.67 149.52 31.1 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.167 -0.469 . . . . 42.35 110.97 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.0 170.24 19.39 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.883 1.722 . . . . 40.8 112.313 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 t -158.19 140.53 14.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 55.75 110.853 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.21 -33.98 6.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.76 . . . . 34.94 112.466 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -80.47 -59.09 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 34.26 110.987 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.12 71.92 2.88 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.767 -0.73 . . . . 36.13 112.54 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 t -127.64 103.57 7.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 57.93 110.924 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 m -158.25 151.78 23.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 72.85 110.921 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -107.86 -33.39 7.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -60.46 -45.55 93.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -66.86 -168.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -56.77 159.47 7.05 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.473 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.42 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 52.5 Cg_endo -68.64 160.11 50.8 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.969 1.78 . . . . 0.0 112.381 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -88.11 129.21 35.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -136.08 -178.28 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 64.04 110.916 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.21 -118.17 1.64 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 35.08 112.766 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.792 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.5 tt -103.9 -25.05 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 111.609 0.226 . . . . 25.61 111.609 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.6 -61.17 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.9 0.381 . . . . 29.9 111.449 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.26 -17.11 64.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.395 -0.366 . . . . 39.04 111.955 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -90.28 -32.74 16.4 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.807 0.669 . . . . 45.6 112.807 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.45 -29.05 5.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.805 0.668 . . . . 28.23 112.805 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -79.95 -46.13 17.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.871 -0.331 . . . . 25.89 110.698 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -74.53 -37.7 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.052 0.453 . . . . 32.64 110.212 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -130.11 159.23 37.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 41.06 109.865 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 p -78.74 127.12 31.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.788 0.328 . . . . 42.62 111.389 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.78 -160.86 0.94 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.3 -0.409 . . . . 28.05 110.46 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.9 175.06 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.47 -0.332 . . . . 46.35 110.403 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.745 ' HG ' HD12 ' B' ' 110' ' ' LEU . 0.3 OUTLIER -91.11 -28.18 18.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.385 -0.37 . . . . 23.79 111.499 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -55.7 -26.01 42.9 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 111.706 0.262 . . . . 74.93 111.706 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -61.19 -29.16 69.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.663 0.268 . . . . 64.42 110.919 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.4 mt -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 32.64 111.567 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.22 -31.93 73.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 41.86 111.394 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.1 mtm -63.29 -53.08 58.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 38.66 111.217 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.792 ' CE2' HD12 ' A' ' 43' ' ' ILE . 86.7 m-85 -57.16 -26.12 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.189 -0.46 . . . . 25.27 111.721 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.43 130.39 46.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.84 0.353 . . . . 25.04 111.038 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -57.75 168.56 1.06 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.233 -0.44 . . . . 36.05 111.286 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 84.2 Cg_endo -81.2 -30.11 1.72 Allowed 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.088 1.859 . . . . 54.36 112.813 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 149.56 29.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 71.54 111.093 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -150.26 157.93 36.74 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.21 134.55 17.61 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.866 1.711 . . . . 0.0 112.331 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -161.25 -53.41 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -147.41 -47.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.4 m -96.58 145.83 25.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.209 -0.901 . . . . 20.0 111.053 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -78.58 125.06 28.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.0 -24.13 33.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.624 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.519 ' C ' HD23 ' A' ' 54' ' ' LEU . 13.6 m-85 -96.0 36.98 1.26 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.795 0.331 . . . . 0.0 111.335 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.63 -33.81 15.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 0.0 110.48 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.473 ' C ' HD21 ' A' ' 54' ' ' LEU . 70.3 m -150.97 174.45 13.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.607 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 4' ' ' THR . 21.0 t -73.43 -29.32 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.337 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.82 76.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.0 86.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.417 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.745 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -60.02 -42.01 93.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.109 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -54.78 -42.67 72.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.636 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 4.2 ttp-105 -60.37 -52.44 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.976 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 5.8 m -67.76 -41.8 82.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.468 ' HE2' ' CE2' ' B' ' 115' ' ' TYR . 50.6 ttp -62.12 -53.14 59.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.223 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 115' ' ' TYR . . . . . 0.468 ' CE2' ' HE2' ' B' ' 114' ' ' MET . 84.0 m-85 -93.38 71.09 4.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.082 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.367 -1.241 . . . . 20.0 112.43 179.939 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 CA-C-O 119.731 -0.483 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.63 152.58 48.28 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.937 1.758 . . . . 0.0 112.506 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.88 110.47 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 75.5 110.826 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.5 p -135.68 166.78 22.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.169 -0.468 . . . . 31.38 110.783 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 9' ' ' GLU . 10.1 tp -124.13 116.33 22.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.372 -0.376 . . . . 28.27 111.431 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 m -140.56 161.32 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 32.91 110.933 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.03 -147.67 44.96 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.77 -0.729 . . . . 19.09 113.047 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.15 66.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 21.73 111.475 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HB3' HD11 ' A' ' 5' ' ' LEU . 48.8 mt-10 -60.63 -40.06 90.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 63.42 110.805 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.98 -43.58 74.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 20.39 110.587 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.94 -31.25 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 19.22 111.069 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.45 -31.0 67.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 31.0 111.008 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.819 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -74.1 -47.2 37.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 18.28 110.755 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.8 mt -60.46 -49.04 79.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 22.05 110.763 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -30.39 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 32.76 110.672 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' PHE . . . . . 0.452 ' CE2' ' CE ' ' B' ' 114' ' ' MET . 48.2 t80 -79.68 -35.16 39.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.427 -0.351 . . . . 27.25 110.937 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 13' ' ' ALA . 34.3 t -85.01 -57.47 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 25.51 111.039 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.4 m -77.67 -51.26 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 29.49 111.442 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.37 -115.09 6.78 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.61 -0.805 . . . . 40.61 112.691 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -82.5 7.55 14.08 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.686 0.624 . . . . 79.05 112.686 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.9 mmm180 -75.57 -32.7 60.48 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.973 -0.455 . . . . 50.6 111.017 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.04 83.3 1.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.61 -0.805 . . . . 35.48 112.151 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.62 ' CD1' HD13 ' A' ' 14' ' ' LEU . 35.6 p90 -76.96 157.88 31.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.972 0.415 . . . . 25.52 111.318 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -134.69 131.2 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 56.07 110.605 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -67.19 -52.02 46.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 29.3 111.156 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -75.87 116.49 16.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 38.35 110.955 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -112.37 96.91 37.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.22 -0.445 . . . . 42.35 110.888 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.62 171.85 15.52 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.854 1.703 . . . . 40.8 112.359 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.5 p -153.4 -54.32 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 55.75 110.901 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.17 139.41 48.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 34.94 112.567 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.7 -169.21 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.881 0.372 . . . . 34.26 110.626 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.17 79.12 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.818 -0.706 . . . . 36.13 112.53 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.9 p -149.27 -47.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 57.93 110.962 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.8 m -72.1 176.87 4.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 72.85 110.829 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 t -78.64 177.3 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.3 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.159 0.504 . . . . 0.0 111.849 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -159.53 122.4 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.52 135.98 11.16 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.0 112.86 2.66 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.988 1.792 . . . . 0.0 112.382 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -77.35 104.3 7.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -176.75 150.23 0.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 64.04 110.923 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.18 -128.41 1.86 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 35.08 112.475 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.691 HD13 ' CE2' ' A' ' 60' ' ' TYR . 5.3 tp -87.4 -42.63 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.7 0.286 . . . . 25.61 111.081 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.28 -52.46 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 29.9 111.293 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.2 m-20 -69.97 -24.71 63.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 39.04 111.811 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.51 -23.71 20.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.283 0.475 . . . . 45.6 112.283 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 55.8 m -116.0 -44.78 2.89 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.337 0.495 . . . . 28.23 112.337 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -75.02 -49.26 20.4 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.924 -0.311 . . . . 25.89 111.008 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 29.3 m-85 -72.15 -34.3 68.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.859 0.362 . . . . 32.64 110.577 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -134.68 149.86 50.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 41.06 110.273 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 p -67.41 136.54 54.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 42.62 110.821 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.4 p -130.1 -171.94 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 28.05 111.156 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.16 139.37 49.97 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.914 -0.585 . . . . 46.35 110.007 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.557 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.18 -28.84 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 23.79 111.541 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp85 -58.47 -29.21 66.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.776 0.322 . . . . 74.93 111.282 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -66.12 -28.37 68.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.378 -0.374 . . . . 64.42 111.302 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 54' ' ' LEU . 6.2 mt -56.93 -29.21 62.9 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.544 -0.298 . . . . 32.64 111.482 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.5 -31.37 69.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 41.86 111.047 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.8 mtm -61.36 -48.11 82.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 38.66 110.958 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.691 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.0 m-85 -59.15 -29.93 67.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 25.27 111.234 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.5 m -58.91 132.72 54.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 25.04 111.08 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -63.06 161.96 26.72 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.141 -0.481 . . . . 36.05 111.111 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 89.1 Cg_endo -77.81 -27.16 6.18 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.964 1.776 . . . . 54.36 112.545 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.608 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -59.54 161.01 6.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 71.54 111.071 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -140.14 157.61 68.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.812 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.92 132.56 17.1 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.928 1.752 . . . . 0.0 112.242 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.39 -54.13 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.09 31.31 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.1 m -141.53 32.95 1.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.186 -0.911 . . . . 20.0 111.118 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 35.0 ttp85 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.812 0.339 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -81.72 110.91 17.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.9 m -82.96 -28.76 29.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.256 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.449 ' C ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -97.68 33.19 2.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.779 0.323 . . . . 0.0 111.049 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.48 -34.12 11.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.001 0.429 . . . . 0.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.536 ' C ' HD21 ' A' ' 54' ' ' LEU . 70.6 m -154.38 175.16 13.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.298 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 15.4 t -76.62 -30.91 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 111.193 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.62 90.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.84 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.337 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.481 ' CD1' HD12 ' A' ' 54' ' ' LEU . 1.3 mt -57.65 -44.71 85.83 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.235 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -64.8 -51.11 63.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.975 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -61.64 -37.88 85.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 58.6 m -64.29 -58.55 6.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.795 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 114' ' ' MET . . . . . 0.452 ' CE ' ' CE2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -61.98 -51.57 67.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.839 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.1 71.17 10.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.174 0.512 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.423 -1.209 . . . . 20.0 112.509 -179.921 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 CA-C-O 119.744 -0.476 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.61 -168.97 0.59 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.959 1.773 . . . . 0.0 112.433 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -82.21 102.09 10.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.5 111.04 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.749 ' O ' HG11 ' B' ' 107' ' ' VAL . 43.0 p -119.91 174.2 6.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 31.38 110.775 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.823 HD13 HG13 ' B' ' 107' ' ' VAL . 7.2 tp -133.54 106.96 7.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 28.27 111.174 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.2 m -140.13 162.38 35.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.286 -0.415 . . . . 32.91 110.845 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.78 -143.35 38.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.713 -0.756 . . . . 19.09 112.634 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.79 -30.72 69.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.711 0.291 . . . . 21.73 111.218 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.42 -41.91 94.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 63.42 110.974 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.548 HD12 HD23 ' A' ' 5' ' ' LEU . 29.6 tp -70.46 -41.95 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 20.39 111.089 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -72.98 -33.47 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 19.22 111.142 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.54 -30.8 67.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 31.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -73.52 -47.27 42.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 18.28 110.902 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.758 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.6 mt -62.39 -50.26 72.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 22.05 110.647 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -61.33 -32.02 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 32.76 110.702 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -77.02 -36.4 56.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 27.25 110.91 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 13' ' ' ALA . 33.9 t -85.15 -66.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 25.51 110.844 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.17 -51.39 21.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 29.49 110.96 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.97 -126.08 41.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.899 -0.667 . . . . 40.61 112.983 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.2 -25.02 45.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.941 0.348 . . . . 79.05 111.941 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 mtm-85 -55.33 -25.97 37.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.918 0.34 . . . . 50.6 111.918 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.31 94.03 0.4 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.558 -0.829 . . . . 35.48 112.12 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.758 ' CD1' HD13 ' A' ' 14' ' ' LEU . 46.1 p90 -84.03 151.85 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.004 0.43 . . . . 25.52 111.552 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -131.41 134.64 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 56.07 110.386 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -71.07 -65.9 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 29.3 111.176 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -68.18 128.21 35.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 38.35 111.163 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -101.32 157.1 34.3 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.075 -0.511 . . . . 42.35 110.659 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.19 143.87 99.6 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.936 1.757 . . . . 40.8 112.201 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.9 t -86.71 -43.22 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 55.75 110.963 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.43 -172.01 41.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 34.94 112.562 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -97.6 -57.05 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.716 0.293 . . . . 34.26 110.92 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.03 80.95 0.69 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 36.13 112.499 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.3 m -150.01 114.32 5.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 57.93 110.861 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.7 p -102.94 -39.26 7.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 72.85 110.993 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.0 m -78.58 112.5 15.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.22 159.8 24.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.14 -177.96 6.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.82 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.88 73.78 4.81 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.256 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.17 170.98 14.43 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.049 1.832 . . . . 0.0 112.189 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -158.44 93.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -177.6 125.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 64.04 110.83 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.24 -128.33 0.94 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.668 -0.777 . . . . 35.08 112.546 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.472 HD13 ' CE1' ' A' ' 60' ' ' TYR . 5.6 tp -58.57 -34.93 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.845 0.355 . . . . 25.61 111.202 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.9 t -64.97 -62.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 29.9 111.122 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.43 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -63.68 -24.03 67.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.251 -0.431 . . . . 39.04 111.976 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -90.77 -31.54 16.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.448 0.536 . . . . 45.6 112.448 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.21 -48.48 3.1 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.393 0.516 . . . . 28.23 112.393 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.9 t -63.41 -51.33 66.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.981 -0.287 . . . . 25.89 110.914 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.0 m-85 -65.38 -49.99 67.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 32.64 110.271 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -124.28 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 41.06 110.285 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 p -56.71 131.31 48.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.126 -0.488 . . . . 42.62 111.732 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -123.32 -163.29 1.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.329 -0.396 . . . . 28.05 110.844 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.63 134.84 54.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 46.35 110.128 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.624 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -55.64 -27.28 48.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 23.79 112.005 -179.085 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -58.26 -26.22 62.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.549 -0.296 . . . . 74.93 111.618 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -65.13 -26.85 68.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.55 0.214 . . . . 64.42 111.238 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.624 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.2 mt -56.18 -30.84 62.8 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.777 0.323 . . . . 32.64 111.545 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -68.35 -30.34 69.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 41.86 111.524 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.9 mtm -66.13 -39.39 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.855 0.36 . . . . 38.66 111.451 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 43' ' ' ILE . 70.9 m-85 -69.96 -24.61 63.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 25.27 112.045 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.11 138.45 58.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 25.04 110.789 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -65.61 173.76 1.83 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.165 -0.471 . . . . 36.05 110.915 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 92.6 Cg_endo -83.06 -26.77 2.18 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.03 1.82 . . . . 54.36 112.731 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.98 174.4 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 71.54 111.224 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.13 161.93 58.44 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.713 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.08 132.94 6.36 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.985 1.79 . . . . 0.0 112.534 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.3 155.14 39.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -178.04 94.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.0 t -77.44 143.88 38.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.236 -0.888 . . . . 20.0 111.063 -179.972 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.769 0.319 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -78.26 115.92 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.837 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.5 m -83.0 -41.92 18.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -82.11 62.73 5.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.387 0.613 . . . . 0.0 110.949 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.44 -44.27 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.543 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 45.9 p -149.91 174.84 12.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.497 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.823 HG13 HD13 ' A' ' 5' ' ' LEU . 23.7 t -71.05 -35.57 59.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.009 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.3 -39.97 64.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.176 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.02 -42.33 85.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.594 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -42.99 97.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -61.3 -42.96 99.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -63.12 -35.96 82.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 65.9 m -60.62 -47.7 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.889 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 72.6 mtm -75.43 -51.66 12.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -82.55 71.17 9.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.165 0.507 . . . . 0.0 110.829 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.388 -1.229 . . . . 20.0 112.511 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 CA-C-O 119.745 -0.475 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.26 172.49 13.03 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.975 1.784 . . . . 0.0 112.276 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -104.28 97.88 7.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 75.5 111.093 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' HG11 ' B' ' 107' ' ' VAL . 37.8 p -133.98 -178.33 4.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 31.38 110.74 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 tp -137.91 107.4 6.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.489 -0.323 . . . . 28.27 111.247 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.2 157.13 46.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 32.91 111.029 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.0 -142.88 36.99 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.926 -0.654 . . . . 19.09 112.878 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.69 63.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.691 0.281 . . . . 21.73 111.633 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.33 -40.82 92.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.386 . . . . 63.42 110.918 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.551 HD11 HG12 ' A' ' 43' ' ' ILE . 21.9 tp -71.94 -44.89 62.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 20.39 110.643 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.12 -29.91 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 19.22 111.238 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.54 -41.08 76.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.329 -0.396 . . . . 31.0 111.02 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.721 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -65.57 -48.93 70.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 18.28 111.194 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.4 mt -59.91 -46.08 90.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 22.05 110.919 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -66.44 -31.6 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 32.76 110.783 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -77.32 -31.96 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 27.25 110.808 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.4 t -89.48 -67.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 25.51 110.804 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.2 m -70.45 -51.64 27.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 29.49 111.173 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.63 -115.88 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 40.61 112.739 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.45 7.53 19.43 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.825 0.676 . . . . 79.05 112.825 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 1.2 mmm180 -69.11 -30.47 68.76 Favored 'General case' 0 C--O 1.231 0.09 0 O-C-N 122.032 -0.418 . . . . 50.6 111.052 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 60.63 1.29 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 35.48 111.906 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.583 ' CD1' HD13 ' A' ' 14' ' ' LEU . 22.1 p90 -57.1 155.33 8.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 25.52 111.783 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -136.23 147.94 47.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.499 -0.773 . . . . 56.07 110.214 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -78.81 -57.49 3.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.546 -0.297 . . . . 29.3 111.133 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -87.88 121.7 30.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.371 -0.377 . . . . 38.35 111.039 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HE3' ' CE2' ' A' ' 60' ' ' TYR . 22.1 pttp -143.09 143.56 25.3 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.225 -0.443 . . . . 42.35 110.823 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.07 127.62 11.52 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.843 1.695 . . . . 40.8 112.463 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 t -112.38 -35.65 5.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 55.75 110.738 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.0 91.45 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 34.94 112.456 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -86.78 123.01 31.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 34.26 110.886 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.96 60.84 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.774 -0.727 . . . . 36.13 112.514 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 t -150.03 -54.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.87 0.367 . . . . 57.93 110.947 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 m -148.23 118.17 7.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.85 110.834 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 t -105.85 31.04 5.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.015 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -80.31 -38.91 29.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -149.62 155.84 40.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.759 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.28 99.59 7.48 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.276 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.16 144.65 29.99 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.886 1.724 . . . . 0.0 112.306 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -97.54 104.84 16.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.852 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.5 p -148.54 138.81 22.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 64.04 110.892 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.85 -105.4 0.24 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.73 . . . . 35.08 112.403 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.551 HG12 HD11 ' A' ' 10' ' ' LEU . 2.6 tp -105.29 -30.71 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.778 0.323 . . . . 25.61 110.933 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.73 -65.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 29.9 111.073 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.17 -22.95 67.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.376 -0.375 . . . . 39.04 111.784 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -90.43 -30.65 17.22 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.263 0.468 . . . . 45.6 112.263 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.21 -51.12 2.9 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 28.23 112.274 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.24 -55.26 34.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.73 0.3 . . . . 25.89 110.92 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.98 -55.0 33.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.956 0.408 . . . . 32.64 110.216 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -122.87 147.15 46.89 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 116.004 -0.544 . . . . 41.06 109.967 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.6 p -58.73 133.98 56.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.78 0.324 . . . . 42.62 111.461 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.4 p -118.65 -164.47 1.04 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.892 0.377 . . . . 28.05 111.016 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.31 129.61 56.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.051 -0.522 . . . . 46.35 110.398 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.789 HD22 ' CD1' ' B' ' 110' ' ' LEU . 92.8 mt -54.08 -35.52 62.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.794 -0.639 . . . . 23.79 112.346 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -55.74 -26.43 45.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.779 0.289 . . . . 74.93 111.779 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.697 0.284 . . . . 64.42 111.115 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.6 mt -55.05 -29.28 57.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.28 -0.418 . . . . 32.64 111.799 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.56 -25.89 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 41.86 112.0 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.19 -45.54 55.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 38.66 110.906 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CE1' HD13 ' A' ' 43' ' ' ILE . 55.9 m-85 -60.85 -26.26 67.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.164 -0.471 . . . . 25.27 111.312 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.6 m -59.23 147.12 36.74 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.746 0.308 . . . . 25.04 110.902 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -80.47 160.71 66.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 36.05 110.929 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.5 Cg_endo -75.9 -30.17 6.19 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.905 1.737 . . . . 54.36 112.499 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.16 172.56 1.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.414 -0.357 . . . . 71.54 111.058 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -150.18 155.84 37.33 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.79 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.58 86.61 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.86 1.707 . . . . 0.0 112.363 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.43 32.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -101.93 -169.63 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -57.15 -49.88 74.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.346 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.335 -0.841 . . . . 20.0 111.115 179.949 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 120.811 0.338 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -101.18 145.26 29.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 29.3 t -76.76 -28.5 55.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.288 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 104' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 54' ' ' LEU . 18.8 m-85 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.782 0.325 . . . . 0.0 111.125 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -79.43 -51.04 9.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 110.574 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 106' ' ' SER . . . . . 0.724 ' O ' HD11 ' A' ' 54' ' ' LEU . 49.7 p -149.4 174.14 12.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 4' ' ' THR . 21.2 t -56.01 -29.72 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.871 0.367 . . . . 0.0 111.673 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.88 -39.08 83.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.957 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.25 43.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.025 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.789 ' CD1' HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -59.63 -42.67 93.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 0.0 110.728 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' B' ' 115' ' ' TYR . 1.1 tpp85 -58.85 -46.28 88.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.17 -35.7 74.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.711 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 10.4 m -58.84 -59.1 5.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.278 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -52.35 51.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.15 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 115' ' ' TYR . . . . . 0.426 ' CD2' ' HG3' ' B' ' 111' ' ' ARG . 3.3 m-85 -86.53 71.18 10.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.822 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.33 -1.261 . . . . 20.0 112.554 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 CA-C-O 119.77 -0.461 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.46 -169.08 0.49 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.985 1.79 . . . . 0.0 112.421 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -72.1 101.83 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 75.5 110.96 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' THR . . . . . 0.678 ' O ' HG11 ' B' ' 107' ' ' VAL . 43.8 p -127.35 170.88 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 31.38 110.807 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD13 HG13 ' B' ' 107' ' ' VAL . 11.5 tp -133.05 109.82 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 28.27 111.265 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 m -140.07 163.24 33.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 32.91 110.902 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -146.15 42.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 19.09 112.867 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.22 -31.81 67.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.804 0.335 . . . . 21.73 111.533 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -59.61 -44.09 93.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 63.42 110.905 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.05 -44.97 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 20.39 110.697 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.25 -31.53 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 19.22 111.101 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.58 -49.24 74.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 31.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' ALA . . . . . 0.799 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.44 -50.69 72.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 18.28 111.339 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.661 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -58.61 -43.12 89.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.303 -0.408 . . . . 22.05 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -70.42 -32.03 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 32.76 110.667 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -79.04 -31.35 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 27.25 110.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.3 t -88.28 -68.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 25.51 111.112 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -71.22 -51.66 23.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 29.49 111.21 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.94 -112.87 3.48 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.995 -0.622 . . . . 40.61 113.089 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.89 -27.98 69.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 79.05 111.449 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ARG . . . . . 0.696 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.7 OUTLIER -55.47 -27.31 47.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.796 0.295 . . . . 50.6 111.796 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.45 108.63 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 35.48 112.033 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' PHE . . . . . 0.661 ' CD1' HD13 ' A' ' 14' ' ' LEU . 29.2 p90 -95.82 150.06 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.448 . . . . 25.52 111.266 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -126.62 120.6 29.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 56.07 110.492 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -57.84 -49.67 75.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 29.3 111.401 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -71.16 121.74 18.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 38.35 111.0 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HD3' ' CE1' ' A' ' 60' ' ' TYR . 11.2 tptp -101.72 131.96 22.26 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.22 -0.446 . . . . 42.35 110.654 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.72 109.73 2.37 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.866 1.711 . . . . 40.8 112.334 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 29' ' ' THR . 4.9 t -149.28 91.79 1.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 55.75 110.892 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.37 -110.19 0.61 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 34.94 112.482 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 32' ' ' GLY . 42.1 p90 -99.63 -46.43 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.843 0.354 . . . . 34.26 110.925 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' N ' ' CD2' ' A' ' 31' ' ' TYR . . . -172.4 -101.51 0.15 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.758 -0.734 . . . . 36.13 112.518 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.0 m -139.86 164.95 28.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 57.93 110.942 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.3 p -75.9 153.41 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 72.85 110.921 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -153.0 -64.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -90.56 -60.21 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -161.65 111.16 1.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -155.01 160.34 31.0 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.069 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 59.3 Cg_endo -71.49 121.04 7.37 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 121.846 1.698 . . . . 0.0 112.335 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -102.06 134.52 45.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -177.6 107.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 64.04 110.777 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.79 -104.92 2.18 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.851 -0.69 . . . . 35.08 112.623 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ILE . . . . . 0.785 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.6 tp -87.51 -32.31 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.797 0.332 . . . . 25.61 111.094 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.59 -65.56 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 29.9 111.16 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.1 m-20 -60.86 -22.38 64.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.277 -0.419 . . . . 39.04 111.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.68 -38.04 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.115 0.413 . . . . 45.6 112.115 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.42 -49.73 3.38 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.362 0.504 . . . . 28.23 112.362 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.0 t -60.67 -50.77 72.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.728 0.299 . . . . 25.89 111.134 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 10.5 m-85 -66.99 -49.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 32.64 110.513 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 140.58 52.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.107 -0.497 . . . . 41.06 110.449 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -57.09 125.01 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.018 -0.537 . . . . 42.62 111.565 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.0 -163.06 0.89 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.327 -0.397 . . . . 28.05 110.937 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.34 141.22 46.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 46.35 110.149 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.73 HD12 ' CD1' ' B' ' 110' ' ' LEU . 3.4 mm? -64.59 -27.55 69.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 23.79 111.531 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.2 mtp-105 -58.13 -29.0 65.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.693 0.282 . . . . 74.93 111.314 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -61.23 -26.69 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 64.42 111.504 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 54' ' ' LEU . 9.8 mt -55.77 -29.23 59.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.719 0.295 . . . . 32.64 111.679 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -30.69 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 41.86 111.029 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -61.9 -49.47 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 38.66 111.186 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . 0.785 ' CE2' HD13 ' A' ' 43' ' ' ILE . 98.7 m-85 -58.44 -28.77 65.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.043 -0.526 . . . . 25.27 111.527 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 54.1 m -59.42 138.76 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.908 0.385 . . . . 25.04 111.241 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -74.44 166.14 47.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.016 -0.538 . . . . 36.05 111.165 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 87.6 Cg_endo -81.63 -25.13 3.84 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.145 1.897 . . . . 54.36 112.869 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 64' ' ' LEU . . . . . 0.566 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -58.31 173.27 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 71.54 111.368 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -141.28 161.3 53.73 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.45 -32.29 93.6 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.013 1.809 . . . . 0.0 112.226 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.07 121.68 38.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.16 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.23 103.3 12.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.1 t -96.41 -42.36 8.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.26 -0.876 . . . . 20.0 111.002 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.787 0.327 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -87.34 113.28 22.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 49.6 t -82.86 -28.76 29.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.215 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -92.62 47.9 1.33 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.154 0.502 . . . . 0.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -93.17 -34.18 13.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.527 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.2 t -160.12 174.67 13.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.599 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 107' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 4' ' ' THR . 33.1 t -67.14 -34.95 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.797 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.76 65.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.11 86.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.515 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 110' ' ' LEU . . . . . 0.73 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -59.79 -43.12 94.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.958 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' B' B ' 111' ' ' ARG . . . . . 0.423 ' HG3' ' CE1' ' B' ' 115' ' ' TYR . 49.0 ttp180 -64.08 -42.71 96.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.748 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 13.7 mtp-105 -58.61 -35.6 72.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 91.5 m -58.57 -53.18 61.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.188 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 7.6 tpt -74.96 -42.04 58.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' B' B ' 115' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' B' ' 111' ' ' ARG . 10.0 m-85 -69.13 71.17 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.149 0.499 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.384 -1.231 . . . . 20.0 112.499 -179.901 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.798 0.332 . . . . 75.5 110.941 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.75 ' O ' HG11 ' B' ' 107' ' ' VAL . 14.2 p -128.99 170.81 13.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 31.38 110.769 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.784 HD13 HG13 ' B' ' 107' ' ' VAL . 8.5 tp -130.87 110.08 11.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 28.27 111.164 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.5 m -140.19 161.19 38.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 32.91 110.766 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -143.04 37.32 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.792 -0.718 . . . . 19.09 112.669 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.31 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.723 0.297 . . . . 21.73 111.201 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.14 -40.4 89.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 63.42 110.996 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 -46.64 62.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 20.39 110.828 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.25 -33.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 19.22 111.165 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.3 -42.34 96.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 31.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.79 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -64.17 -49.21 72.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 18.28 111.072 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.642 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.26 -39.82 88.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 22.05 110.905 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -74.69 -31.75 61.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 32.76 110.701 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -77.9 -32.01 51.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 27.25 110.837 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 13' ' ' ALA . 37.4 t -87.64 -67.68 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 25.51 110.831 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.4 m -70.41 -51.49 29.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 29.49 110.922 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.5 -113.31 5.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.772 . . . . 40.61 112.918 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.09 7.48 13.3 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.892 0.701 . . . . 79.05 112.892 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -76.11 -30.99 58.46 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.969 -0.457 . . . . 50.6 110.886 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.19 75.98 1.31 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.648 -0.787 . . . . 35.48 112.197 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.642 ' CD1' HD13 ' A' ' 14' ' ' LEU . 31.0 p90 -69.86 150.35 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 25.52 111.333 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.431 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 3.0 p90 -124.78 138.91 54.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 56.07 110.462 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD2' ' CG2' ' A' ' 43' ' ' ILE . 14.7 m-85 . . . . . 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 29.3 111.278 -179.551 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.764 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.5 tp . . . . . 0 CA--C 1.529 0.163 0 CA-C-O 120.747 0.308 . . . . 25.61 110.823 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.24 -68.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.27 -0.423 . . . . 29.9 111.058 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.8 -17.6 37.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.101 0.408 . . . . 39.04 112.101 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.45 -38.48 13.24 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.936 0.717 . . . . 45.6 112.936 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.12 -27.69 7.93 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.993 0.738 . . . . 28.23 112.993 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.64 -45.2 22.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 25.89 110.633 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -79.86 -35.92 37.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 32.64 110.395 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mtp85 -123.92 156.32 36.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 41.06 110.071 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -82.41 111.58 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.795 0.331 . . . . 42.62 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.1 p -105.49 -163.05 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.849 0.357 . . . . 28.05 110.974 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -113.75 147.47 38.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 46.35 110.287 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.784 ' CD2' HD12 ' B' ' 110' ' ' LEU . 8.5 mp -63.49 -27.29 69.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 23.79 111.705 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -58.32 -26.9 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.606 0.241 . . . . 74.93 111.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -60.76 -29.81 69.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.604 0.24 . . . . 64.42 111.07 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.4 mt -56.86 -30.96 64.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 32.64 111.619 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -69.34 -34.11 74.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.449 -0.341 . . . . 41.86 111.413 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.2 mtm -58.66 -45.01 90.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.924 0.392 . . . . 38.66 111.305 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.764 ' CE2' HD13 ' A' ' 43' ' ' ILE . 79.5 m-85 -67.49 -27.74 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 25.27 111.586 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.6 m -60.53 130.76 48.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 25.04 110.775 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.02 162.24 55.64 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.212 -0.449 . . . . 36.05 111.184 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 75.8 Cg_endo -76.18 -25.53 9.99 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.008 1.806 . . . . 54.36 112.713 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 pp . . . . . 0 C--N 1.331 -0.198 0 CA-C-O 120.825 0.345 . . . . 71.54 111.273 -179.853 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 4.7 m . . . . . 0 C--O 1.23 0.065 0 CA-C-O 120.83 0.348 . . . . 0.0 110.937 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.416 ' HA ' HD22 ' A' ' 54' ' ' LEU . 19.7 m-85 -82.01 72.24 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.08 0.467 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -125.62 -45.38 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.625 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -144.82 174.62 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.797 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 5' ' ' LEU . 33.0 t -68.64 -30.75 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.094 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.16 -39.56 65.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.267 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.93 -40.17 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.832 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.784 HD12 ' CD2' ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 0.0 110.992 -179.827 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.861 0.362 . . . . 75.5 110.974 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.57 ' O ' HG11 ' B' ' 107' ' ' VAL . 27.0 p -129.96 176.29 8.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 31.38 110.823 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.464 HD13 HG13 ' B' ' 107' ' ' VAL . 10.2 tp -136.27 115.52 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 28.27 111.164 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 m -140.23 159.79 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 32.91 111.013 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.32 -146.6 44.43 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.792 -0.718 . . . . 19.09 112.811 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.26 66.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.732 0.301 . . . . 21.73 111.32 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 63.42 110.748 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 tp -71.69 -49.69 37.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 20.39 110.516 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.08 -32.01 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 19.22 111.002 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.47 -44.36 87.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 31.0 110.846 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.765 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.79 -48.02 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 18.28 111.071 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.724 HD13 ' CD1' ' A' ' 23' ' ' PHE . 14.2 mt -60.38 -41.74 94.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 22.05 110.764 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.99 -31.98 64.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 32.76 110.736 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -76.84 -30.9 56.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.506 . . . . 27.25 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.1 t -90.1 -56.78 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 25.51 110.939 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.14 -51.34 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 29.49 111.178 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.49 -112.51 5.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 40.61 112.593 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.85 7.75 22.79 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.777 0.658 . . . . 79.05 112.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.677 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.6 mtm180 -81.76 -33.39 30.97 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 122.106 -0.371 . . . . 50.6 111.152 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.52 115.13 1.97 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.655 -0.783 . . . . 35.48 112.141 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.724 ' CD1' HD13 ' A' ' 14' ' ' LEU . 20.6 p90 -106.13 156.29 18.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 25.52 111.456 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 2.5 p90 -124.6 127.7 47.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 56.07 110.322 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 . . . . . 0 C--N 1.327 -0.392 0 CA-C-N 116.372 -0.376 . . . . 29.3 111.665 -179.182 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.431 HD13 ' CE1' ' A' ' 60' ' ' TYR . 1.9 tp . . . . . 0 CA--C 1.528 0.115 0 CA-C-O 120.814 0.34 . . . . 25.61 111.099 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.08 -59.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 29.9 111.49 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.43 -22.58 64.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.293 -0.412 . . . . 39.04 112.088 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.21 -23.71 21.19 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.437 0.532 . . . . 45.6 112.437 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.0 m -114.2 -43.63 3.2 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.067 0.395 . . . . 28.23 112.067 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -74.5 -54.04 8.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.74 0.305 . . . . 25.89 110.95 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.97 -32.61 67.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 32.64 110.652 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -133.0 150.86 52.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.515 . . . . 41.06 110.499 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.8 p -73.09 127.56 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 42.62 110.995 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.62 -173.25 2.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 28.05 111.132 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.88 54.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 46.35 109.824 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.697 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -51.02 -24.92 4.15 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 23.79 112.419 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -63.35 -30.51 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 74.93 111.113 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.51 -30.04 62.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.327 -0.397 . . . . 64.42 111.703 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.2 mt -56.39 -34.8 67.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 32.64 111.953 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.28 -24.38 63.03 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.9 0.333 . . . . 41.86 111.9 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -68.13 -34.22 75.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 38.66 110.942 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CE1' HD13 ' A' ' 43' ' ' ILE . 44.0 m-85 -78.75 -28.72 44.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 25.27 111.434 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.4 m -60.43 126.43 27.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 25.04 110.808 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.721 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -58.04 153.77 32.87 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.27 -0.423 . . . . 36.05 111.371 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 -24.55 13.0 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.971 1.78 . . . . 54.36 112.728 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.721 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.245 0 CA-C-O 120.898 0.38 . . . . 71.54 111.366 -179.834 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 52.3 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.757 0.313 . . . . 0.0 111.101 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -97.92 36.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.35 -42.09 9.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.0 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.565 ' CA ' HD21 ' A' ' 54' ' ' LEU . 70.2 m -144.74 175.9 9.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 4' ' ' THR . 27.6 t -72.13 -30.11 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.138 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.08 -39.96 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.041 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.78 84.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.298 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.54 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.419 -179.59 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.939 0.399 . . . . 75.5 110.964 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 p -134.22 161.84 33.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 31.38 110.456 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 5' ' ' LEU . 9.9 tp -119.98 115.62 24.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 28.27 111.165 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.25 164.22 30.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 32.91 110.991 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.8 -143.6 46.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.84 -0.695 . . . . 19.09 112.848 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.8 68.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 21.73 111.283 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HB3' HD11 ' A' ' 5' ' ' LEU . 45.4 mt-10 -60.82 -39.94 90.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 63.42 110.742 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.6 tp -67.76 -46.69 71.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 20.39 110.542 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.84 -31.86 49.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 19.22 110.878 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.97 -36.48 84.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 31.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.776 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -71.94 -46.47 57.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 18.28 111.025 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.31 -43.03 96.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 22.05 110.795 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -68.9 -31.76 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 32.76 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.17 -31.71 49.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 27.25 110.837 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 13' ' ' ALA . 34.0 t -88.9 -67.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 25.51 110.881 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.25 -51.25 25.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 29.49 110.984 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.57 -115.12 6.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.668 -0.777 . . . . 40.61 112.731 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.81 7.37 15.33 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.729 0.64 . . . . 79.05 112.729 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -70.29 -35.92 74.03 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 118.097 0.408 . . . . 50.6 110.886 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.37 62.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 35.48 112.255 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.506 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.5 p90 -59.2 159.45 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 25.52 111.271 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.05 123.9 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 56.07 110.637 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 29.3 111.074 -179.838 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.574 HD13 ' CE2' ' A' ' 60' ' ' TYR . 3.3 tp . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.796 0.331 . . . . 25.61 110.997 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.61 -54.13 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 29.9 111.466 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.411 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.1 m-20 -70.89 -23.3 62.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 39.04 111.954 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -90.06 -23.89 21.32 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.221 0.452 . . . . 45.6 112.221 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -115.66 -45.7 2.88 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.098 0.407 . . . . 28.23 112.098 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.0 t -73.1 -51.37 18.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.676 0.274 . . . . 25.89 111.117 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 26.5 m-85 -70.4 -32.47 70.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.895 0.378 . . . . 32.64 110.809 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -137.92 147.28 44.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 41.06 110.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -65.16 134.07 52.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 42.62 110.983 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -126.34 -172.51 2.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 28.05 111.066 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -116.68 142.98 46.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 46.35 110.088 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.756 HD23 ' CD1' ' B' ' 110' ' ' LEU . 2.1 mp -55.55 -27.57 49.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 23.79 111.937 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -60.59 -26.46 66.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.549 -0.296 . . . . 74.93 111.578 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.4 -30.55 70.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.806 0.336 . . . . 64.42 111.159 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.4 mt -57.1 -28.7 62.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 32.64 111.676 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -32.31 71.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 41.86 111.139 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.54 -43.81 96.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.394 -0.366 . . . . 38.66 111.094 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.3 m-85 -69.24 -27.61 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 25.27 111.546 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.5 m -59.58 132.23 53.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 25.04 110.954 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -63.83 162.81 26.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.151 -0.477 . . . . 36.05 111.244 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 94.9 Cg_endo -79.1 -32.11 1.96 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.056 1.837 . . . . 54.36 112.581 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.409 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 71.54 111.077 -179.902 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.9 t . . . . . 0 C--O 1.231 0.089 0 CA-C-O 120.76 0.314 . . . . 0.0 110.904 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.538 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -94.63 46.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.468 0.651 . . . . 0.0 110.665 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -109.66 -30.8 7.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.966 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.653 ' O ' HD21 ' A' ' 54' ' ' LEU . 66.0 m -156.37 -179.02 7.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.156 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.401 HG13 HD13 ' A' ' 5' ' ' LEU . 51.4 t -80.66 -28.75 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.121 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.63 -39.49 73.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.353 . . . . 0.0 111.478 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -36.91 66.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.997 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.756 ' CD1' HD23 ' A' ' 54' ' ' LEU . 4.6 mt . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.256 -179.545 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 . . . . . 0 C--O 1.232 0.137 0 CA-C-O 120.856 0.36 . . . . 75.5 110.925 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.565 ' O ' HG11 ' B' ' 107' ' ' VAL . 44.3 p -127.93 178.1 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 31.38 110.585 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.642 HD13 HG13 ' B' ' 107' ' ' VAL . 8.1 tp -135.48 108.99 7.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 28.27 111.099 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.5 m -140.16 167.88 21.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.196 -0.456 . . . . 32.91 110.992 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.62 -137.19 50.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.879 -0.677 . . . . 19.09 112.778 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.91 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.638 0.256 . . . . 21.73 111.343 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.84 -42.53 97.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.385 -0.37 . . . . 63.42 110.989 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.434 HD11 HG12 ' A' ' 43' ' ' ILE . 47.7 tp -68.72 -42.68 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 20.39 110.936 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.67 -34.58 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 19.22 110.928 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.23 -35.04 79.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 31.0 110.967 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' B' ' 110' ' ' LEU . . . -72.99 -49.38 29.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 18.28 111.363 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.7 HD13 ' CD1' ' A' ' 23' ' ' PHE . 11.8 mt -57.9 -30.41 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 22.05 111.171 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -80.78 -31.48 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 32.76 110.609 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.7 t80 -76.6 -33.88 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 27.25 110.81 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 13' ' ' ALA . 25.3 t -89.48 -40.36 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 25.51 111.406 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 m -100.27 -51.93 3.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 29.49 111.315 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.18 -110.38 3.17 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.655 -0.783 . . . . 40.61 112.723 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.19 7.62 37.14 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.846 0.684 . . . . 79.05 112.846 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.559 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -66.67 -38.45 86.84 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.029 -0.419 . . . . 50.6 110.844 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.88 60.41 0.88 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 35.48 112.233 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.0 p90 -58.07 140.56 52.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 25.52 111.345 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.0 p90 -123.96 127.69 48.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 56.07 110.501 179.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 . . . . . 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 29.3 111.509 -179.478 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.582 HD13 ' CE1' ' A' ' 60' ' ' TYR . 2.9 tp . . . . . 0 CA--C 1.528 0.116 0 CA-C-O 120.724 0.297 . . . . 25.61 111.05 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.98 -58.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 29.9 111.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.59 -22.58 63.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 39.04 112.027 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.17 -19.76 23.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.562 0.578 . . . . 45.6 112.562 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.8 m -121.81 -41.74 2.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.192 0.441 . . . . 28.23 112.192 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.7 t -73.97 -53.9 9.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 25.89 110.963 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -65.67 -34.05 77.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 32.64 110.617 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -139.01 148.31 43.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 41.06 110.717 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 p -65.73 131.88 47.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 42.62 110.989 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.0 p -122.17 -171.92 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 28.05 110.883 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -111.53 132.78 54.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 46.35 110.131 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.556 HD23 ' C ' ' B' ' 104' ' ' PHE . 0.3 OUTLIER -53.43 -24.28 12.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.332 0.493 . . . . 23.79 112.332 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.65 -26.96 67.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.477 0.177 . . . . 74.93 111.477 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.456 ' NE ' ' HE2' ' A' ' 59' ' ' MET . 20.9 mmm180 -68.58 -28.83 67.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.649 0.261 . . . . 64.42 111.271 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.8 mt -56.08 -28.84 59.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.447 -0.342 . . . . 32.64 111.788 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -68.66 -32.22 71.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 41.86 111.193 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.456 ' HE2' ' NE ' ' A' ' 56' ' ' ARG . 71.3 mtm -62.64 -49.77 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 38.66 111.148 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.582 ' CE1' HD13 ' A' ' 43' ' ' ILE . 84.6 m-85 -56.83 -28.56 61.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 25.27 111.675 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -59.23 141.73 53.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 25.04 111.197 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.772 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -78.43 176.59 3.49 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.235 -0.438 . . . . 36.05 110.985 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.772 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 93.5 Cg_endo -83.21 -34.81 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.018 1.812 . . . . 54.36 112.701 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.451 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 71.54 111.058 -179.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t . . . . . 0 CA--C 1.53 0.188 0 CA-C-O 120.496 0.188 . . . . 0.0 111.421 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.556 ' C ' HD23 ' A' ' 54' ' ' LEU . 2.8 m-30 -96.52 32.84 1.93 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.718 0.295 . . . . 0.0 111.353 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -88.51 -33.49 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.892 0.377 . . . . 0.0 110.447 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.54 ' C ' HD21 ' A' ' 54' ' ' LEU . 50.8 p -155.86 174.82 14.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.407 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 5' ' ' LEU . 21.2 t -74.08 -30.87 28.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.131 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.19 96.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.83 83.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.078 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.531 HD21 ' CB ' ' A' ' 13' ' ' ALA . 26.6 tp . . . . . 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.157 -179.917 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.743 0.306 . . . . 75.5 110.896 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.703 ' O ' HG11 ' B' ' 107' ' ' VAL . 13.0 p -129.33 -171.39 2.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 31.38 110.607 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.418 HD13 HG13 ' B' ' 107' ' ' VAL . 9.1 tp -140.28 111.84 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.494 -0.321 . . . . 28.27 111.195 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.4 m -140.15 162.95 34.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 32.91 111.148 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.91 -139.53 48.37 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.815 -0.707 . . . . 19.09 113.052 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.34 64.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.625 0.25 . . . . 21.73 111.485 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.0 -39.79 91.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.439 -0.346 . . . . 63.42 110.855 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.477 HD11 HG12 ' A' ' 43' ' ' ILE . 32.6 tp -71.81 -45.38 61.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 20.39 110.737 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.12 -31.41 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 19.22 111.019 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.62 -45.01 84.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 31.0 111.008 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.971 ' HB2' HD21 ' B' ' 110' ' ' LEU . . . -64.19 -47.33 80.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 18.28 111.155 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -60.74 -36.25 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 22.05 110.798 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -79.1 -31.58 44.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 32.76 110.794 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -79.0 -31.7 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 27.25 110.869 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.4 t -88.14 -68.1 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 25.51 110.945 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.8 m -67.99 -51.32 48.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 29.49 111.053 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.35 -114.3 5.37 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.767 . . . . 40.61 112.835 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -84.41 7.55 19.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.805 0.668 . . . . 79.05 112.805 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.5 mmm180 -71.95 -30.74 65.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.036 0.38 . . . . 50.6 110.936 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.34 67.72 1.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 35.48 112.082 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.674 ' CD1' HD13 ' A' ' 14' ' ' LEU . 30.6 p90 -60.46 164.85 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 25.52 111.501 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.5 p90 -144.32 125.25 14.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.72 -0.673 . . . . 56.07 110.465 179.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 29.3 111.428 -179.555 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.579 HD13 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER . . . . . 0 CA--C 1.529 0.171 0 CA-C-O 120.786 0.327 . . . . 25.61 111.009 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.69 -64.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 29.9 111.682 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 12.0 m-20 -67.47 -19.73 65.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.276 -0.42 . . . . 39.04 112.116 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.29 -25.56 20.46 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 111.961 0.356 . . . . 45.6 111.961 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 96.9 m -117.25 -51.52 2.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.108 0.41 . . . . 28.23 112.108 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 t -63.43 -44.04 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 25.89 111.153 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.4 m-85 -74.96 -49.23 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.443 -0.344 . . . . 32.64 110.604 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.84 150.0 45.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 41.06 110.364 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 143.39 56.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.899 0.38 . . . . 42.62 111.02 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 p -138.03 -166.36 1.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.132 -0.485 . . . . 28.05 110.932 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -113.55 138.79 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 46.35 109.851 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.729 HD12 HD22 ' B' ' 110' ' ' LEU . 3.3 mm? -61.32 -27.03 68.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.564 -0.289 . . . . 23.79 111.524 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -55.81 -26.51 46.73 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.736 0.273 . . . . 74.93 111.736 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -63.1 -28.07 69.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.68 0.276 . . . . 64.42 111.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.572 HD11 HD12 ' A' ' 54' ' ' LEU . 6.9 mt -56.26 -31.34 63.49 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.792 0.33 . . . . 32.64 111.426 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -67.02 -33.58 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 41.86 111.334 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.8 mtm -59.41 -54.07 50.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 38.66 111.064 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.579 ' CE2' HD13 ' A' ' 43' ' ' ILE . 78.9 m-85 -57.83 -26.96 62.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.974 -0.557 . . . . 25.27 111.614 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.3 m -60.19 130.3 45.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.836 0.35 . . . . 25.04 110.806 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -65.0 156.28 80.99 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.286 -0.415 . . . . 36.05 111.129 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.84 -26.49 9.57 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.033 1.822 . . . . 54.36 112.527 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.689 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 71.54 111.178 -179.837 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 7.0 m . . . . . 0 CA--C 1.528 0.1 0 CA-C-O 120.718 0.294 . . . . 0.0 111.011 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.508 ' HZ ' HG21 ' A' ' 17' ' ' VAL . 2.2 m-30 -87.87 55.77 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.26 0.552 . . . . 0.0 111.079 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.48 -35.62 6.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.165 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.1 m -160.28 174.72 13.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.703 HG11 ' O ' ' A' ' 4' ' ' THR . 23.5 t -72.44 -31.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.95 90.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.062 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.88 78.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.213 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.971 HD21 ' HB2' ' A' ' 13' ' ' ALA . 67.4 tp . . . . . 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.151 179.993 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.748 0.309 . . . . 75.5 110.854 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.651 ' O ' HG11 ' B' ' 107' ' ' VAL . 17.0 p -124.9 175.96 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 31.38 110.73 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.677 HD13 HG13 ' B' ' 107' ' ' VAL . 8.6 tp -129.52 110.25 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 28.27 111.213 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.9 m -140.22 161.7 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 32.91 110.933 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.36 -139.3 45.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.802 -0.713 . . . . 19.09 112.843 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.09 66.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.343 . . . . 21.73 111.454 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.39 -41.29 93.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 63.42 110.942 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.18 -43.87 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 20.39 110.73 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.42 -31.78 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 19.22 110.968 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.42 -42.12 92.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 31.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.787 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -66.01 -48.51 70.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 18.28 111.168 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.908 HD13 ' CD2' ' A' ' 23' ' ' PHE . 17.6 mt -60.12 -38.47 83.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 22.05 110.827 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -73.26 -32.38 64.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 32.76 110.594 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -79.35 -32.08 43.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.047 -0.524 . . . . 27.25 110.755 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.6 t -87.32 -44.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.042 -0.526 . . . . 25.51 110.905 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -100.43 -51.63 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 29.49 111.233 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.09 -95.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.967 -0.635 . . . . 40.61 112.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.58 -28.42 26.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 79.05 111.459 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 19.8 mtm-85 -57.7 -34.28 69.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.799 0.333 . . . . 50.6 111.365 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.75 150.93 27.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 35.48 112.214 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.908 ' CD2' HD13 ' A' ' 14' ' ' LEU . 15.5 p90 -141.33 145.02 34.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.965 0.412 . . . . 25.52 111.143 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -109.52 127.67 54.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 56.07 110.771 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 . . . . . 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 29.3 110.827 179.923 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 ' CE1' ' A' ' 60' ' ' TYR . 3.1 tp . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.759 0.314 . . . . 25.61 110.991 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.8 t -58.27 -57.97 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 29.9 111.446 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.4 m-20 -68.32 -22.22 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 39.04 111.932 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.31 -23.87 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.276 0.473 . . . . 45.6 112.276 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.8 m -117.22 -46.68 2.69 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.238 0.459 . . . . 28.23 112.238 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.7 t -71.26 -52.47 18.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.312 . . . . 25.89 111.072 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 15.1 m-85 -64.44 -37.09 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 32.64 110.798 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -140.31 149.85 43.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 41.06 110.913 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -60.06 140.65 56.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 42.62 111.11 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -133.12 -174.63 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 28.05 110.817 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.89 127.63 53.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.995 -0.548 . . . . 46.35 109.929 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.561 HD21 ' CA ' ' B' ' 106' ' ' SER . 0.1 OUTLIER -53.81 -26.56 24.61 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.173 -0.467 . . . . 23.79 111.979 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -58.11 -22.71 51.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.606 -0.27 . . . . 74.93 111.498 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HB3' ' HE3' ' A' ' 59' ' ' MET . 1.5 mmt180 -81.21 7.04 12.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.883 0.698 . . . . 64.42 112.883 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.1 mt -90.06 -39.21 13.05 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.032 -0.417 . . . . 32.64 111.333 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.05 67.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 41.86 111.52 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.42 ' HE3' ' HB3' ' A' ' 56' ' ' ARG . 1.2 ptp -63.84 -31.8 73.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.466 -0.334 . . . . 38.66 111.466 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.414 ' CE1' HD13 ' A' ' 43' ' ' ILE . 65.6 m-85 -70.52 -29.07 65.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 25.27 111.445 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.7 m -61.18 130.28 45.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 25.04 111.12 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.603 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -57.44 157.37 13.39 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.095 -0.502 . . . . 36.05 111.191 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.99 -24.78 38.95 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.888 1.726 . . . . 54.36 112.785 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.603 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 71.54 111.044 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 90.8 m . . . . . 0 CA--C 1.53 0.206 0 CA-C-O 120.596 0.236 . . . . 0.0 111.242 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -96.04 37.89 1.21 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.853 0.359 . . . . 0.0 111.256 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.13 -51.07 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.561 ' CA ' HD21 ' A' ' 54' ' ' LEU . 54.3 p -142.11 174.96 10.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.801 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.677 HG13 HD13 ' A' ' 5' ' ' LEU . 21.3 t -67.67 -36.49 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.093 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.8 82.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.78 92.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.916 0.389 . . . . 75.5 111.044 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 p -136.19 147.77 47.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 31.38 110.451 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 5' ' ' LEU . 9.9 tp -109.49 114.31 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 28.27 111.148 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.2 m -140.37 162.06 36.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 32.91 110.999 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.49 -145.86 46.37 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.874 -0.679 . . . . 19.09 113.048 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.57 65.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.794 0.33 . . . . 21.73 111.461 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.15 -43.11 96.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 63.42 110.898 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.61 -43.7 84.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 20.39 110.499 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.37 -33.35 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 19.22 111.006 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.0 -48.82 80.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 31.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.775 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.9 -47.45 86.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 18.28 111.172 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 23' ' ' PHE . 24.2 mt -60.0 -39.61 86.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 22.05 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -75.79 -31.38 59.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 32.76 110.84 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -79.3 -30.75 43.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 27.25 111.085 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 13' ' ' ALA . 36.9 t -89.28 -48.22 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 25.51 111.023 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 m -86.9 -51.27 6.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.392 -0.367 . . . . 29.49 111.191 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.86 -109.41 2.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.671 -0.776 . . . . 40.61 112.492 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.85 7.77 35.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.611 0.597 . . . . 79.05 112.611 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.684 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.8 mmm180 -72.52 -30.12 64.19 Favored 'General case' 0 C--O 1.231 0.092 0 O-C-N 122.041 -0.412 . . . . 50.6 111.044 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.15 84.39 0.8 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 35.48 112.136 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 14' ' ' LEU . 38.3 p90 -84.47 171.56 12.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.127 0.489 . . . . 25.52 111.389 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 12.7 p90 -145.27 124.3 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.63 . . . . 56.07 110.47 179.701 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 . . . . . 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 29.3 111.491 -179.605 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.517 HD13 ' CE2' ' A' ' 60' ' ' TYR . 2.3 tp . . . . . 0 CA--C 1.528 0.122 0 CA-C-O 120.87 0.367 . . . . 25.61 111.076 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.1 -59.53 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 29.9 111.537 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.43 -21.56 63.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.06 0.393 . . . . 39.04 112.06 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.14 -24.11 21.16 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 112.258 0.466 . . . . 45.6 112.258 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 75.9 m -116.49 -45.57 2.81 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.13 0.419 . . . . 28.23 112.13 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.2 t -71.88 -53.03 14.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 25.89 110.995 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 22.5 m-85 -67.45 -37.16 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 32.64 110.57 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -134.01 145.86 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 41.06 110.347 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 p -66.87 124.24 22.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.287 -0.415 . . . . 42.62 111.038 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -111.99 -174.92 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 28.05 111.278 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.88 138.64 45.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 46.35 109.951 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.75 HD23 ' CD1' ' B' ' 110' ' ' LEU . 3.2 mp -53.55 -31.45 46.49 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.134 0.42 . . . . 23.79 112.134 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -57.66 -28.45 63.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 74.93 111.424 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.2 mmm-85 -68.87 -22.5 64.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.515 -0.311 . . . . 64.42 111.609 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.54 -40.53 87.53 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.871 0.367 . . . . 32.64 110.592 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -62.5 -32.95 73.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 41.86 109.887 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.69 -31.37 57.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.711 -0.677 . . . . 38.66 111.335 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.517 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.3 m-85 -85.37 -29.15 24.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 25.27 111.569 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 65.4 m -58.34 130.39 46.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 25.04 111.258 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -62.36 163.42 14.55 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.538 . . . . 36.05 111.313 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 83.8 Cg_endo -80.64 -24.89 4.8 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.101 1.867 . . . . 54.36 112.872 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.562 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.36 . . . . 71.54 111.151 -179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.5 m . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.747 0.308 . . . . 0.0 110.911 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.561 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.7 m-85 -83.34 66.28 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 110.947 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -124.33 -45.07 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.611 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 17.0 p -147.0 174.94 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.58 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.92 -31.02 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.004 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.46 70.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.55 68.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.79 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.75 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.9 OUTLIER . . . . . 0 CA--C 1.533 0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.372 -179.786 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.795 0.331 . . . . 75.5 110.967 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.682 ' O ' HG11 ' B' ' 107' ' ' VAL . 54.2 p -137.64 176.5 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 31.38 110.596 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.549 HD13 HG13 ' B' ' 107' ' ' VAL . 9.9 tp -135.93 110.08 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 28.27 111.251 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -140.22 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 32.91 110.963 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.04 -144.79 40.26 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.854 -0.688 . . . . 19.09 112.915 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.75 64.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.785 0.326 . . . . 21.73 111.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.67 -46.52 90.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 63.42 110.805 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 43' ' ' ILE . 58.7 tp -64.37 -44.94 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.052 -0.522 . . . . 20.39 110.766 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.77 -33.96 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 19.22 111.139 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.69 -31.02 71.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 31.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -74.66 -47.49 31.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 18.28 110.966 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.749 HD13 ' CD1' ' A' ' 23' ' ' PHE . 14.8 mt -61.73 -47.09 86.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.209 -0.451 . . . . 22.05 110.871 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -32.29 73.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 32.76 110.665 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.68 -34.38 58.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 27.25 110.971 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.6 t -86.71 -61.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 25.51 110.96 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.1 m -76.78 -51.58 11.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 29.49 111.139 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.22 -122.46 29.13 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.895 -0.669 . . . . 40.61 113.059 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -58.71 -25.71 63.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.855 0.317 . . . . 79.05 111.855 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.592 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 mtm-85 -56.02 -30.03 61.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.75 0.31 . . . . 50.6 111.751 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.01 104.99 0.4 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.686 -0.769 . . . . 35.48 111.955 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.749 ' CD1' HD13 ' A' ' 14' ' ' LEU . 41.4 p90 -93.21 153.37 18.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 25.52 111.554 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.6 139.74 46.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.783 -0.644 . . . . 56.07 110.469 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.37 -0.377 . . . . 29.3 110.862 -179.857 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.759 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.2 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.875 0.369 . . . . 25.61 110.941 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.22 -66.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 29.9 111.104 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.418 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.9 m-20 -61.06 -20.73 62.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.11 0.411 . . . . 39.04 112.11 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.96 -28.79 17.81 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.261 0.837 . . . . 45.6 113.261 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -33.95 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.937 0.717 . . . . 28.23 112.937 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 45.5 t -73.67 -33.66 64.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 25.89 110.478 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.9 m-85 -84.84 -47.75 10.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 32.64 110.342 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 160.71 22.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.805 -0.634 . . . . 41.06 109.957 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 p -79.25 116.4 19.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.735 0.303 . . . . 42.62 111.059 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.59 -171.06 1.77 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.799 0.333 . . . . 28.05 110.911 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.28 134.6 45.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 46.35 110.338 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -57.6 -27.39 62.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.005 -0.543 . . . . 23.79 111.759 -179.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -26.21 62.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.636 0.236 . . . . 74.93 111.636 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -62.31 -28.4 69.71 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.601 0.238 . . . . 64.42 111.192 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.6 mt -56.1 -29.15 60.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.745 0.307 . . . . 32.64 111.627 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -69.71 -29.74 67.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 41.86 111.396 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.3 mtm -65.23 -49.84 68.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.841 0.353 . . . . 38.66 111.265 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.759 ' CE2' HD13 ' A' ' 43' ' ' ILE . 87.7 m-85 -56.52 -25.59 52.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 25.27 111.855 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.2 m -64.64 134.66 54.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.398 . . . . 25.04 111.055 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -64.61 158.67 66.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 36.05 111.024 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 -30.33 56.83 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.897 1.731 . . . . 54.36 112.757 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.521 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.387 . . . . 71.54 110.875 -179.865 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.699 0.285 . . . . 0.0 111.231 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.595 ' C ' HD13 ' A' ' 54' ' ' LEU . 20.3 m-85 -98.6 32.86 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.041 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -86.47 -33.08 20.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.54 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.437 ' O ' HD21 ' A' ' 54' ' ' LEU . 13.1 t -158.58 174.84 14.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.528 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 4' ' ' THR . 22.0 t -65.02 -31.06 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.162 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.35 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.52 -50.2 70.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.888 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.513 HD12 HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.051 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.922 0.392 . . . . 75.5 110.978 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.549 ' O ' HG11 ' B' ' 107' ' ' VAL . 10.9 p -122.1 171.05 9.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 31.38 110.609 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.814 HD13 HG13 ' B' ' 107' ' ' VAL . 8.1 tp -128.66 113.32 15.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.386 -0.37 . . . . 28.27 111.035 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.18 164.09 31.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.915 0.388 . . . . 32.91 111.234 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 57.5 -137.86 48.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.016 -0.612 . . . . 19.09 113.003 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.86 66.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.687 0.279 . . . . 21.73 111.664 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.03 -38.97 77.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.823 0.344 . . . . 63.42 111.278 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 tp -72.33 -39.92 67.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 20.39 110.493 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -33.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.518 . . . . 19.22 111.143 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.67 -50.13 70.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 31.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.776 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.69 -50.78 72.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 18.28 111.147 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.549 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -60.28 -42.21 94.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 22.05 110.875 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -71.84 -31.8 66.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 32.76 110.69 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -78.09 -31.28 50.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 27.25 110.871 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.5 t -89.13 -60.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 25.51 111.038 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 m -78.61 -51.54 9.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 29.49 111.033 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.88 -103.67 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 40.61 113.14 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.93 -5.28 56.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.074 0.768 . . . . 79.05 113.074 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -59.25 -42.51 91.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.205 0.457 . . . . 50.6 111.113 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.24 65.78 0.81 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 35.48 112.342 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CD1' HD13 ' A' ' 14' ' ' LEU . 26.6 p90 -58.87 156.36 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.921 0.391 . . . . 25.52 111.411 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 117.07 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 56.07 110.212 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 . . . . . 0 C--N 1.331 -0.225 0 CA-C-N 116.421 -0.354 . . . . 29.3 111.493 -179.579 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.86 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.7 tt . . . . . 0 CA--C 1.534 0.339 0 N-CA-C 111.755 0.28 . . . . 25.61 111.755 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -56.34 -55.4 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.939 0.4 . . . . 29.9 111.582 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.413 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.11 -21.75 64.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 39.04 111.906 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -90.39 -25.11 20.57 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.192 0.441 . . . . 45.6 112.192 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -114.36 -45.03 3.05 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.265 0.469 . . . . 28.23 112.265 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.3 t -73.25 -55.14 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 25.89 111.167 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 20.7 m-85 -63.81 -33.81 76.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.884 0.373 . . . . 32.64 110.873 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 ptm85 -142.05 150.69 41.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 41.06 110.854 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 p -62.87 137.29 58.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.594 . . . . 42.62 110.949 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -128.12 175.09 8.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 28.05 110.904 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.84 128.06 45.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 46.35 110.291 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.731 HD11 ' O ' ' B' ' 106' ' ' SER . 86.0 mt -54.12 -25.72 23.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 23.79 112.274 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -59.53 -30.02 68.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 74.93 111.011 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HB3' ' HE2' ' A' ' 59' ' ' MET . 11.5 mmm-85 -65.96 -26.87 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 64.42 111.393 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.51 -30.95 63.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.869 0.366 . . . . 32.64 111.491 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.28 -26.63 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 41.86 111.809 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.491 ' HE2' ' HB3' ' A' ' 56' ' ' ARG . 57.4 mtm -67.56 -52.2 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 38.66 111.545 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.86 ' CE2' HD12 ' A' ' 43' ' ' ILE . 93.0 m-85 -54.48 -25.45 25.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 25.27 112.222 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.0 m -61.74 131.11 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 25.04 110.979 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -58.65 169.87 0.94 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.155 -0.475 . . . . 36.05 111.079 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.6 Cg_endo -76.7 -33.2 3.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.847 1.698 . . . . 54.36 112.488 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 71.54 110.986 -179.99 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 24.7 t . . . . . 0 CA--C 1.528 0.123 0 CA-C-O 120.655 0.264 . . . . 0.0 111.451 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.429 ' HA ' HD12 ' A' ' 54' ' ' LEU . 18.6 m-85 -97.27 32.82 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.099 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -80.03 -51.12 9.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 110.459 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.731 ' O ' HD11 ' A' ' 54' ' ' LEU . 34.4 p -143.44 173.92 11.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.425 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.814 HG13 HD13 ' A' ' 5' ' ' LEU . 22.4 t -61.74 -30.45 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.308 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.46 -39.47 70.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.412 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.37 74.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.681 HD12 HD13 ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.281 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.115 -179.599 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.757 0.313 . . . . 75.5 110.787 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' HG11 ' B' ' 107' ' ' VAL . 44.8 p -133.46 177.1 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 31.38 111.156 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 9' ' ' GLU . 10.3 tp -140.22 118.74 12.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.272 -0.422 . . . . 28.27 111.318 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.0 m -140.44 159.52 42.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.354 -0.385 . . . . 32.91 111.072 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.1 -149.53 47.61 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.953 -0.642 . . . . 19.09 113.017 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.87 62.16 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.748 0.309 . . . . 21.73 111.65 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HB3' HD11 ' A' ' 5' ' ' LEU . 46.7 mt-10 -60.07 -39.5 86.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 63.42 110.685 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.0 tp -71.11 -47.5 57.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 20.39 110.314 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.89 -31.61 54.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.958 -0.565 . . . . 19.22 110.948 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.72 -42.64 90.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 31.0 110.782 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -62.28 -46.49 88.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 18.28 111.087 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.589 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.4 mt -59.7 -42.59 93.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 22.05 110.939 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.32 -31.33 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 32.76 110.876 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -76.84 -31.77 57.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 27.25 110.943 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 13' ' ' ALA . 28.9 t -90.07 -59.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 25.51 110.927 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.4 m -77.86 -51.59 10.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 29.49 110.949 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.79 -121.89 26.55 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.939 -0.648 . . . . 40.61 113.108 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.25 -24.58 66.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.845 0.313 . . . . 79.05 111.845 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.598 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 12.0 mtm-85 -55.46 -27.31 47.39 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.897 0.332 . . . . 50.6 111.897 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 109.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.563 -0.827 . . . . 35.48 111.973 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.589 ' CD1' HD13 ' A' ' 14' ' ' LEU . 39.7 p90 -102.0 160.34 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.109 0.481 . . . . 25.52 111.632 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 5.8 p90 -134.58 128.71 33.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.628 -0.715 . . . . 56.07 110.2 179.626 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 29.3 111.387 -179.517 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.965 HD13 ' CE2' ' A' ' 60' ' ' TYR . 9.2 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.7 0.286 . . . . 25.61 111.207 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.38 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 29.9 111.198 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -56.1 -20.31 16.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.178 -0.465 . . . . 39.04 112.195 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -86.56 -48.41 8.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.677 0.621 . . . . 45.6 112.677 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.55 -36.24 6.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.69 0.626 . . . . 28.23 112.69 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.28 -49.07 53.49 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.677 -0.409 . . . . 25.89 110.502 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -79.69 -56.58 4.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.477 . . . . 32.64 109.711 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -103.33 170.28 8.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.824 -0.626 . . . . 41.06 109.339 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -95.15 110.46 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 42.62 111.354 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.77 -169.2 1.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.23 -0.441 . . . . 28.05 110.804 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -108.51 168.04 9.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 46.35 110.828 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' B' ' 104' ' ' PHE . 6.6 mp -76.25 -30.49 57.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.447 . . . . 23.79 110.995 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -55.53 -26.76 44.87 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 74.93 111.712 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -64.5 -28.89 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.698 0.285 . . . . 64.42 111.005 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.1 mt -57.24 -30.29 64.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.856 0.36 . . . . 32.64 111.4 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -31.2 70.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 41.86 111.433 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.7 mtm -61.32 -30.24 70.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 38.66 111.549 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.965 ' CE2' HD13 ' A' ' 43' ' ' ILE . 56.4 m-85 -83.68 -24.83 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 25.27 111.999 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -67.27 130.35 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 25.04 110.892 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -58.03 164.05 3.76 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.133 -0.485 . . . . 36.05 111.19 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.1 Cg_endo -74.37 -28.67 10.16 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.92 1.746 . . . . 54.36 112.598 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.49 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 71.54 111.065 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 41.9 m . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.868 0.366 . . . . 0.0 110.987 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.622 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.2 m-85 -81.75 66.79 7.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.777 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -127.92 -46.38 1.4 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.685 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -141.36 174.75 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.606 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 4' ' ' THR . 30.7 t -74.39 -30.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.037 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.38 -39.93 89.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.042 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.56 82.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.214 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.612 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.36 -179.781 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.409 ' O ' HG21 ' B' ' 107' ' ' VAL . 2.7 mp0 . . . . . 0 C--O 1.231 0.097 0 CA-C-O 120.836 0.35 . . . . 75.5 110.747 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.442 ' O ' HG11 ' B' ' 107' ' ' VAL . 11.2 p -118.2 176.17 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 31.38 110.65 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.556 HD13 HG13 ' B' ' 107' ' ' VAL . 10.0 tp -130.99 114.44 15.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 28.27 111.446 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.7 m -140.46 158.71 43.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.271 -0.422 . . . . 32.91 111.042 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.76 -145.45 41.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.929 -0.653 . . . . 19.09 113.083 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -30.34 65.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 21.73 111.461 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.21 -37.65 80.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 63.42 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.441 HD11 HG12 ' A' ' 43' ' ' ILE . 63.1 tp -73.18 -47.94 39.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 20.39 110.721 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.21 -30.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 19.22 111.19 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -45.65 78.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 31.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -61.57 -48.77 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 18.28 111.242 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.748 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.2 mt -59.48 -44.67 93.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 22.05 111.049 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -65.37 -32.27 73.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 32.76 110.821 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -76.54 -34.48 58.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 27.25 110.936 -179.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 13' ' ' ALA . 26.1 t -88.25 -66.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 25.51 111.048 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -77.42 -51.44 10.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 29.49 111.019 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.9 -121.25 24.38 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.913 -0.66 . . . . 40.61 113.286 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.06 -22.96 66.19 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.14 0.422 . . . . 79.05 112.14 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 8.3 mtm-85 -54.88 -25.62 30.1 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.992 0.367 . . . . 50.6 111.992 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 85.52 0.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.642 -0.79 . . . . 35.48 112.037 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.748 ' CD1' HD13 ' A' ' 14' ' ' LEU . 30.3 p90 -81.38 135.46 35.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.39 . . . . 25.52 111.51 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 1.6 p90 -105.74 151.6 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.945 -0.571 . . . . 56.07 110.335 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 . . . . . 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.38 . . . . 29.3 111.269 -179.607 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.772 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.1 tp . . . . . 0 C--O 1.232 0.136 0 CA-C-O 120.862 0.363 . . . . 25.61 111.0 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.6 -59.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 29.9 111.657 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 7.5 m-20 -66.9 -24.0 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.424 . . . . 39.04 112.113 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.11 -21.78 22.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.634 0.605 . . . . 45.6 112.634 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -121.77 -47.8 2.18 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.326 0.491 . . . . 28.23 112.326 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.7 t -70.03 -44.18 69.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.885 -0.326 . . . . 25.89 111.018 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 14.5 m-85 -73.17 -38.19 66.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 32.64 110.56 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 41.06 110.705 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.9 p -58.87 153.39 17.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 42.62 111.185 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.4 p -151.14 -172.62 4.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 28.05 111.043 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -110.7 130.08 55.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 46.35 110.031 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.74 HD11 ' O ' ' B' ' 106' ' ' SER . 47.6 mt -55.58 -25.29 37.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 23.79 112.184 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -27.12 63.66 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 74.93 111.341 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . 0.439 ' NE ' ' HE1' ' A' ' 59' ' ' MET . 12.6 mmm180 -63.18 -28.36 69.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.632 -0.258 . . . . 64.42 111.298 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.9 mt -55.72 -28.25 54.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.557 -0.292 . . . . 32.64 111.754 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -70.37 -28.77 65.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.338 -0.392 . . . . 41.86 111.591 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . 0.439 ' HE1' ' NE ' ' A' ' 56' ' ' ARG . 71.0 mtm -66.17 -51.97 52.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 38.66 111.298 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.772 ' CE2' HD13 ' A' ' 43' ' ' ILE . 82.5 m-85 -54.32 -22.76 12.93 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.86 -0.609 . . . . 25.27 112.234 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.3 m -67.92 145.47 54.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 25.04 110.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.813 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -80.16 175.23 5.0 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.341 -0.391 . . . . 36.05 111.145 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.813 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 85.8 Cg_endo -77.82 -30.84 3.49 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.961 1.774 . . . . 54.36 112.697 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 71.54 111.092 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.598 0.237 . . . . 0.0 111.24 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -97.87 35.8 1.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.96 -51.37 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 110.481 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.74 ' O ' HD11 ' A' ' 54' ' ' LEU . 13.3 p -146.72 173.33 12.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.515 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 5' ' ' LEU . 22.7 t -58.03 -27.93 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.572 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.64 -39.04 67.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.957 0.408 . . . . 0.0 111.016 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.88 -50.95 67.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.115 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.622 HD12 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.211 0 CA-C-O 120.736 0.303 . . . . 0.0 111.032 -179.754 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.514 ' OE2' ' HB2' ' B' ' 108' ' ' ALA . 4.2 mm-40 . . . . . 0 C--O 1.231 0.122 0 CA-C-O 120.947 0.403 . . . . 75.5 111.101 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.69 ' O ' HG11 ' B' ' 107' ' ' VAL . 16.1 p -137.96 -176.03 4.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 31.38 110.512 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.18 112.93 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 28.27 111.131 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.4 m -140.21 162.58 34.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 32.91 111.195 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.97 -145.78 49.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.92 -0.657 . . . . 19.09 113.166 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -29.46 65.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.298 . . . . 21.73 111.508 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.13 -38.6 83.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.398 -0.365 . . . . 63.42 110.961 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.17 -48.82 32.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 20.39 110.57 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.68 -31.71 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 19.22 110.972 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.82 -46.34 78.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 31.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.806 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.3 -47.59 84.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 18.28 110.998 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.921 HD13 ' CD2' ' A' ' 23' ' ' PHE . 14.9 mt -60.66 -41.0 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 22.05 110.77 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -70.73 -32.75 70.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 32.76 110.568 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.62 -32.67 53.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 27.25 110.624 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 13' ' ' ALA . 36.3 t -86.43 -65.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 25.51 110.8 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -71.1 -51.46 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 29.49 111.008 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.0 -119.75 17.28 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.058 -0.592 . . . . 40.61 112.843 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.33 -27.38 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.579 0.228 . . . . 79.05 111.386 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.56 -67.28 0.32 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.826 0.346 . . . . 50.6 111.511 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.76 141.87 5.91 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.083 -0.58 . . . . 35.48 111.864 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.921 ' CD2' HD13 ' A' ' 14' ' ' LEU . 25.5 p90 -132.3 139.97 48.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 25.52 111.361 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -113.09 146.92 38.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 56.07 110.484 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 . . . . . 0 C--N 1.33 -0.265 0 CA-C-N 116.453 -0.34 . . . . 29.3 111.786 -179.755 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.1 tt . . . . . 0 CA--C 1.531 0.222 0 CA-C-O 120.599 0.238 . . . . 25.61 111.51 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.89 -56.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.981 0.42 . . . . 29.9 111.3 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -21.41 64.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.075 -0.511 . . . . 39.04 111.933 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.02 -28.37 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.845 0.313 . . . . 45.6 111.845 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.0 -51.95 2.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.053 0.39 . . . . 28.23 112.053 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -65.36 -53.45 43.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.64 0.257 . . . . 25.89 111.182 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -66.01 -45.2 82.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 32.64 110.739 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 148.29 50.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 41.06 110.604 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 p -60.39 139.63 57.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 42.62 110.872 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.43 -173.81 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 28.05 111.017 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.58 132.21 54.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 46.35 110.208 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.704 ' HG ' HD12 ' B' ' 110' ' ' LEU . 0.7 OUTLIER -57.27 -28.1 62.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 23.79 111.704 -179.031 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -59.15 -29.28 67.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.661 0.267 . . . . 74.93 111.323 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 3.5 mmt85 -61.12 -27.59 68.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.449 -0.342 . . . . 64.42 111.601 -179.967 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.7 mt -57.02 -29.87 63.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.777 0.322 . . . . 32.64 111.555 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.84 -29.73 67.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 41.86 111.407 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.1 mtm -64.91 -47.54 77.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.433 -0.349 . . . . 38.66 111.323 -179.843 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.764 ' CE2' HD12 ' A' ' 43' ' ' ILE . 97.8 m-85 -60.21 -30.68 69.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 25.27 111.501 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.5 m -60.16 129.51 42.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 25.04 110.873 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.58 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -57.28 151.84 34.89 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.18 -0.464 . . . . 36.05 111.346 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.41 -22.6 38.99 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.022 1.814 . . . . 54.36 112.979 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER . . . . . 0 N--CA 1.464 0.248 0 CA-C-O 120.929 0.395 . . . . 71.54 111.57 -179.726 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.685 0.279 . . . . 0.0 111.024 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -98.34 32.77 2.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.202 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -79.77 -33.5 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.424 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.691 ' C ' HD21 ' A' ' 54' ' ' LEU . 24.8 t -157.08 174.36 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.391 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 4' ' ' THR . 32.1 t -68.06 -30.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.96 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . 0.514 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . . . -69.51 -39.83 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.176 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.78 -42.65 97.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.473 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.704 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.279 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 . . . . . 0 C--O 1.232 0.178 0 CA-C-O 120.734 0.302 . . . . 75.5 110.884 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.662 ' O ' HG11 ' B' ' 107' ' ' VAL . 31.1 p -133.16 178.85 6.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 31.38 110.902 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.481 HD13 HG13 ' B' ' 107' ' ' VAL . 10.1 tp -136.6 109.48 7.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.375 . . . . 28.27 111.322 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.19 164.72 29.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 32.91 110.666 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.06 -146.83 43.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.759 -0.734 . . . . 19.09 112.742 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.94 -32.08 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 21.73 111.373 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.08 -37.42 77.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.233 -0.439 . . . . 63.42 111.14 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.419 HD11 ' CG1' ' A' ' 43' ' ' ILE . 31.2 tp -73.94 -51.22 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 20.39 110.974 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.87 -30.1 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 19.22 111.242 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.71 -48.78 65.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.4 . . . . 31.0 111.051 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.55 -45.61 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 18.28 111.258 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.751 HD13 ' CD1' ' A' ' 23' ' ' PHE . 11.7 mt -60.65 -40.62 92.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 22.05 110.809 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -74.02 -32.84 63.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 32.76 110.434 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -66.31 -41.97 88.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 27.25 110.515 179.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.448 HG22 ' HZ ' ' B' ' 104' ' ' PHE . 25.4 t -86.8 -61.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 25.51 111.198 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.87 -51.35 12.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 29.49 111.224 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.9 -117.15 9.39 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 40.61 112.693 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.47 7.73 13.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.772 0.656 . . . . 79.05 112.772 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.83 -36.0 77.66 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.036 -0.415 . . . . 50.6 110.891 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.33 59.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 35.48 112.382 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.751 ' CD1' HD13 ' A' ' 14' ' ' LEU . 29.8 p90 -58.71 133.88 56.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 25.52 111.422 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -86.47 142.37 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 56.07 110.779 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.391 . . . . 29.3 110.886 179.861 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.916 HD13 ' CE2' ' A' ' 60' ' ' TYR . 8.2 tp . . . . . 0 CA--C 1.529 0.152 0 CA-C-O 120.876 0.369 . . . . 25.61 110.954 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.23 -65.72 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 29.9 110.958 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 19.1 m-20 -61.29 -21.07 63.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.226 -0.443 . . . . 39.04 111.791 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.58 -36.97 14.13 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.974 0.361 . . . . 45.6 111.974 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -106.44 -50.33 3.16 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.41 0.522 . . . . 28.23 112.41 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.2 t -60.42 -50.32 74.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.763 0.316 . . . . 25.89 111.071 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.0 m-85 -67.21 -56.22 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 32.64 110.219 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.22 145.99 44.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 41.06 110.354 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -57.36 136.51 56.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.207 -0.451 . . . . 42.62 111.77 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -126.47 -160.47 0.99 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.132 -0.485 . . . . 28.05 110.483 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -128.11 145.71 50.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.907 0.384 . . . . 46.35 110.578 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 1.021 HD23 HD12 ' B' ' 110' ' ' LEU . 1.6 mp -59.23 -26.38 64.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.168 -0.469 . . . . 23.79 111.535 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -57.82 -28.58 64.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.651 0.262 . . . . 74.93 111.442 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.4 mmm180 -68.75 -26.71 65.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 64.42 111.206 179.738 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.0 mt -55.45 -47.81 75.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.785 0.326 . . . . 32.64 111.78 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.49 -29.08 65.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 41.86 111.519 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 30.3 mtm -63.77 -50.01 70.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 38.66 111.465 -179.611 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.916 ' CE2' HD13 ' A' ' 43' ' ' ILE . 93.2 m-85 -56.82 -28.26 61.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 25.27 111.813 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.1 m -60.35 127.15 30.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.369 . . . . 25.04 111.025 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -70.69 168.82 17.16 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.116 -0.493 . . . . 36.05 110.951 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 82.7 Cg_endo -77.76 -30.62 3.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.832 1.688 . . . . 54.36 112.842 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 71.54 110.995 -179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 11.5 m . . . . . 0 C--O 1.232 0.132 0 CA-C-O 120.83 0.348 . . . . 0.0 111.028 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.618 ' C ' HD13 ' A' ' 54' ' ' LEU . 14.5 m-30 -82.05 67.02 7.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.246 0.546 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -116.01 -41.0 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 54' ' ' LEU . 20.2 t -142.96 178.3 7.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.543 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.662 HG11 ' O ' ' A' ' 4' ' ' THR . 23.8 t -73.9 -31.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.034 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.82 -39.58 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.6 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.47 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 1.021 HD12 HD23 ' A' ' 54' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.332 -179.734 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.817 0.341 . . . . 75.5 110.863 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.575 ' O ' HG11 ' B' ' 107' ' ' VAL . 60.9 p -128.43 176.1 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 31.38 111.048 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 9' ' ' GLU . 11.6 tp -140.2 117.92 11.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 28.27 111.045 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 m -140.25 164.97 28.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.92 0.39 . . . . 32.91 110.963 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.64 -149.76 48.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.9 -0.667 . . . . 19.09 112.959 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.91 -29.83 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 21.73 111.475 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HB3' HD11 ' A' ' 5' ' ' LEU . 34.0 mt-10 -59.78 -39.41 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 63.42 110.92 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.518 HD11 HG12 ' A' ' 43' ' ' ILE . 58.1 tp -72.69 -49.26 32.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 20.39 110.773 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.67 -31.9 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 19.22 110.952 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 -45.55 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 31.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.531 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -61.43 -42.8 99.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 18.28 111.223 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 23' ' ' PHE . 12.1 mt -60.53 -38.31 84.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.881 0.372 . . . . 22.05 110.551 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . 0.405 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 1.5 mm-40 -76.5 -33.51 58.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 32.76 110.177 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -68.34 -44.96 74.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 27.25 110.622 179.736 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 13' ' ' ALA . 33.5 t -78.88 -65.62 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 25.51 111.289 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.7 m -64.6 -51.72 61.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 29.49 111.426 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.96 -109.07 1.29 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.96 -0.638 . . . . 40.61 113.18 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.79 -37.61 88.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 79.05 111.301 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.646 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.6 mtm180 -58.52 -28.97 65.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 50.6 111.446 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.86 174.56 46.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.555 -0.831 . . . . 35.48 111.721 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.901 ' CD2' HD13 ' A' ' 14' ' ' LEU . 13.6 p90 -150.37 156.0 40.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 25.52 111.546 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 112.45 14.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.646 -0.706 . . . . 56.07 110.285 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 . . . . . 0 N--CA 1.466 0.354 0 CA-C-N 116.206 -0.452 . . . . 29.3 112.206 -179.264 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 10' ' ' LEU . 1.1 tp . . . . . 0 CA--C 1.528 0.097 0 CA-C-O 120.827 0.346 . . . . 25.61 110.353 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.05 -48.72 86.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 29.9 111.327 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -25.61 61.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 39.04 111.936 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -90.34 -26.18 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.867 0.321 . . . . 45.6 111.867 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -107.12 -41.09 5.24 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 28.23 112.016 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.9 t -80.72 -57.98 3.31 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.974 -0.29 . . . . 25.89 110.907 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -65.1 -37.43 87.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 32.64 110.488 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -126.91 158.87 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 41.06 110.253 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 p -82.2 113.19 19.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 42.62 110.99 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.7 p -99.21 -171.86 2.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 28.05 111.05 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -125.0 147.61 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 46.35 110.082 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.788 HD23 ' CD1' ' B' ' 110' ' ' LEU . 2.1 mp -55.32 -28.72 55.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.207 -0.451 . . . . 23.79 111.824 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -59.63 -28.21 67.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 74.93 111.323 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -66.44 -32.18 73.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 64.42 111.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.5 mt -55.1 -28.61 53.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.019 -0.537 . . . . 32.64 111.88 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.12 -35.95 71.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 41.86 111.287 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.7 mtm -59.02 -37.14 76.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 38.66 111.292 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 43' ' ' ILE . 84.8 m-85 -71.94 -29.59 64.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 25.27 111.324 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.66 128.85 37.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.377 . . . . 25.04 111.122 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.71 171.29 1.46 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.992 -0.549 . . . . 36.05 111.213 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.57 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 83.5 Cg_endo -88.06 -21.75 1.56 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.312 2.008 . . . . 54.36 113.23 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.465 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER . . . . . 0 N--CA 1.465 0.31 0 CA-C-O 120.928 0.394 . . . . 71.54 111.872 -179.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 86.5 m . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.674 0.273 . . . . 0.0 110.921 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.506 ' C ' HD13 ' A' ' 54' ' ' LEU . 1.5 m-85 -86.08 57.49 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.46 0.648 . . . . 0.0 110.824 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -118.9 -42.82 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.495 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.434 ' O ' HD11 ' A' ' 54' ' ' LEU . 44.1 p -143.63 175.02 10.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.586 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 4' ' ' THR . 22.0 t -74.34 -30.96 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.73 85.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.61 75.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.327 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.788 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 CA--C 1.532 0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.18 -179.829 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . 0.572 ' OE2' ' HB2' ' B' ' 108' ' ' ALA . 3.5 mm-40 . . . . . 0 C--O 1.232 0.179 0 CA-C-O 120.841 0.353 . . . . 75.5 110.941 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.52 ' O ' HG11 ' B' ' 107' ' ' VAL . 16.5 p -130.97 167.4 19.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.098 -0.501 . . . . 31.38 110.75 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.537 HD13 HG13 ' B' ' 107' ' ' VAL . 9.1 tp -122.05 113.25 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 28.27 111.095 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.3 m -140.22 162.74 34.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 32.91 111.216 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.68 -139.64 48.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.677 . . . . 19.09 112.949 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.62 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.665 0.269 . . . . 21.73 111.494 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.58 -38.53 87.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 63.42 110.841 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.63 -45.38 62.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 20.39 110.873 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.68 -30.79 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 19.22 111.241 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.59 -43.37 85.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 31.0 111.066 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.778 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -67.9 -48.52 65.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 18.28 111.393 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.55 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -59.65 -37.9 79.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 22.05 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.52 -32.09 60.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 32.76 110.725 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -79.29 -31.6 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 27.25 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.7 t -86.51 -63.25 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 25.51 110.928 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.0 m -74.26 -51.34 15.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 29.49 111.244 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.95 -112.51 4.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 40.61 112.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.74 7.49 17.55 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.758 0.651 . . . . 79.05 112.758 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.5 mmm180 -75.84 -33.59 60.06 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.974 -0.454 . . . . 50.6 111.123 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.32 80.85 1.37 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 35.48 112.19 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.55 ' CD1' HD13 ' A' ' 14' ' ' LEU . 26.9 p90 -74.7 154.23 38.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.062 0.458 . . . . 25.52 111.396 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -130.95 120.78 24.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 56.07 110.423 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 . . . . . 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 29.3 111.544 -179.505 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.732 HD13 ' CE2' ' A' ' 60' ' ' TYR . 3.6 tp . . . . . 0 CA--C 1.528 0.126 0 CA-C-O 120.844 0.354 . . . . 25.61 110.989 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.07 -57.28 11.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 29.9 111.415 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.99 -21.88 64.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.064 0.394 . . . . 39.04 112.064 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.4 -25.5 20.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.117 0.414 . . . . 45.6 112.117 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.3 m -112.66 -46.45 3.14 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.118 0.414 . . . . 28.23 112.118 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.0 t -71.67 -57.48 4.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.313 . . . . 25.89 110.987 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.54 -35.29 79.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 32.64 110.739 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -137.83 146.78 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 41.06 110.42 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -60.59 147.88 40.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 42.62 110.957 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.3 p -141.14 -173.84 3.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 28.05 111.047 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -111.24 128.71 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 46.35 110.137 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.701 HD21 ' C ' ' B' ' 106' ' ' SER . 0.2 OUTLIER -52.76 -23.2 6.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.413 0.523 . . . . 23.79 112.413 -178.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -61.47 -28.4 69.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.684 0.278 . . . . 74.93 111.296 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -64.73 -29.22 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.567 -0.288 . . . . 64.42 111.218 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 54' ' ' LEU . 6.5 mt -56.22 -28.71 59.38 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.422 -0.354 . . . . 32.64 111.654 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.66 -29.94 66.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 41.86 111.256 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.7 mtm -63.86 -50.09 70.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 38.66 111.2 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 43' ' ' ILE . 97.7 m-85 -57.22 -29.15 63.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 25.27 111.491 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.26 134.17 56.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 25.04 111.071 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.44 163.81 43.82 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.077 -0.51 . . . . 36.05 111.138 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 94.5 Cg_endo -82.45 -23.12 4.33 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.136 1.891 . . . . 54.36 113.01 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.57 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.5 OUTLIER . . . . . 0 CA--C 1.528 0.109 0 CA-C-O 120.921 0.391 . . . . 71.54 111.538 -179.491 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 33.6 t . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.804 0.335 . . . . 0.0 111.062 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.64 32.74 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -89.24 -38.43 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.761 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.701 ' C ' HD21 ' A' ' 54' ' ' LEU . 33.2 t -155.8 174.96 14.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.756 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.537 HG13 HD13 ' A' ' 5' ' ' LEU . 46.0 t -67.24 -31.09 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.987 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . 0.572 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . . . -73.3 -42.71 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.243 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.84 82.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.523 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.493 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.263 -179.778 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 . . . . . 0 C--O 1.231 0.104 0 CA-C-O 120.803 0.335 . . . . 75.5 110.89 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.461 ' O ' HG11 ' B' ' 107' ' ' VAL . 28.7 p -120.02 174.37 6.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 31.38 110.857 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 9' ' ' GLU . 11.6 tp -140.12 116.57 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 28.27 111.146 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m -140.11 168.2 20.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 32.91 110.834 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.39 -150.11 49.43 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.748 -0.739 . . . . 19.09 112.856 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.74 -30.05 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.752 0.311 . . . . 21.73 111.319 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.475 ' HB3' HD11 ' A' ' 5' ' ' LEU . 32.8 mt-10 -59.19 -43.0 92.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 63.42 111.046 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -69.24 -43.52 73.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 20.39 110.595 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.75 -30.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 19.22 111.152 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -68.77 -37.53 79.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 31.0 111.057 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -70.31 -42.43 71.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.471 -0.331 . . . . 18.28 111.002 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.453 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.2 mt -60.25 -42.16 94.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.854 0.359 . . . . 22.05 110.516 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -68.57 -32.52 72.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 32.76 110.325 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER -71.07 -43.3 68.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 27.25 110.737 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 13' ' ' ALA . 22.6 t -81.76 -52.29 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.601 . . . . 25.51 111.413 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.9 m -83.23 -51.58 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 29.49 111.436 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.17 -109.83 2.34 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.752 -0.737 . . . . 40.61 112.797 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.87 7.3 13.22 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.889 0.7 . . . . 79.05 112.889 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.614 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.0 mmm180 -77.11 -39.82 48.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.05 0.386 . . . . 50.6 111.061 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.39 78.18 1.4 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.737 -0.744 . . . . 35.48 112.172 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.5 p90 -72.06 163.17 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.079 0.466 . . . . 25.52 111.494 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.99 151.82 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.694 -0.684 . . . . 56.07 110.543 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CD2' HG22 ' A' ' 43' ' ' ILE . 73.9 m-85 . . . . . 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 29.3 111.258 -179.616 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.792 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.5 tt . . . . . 0 CA--C 1.533 0.303 0 N-CA-C 111.609 0.226 . . . . 25.61 111.609 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.6 -61.17 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.9 0.381 . . . . 29.9 111.449 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.26 -17.11 64.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.395 -0.366 . . . . 39.04 111.955 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -90.28 -32.74 16.4 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.807 0.669 . . . . 45.6 112.807 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.45 -29.05 5.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.805 0.668 . . . . 28.23 112.805 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -79.95 -46.13 17.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.871 -0.331 . . . . 25.89 110.698 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -74.53 -37.7 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.052 0.453 . . . . 32.64 110.212 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -130.11 159.23 37.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 41.06 109.865 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 p -78.74 127.12 31.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.788 0.328 . . . . 42.62 111.389 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.78 -160.86 0.94 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.3 -0.409 . . . . 28.05 110.46 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.9 175.06 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.47 -0.332 . . . . 46.35 110.403 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.745 ' HG ' HD12 ' B' ' 110' ' ' LEU . 0.3 OUTLIER -91.11 -28.18 18.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.385 -0.37 . . . . 23.79 111.499 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -55.7 -26.01 42.9 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 111.706 0.262 . . . . 74.93 111.706 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -61.19 -29.16 69.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.663 0.268 . . . . 64.42 110.919 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.4 mt -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 32.64 111.567 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.22 -31.93 73.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 41.86 111.394 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.1 mtm -63.29 -53.08 58.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 38.66 111.217 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.792 ' CE2' HD12 ' A' ' 43' ' ' ILE . 86.7 m-85 -57.16 -26.12 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.189 -0.46 . . . . 25.27 111.721 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.43 130.39 46.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.84 0.353 . . . . 25.04 111.038 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -57.75 168.56 1.06 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.233 -0.44 . . . . 36.05 111.286 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 84.2 Cg_endo -81.2 -30.11 1.72 Allowed 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.088 1.859 . . . . 54.36 112.813 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 71.54 111.093 -179.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 44.6 t . . . . . 0 CA--C 1.53 0.189 0 N-CA-C 111.624 0.231 . . . . 0.0 111.624 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.519 ' C ' HD23 ' A' ' 54' ' ' LEU . 13.6 m-85 -96.0 36.98 1.26 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.795 0.331 . . . . 0.0 111.335 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.63 -33.81 15.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 0.0 110.48 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.473 ' C ' HD21 ' A' ' 54' ' ' LEU . 70.3 m -150.97 174.45 13.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.607 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 4' ' ' THR . 21.0 t -73.43 -29.32 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.337 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.82 76.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.0 86.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.417 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.745 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER . . . . . 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.109 -179.858 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.772 0.32 . . . . 75.5 110.826 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.5 p -135.68 166.78 22.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.169 -0.468 . . . . 31.38 110.783 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 9' ' ' GLU . 10.1 tp -124.13 116.33 22.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.372 -0.376 . . . . 28.27 111.431 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 m -140.56 161.32 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 32.91 110.933 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.03 -147.67 44.96 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.77 -0.729 . . . . 19.09 113.047 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.15 66.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 21.73 111.475 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HB3' HD11 ' A' ' 5' ' ' LEU . 48.8 mt-10 -60.63 -40.06 90.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 63.42 110.805 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.98 -43.58 74.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 20.39 110.587 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.94 -31.25 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 19.22 111.069 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.45 -31.0 67.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 31.0 111.008 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.819 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -74.1 -47.2 37.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 18.28 110.755 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.8 mt -60.46 -49.04 79.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 22.05 110.763 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -30.39 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 32.76 110.672 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 48.2 t80 -79.68 -35.16 39.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.427 -0.351 . . . . 27.25 110.937 -179.884 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 13' ' ' ALA . 34.3 t -85.01 -57.47 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 25.51 111.039 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.4 m -77.67 -51.26 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 29.49 111.442 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.37 -115.09 6.78 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.61 -0.805 . . . . 40.61 112.691 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -82.5 7.55 14.08 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.686 0.624 . . . . 79.05 112.686 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.9 mmm180 -75.57 -32.7 60.48 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.973 -0.455 . . . . 50.6 111.017 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.04 83.3 1.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.61 -0.805 . . . . 35.48 112.151 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.62 ' CD1' HD13 ' A' ' 14' ' ' LEU . 35.6 p90 -76.96 157.88 31.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.972 0.415 . . . . 25.52 111.318 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -134.69 131.2 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 56.07 110.605 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 . . . . . 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 29.3 111.156 -179.858 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.691 HD13 ' CE2' ' A' ' 60' ' ' TYR . 5.3 tp . . . . . 0 CA--C 1.529 0.14 0 CA-C-O 120.7 0.286 . . . . 25.61 111.081 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.28 -52.46 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 29.9 111.293 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.2 m-20 -69.97 -24.71 63.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 39.04 111.811 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.51 -23.71 20.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.283 0.475 . . . . 45.6 112.283 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 55.8 m -116.0 -44.78 2.89 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.337 0.495 . . . . 28.23 112.337 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -75.02 -49.26 20.4 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.924 -0.311 . . . . 25.89 111.008 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 29.3 m-85 -72.15 -34.3 68.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.859 0.362 . . . . 32.64 110.577 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -134.68 149.86 50.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 41.06 110.273 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 p -67.41 136.54 54.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 42.62 110.821 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.4 p -130.1 -171.94 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 28.05 111.156 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.16 139.37 49.97 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.914 -0.585 . . . . 46.35 110.007 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.557 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.18 -28.84 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 23.79 111.541 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp85 -58.47 -29.21 66.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.776 0.322 . . . . 74.93 111.282 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -66.12 -28.37 68.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.378 -0.374 . . . . 64.42 111.302 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 54' ' ' LEU . 6.2 mt -56.93 -29.21 62.9 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.544 -0.298 . . . . 32.64 111.482 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.5 -31.37 69.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 41.86 111.047 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.8 mtm -61.36 -48.11 82.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 38.66 110.958 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.691 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.0 m-85 -59.15 -29.93 67.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 25.27 111.234 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.5 m -58.91 132.72 54.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 25.04 111.08 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -63.06 161.96 26.72 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.141 -0.481 . . . . 36.05 111.111 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 89.1 Cg_endo -77.81 -27.16 6.18 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.964 1.776 . . . . 54.36 112.545 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.608 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 71.54 111.071 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.9 m . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.644 0.259 . . . . 0.0 111.256 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.449 ' C ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -97.68 33.19 2.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.779 0.323 . . . . 0.0 111.049 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.48 -34.12 11.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.001 0.429 . . . . 0.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.536 ' C ' HD21 ' A' ' 54' ' ' LEU . 70.6 m -154.38 175.16 13.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.298 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 15.4 t -76.62 -30.91 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 111.193 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.62 90.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.84 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.337 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.481 ' CD1' HD12 ' A' ' 54' ' ' LEU . 1.3 mt . . . . . 0 CA--C 1.531 0.212 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.235 -179.796 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.9 0.381 . . . . 75.5 111.04 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.749 ' O ' HG11 ' B' ' 107' ' ' VAL . 43.0 p -119.91 174.2 6.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 31.38 110.775 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.823 HD13 HG13 ' B' ' 107' ' ' VAL . 7.2 tp -133.54 106.96 7.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 28.27 111.174 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.2 m -140.13 162.38 35.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.286 -0.415 . . . . 32.91 110.845 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.78 -143.35 38.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.713 -0.756 . . . . 19.09 112.634 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.79 -30.72 69.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.711 0.291 . . . . 21.73 111.218 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.42 -41.91 94.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 63.42 110.974 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.548 HD12 HD23 ' A' ' 5' ' ' LEU . 29.6 tp -70.46 -41.95 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 20.39 111.089 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -72.98 -33.47 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 19.22 111.142 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.54 -30.8 67.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 31.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -73.52 -47.27 42.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 18.28 110.902 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.758 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.6 mt -62.39 -50.26 72.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 22.05 110.647 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -61.33 -32.02 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 32.76 110.702 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -77.02 -36.4 56.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 27.25 110.91 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 13' ' ' ALA . 33.9 t -85.15 -66.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 25.51 110.844 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.17 -51.39 21.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 29.49 110.96 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.97 -126.08 41.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.899 -0.667 . . . . 40.61 112.983 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.2 -25.02 45.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.941 0.348 . . . . 79.05 111.941 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 mtm-85 -55.33 -25.97 37.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.918 0.34 . . . . 50.6 111.918 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.31 94.03 0.4 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.558 -0.829 . . . . 35.48 112.12 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.758 ' CD1' HD13 ' A' ' 14' ' ' LEU . 46.1 p90 -84.03 151.85 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.004 0.43 . . . . 25.52 111.552 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -131.41 134.64 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 56.07 110.386 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 . . . . . 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 29.3 111.176 -179.616 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.472 HD13 ' CE1' ' A' ' 60' ' ' TYR . 5.6 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.845 0.355 . . . . 25.61 111.202 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.9 t -64.97 -62.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 29.9 111.122 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.43 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -63.68 -24.03 67.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.251 -0.431 . . . . 39.04 111.976 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -90.77 -31.54 16.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.448 0.536 . . . . 45.6 112.448 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.21 -48.48 3.1 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.393 0.516 . . . . 28.23 112.393 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.9 t -63.41 -51.33 66.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.981 -0.287 . . . . 25.89 110.914 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.0 m-85 -65.38 -49.99 67.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 32.64 110.271 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -124.28 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 41.06 110.285 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 p -56.71 131.31 48.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.126 -0.488 . . . . 42.62 111.732 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -123.32 -163.29 1.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.329 -0.396 . . . . 28.05 110.844 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.63 134.84 54.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 46.35 110.128 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.624 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -55.64 -27.28 48.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 23.79 112.005 -179.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -58.26 -26.22 62.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.549 -0.296 . . . . 74.93 111.618 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -65.13 -26.85 68.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.55 0.214 . . . . 64.42 111.238 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.624 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.2 mt -56.18 -30.84 62.8 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.777 0.323 . . . . 32.64 111.545 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -68.35 -30.34 69.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 41.86 111.524 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.9 mtm -66.13 -39.39 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.855 0.36 . . . . 38.66 111.451 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 43' ' ' ILE . 70.9 m-85 -69.96 -24.61 63.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 25.27 112.045 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.11 138.45 58.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 25.04 110.789 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -65.61 173.76 1.83 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.165 -0.471 . . . . 36.05 110.915 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 92.6 Cg_endo -83.06 -26.77 2.18 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.03 1.82 . . . . 54.36 112.731 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 71.54 111.224 -179.724 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.5 m . . . . . 0 N--CA 1.457 -0.082 0 CA-C-O 120.851 0.357 . . . . 0.0 111.12 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -82.11 62.73 5.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.387 0.613 . . . . 0.0 110.949 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.44 -44.27 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.543 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 45.9 p -149.91 174.84 12.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.497 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.823 HG13 HD13 ' A' ' 5' ' ' LEU . 23.7 t -71.05 -35.57 59.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.009 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.3 -39.97 64.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.176 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.02 -42.33 85.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.594 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.848 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 . . . . . 0 N--CA 1.458 -0.073 0 CA-C-O 120.883 0.373 . . . . 75.5 111.093 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' HG11 ' B' ' 107' ' ' VAL . 37.8 p -133.98 -178.33 4.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 31.38 110.74 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 tp -137.91 107.4 6.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.489 -0.323 . . . . 28.27 111.247 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.2 157.13 46.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 32.91 111.029 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.0 -142.88 36.99 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.926 -0.654 . . . . 19.09 112.878 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.69 63.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.691 0.281 . . . . 21.73 111.633 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.33 -40.82 92.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.386 . . . . 63.42 110.918 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.551 HD11 HG12 ' A' ' 43' ' ' ILE . 21.9 tp -71.94 -44.89 62.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 20.39 110.643 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.12 -29.91 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 19.22 111.238 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.54 -41.08 76.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.329 -0.396 . . . . 31.0 111.02 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.721 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -65.57 -48.93 70.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 18.28 111.194 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.4 mt -59.91 -46.08 90.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 22.05 110.919 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -66.44 -31.6 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 32.76 110.783 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -77.32 -31.96 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 27.25 110.808 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.4 t -89.48 -67.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 25.51 110.804 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.2 m -70.45 -51.64 27.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 29.49 111.173 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.63 -115.88 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 40.61 112.739 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.45 7.53 19.43 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.825 0.676 . . . . 79.05 112.825 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 1.2 mmm180 -69.11 -30.47 68.76 Favored 'General case' 0 C--O 1.231 0.09 0 O-C-N 122.032 -0.418 . . . . 50.6 111.052 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 60.63 1.29 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 35.48 111.906 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.583 ' CD1' HD13 ' A' ' 14' ' ' LEU . 22.1 p90 -57.1 155.33 8.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 25.52 111.783 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -136.23 147.94 47.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.499 -0.773 . . . . 56.07 110.214 179.525 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.546 -0.297 . . . . 29.3 111.133 -179.618 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.551 HG12 HD11 ' A' ' 10' ' ' LEU . 2.6 tp . . . . . 0 CA--C 1.529 0.172 0 CA-C-O 120.778 0.323 . . . . 25.61 110.933 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.73 -65.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 29.9 111.073 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.17 -22.95 67.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.376 -0.375 . . . . 39.04 111.784 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -90.43 -30.65 17.22 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.263 0.468 . . . . 45.6 112.263 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.21 -51.12 2.9 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 28.23 112.274 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.24 -55.26 34.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.73 0.3 . . . . 25.89 110.92 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.98 -55.0 33.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.956 0.408 . . . . 32.64 110.216 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -122.87 147.15 46.89 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 116.004 -0.544 . . . . 41.06 109.967 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.6 p -58.73 133.98 56.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.78 0.324 . . . . 42.62 111.461 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.4 p -118.65 -164.47 1.04 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.892 0.377 . . . . 28.05 111.016 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.31 129.61 56.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.051 -0.522 . . . . 46.35 110.398 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.789 HD22 ' CD1' ' B' ' 110' ' ' LEU . 92.8 mt -54.08 -35.52 62.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.794 -0.639 . . . . 23.79 112.346 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -55.74 -26.43 45.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.779 0.289 . . . . 74.93 111.779 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.697 0.284 . . . . 64.42 111.115 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.6 mt -55.05 -29.28 57.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.28 -0.418 . . . . 32.64 111.799 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.56 -25.89 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 41.86 112.0 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.19 -45.54 55.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 38.66 110.906 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CE1' HD13 ' A' ' 43' ' ' ILE . 55.9 m-85 -60.85 -26.26 67.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.164 -0.471 . . . . 25.27 111.312 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.6 m -59.23 147.12 36.74 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.746 0.308 . . . . 25.04 110.902 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -80.47 160.71 66.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 36.05 110.929 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.5 Cg_endo -75.9 -30.17 6.19 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.905 1.737 . . . . 54.36 112.499 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.35 0 CA-C-N 116.414 -0.357 . . . . 71.54 111.058 -179.918 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 29.3 t . . . . . 0 CA--C 1.527 0.077 0 CA-C-O 120.621 0.248 . . . . 0.0 111.288 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 54' ' ' LEU . 18.8 m-85 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.782 0.325 . . . . 0.0 111.125 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -79.43 -51.04 9.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 110.574 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . 0.724 ' O ' HD11 ' A' ' 54' ' ' LEU . 49.7 p -149.4 174.14 12.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 4' ' ' THR . 21.2 t -56.01 -29.72 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.871 0.367 . . . . 0.0 111.673 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.88 -39.08 83.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.957 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.25 43.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.025 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.789 ' CD1' HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 0.0 110.728 -179.888 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 . . . . . 0 C--O 1.231 0.086 0 CA-C-O 120.855 0.36 . . . . 75.5 110.96 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' THR . . . . . 0.678 ' O ' HG11 ' B' ' 107' ' ' VAL . 43.8 p -127.35 170.88 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 31.38 110.807 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' LEU . . . . . 0.588 HD13 HG13 ' B' ' 107' ' ' VAL . 11.5 tp -133.05 109.82 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 28.27 111.265 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 m -140.07 163.24 33.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 32.91 110.902 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -146.15 42.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 19.09 112.867 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.22 -31.81 67.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.804 0.335 . . . . 21.73 111.533 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -59.61 -44.09 93.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 63.42 110.905 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.05 -44.97 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 20.39 110.697 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.25 -31.53 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 19.22 111.101 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.58 -49.24 74.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 31.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' ALA . . . . . 0.799 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.44 -50.69 72.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 18.28 111.339 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.661 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -58.61 -43.12 89.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.303 -0.408 . . . . 22.05 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -70.42 -32.03 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 32.76 110.667 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -79.04 -31.35 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 27.25 110.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.3 t -88.28 -68.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 25.51 111.112 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -71.22 -51.66 23.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 29.49 111.21 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.94 -112.87 3.48 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.995 -0.622 . . . . 40.61 113.089 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.89 -27.98 69.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 79.05 111.449 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ARG . . . . . 0.696 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.7 OUTLIER -55.47 -27.31 47.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.796 0.295 . . . . 50.6 111.796 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.45 108.63 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 35.48 112.033 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' PHE . . . . . 0.661 ' CD1' HD13 ' A' ' 14' ' ' LEU . 29.2 p90 -95.82 150.06 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.448 . . . . 25.52 111.266 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -126.62 120.6 29.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 56.07 110.492 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 . . . . . 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 29.3 111.401 -179.773 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ILE . . . . . 0.785 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.6 tp . . . . . 0 CA--C 1.528 0.121 0 CA-C-O 120.797 0.332 . . . . 25.61 111.094 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.59 -65.56 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 29.9 111.16 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.1 m-20 -60.86 -22.38 64.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.277 -0.419 . . . . 39.04 111.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.68 -38.04 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.115 0.413 . . . . 45.6 112.115 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.42 -49.73 3.38 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.362 0.504 . . . . 28.23 112.362 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.0 t -60.67 -50.77 72.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.728 0.299 . . . . 25.89 111.134 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 10.5 m-85 -66.99 -49.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 32.64 110.513 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 140.58 52.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.107 -0.497 . . . . 41.06 110.449 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -57.09 125.01 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.018 -0.537 . . . . 42.62 111.565 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.0 -163.06 0.89 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.327 -0.397 . . . . 28.05 110.937 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.34 141.22 46.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 46.35 110.149 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.73 HD12 ' CD1' ' B' ' 110' ' ' LEU . 3.4 mm? -64.59 -27.55 69.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 23.79 111.531 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.2 mtp-105 -58.13 -29.0 65.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.693 0.282 . . . . 74.93 111.314 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -61.23 -26.69 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 64.42 111.504 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 54' ' ' LEU . 9.8 mt -55.77 -29.23 59.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.719 0.295 . . . . 32.64 111.679 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -30.69 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 41.86 111.029 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -61.9 -49.47 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 38.66 111.186 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . 0.785 ' CE2' HD13 ' A' ' 43' ' ' ILE . 98.7 m-85 -58.44 -28.77 65.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.043 -0.526 . . . . 25.27 111.527 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 54.1 m -59.42 138.76 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.908 0.385 . . . . 25.04 111.241 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -74.44 166.14 47.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.016 -0.538 . . . . 36.05 111.165 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 87.6 Cg_endo -81.63 -25.13 3.84 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.145 1.897 . . . . 54.36 112.869 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' LEU . . . . . 0.566 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 71.54 111.368 -179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 49.6 t . . . . . 0 CA--C 1.529 0.138 0 CA-C-O 120.67 0.271 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -92.62 47.9 1.33 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.154 0.502 . . . . 0.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -93.17 -34.18 13.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.527 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.2 t -160.12 174.67 13.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.599 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 107' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 4' ' ' THR . 33.1 t -67.14 -34.95 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.797 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.76 65.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.11 86.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.515 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' B' B ' 110' ' ' LEU . . . . . 0.73 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER . . . . . 0 C--N 1.331 -0.201 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.958 -179.853 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.298 0 CA-C-O 119.739 -0.479 . . . . 0.0 112.457 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.22 161.5 44.34 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 121.97 1.78 . . . . 0.0 112.356 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -105.32 106.96 17.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.13 -0.486 . . . . 75.5 110.941 -179.946 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.75 ' O ' HG11 ' B' ' 107' ' ' VAL . 14.2 p -128.99 170.81 13.0 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.233 -0.44 . . . . 31.38 110.769 179.966 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.784 HD13 HG13 ' B' ' 107' ' ' VAL . 8.5 tp -130.87 110.08 11.03 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.349 -0.387 . . . . 28.27 111.164 -179.779 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.5 m -140.19 161.19 38.25 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.201 -0.454 . . . . 32.91 110.766 179.781 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -143.04 37.32 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.792 -0.718 . . . . 19.09 112.669 179.782 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.39 -31.31 69.11 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.723 0.297 . . . . 21.73 111.201 -179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.9 mt-10 -60.14 -40.4 89.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.319 -0.4 . . . . 63.42 110.996 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 34.4 tp -70.74 -46.64 62.64 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.292 -0.413 . . . . 20.39 110.828 179.716 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -68.25 -33.5 60.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.166 -0.47 . . . . 19.22 111.165 179.807 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 30.9 m-20 -64.3 -42.34 96.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.104 -0.498 . . . . 31.0 110.877 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.79 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -64.17 -49.21 72.97 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.22 -0.446 . . . . 18.28 111.072 -179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.642 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.26 -39.82 88.14 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.208 -0.451 . . . . 22.05 110.905 179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 26.9 mm-40 -74.69 -31.75 61.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.187 -0.46 . . . . 32.76 110.701 179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.2 t80 -77.9 -32.01 51.51 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.214 -0.448 . . . . 27.25 110.837 179.857 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.79 HG23 ' O ' ' A' ' 13' ' ' ALA . 37.4 t -87.64 -67.68 0.7 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.029 -0.532 . . . . 25.51 110.831 -179.956 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.4 m -70.41 -51.49 29.15 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.181 -0.463 . . . . 29.49 110.922 -179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.5 -113.31 5.58 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.678 -0.772 . . . . 40.61 112.918 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 t70 -82.09 7.48 13.3 Favored 'General case' 0 CA--C 1.536 0.432 0 N-CA-C 112.892 0.701 . . . . 79.05 112.892 -179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.541 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -76.11 -30.99 58.46 Favored 'General case' 0 N--CA 1.457 -0.123 0 O-C-N 121.969 -0.457 . . . . 50.6 110.886 179.942 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.19 75.98 1.31 Allowed Glycine 0 N--CA 1.453 -0.215 0 C-N-CA 120.648 -0.787 . . . . 35.48 112.197 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.642 ' CD1' HD13 ' A' ' 14' ' ' LEU . 31.0 p90 -69.86 150.35 46.9 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.988 0.423 . . . . 25.52 111.333 -179.526 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.431 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 3.0 p90 -124.78 138.91 54.25 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.878 -0.601 . . . . 56.07 110.462 179.746 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.424 ' CD2' ' CG2' ' A' ' 43' ' ' ILE . 14.7 m-85 -77.94 -42.85 31.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.168 -0.469 . . . . 29.3 111.278 -179.551 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -99.48 120.64 39.95 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.986 0.422 . . . . 38.35 111.259 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.423 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -150.61 150.04 27.5 Favored Pre-proline 0 CA--C 1.533 0.304 0 CA-C-N 115.996 -0.547 . . . . 42.35 110.822 179.574 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_endo -63.42 160.91 33.3 Favored 'Trans proline' 0 C--N 1.355 0.914 0 C-N-CA 121.957 1.771 . . . . 40.8 112.38 -179.715 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 68.5 p -151.29 -47.15 0.11 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 115.956 -0.566 . . . . 55.75 110.759 -179.952 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -109.41 -81.86 1.32 Allowed Glycine 0 N--CA 1.452 -0.251 0 C-N-CA 120.855 -0.688 . . . . 34.94 112.536 179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 43.0 m-85 -159.96 125.67 4.14 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 120.813 0.34 . . . . 34.26 110.865 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -119.27 50.9 0.79 Allowed Glycine 0 C--N 1.332 0.33 0 C-N-CA 120.876 -0.678 . . . . 36.13 112.473 179.982 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 29.7 t -150.06 -48.76 0.13 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.836 0.351 . . . . 57.93 110.859 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 20.1 t -78.65 -38.83 38.63 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.219 -0.446 . . . . 72.85 110.876 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 35.8 m -87.7 124.18 33.3 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.189 -0.459 . . . . 0.0 110.851 -179.978 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.3 ttp-105 -87.7 -58.58 2.52 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.851 179.944 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -72.04 111.84 7.62 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.906 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -156.73 133.89 6.64 Favored Pre-proline 0 C--N 1.327 -0.382 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.019 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 95.1 Cg_endo -82.66 171.46 12.04 Favored 'Trans proline' 0 C--N 1.357 1.002 0 C-N-CA 122.005 1.803 . . . . 0.0 112.44 -179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.4 tt0 -95.46 119.56 34.18 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.686 179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.5 t -162.3 142.51 9.92 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.303 -0.408 . . . . 64.04 110.988 -179.783 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -144.2 -90.86 0.12 Allowed Glycine 0 N--CA 1.452 -0.27 0 C-N-CA 120.773 -0.727 . . . . 35.08 112.37 179.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.764 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.5 tp -103.0 -30.95 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-O 120.747 0.308 . . . . 25.61 110.823 179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 23.2 t -71.24 -68.37 0.4 Allowed 'Isoleucine or valine' 0 C--O 1.224 -0.272 0 CA-C-N 116.27 -0.423 . . . . 29.9 111.058 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 3.8 m-20 -59.8 -17.6 37.18 Favored 'General case' 0 C--N 1.324 -0.509 0 N-CA-C 112.101 0.408 . . . . 39.04 112.101 179.879 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 11.2 tp10 -90.45 -38.48 13.24 Favored 'General case' 0 CA--C 1.531 0.225 0 N-CA-C 112.936 0.717 . . . . 45.6 112.936 -178.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -113.12 -27.69 7.93 Favored 'General case' 0 N--CA 1.47 0.545 0 N-CA-C 112.993 0.738 . . . . 28.23 112.993 -178.344 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 35.7 t -78.64 -45.2 22.06 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.855 0.36 . . . . 25.89 110.633 -179.827 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 14.5 m-85 -79.86 -35.92 37.44 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.037 0.446 . . . . 32.64 110.395 179.552 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 25.7 mtp85 -123.92 156.32 36.54 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.887 -0.597 . . . . 41.06 110.071 179.374 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.1 p -82.41 111.58 18.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.795 0.331 . . . . 42.62 111.079 -179.846 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.1 p -105.49 -163.05 0.91 Allowed 'General case' 0 CA--C 1.535 0.387 0 CA-C-O 120.849 0.357 . . . . 28.05 110.974 -179.974 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.9 p-10 -113.75 147.47 38.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.033 -0.53 . . . . 46.35 110.287 179.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.784 ' CD2' HD12 ' B' ' 110' ' ' LEU . 8.5 mp -63.49 -27.29 69.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.192 -0.458 . . . . 23.79 111.705 -179.388 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.4 mtt180 -58.32 -26.9 63.61 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.606 0.241 . . . . 74.93 111.53 -179.808 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 13.2 mmm180 -60.76 -29.81 69.64 Favored 'General case' 0 C--N 1.333 -0.119 0 CA-C-O 120.604 0.24 . . . . 64.42 111.07 179.817 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.676 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.4 mt -56.86 -30.96 64.32 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.394 -0.366 . . . . 32.64 111.619 -179.613 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 33.9 mt-10 -69.34 -34.11 74.12 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.449 -0.341 . . . . 41.86 111.413 -179.688 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.2 mtm -58.66 -45.01 90.3 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.924 0.392 . . . . 38.66 111.305 -179.788 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.764 ' CE2' HD13 ' A' ' 43' ' ' ILE . 79.5 m-85 -67.49 -27.74 67.26 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.969 -0.559 . . . . 25.27 111.586 -179.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.6 m -60.53 130.76 48.19 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-O 120.821 0.343 . . . . 25.04 110.775 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.541 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.02 162.24 55.64 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.212 -0.449 . . . . 36.05 111.184 -179.976 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.471 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 75.8 Cg_endo -76.18 -25.53 9.99 Favored 'Trans proline' 0 C--N 1.358 1.048 0 C-N-CA 122.008 1.806 . . . . 54.36 112.713 -179.907 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 3.5 pp -58.34 170.95 0.64 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.825 0.345 . . . . 71.54 111.273 -179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 35.6 ttpt -148.37 140.04 14.16 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.91 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 56.2 Cg_endo -69.85 -169.18 0.32 Allowed 'Trans proline' 0 C--N 1.356 0.949 0 C-N-CA 121.895 1.73 . . . . 0.0 112.322 -179.96 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -89.28 148.49 23.54 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.153 179.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -164.99 153.12 11.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.189 -0.46 . . . . 0.0 110.829 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 22.5 t -86.15 131.0 34.35 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.908 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.162 -0.923 . . . . 20.0 111.138 -179.922 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 ptp180 . . . . . 0 N--CA 1.486 1.357 0 CA-C-O 120.924 0.392 . . . . 0.0 111.147 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 32.1 m-80 -65.13 133.97 52.74 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.154 -0.476 . . . . 0.0 111.003 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 4.7 m -82.98 -41.46 18.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.937 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.416 ' HA ' HD22 ' A' ' 54' ' ' LEU . 19.7 m-85 -82.01 72.24 9.06 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-O 121.08 0.467 . . . . 0.0 110.857 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -125.62 -45.38 1.78 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.625 179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.0 p -144.82 174.62 10.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.797 179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.784 HG13 HD13 ' A' ' 5' ' ' LEU . 33.0 t -68.64 -30.75 48.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.33 -0.396 . . . . 0.0 111.094 -179.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.16 -39.56 65.55 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.244 -0.435 . . . . 0.0 111.267 -179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.93 -40.17 75.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.189 -0.46 . . . . 0.0 111.832 -179.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.784 HD12 ' CD2' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -59.76 -43.74 94.18 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.85 0.357 . . . . 0.0 110.992 -179.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 44.9 mtm180 -64.96 -51.24 62.89 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.911 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 39.7 mtm180 -59.66 -40.48 87.89 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.129 179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 55.9 m -62.89 -47.28 84.0 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.981 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 29.9 ttp -72.86 -52.17 15.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.241 -0.436 . . . . 0.0 111.001 -179.91 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 47.8 m-85 -73.3 71.2 1.22 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.879 -179.933 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.031 0 CA-C-O 118.339 -1.256 . . . . 20.0 112.551 -179.932 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 CA-C-O 119.682 -0.51 . . . . 0.0 112.513 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.6 Cg_endo -72.9 -168.8 0.43 Allowed 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.968 1.779 . . . . 0.0 112.454 -179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.9 mp0 -86.91 108.17 18.68 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.1 -0.5 . . . . 75.5 110.974 179.979 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.57 ' O ' HG11 ' B' ' 107' ' ' VAL . 27.0 p -129.96 176.29 8.18 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.22 -0.446 . . . . 31.38 110.823 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.464 HD13 HG13 ' B' ' 107' ' ' VAL . 10.2 tp -136.27 115.52 12.56 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.28 -0.418 . . . . 28.27 111.164 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 19.7 m -140.23 159.79 41.4 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.153 -0.476 . . . . 32.91 111.013 179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.32 -146.6 44.43 Favored Glycine 0 N--CA 1.453 -0.207 0 C-N-CA 120.792 -0.718 . . . . 19.09 112.811 179.647 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.31 -30.26 66.53 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.732 0.301 . . . . 21.73 111.32 -179.832 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 39.2 mt-10 -60.45 -37.95 82.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.27 -0.423 . . . . 63.42 110.748 179.893 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 65.1 tp -71.69 -49.69 37.22 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.129 -0.487 . . . . 20.39 110.516 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.08 -32.01 56.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.03 -0.532 . . . . 19.22 111.002 179.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -65.47 -44.36 87.4 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.105 -0.498 . . . . 31.0 110.846 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.765 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.79 -48.02 83.7 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.258 -0.428 . . . . 18.28 111.071 179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.724 HD13 ' CD1' ' A' ' 23' ' ' PHE . 14.2 mt -60.38 -41.74 94.4 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.246 -0.434 . . . . 22.05 110.764 -179.985 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.4 mm-40 -72.99 -31.98 64.86 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.253 -0.431 . . . . 32.76 110.736 179.723 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -76.84 -30.9 56.54 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.088 -0.506 . . . . 27.25 111.025 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.765 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.1 t -90.1 -56.78 4.82 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.146 -0.479 . . . . 25.51 110.939 -179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.9 m -77.14 -51.34 11.17 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.2 -0.454 . . . . 29.49 111.178 -179.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.49 -112.51 5.03 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.761 -0.733 . . . . 40.61 112.593 -179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -85.85 7.75 22.79 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 112.777 0.658 . . . . 79.05 112.777 -179.716 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.677 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.6 mtm180 -81.76 -33.39 30.97 Favored 'General case' 0 C--N 1.339 0.116 0 O-C-N 122.106 -0.371 . . . . 50.6 111.152 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.52 115.13 1.97 Allowed Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.655 -0.783 . . . . 35.48 112.141 -179.718 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.724 ' CD1' HD13 ' A' ' 14' ' ' LEU . 20.6 p90 -106.13 156.29 18.58 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 121.098 0.475 . . . . 25.52 111.456 -179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.429 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 2.5 p90 -124.6 127.7 47.77 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 115.732 -0.667 . . . . 56.07 110.322 179.409 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.1 m-85 -66.28 -27.37 67.88 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.372 -0.376 . . . . 29.3 111.665 -179.182 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 6.5 t-20 -88.87 138.86 31.03 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.937 0.399 . . . . 38.35 111.318 -179.7 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.41 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 15.2 tptp -135.08 133.21 20.66 Favored Pre-proline 0 CA--C 1.535 0.39 0 CA-C-N 115.958 -0.564 . . . . 42.35 110.821 179.902 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.0 Cg_endo -76.74 160.83 34.18 Favored 'Trans proline' 0 C--N 1.357 0.995 0 C-N-CA 121.857 1.705 . . . . 40.8 112.318 179.996 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.437 HG23 ' N ' ' A' ' 30' ' ' GLY . 9.2 t -172.58 -46.65 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.24 -0.436 . . . . 55.75 110.924 179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . 0.437 ' N ' HG23 ' A' ' 29' ' ' THR . . . -99.36 -100.42 2.26 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.706 -0.759 . . . . 34.94 112.543 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 94.3 m-85 -85.23 -34.95 21.88 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.799 0.333 . . . . 34.26 110.867 179.966 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.04 113.41 3.39 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.784 -0.722 . . . . 36.13 112.5 -179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 11.9 t -89.94 107.07 18.89 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.811 0.339 . . . . 57.93 111.011 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.5 p -157.8 -56.39 0.08 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 72.85 110.922 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.2 p -90.59 -52.22 5.0 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.828 -179.933 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 16.4 ttp180 -87.39 159.93 18.53 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.887 -179.993 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -77.7 139.34 39.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.869 179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.605 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -156.25 165.26 18.99 Favored Pre-proline 0 CA--C 1.533 0.317 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.115 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.605 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 44.3 Cg_endo -67.72 167.03 22.23 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 121.86 1.707 . . . . 0.0 112.227 -179.988 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.5 tp60 -101.12 128.54 47.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.931 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 2.9 t -177.56 127.77 0.14 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.056 -0.52 . . . . 64.04 110.719 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -158.95 -107.12 0.23 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.666 -0.778 . . . . 35.08 112.727 -179.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.431 HD13 ' CE1' ' A' ' 60' ' ' TYR . 1.9 tp -72.05 -38.93 65.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.814 0.34 . . . . 25.61 111.099 -179.922 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.1 t -58.08 -59.32 3.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.305 -0.407 . . . . 29.9 111.49 -179.744 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -68.43 -22.58 64.6 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.293 -0.412 . . . . 39.04 112.088 -179.607 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -90.21 -23.71 21.19 Favored 'General case' 0 C--N 1.332 -0.173 0 N-CA-C 112.437 0.532 . . . . 45.6 112.437 -179.119 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 97.0 m -114.2 -43.63 3.2 Favored 'General case' 0 N--CA 1.465 0.297 0 N-CA-C 112.067 0.395 . . . . 28.23 112.067 -178.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 14.6 t -74.5 -54.04 8.31 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.74 0.305 . . . . 25.89 110.95 -179.76 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.5 m-85 -71.97 -32.61 67.43 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.886 0.374 . . . . 32.64 110.652 179.736 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 9.5 mtp-105 -133.0 150.86 52.13 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.068 -0.515 . . . . 41.06 110.499 179.652 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 11.8 p -73.09 127.56 32.94 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.346 -0.388 . . . . 42.62 110.995 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 27.0 p -118.62 -173.25 2.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.158 -0.474 . . . . 28.05 111.132 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -109.6 131.88 54.65 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.917 -0.583 . . . . 46.35 109.824 178.85 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.697 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.2 OUTLIER -51.02 -24.92 4.15 Favored 'General case' 0 N--CA 1.47 0.544 0 N-CA-C 112.419 0.526 . . . . 23.79 112.419 -179.03 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 68.9 mtp180 -63.35 -30.51 71.63 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.793 0.33 . . . . 74.93 111.113 179.845 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.51 -30.04 62.55 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 116.327 -0.397 . . . . 64.42 111.703 -179.722 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.2 mt -56.39 -34.8 67.05 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.182 -0.463 . . . . 32.64 111.953 -179.519 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 1.8 mm-40 -70.28 -24.38 63.03 Favored 'General case' 0 C--N 1.328 -0.33 0 N-CA-C 111.9 0.333 . . . . 41.86 111.9 -179.691 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.6 mpp? -68.13 -34.22 75.95 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-O 120.848 0.356 . . . . 38.66 110.942 -179.754 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.431 ' CE1' HD13 ' A' ' 43' ' ' ILE . 44.0 m-85 -78.75 -28.72 44.88 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.293 -0.412 . . . . 25.27 111.434 -179.412 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 33.4 m -60.43 126.43 27.43 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.738 0.304 . . . . 25.04 110.808 179.733 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.721 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -58.04 153.77 32.87 Favored Pre-proline 0 CA--C 1.535 0.385 0 CA-C-N 116.27 -0.423 . . . . 36.05 111.371 -179.845 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -74.87 -24.55 13.0 Favored 'Trans proline' 0 C--N 1.358 1.055 0 C-N-CA 121.971 1.78 . . . . 54.36 112.728 -179.824 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.721 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -58.16 -179.73 0.06 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.898 0.38 . . . . 71.54 111.366 -179.834 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 46.6 mtmt -145.89 161.97 37.78 Favored Pre-proline 0 CA--C 1.533 0.323 0 CA-C-N 116.053 -0.521 . . . . 0.0 110.725 -179.987 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -65.42 113.13 2.34 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 121.882 1.721 . . . . 0.0 112.349 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.45 -68.0 0.11 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.232 -0.44 . . . . 0.0 111.09 179.921 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 56.0 pttt -160.61 145.69 14.48 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.107 -0.497 . . . . 0.0 110.865 -179.988 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 79.1 p -83.19 151.66 25.58 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.18 -0.463 . . . . 0.0 110.878 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.241 -0.885 . . . . 20.0 111.061 179.989 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 2.6 mpp_? . . . . . 0 N--CA 1.488 1.438 0 CA-C-O 120.848 0.356 . . . . 0.0 111.172 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 8.6 m120 -113.3 139.23 49.01 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.845 179.884 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 52.3 t -83.02 -30.61 27.98 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.163 -0.471 . . . . 0.0 111.101 -179.981 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 57.8 m-85 -97.92 36.37 1.56 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.333 -0.394 . . . . 0.0 110.861 -179.934 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.2 tp10 -92.35 -42.09 9.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.0 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.565 ' CA ' HD21 ' A' ' 54' ' ' LEU . 70.2 m -144.74 175.9 9.83 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.026 -179.953 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.57 HG11 ' O ' ' A' ' 4' ' ' THR . 27.6 t -72.13 -30.11 34.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.138 -179.914 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.08 -39.96 71.87 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.375 -0.375 . . . . 0.0 111.041 179.922 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.13 -36.78 84.74 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.078 -0.51 . . . . 0.0 111.298 -179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.54 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -63.12 -42.85 99.61 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.169 -0.468 . . . . 0.0 111.419 -179.59 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -61.72 -53.8 51.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.311 -0.404 . . . . 0.0 111.585 -179.364 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 1.3 ptt-85 -56.83 -34.36 67.67 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.44 -0.345 . . . . 0.0 111.739 -179.536 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 63.7 m -58.24 -44.99 88.53 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.598 -0.274 . . . . 0.0 111.649 -179.426 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 4.5 ttp -76.54 -52.75 9.15 Favored 'General case' 0 C--N 1.329 -0.305 0 N-CA-C 112.386 0.514 . . . . 0.0 112.386 -178.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 94.4 m-85 -74.91 -49.78 19.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.742 0.306 . . . . 0.0 111.746 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.143 0 CA-C-O 118.453 -1.193 . . . . 20.0 112.519 -179.88 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.174 0 CA-C-O 119.787 -0.452 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.1 Cg_endo -74.09 129.26 13.0 Favored 'Trans proline' 0 C--N 1.356 0.928 0 C-N-CA 122.028 1.819 . . . . 0.0 112.431 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.9 mm-40 -146.24 110.77 5.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.192 -0.458 . . . . 75.5 110.964 179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 16.6 p -134.22 161.84 33.8 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.96 -0.564 . . . . 31.38 110.456 179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.44 HD12 ' HA ' ' A' ' 5' ' ' LEU . 9.9 tp -119.98 115.62 24.12 Favored 'General case' 0 C--N 1.33 -0.245 0 CA-C-O 120.966 0.412 . . . . 28.27 111.165 -179.436 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.25 164.22 30.66 Favored 'General case' 0 C--N 1.332 -0.188 0 CA-C-N 116.214 -0.448 . . . . 32.91 110.991 179.862 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.8 -143.6 46.95 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.84 -0.695 . . . . 19.09 112.848 179.737 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.69 -31.8 68.56 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.751 0.31 . . . . 21.73 111.283 -179.816 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.409 ' HB3' HD11 ' A' ' 5' ' ' LEU . 45.4 mt-10 -60.82 -39.94 90.86 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.224 -0.444 . . . . 63.42 110.742 179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 61.6 tp -67.76 -46.69 71.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.133 -0.485 . . . . 20.39 110.542 179.676 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.84 -31.86 49.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.346 0 CA-C-N 116.068 -0.514 . . . . 19.22 110.878 179.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -64.97 -36.48 84.55 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.081 -0.509 . . . . 31.0 110.898 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.776 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -71.94 -46.47 57.43 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.241 -0.436 . . . . 18.28 111.025 -179.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.506 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.0 mt -60.31 -43.03 96.7 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.26 -0.427 . . . . 22.05 110.795 179.889 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -68.9 -31.76 70.92 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.218 -0.446 . . . . 32.76 110.721 179.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 34.5 t80 -78.17 -31.71 49.76 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.168 -0.469 . . . . 27.25 110.837 179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 13' ' ' ALA . 34.0 t -88.9 -67.06 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 25.51 110.881 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.2 m -71.25 -51.25 25.61 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.043 -0.526 . . . . 29.49 110.984 179.997 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.57 -115.12 6.75 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.668 -0.777 . . . . 40.61 112.731 179.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -82.81 7.37 15.33 Favored 'General case' 0 CA--C 1.537 0.459 0 N-CA-C 112.729 0.64 . . . . 79.05 112.729 -179.622 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.533 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -70.29 -35.92 74.03 Favored 'General case' 0 C--O 1.23 0.05 0 CA-C-N 118.097 0.408 . . . . 50.6 110.886 179.926 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 96.37 62.77 0.95 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.759 -0.734 . . . . 35.48 112.255 -179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.506 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.5 p90 -59.2 159.45 7.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.88 0.371 . . . . 25.52 111.271 -179.688 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -139.05 123.9 18.71 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.985 -0.552 . . . . 56.07 110.637 179.847 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 31.1 m-85 -59.23 -75.0 0.06 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.214 -0.448 . . . . 29.3 111.074 -179.838 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -60.39 126.45 27.53 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.377 -0.374 . . . . 38.35 110.941 -179.888 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 16.2 tttm -102.63 91.67 2.92 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.148 -0.478 . . . . 42.35 110.753 179.861 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.13 -175.6 2.03 Favored 'Trans proline' 0 C--N 1.357 1.024 0 C-N-CA 122.051 1.834 . . . . 40.8 112.45 -179.837 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.1 p -133.61 95.69 3.54 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.474 . . . . 55.75 110.899 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 96.08 -89.66 1.13 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.72 -0.752 . . . . 34.94 112.525 179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 44.1 m-85 -97.5 -43.65 7.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.82 0.343 . . . . 34.26 110.901 179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 95.98 123.79 4.35 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.687 -0.768 . . . . 36.13 112.527 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.6 p -96.59 163.76 12.89 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.819 0.342 . . . . 57.93 110.893 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 52.1 m -94.41 -65.24 1.0 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.226 -0.443 . . . . 72.85 110.91 -179.96 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.5 p -158.9 103.17 1.68 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.912 -179.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -105.32 -68.92 0.84 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.748 179.882 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.1 ptm180 -162.92 34.73 0.1 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.19 -0.459 . . . . 0.0 110.95 -179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -137.04 145.34 50.01 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.111 -179.961 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.33 -168.64 0.45 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.94 1.76 . . . . 0.0 112.355 -179.968 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 3.7 pt20 -89.81 128.04 36.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.482 . . . . 0.0 110.88 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 70.8 p -145.03 145.15 31.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.191 -0.459 . . . . 64.04 110.941 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 169.83 -120.23 0.86 Allowed Glycine 0 N--CA 1.449 -0.443 0 C-N-CA 120.752 -0.737 . . . . 35.08 112.534 -179.99 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.574 HD13 ' CE2' ' A' ' 60' ' ' TYR . 3.3 tp -77.17 -39.88 29.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.796 0.331 . . . . 25.61 110.997 179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.3 t -58.61 -54.13 37.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.28 -0.418 . . . . 29.9 111.466 -179.972 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.411 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.1 m-20 -70.89 -23.3 62.26 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.296 -0.411 . . . . 39.04 111.954 -179.775 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -90.06 -23.89 21.32 Favored 'General case' 0 CA--C 1.529 0.156 0 N-CA-C 112.221 0.452 . . . . 45.6 112.221 -179.291 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 57.5 m -115.66 -45.7 2.88 Favored 'General case' 0 N--CA 1.463 0.204 0 N-CA-C 112.098 0.407 . . . . 28.23 112.098 -178.998 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 6.0 t -73.1 -51.37 18.26 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 120.676 0.274 . . . . 25.89 111.117 -179.433 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.411 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 26.5 m-85 -70.4 -32.47 70.13 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.895 0.378 . . . . 32.64 110.809 179.83 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.1 mtt180 -137.92 147.28 44.2 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.079 -0.51 . . . . 41.06 110.386 179.63 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.6 p -65.16 134.07 52.94 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.334 -0.394 . . . . 42.62 110.983 -179.825 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 28.2 p -126.34 -172.51 2.64 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.011 -0.54 . . . . 28.05 111.066 -179.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 2.0 p-10 -116.68 142.98 46.2 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.018 -0.537 . . . . 46.35 110.088 178.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.756 HD23 ' CD1' ' B' ' 110' ' ' LEU . 2.1 mp -55.55 -27.57 49.81 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.217 -0.447 . . . . 23.79 111.937 -179.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 40.9 mtp85 -60.59 -26.46 66.99 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.549 -0.296 . . . . 74.93 111.578 -179.68 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.6 mmm180 -66.4 -30.55 70.95 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.806 0.336 . . . . 64.42 111.159 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.448 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.4 mt -57.1 -28.7 62.89 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.25 -0.432 . . . . 32.64 111.676 -179.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -68.95 -32.31 71.8 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.443 -0.344 . . . . 41.86 111.139 -179.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 59.7 mtm -60.54 -43.81 96.78 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.394 -0.366 . . . . 38.66 111.094 -179.788 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.574 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.3 m-85 -69.24 -27.61 65.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.151 -0.477 . . . . 25.27 111.546 -179.564 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 63.5 m -59.58 132.23 53.34 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.835 0.35 . . . . 25.04 110.954 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.533 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -63.83 162.81 26.01 Favored Pre-proline 0 CA--C 1.534 0.329 0 CA-C-N 116.151 -0.477 . . . . 36.05 111.244 -179.874 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.48 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 94.9 Cg_endo -79.1 -32.11 1.96 Allowed 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.056 1.837 . . . . 54.36 112.581 -179.858 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.409 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -59.88 157.33 12.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.925 0.393 . . . . 71.54 111.077 -179.902 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.43 158.0 44.32 Favored Pre-proline 0 CA--C 1.534 0.346 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.886 179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 66.6 Cg_endo -73.64 -35.3 4.75 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.914 1.743 . . . . 0.0 112.349 -179.826 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -135.19 121.67 20.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.149 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 15.5 ptpt -112.06 155.81 23.22 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.167 -0.47 . . . . 0.0 110.973 -179.995 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.4 p -89.6 -42.49 11.37 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.862 179.864 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.112 0 CA-C-O 118.29 -0.862 . . . . 20.0 111.133 179.944 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 33.0 ttm-85 . . . . . 0 N--CA 1.484 1.273 0 CA-C-O 120.815 0.341 . . . . 0.0 111.257 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 70.6 m-80 -116.39 124.95 51.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.857 179.978 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.9 t -82.93 -34.05 26.64 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.904 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.538 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.0 OUTLIER -94.63 46.57 1.14 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 121.468 0.651 . . . . 0.0 110.665 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.5 tp10 -109.66 -30.8 7.72 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 115.883 -0.599 . . . . 0.0 110.966 179.766 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.653 ' O ' HD21 ' A' ' 54' ' ' LEU . 66.0 m -156.37 -179.02 7.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.156 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.401 HG13 HD13 ' A' ' 5' ' ' LEU . 51.4 t -80.66 -28.75 11.62 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.121 -179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.63 -39.49 73.67 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.84 0.353 . . . . 0.0 111.478 -179.827 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -36.91 66.9 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.224 -0.444 . . . . 0.0 111.997 -179.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.756 ' CD1' HD23 ' A' ' 54' ' ' LEU . 4.6 mt -58.11 -44.73 87.86 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.553 -0.294 . . . . 0.0 111.256 -179.545 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -59.08 -45.46 90.77 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.189 -179.791 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -68.51 -34.77 76.48 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.103 -179.851 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 96.5 m -61.32 -49.07 78.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.308 -0.406 . . . . 0.0 111.699 -179.479 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 4.0 mmt -76.31 -52.64 9.54 Favored 'General case' 0 C--N 1.33 -0.244 0 N-CA-C 112.158 0.429 . . . . 0.0 112.158 -178.89 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 72.6 m-85 -77.54 -49.44 14.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.704 0.288 . . . . 0.0 111.428 -179.107 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.032 0 CA-C-O 118.368 -1.24 . . . . 20.0 112.504 179.995 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 119.724 -0.486 . . . . 0.0 112.526 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -70.23 -179.66 3.29 Favored 'Trans proline' 0 C--N 1.356 0.93 0 C-N-CA 121.932 1.755 . . . . 0.0 112.291 -179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.0 mp0 -99.96 100.01 10.85 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.164 -0.471 . . . . 75.5 110.925 -179.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.565 ' O ' HG11 ' B' ' 107' ' ' VAL . 44.3 p -127.93 178.1 6.41 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.15 -0.477 . . . . 31.38 110.585 179.668 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.642 HD13 HG13 ' B' ' 107' ' ' VAL . 8.1 tp -135.48 108.99 7.9 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.909 0.385 . . . . 28.27 111.099 -179.547 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.5 m -140.16 167.88 21.09 Favored 'General case' 0 C--N 1.332 -0.182 0 CA-C-N 116.196 -0.456 . . . . 32.91 110.992 -179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 58.62 -137.19 50.47 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.879 -0.677 . . . . 19.09 112.778 179.72 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -60.56 -29.91 69.45 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.638 0.256 . . . . 21.73 111.343 -179.73 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -63.84 -42.53 97.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.385 -0.37 . . . . 63.42 110.989 -179.89 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.434 HD11 HG12 ' A' ' 43' ' ' ILE . 47.7 tp -68.72 -42.68 77.33 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.282 -0.417 . . . . 20.39 110.936 179.952 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.0 t -73.67 -34.58 41.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.148 -0.478 . . . . 19.22 110.928 179.913 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 14.7 m-20 -64.23 -35.04 79.51 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.28 -0.418 . . . . 31.0 110.967 -179.935 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' CB ' HD21 ' B' ' 110' ' ' LEU . . . -72.99 -49.38 29.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.326 -0.397 . . . . 18.28 111.363 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.7 HD13 ' CD1' ' A' ' 23' ' ' PHE . 11.8 mt -57.9 -30.41 65.86 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.285 -0.416 . . . . 22.05 111.171 -179.838 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 22.7 mt-30 -80.78 -31.48 35.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.219 -0.446 . . . . 32.76 110.609 179.493 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.416 ' CE2' ' HB3' ' B' ' 113' ' ' CYS . 34.7 t80 -76.6 -33.88 58.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.309 -0.405 . . . . 27.25 110.81 179.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.422 HG23 ' O ' ' A' ' 13' ' ' ALA . 25.3 t -89.48 -40.36 13.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.282 -0.417 . . . . 25.51 111.406 -179.627 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.6 m -100.27 -51.93 3.52 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.844 0.354 . . . . 29.49 111.315 -179.594 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 72.18 -110.38 3.17 Favored Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.655 -0.783 . . . . 40.61 112.723 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t70 -90.19 7.62 37.14 Favored 'General case' 0 CA--C 1.536 0.405 0 N-CA-C 112.846 0.684 . . . . 79.05 112.846 -179.801 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.559 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -66.67 -38.45 86.84 Favored 'General case' 0 C--O 1.232 0.135 0 O-C-N 122.029 -0.419 . . . . 50.6 110.844 179.949 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 98.88 60.41 0.88 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.753 -0.737 . . . . 35.48 112.233 -179.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.7 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.0 p90 -58.07 140.56 52.36 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.896 0.379 . . . . 25.52 111.345 -179.703 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.415 ' CE1' ' HG2' ' A' ' 27' ' ' LYS . 8.0 p90 -123.96 127.69 48.31 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.962 -0.563 . . . . 56.07 110.501 179.824 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 -58.03 -67.42 0.35 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.158 -0.474 . . . . 29.3 111.509 -179.478 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 10.5 t-20 -80.22 104.26 10.65 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.436 -0.347 . . . . 38.35 111.329 -179.551 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HD2' ' CE2' ' A' ' 60' ' ' TYR . 0.3 OUTLIER -90.71 -47.26 0.37 Allowed Pre-proline 0 CA--C 1.535 0.389 0 CA-C-N 116.238 -0.437 . . . . 42.35 111.451 179.81 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.641 ' O ' HG23 ' A' ' 29' ' ' THR . 62.6 Cg_endo -87.43 -170.05 0.55 Allowed 'Trans proline' 0 C--N 1.356 0.923 0 C-N-CA 122.245 1.963 . . . . 40.8 112.658 -179.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.641 HG23 ' O ' ' A' ' 28' ' ' PRO . 2.0 p -164.42 32.22 0.07 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.948 -0.569 . . . . 55.75 110.676 179.746 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -68.29 -145.39 0.13 Allowed Glycine 0 N--CA 1.449 -0.467 0 C-N-CA 120.878 -0.677 . . . . 34.94 112.677 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -103.32 -175.09 2.7 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.862 0.363 . . . . 34.26 110.988 -179.939 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 92.92 -113.42 4.45 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.819 -0.705 . . . . 36.13 112.483 -179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 23.7 p -90.45 -43.69 10.11 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.785 0.326 . . . . 57.93 110.917 179.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.2 m -91.86 107.68 19.38 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.239 -0.437 . . . . 72.85 110.9 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 55.6 p -148.8 -65.54 0.23 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.94 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -84.86 161.26 19.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.936 -179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 10.8 ttt85 -91.09 97.93 11.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.953 -179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.695 ' HB3' ' HD3' ' A' ' 39' ' ' PRO . . . -168.94 -64.17 0.01 OUTLIER Pre-proline 0 C--N 1.329 -0.324 0 CA-C-N 116.139 -0.482 . . . . 0.0 111.089 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.695 ' HD3' ' HB3' ' A' ' 38' ' ' ALA . 59.1 Cg_endo -71.07 -171.21 0.56 Allowed 'Trans proline' 0 C--N 1.357 0.981 0 C-N-CA 121.847 1.698 . . . . 0.0 112.334 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.412 ' O ' HG23 ' A' ' 41' ' ' THR . 0.0 OUTLIER -136.81 124.94 22.98 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.905 -179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.412 HG23 ' O ' ' A' ' 40' ' ' GLN . 38.6 p -157.78 150.5 22.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.267 -0.424 . . . . 64.04 110.859 179.94 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 150.26 -101.33 0.22 Allowed Glycine 0 N--CA 1.45 -0.422 0 C-N-CA 120.748 -0.739 . . . . 35.08 112.626 179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.582 HD13 ' CE1' ' A' ' 60' ' ' TYR . 2.9 tp -72.51 -35.89 52.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.724 0.297 . . . . 25.61 111.05 -179.898 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.98 -58.99 4.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.245 -0.434 . . . . 29.9 111.487 -179.755 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -69.59 -22.58 63.5 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-N 116.338 -0.392 . . . . 39.04 112.027 -179.641 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.17 -19.76 23.85 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 112.562 0.578 . . . . 45.6 112.562 -179.033 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 63.8 m -121.81 -41.74 2.44 Favored 'General case' 0 N--CA 1.465 0.324 0 N-CA-C 112.192 0.441 . . . . 28.23 112.192 -179.114 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.7 t -73.97 -53.9 9.07 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.717 0.294 . . . . 25.89 110.963 -179.639 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.5 m-85 -65.67 -34.05 77.3 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.84 0.352 . . . . 32.64 110.617 179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.6 ptp85 -139.01 148.31 43.27 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.162 -0.472 . . . . 41.06 110.717 179.531 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 5.0 p -65.73 131.88 47.41 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.871 -0.604 . . . . 42.62 110.989 -179.71 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.0 p -122.17 -171.92 2.35 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.991 -0.55 . . . . 28.05 110.883 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.0 p-10 -111.53 132.78 54.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.219 -0.446 . . . . 46.35 110.131 179.09 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.556 HD23 ' C ' ' B' ' 104' ' ' PHE . 0.3 OUTLIER -53.43 -24.28 12.22 Favored 'General case' 0 C--N 1.33 -0.278 0 N-CA-C 112.332 0.493 . . . . 23.79 112.332 -179.148 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -60.65 -26.96 67.44 Favored 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 111.477 0.177 . . . . 74.93 111.477 -179.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.456 ' NE ' ' HE2' ' A' ' 59' ' ' MET . 20.9 mmm180 -68.58 -28.83 67.29 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.649 0.261 . . . . 64.42 111.271 179.996 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.456 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.8 mt -56.08 -28.84 59.28 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 116.447 -0.342 . . . . 32.64 111.788 -179.552 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -68.66 -32.22 71.91 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.397 -0.365 . . . . 41.86 111.193 -179.706 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.456 ' HE2' ' NE ' ' A' ' 56' ' ' ARG . 71.3 mtm -62.64 -49.77 73.86 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.353 -0.385 . . . . 38.66 111.148 -179.885 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.582 ' CE1' HD13 ' A' ' 43' ' ' ILE . 84.6 m-85 -56.83 -28.56 61.75 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.121 -0.491 . . . . 25.27 111.675 -179.546 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.5 m -59.23 141.73 53.59 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.803 0.335 . . . . 25.04 111.197 -179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.772 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -78.43 176.59 3.49 Favored Pre-proline 0 CA--C 1.533 0.314 0 CA-C-N 116.235 -0.438 . . . . 36.05 110.985 179.83 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.772 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 93.5 Cg_endo -83.21 -34.81 0.3 Allowed 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 122.018 1.812 . . . . 54.36 112.701 -179.692 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.451 HD23 ' HD2' ' A' ' 63' ' ' PRO . 0.4 OUTLIER -59.49 148.38 33.28 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.348 -0.387 . . . . 71.54 111.058 -179.858 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -112.19 159.94 31.94 Favored Pre-proline 0 CA--C 1.534 0.352 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.859 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -76.22 -179.04 4.87 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.957 1.772 . . . . 0.0 112.374 -179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -109.08 170.76 7.84 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.125 -0.489 . . . . 0.0 111.153 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -100.81 -48.83 4.35 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.975 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -67.72 158.95 31.14 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.136 -0.484 . . . . 0.0 110.904 -179.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.183 -0.913 . . . . 20.0 111.077 -179.982 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 3.2 mpp_? . . . . . 0 N--CA 1.486 1.366 0 CA-C-O 120.821 0.344 . . . . 0.0 111.178 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -77.7 137.91 38.76 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.826 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 42.5 t -79.85 -26.23 40.46 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.421 179.977 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.556 ' C ' HD23 ' A' ' 54' ' ' LEU . 2.8 m-30 -96.52 32.84 1.93 Allowed 'General case' 0 CA--C 1.53 0.208 0 CA-C-O 120.718 0.295 . . . . 0.0 111.353 -179.79 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.6 tt0 -88.51 -33.49 17.75 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.892 0.377 . . . . 0.0 110.447 179.641 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.54 ' C ' HD21 ' A' ' 54' ' ' LEU . 50.8 p -155.86 174.82 14.76 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.935 -0.575 . . . . 0.0 110.407 179.801 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.642 HG13 HD13 ' A' ' 5' ' ' LEU . 21.2 t -74.08 -30.87 28.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.41 -0.359 . . . . 0.0 111.131 -179.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -62.6 -44.19 96.92 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.09 179.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -66.61 -36.83 83.56 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.119 -0.491 . . . . 0.0 111.078 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.531 HD21 ' CB ' ' A' ' 13' ' ' ALA . 26.6 tp -58.68 -43.21 89.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.094 -0.503 . . . . 0.0 111.157 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 53.8 ttp85 -64.84 -43.02 94.4 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.331 -0.395 . . . . 0.0 110.968 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 53.2 mtt-85 -60.8 -37.27 81.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.027 -179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . 0.416 ' HB3' ' CE2' ' A' ' 16' ' ' PHE . 3.7 m -59.36 -46.93 87.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.274 -0.421 . . . . 0.0 111.056 -179.89 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 8.9 tpt -67.56 -51.7 47.53 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.261 -0.427 . . . . 0.0 110.908 180.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 87.3 m-85 -80.25 71.24 7.02 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.177 0.513 . . . . 0.0 110.924 -179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.969 0 CA-C-O 118.418 -1.212 . . . . 20.0 112.454 -179.971 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.241 0 CA-C-O 119.789 -0.45 . . . . 0.0 112.562 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 60.4 Cg_endo -71.84 -168.71 0.38 Allowed 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.926 1.751 . . . . 0.0 112.342 179.955 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.2 mp0 -83.06 101.61 11.25 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.264 -0.425 . . . . 75.5 110.896 179.919 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.703 ' O ' HG11 ' B' ' 107' ' ' VAL . 13.0 p -129.33 -171.39 2.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.444 . . . . 31.38 110.607 179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.418 HD13 HG13 ' B' ' 107' ' ' VAL . 9.1 tp -140.28 111.84 7.34 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.494 -0.321 . . . . 28.27 111.195 -179.513 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 23.4 m -140.15 162.95 34.02 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.325 -0.398 . . . . 32.91 111.148 179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.91 -139.53 48.37 Favored Glycine 0 N--CA 1.453 -0.189 0 C-N-CA 120.815 -0.707 . . . . 19.09 113.052 179.553 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.72 -29.34 64.64 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.625 0.25 . . . . 21.73 111.485 -179.588 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 30.6 mt-10 -61.0 -39.79 91.06 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.439 -0.346 . . . . 63.42 110.855 -179.964 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.477 HD11 HG12 ' A' ' 43' ' ' ILE . 32.6 tp -71.81 -45.38 61.71 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.155 -0.475 . . . . 20.39 110.737 179.894 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.7 t -70.12 -31.41 47.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.181 -0.463 . . . . 19.22 111.019 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.62 -45.01 84.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.205 -0.452 . . . . 31.0 111.008 -179.897 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.971 ' HB2' HD21 ' B' ' 110' ' ' LEU . . . -64.19 -47.33 80.21 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.246 -0.434 . . . . 18.28 111.155 -179.872 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.674 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -60.74 -36.25 78.41 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 22.05 110.798 -179.96 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 1.7 mm-40 -79.1 -31.58 44.34 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.255 -0.43 . . . . 32.76 110.794 179.799 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -79.0 -31.7 44.89 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.188 -0.46 . . . . 27.25 110.869 179.907 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.734 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.4 t -88.14 -68.1 0.68 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.185 -0.461 . . . . 25.51 110.945 -179.819 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 9.8 m -67.99 -51.32 48.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.166 -0.47 . . . . 29.49 111.053 -179.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 70.35 -114.3 5.37 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.688 -0.767 . . . . 40.61 112.835 179.775 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.8 t70 -84.41 7.55 19.25 Favored 'General case' 0 CA--C 1.537 0.477 0 N-CA-C 112.805 0.668 . . . . 79.05 112.805 -179.687 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.5 mmm180 -71.95 -30.74 65.62 Favored 'General case' 0 C--O 1.232 0.167 0 CA-C-N 118.036 0.38 . . . . 50.6 110.936 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 88.34 67.72 1.28 Allowed Glycine 0 N--CA 1.452 -0.263 0 C-N-CA 120.71 -0.757 . . . . 35.48 112.082 -179.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.674 ' CD1' HD13 ' A' ' 14' ' ' LEU . 30.6 p90 -60.46 164.85 4.08 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.108 0.48 . . . . 25.52 111.501 -179.521 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.433 ' CD1' ' HB3' ' A' ' 27' ' ' LYS . 3.5 p90 -144.32 125.25 14.34 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.72 -0.673 . . . . 56.07 110.465 179.802 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 58.2 m-85 -58.23 -69.88 0.16 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.27 -0.423 . . . . 29.3 111.428 -179.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.8 t-20 -83.34 127.43 33.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.427 -0.351 . . . . 38.35 111.189 -179.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.433 ' HB3' ' CD1' ' A' ' 24' ' ' TYR . 0.0 OUTLIER -139.7 148.8 57.17 Favored Pre-proline 0 CA--C 1.534 0.336 0 CA-C-N 116.143 -0.48 . . . . 42.35 110.776 179.655 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 69.3 Cg_endo -73.95 142.5 31.51 Favored 'Trans proline' 0 C--N 1.355 0.917 0 C-N-CA 121.88 1.72 . . . . 40.8 112.351 -179.939 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 16.7 p -117.6 135.7 53.79 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.1 -0.5 . . . . 55.75 110.866 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -62.41 87.3 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.73 -0.748 . . . . 34.94 112.492 179.997 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 34.7 p90 -89.79 148.85 22.98 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.85 0.357 . . . . 34.26 110.927 -179.947 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 150.36 66.52 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.761 -0.733 . . . . 36.13 112.586 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 57.2 m -93.91 -58.56 2.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.792 0.33 . . . . 57.93 110.855 -179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 27.2 p -147.55 -63.37 0.27 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.157 -0.474 . . . . 72.85 110.928 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 70.8 m -159.45 -74.83 0.07 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.836 179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 17.6 tpp180 -90.11 128.71 36.39 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.182 -0.463 . . . . 0.0 110.875 -179.966 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.3 tpt85 -131.36 157.03 44.47 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.947 -179.93 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.507 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -66.16 162.15 49.92 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-N 116.286 -0.416 . . . . 0.0 111.135 179.9 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.507 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 48.1 Cg_endo -68.49 140.92 49.17 Favored 'Trans proline' 0 C--N 1.356 0.973 0 C-N-CA 121.958 1.772 . . . . 0.0 112.367 -179.867 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 44.8 tp60 -107.32 142.53 36.96 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.035 -0.529 . . . . 0.0 110.81 179.789 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.5 p -128.32 -172.94 2.82 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.251 -0.432 . . . . 64.04 111.027 -179.881 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -94.25 -130.75 5.94 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.75 -0.738 . . . . 35.08 112.663 -179.872 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.579 HD13 ' CE2' ' A' ' 60' ' ' TYR . 1.0 OUTLIER -97.67 -32.07 3.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.786 0.327 . . . . 25.61 111.009 -179.93 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.3 t -56.69 -64.65 0.48 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.324 -0.398 . . . . 29.9 111.682 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.41 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 12.0 m-20 -67.47 -19.73 65.38 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 116.276 -0.42 . . . . 39.04 112.116 -179.585 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.29 -25.56 20.46 Favored 'General case' 0 C--N 1.332 -0.152 0 N-CA-C 111.961 0.356 . . . . 45.6 111.961 -179.34 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 96.9 m -117.25 -51.52 2.53 Favored 'General case' 0 N--CA 1.463 0.185 0 N-CA-C 112.108 0.41 . . . . 28.23 112.108 -179.047 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 17.3 t -63.43 -44.04 95.73 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 120.761 0.315 . . . . 25.89 111.153 -179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.41 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.4 m-85 -74.96 -49.23 20.71 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.443 -0.344 . . . . 32.64 110.604 179.701 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.84 150.0 45.08 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.219 -0.446 . . . . 41.06 110.364 179.402 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.2 p -61.7 143.39 56.25 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-O 120.899 0.38 . . . . 42.62 111.02 -179.769 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 19.2 p -138.03 -166.36 1.96 Allowed 'General case' 0 CA--C 1.532 0.251 0 CA-C-N 116.132 -0.485 . . . . 28.05 110.932 -179.711 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.3 p-10 -113.55 138.79 49.64 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.14 -0.482 . . . . 46.35 109.851 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.729 HD12 HD22 ' B' ' 110' ' ' LEU . 3.3 mm? -61.32 -27.03 68.2 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.564 -0.289 . . . . 23.79 111.524 -179.269 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.4 mmt85 -55.81 -26.51 46.73 Favored 'General case' 0 N--CA 1.463 0.219 0 N-CA-C 111.736 0.273 . . . . 74.93 111.736 -179.952 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 15.8 mmm180 -63.1 -28.07 69.82 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.68 0.276 . . . . 64.42 111.132 179.818 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.572 HD11 HD12 ' A' ' 54' ' ' LEU . 6.9 mt -56.26 -31.34 63.49 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-O 120.792 0.33 . . . . 32.64 111.426 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 31.0 mt-10 -67.02 -33.58 75.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.229 -0.441 . . . . 41.86 111.334 -179.678 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 34.8 mtm -59.41 -54.07 50.87 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.934 0.397 . . . . 38.66 111.064 -179.927 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.579 ' CE2' HD13 ' A' ' 43' ' ' ILE . 78.9 m-85 -57.83 -26.96 62.74 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 115.974 -0.557 . . . . 25.27 111.614 -179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 67.3 m -60.19 130.3 45.99 Favored 'General case' 0 C--N 1.333 -0.136 0 CA-C-O 120.836 0.35 . . . . 25.04 110.806 179.75 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.689 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -65.0 156.28 80.99 Favored Pre-proline 0 CA--C 1.533 0.312 0 CA-C-N 116.286 -0.415 . . . . 36.05 111.129 179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -75.84 -26.49 9.57 Favored 'Trans proline' 0 C--N 1.357 1.01 0 C-N-CA 122.033 1.822 . . . . 54.36 112.527 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.689 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -59.22 176.33 0.24 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.933 0.397 . . . . 71.54 111.178 -179.837 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.54 156.74 52.87 Favored Pre-proline 0 CA--C 1.533 0.309 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.717 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -61.47 83.21 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.87 1.713 . . . . 0.0 112.194 -179.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -175.58 -176.21 0.86 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.903 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 35.5 tttm -91.54 89.43 7.18 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.865 -179.938 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 31.0 t -102.52 158.07 16.48 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.832 -179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.071 0 CA-C-O 118.245 -0.883 . . . . 20.0 111.113 179.973 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 24.3 ttt-85 . . . . . 0 N--CA 1.485 1.287 0 CA-C-O 120.824 0.345 . . . . 0.0 111.298 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 18.2 m120 -75.08 118.15 17.71 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.836 179.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 7.0 m -83.11 -30.27 28.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.219 -0.446 . . . . 0.0 111.011 -179.858 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.508 ' HZ ' HG21 ' A' ' 17' ' ' VAL . 2.2 m-30 -87.87 55.77 3.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 121.26 0.552 . . . . 0.0 111.079 -179.717 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.2 tm-20 -108.48 -35.62 6.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.787 -0.642 . . . . 0.0 110.165 179.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.1 m -160.28 174.72 13.78 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.854 -0.612 . . . . 0.0 110.229 179.533 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.703 HG11 ' O ' ' A' ' 4' ' ' THR . 23.5 t -72.44 -31.12 37.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-O 120.784 0.326 . . . . 0.0 110.818 -179.979 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.21 -39.95 90.0 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.296 -0.411 . . . . 0.0 111.062 179.699 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -68.84 -36.88 78.71 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.213 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.971 HD21 ' HB2' ' A' ' 13' ' ' ALA . 67.4 tp -58.36 -42.78 87.69 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.192 -0.458 . . . . 0.0 111.151 179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 9.4 mmm-85 -65.1 -49.31 70.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.068 -179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 2.1 mpt_? -59.32 -41.29 88.74 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.368 -0.378 . . . . 0.0 111.116 -179.745 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 93.9 m -59.53 -45.31 92.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.323 -0.399 . . . . 0.0 111.059 -179.76 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -73.08 -51.08 19.4 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.343 -0.39 . . . . 0.0 110.947 179.964 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 89.5 m-85 -86.3 71.23 10.52 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.152 0.501 . . . . 0.0 110.833 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.141 0 CA-C-O 118.324 -1.264 . . . . 20.0 112.426 -179.986 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.188 0 CA-C-O 119.829 -0.429 . . . . 0.0 112.52 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.2 Cg_endo -90.52 21.94 0.8 Allowed 'Trans proline' 0 C--N 1.356 0.937 0 C-N-CA 122.406 2.071 . . . . 0.0 113.201 -179.719 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 12.2 mp0 -83.08 97.87 9.0 Favored 'General case' 0 C--N 1.332 -0.185 0 CA-C-O 120.748 0.309 . . . . 75.5 110.854 179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.651 ' O ' HG11 ' B' ' 107' ' ' VAL . 17.0 p -124.9 175.96 6.95 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.168 -0.469 . . . . 31.38 110.73 179.846 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.677 HD13 HG13 ' B' ' 107' ' ' VAL . 8.6 tp -129.52 110.25 11.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.363 -0.381 . . . . 28.27 111.213 -179.602 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.9 m -140.22 161.7 37.03 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.984 0.421 . . . . 32.91 110.933 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 62.36 -139.3 45.68 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.802 -0.713 . . . . 19.09 112.843 179.758 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.33 -30.09 66.43 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.821 0.343 . . . . 21.73 111.454 -179.8 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.3 mt-10 -60.39 -41.29 93.51 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.305 -0.407 . . . . 63.42 110.942 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 52.5 tp -70.18 -43.87 69.91 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.232 -0.44 . . . . 20.39 110.73 179.772 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -70.42 -31.78 47.88 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.113 -0.494 . . . . 19.22 110.968 179.798 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -65.42 -42.12 92.82 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.142 -0.481 . . . . 31.0 110.919 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.787 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -66.01 -48.51 70.94 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 18.28 111.168 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.908 HD13 ' CD2' ' A' ' 23' ' ' PHE . 17.6 mt -60.12 -38.47 83.12 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.279 -0.419 . . . . 22.05 110.827 179.848 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 32.2 mt-30 -73.26 -32.38 64.65 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.154 -0.476 . . . . 32.76 110.594 179.51 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.9 t80 -79.35 -32.08 43.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.047 -0.524 . . . . 27.25 110.755 179.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.787 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.6 t -87.32 -44.11 15.98 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.042 -0.526 . . . . 25.51 110.905 -179.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.6 m -100.43 -51.63 3.58 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.215 -0.448 . . . . 29.49 111.233 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 58.09 -95.61 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.967 -0.635 . . . . 40.61 112.887 179.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -84.58 -28.42 26.59 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.757 0.313 . . . . 79.05 111.459 -179.689 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.446 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 19.8 mtm-85 -57.7 -34.28 69.28 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-O 120.799 0.333 . . . . 50.6 111.365 -179.712 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 92.75 150.93 27.13 Favored Glycine 0 N--CA 1.45 -0.416 0 C-N-CA 120.695 -0.764 . . . . 35.48 112.214 -179.806 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.908 ' CD2' HD13 ' A' ' 14' ' ' LEU . 15.5 p90 -141.33 145.02 34.92 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.965 0.412 . . . . 25.52 111.143 -179.872 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 58.3 m-85 -109.52 127.67 54.63 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.003 -0.544 . . . . 56.07 110.771 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 2.1 m-85 -65.77 -31.36 72.29 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.225 -0.443 . . . . 29.3 110.827 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 30.5 m120 -125.21 104.86 8.73 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.228 -0.442 . . . . 38.35 110.957 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.5 mmmp? -67.83 137.37 92.56 Favored Pre-proline 0 CA--C 1.535 0.371 0 CA-C-N 116.261 -0.427 . . . . 42.35 110.742 179.923 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . 0.438 ' O ' HG23 ' A' ' 29' ' ' THR . 73.6 Cg_endo -76.56 124.81 7.86 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 121.945 1.763 . . . . 40.8 112.366 -179.996 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.438 HG23 ' O ' ' A' ' 28' ' ' PRO . 33.4 p -158.34 100.32 1.66 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.263 -0.426 . . . . 55.75 110.914 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 80.71 99.73 0.34 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.829 -0.7 . . . . 34.94 112.535 179.981 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -84.43 -67.56 0.79 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.881 0.372 . . . . 34.26 110.876 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 72.89 -98.21 0.86 Allowed Glycine 0 N--CA 1.452 -0.278 0 C-N-CA 120.672 -0.775 . . . . 36.13 112.516 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.6 t -147.64 -174.89 4.66 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.781 0.324 . . . . 57.93 110.911 -179.971 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.6 t -69.91 112.49 6.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.283 -0.417 . . . . 72.85 110.911 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 4.6 m -96.24 117.9 31.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.934 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 11.3 tpt180 -84.58 -34.13 23.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.923 -179.898 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.8 ptp85 -147.56 114.14 6.01 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.896 -179.987 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.439 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -161.76 160.69 22.56 Favored Pre-proline 0 C--N 1.329 -0.316 0 CA-C-N 116.213 -0.449 . . . . 0.0 111.142 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.439 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 60.4 Cg_endo -71.99 107.94 2.34 Favored 'Trans proline' 0 C--N 1.357 1.003 0 C-N-CA 121.89 1.726 . . . . 0.0 112.295 179.98 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -105.64 132.67 51.49 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.176 -0.465 . . . . 0.0 110.951 -179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 39.0 p -150.01 169.01 22.22 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 64.04 110.861 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -164.67 -100.34 0.15 Allowed Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.735 -0.745 . . . . 35.08 112.6 -179.885 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.414 HD13 ' CE1' ' A' ' 60' ' ' TYR . 3.1 tp -106.78 -35.41 3.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.326 0 CA-C-O 120.759 0.314 . . . . 25.61 110.991 -179.882 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.8 t -58.27 -57.97 8.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.264 -0.425 . . . . 29.9 111.446 -179.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.4 m-20 -68.32 -22.22 64.72 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.402 -0.363 . . . . 39.04 111.932 -179.759 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.31 -23.87 21.03 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 112.276 0.473 . . . . 45.6 112.276 -179.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 49.8 m -117.22 -46.68 2.69 Favored 'General case' 0 N--CA 1.465 0.301 0 N-CA-C 112.238 0.459 . . . . 28.23 112.238 -178.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.7 t -71.26 -52.47 18.81 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-O 120.754 0.312 . . . . 25.89 111.072 -179.548 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 15.1 m-85 -64.44 -37.09 86.31 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.837 0.351 . . . . 32.64 110.798 179.763 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.3 ptt-85 -140.31 149.85 43.28 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.135 -0.484 . . . . 41.06 110.913 179.545 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 15.5 p -60.06 140.65 56.7 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.898 -0.592 . . . . 42.62 111.11 -179.81 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -133.12 -174.63 3.54 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.112 -0.494 . . . . 28.05 110.817 -179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -107.89 127.63 53.9 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.995 -0.548 . . . . 46.35 109.929 178.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.561 HD21 ' CA ' ' B' ' 106' ' ' SER . 0.1 OUTLIER -53.81 -26.56 24.61 Favored 'General case' 0 N--CA 1.466 0.327 0 CA-C-N 116.173 -0.467 . . . . 23.79 111.979 -179.117 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 22.9 mtt-85 -58.11 -22.71 51.99 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 116.606 -0.27 . . . . 74.93 111.498 179.297 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.42 ' HB3' ' HE3' ' A' ' 59' ' ' MET . 1.5 mmt180 -81.21 7.04 12.22 Favored 'General case' 0 CA--C 1.538 0.503 0 N-CA-C 112.883 0.698 . . . . 64.42 112.883 -179.856 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.1 mt -90.06 -39.21 13.05 Favored 'General case' 0 C--O 1.232 0.171 0 O-C-N 122.032 -0.417 . . . . 32.64 111.333 -179.589 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -58.67 -30.05 67.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.246 -0.434 . . . . 41.86 111.52 -179.335 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.42 ' HE3' ' HB3' ' A' ' 56' ' ' ARG . 1.2 ptp -63.84 -31.8 73.1 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.466 -0.334 . . . . 38.66 111.466 -179.63 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.414 ' CE1' HD13 ' A' ' 43' ' ' ILE . 65.6 m-85 -70.52 -29.07 65.46 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.425 -0.352 . . . . 25.27 111.445 -179.462 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 30.7 m -61.18 130.28 45.49 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.897 0.379 . . . . 25.04 111.12 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.603 ' HB1' HD23 ' A' ' 64' ' ' LEU . . . -57.44 157.37 13.39 Favored Pre-proline 0 CA--C 1.535 0.384 0 CA-C-N 116.095 -0.502 . . . . 36.05 111.191 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 47.2 Cg_endo -67.99 -24.78 38.95 Favored 'Trans proline' 0 C--N 1.355 0.902 0 C-N-CA 121.888 1.726 . . . . 54.36 112.785 -179.636 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.603 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -60.68 171.8 1.07 Allowed 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.837 0.351 . . . . 71.54 111.044 -179.856 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 1.1 pmtp? -150.88 157.18 35.8 Favored Pre-proline 0 C--N 1.328 -0.348 0 CA-C-N 116.071 -0.513 . . . . 0.0 110.784 -179.997 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.29 148.14 60.98 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.99 1.793 . . . . 0.0 112.243 179.944 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -152.45 -51.89 0.11 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.171 -0.468 . . . . 0.0 111.058 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 50.5 pttt -139.25 -48.16 0.48 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.913 -179.963 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.2 t -158.72 32.73 0.22 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.781 -179.95 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.08 0 CA-C-O 118.326 -0.845 . . . . 20.0 111.036 179.994 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 80.3 mtt-85 . . . . . 0 N--CA 1.486 1.37 0 CA-C-O 120.889 0.375 . . . . 0.0 111.18 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 9.6 t-20 -95.57 109.6 21.81 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.007 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 90.8 m -82.79 -27.31 31.04 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.099 -0.5 . . . . 0.0 111.242 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -96.04 37.89 1.21 Allowed 'General case' 0 C--O 1.233 0.216 0 CA-C-O 120.853 0.359 . . . . 0.0 111.256 -179.891 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -95.13 -51.07 4.79 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.824 0.345 . . . . 0.0 110.868 179.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.561 ' CA ' HD21 ' A' ' 54' ' ' LEU . 54.3 p -142.11 174.96 10.13 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.801 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.677 HG13 HD13 ' A' ' 5' ' ' LEU . 21.3 t -67.67 -36.49 76.22 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.093 179.941 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -68.0 -40.8 82.97 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.144 -179.98 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.92 -38.78 92.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 111.147 -179.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -66.37 -42.86 87.39 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.91 -179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 27.2 ttp85 -60.25 -45.01 94.73 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.807 179.909 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 1.9 tmt_? -69.92 -35.83 74.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.802 179.716 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 16.6 t -59.19 -38.94 81.08 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.967 -179.962 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 12.9 tpt -75.74 -51.72 12.05 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.231 -0.44 . . . . 0.0 110.939 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 65.3 m-85 -80.12 71.05 6.85 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 121.159 0.504 . . . . 0.0 110.952 179.934 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.043 0 CA-C-O 118.312 -1.271 . . . . 20.0 112.571 -179.931 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.172 0 CA-C-O 119.71 -0.494 . . . . 0.0 112.551 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.4 Cg_endo -70.98 144.96 48.88 Favored 'Trans proline' 0 C--N 1.357 1.004 0 C-N-CA 121.91 1.74 . . . . 0.0 112.235 179.963 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.3 mt-10 -105.22 93.49 4.71 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.291 -0.413 . . . . 75.5 111.044 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 31.1 p -136.19 147.77 47.82 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 115.883 -0.599 . . . . 31.38 110.451 179.632 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.458 HD12 ' HA ' ' A' ' 5' ' ' LEU . 9.9 tp -109.49 114.31 27.84 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.297 -0.411 . . . . 28.27 111.148 -179.379 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 17.2 m -140.37 162.06 36.21 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-N 116.273 -0.421 . . . . 32.91 110.999 179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 67.49 -145.86 46.37 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.874 -0.679 . . . . 19.09 113.048 179.606 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.75 -30.57 65.71 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.794 0.33 . . . . 21.73 111.461 -179.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 -60.15 -43.11 96.0 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.281 -0.418 . . . . 63.42 110.898 179.916 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 48.8 tp -66.61 -43.7 84.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.05 -0.523 . . . . 20.39 110.499 179.438 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.8 t -67.37 -33.35 62.02 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 115.975 -0.557 . . . . 19.22 111.006 179.685 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 3.7 t0 -61.0 -48.82 80.05 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.179 -0.464 . . . . 31.0 110.944 179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.775 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -60.9 -47.45 86.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.193 -0.458 . . . . 18.28 111.172 -179.973 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.42 HD13 ' CD1' ' A' ' 23' ' ' PHE . 24.2 mt -60.0 -39.61 86.37 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.299 -0.41 . . . . 22.05 110.926 -179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 85.8 mt-30 -75.79 -31.38 59.43 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.183 -0.462 . . . . 32.76 110.84 179.868 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.4 t80 -79.3 -30.75 43.04 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.165 -0.47 . . . . 27.25 111.085 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.775 HG23 ' O ' ' A' ' 13' ' ' ALA . 36.9 t -89.28 -48.22 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.26 -0.427 . . . . 25.51 111.023 -179.771 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 26.6 m -86.9 -51.27 6.15 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.392 -0.367 . . . . 29.49 111.191 -179.659 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.86 -109.41 2.89 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.671 -0.776 . . . . 40.61 112.492 -179.846 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -89.85 7.77 35.45 Favored 'General case' 0 CA--C 1.538 0.489 0 N-CA-C 112.611 0.597 . . . . 79.05 112.611 -179.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.684 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.8 mmm180 -72.52 -30.12 64.19 Favored 'General case' 0 C--O 1.231 0.092 0 O-C-N 122.041 -0.412 . . . . 50.6 111.044 -179.849 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.15 84.39 0.8 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.659 -0.781 . . . . 35.48 112.136 -179.72 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.42 ' CD1' HD13 ' A' ' 14' ' ' LEU . 38.3 p90 -84.47 171.56 12.45 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 121.127 0.489 . . . . 25.52 111.389 -179.577 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.401 ' CE1' ' HE2' ' A' ' 27' ' ' LYS . 12.7 p90 -145.27 124.3 12.81 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 115.815 -0.63 . . . . 56.07 110.47 179.701 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 7.8 m-85 -57.27 -63.54 1.19 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.155 -0.475 . . . . 29.3 111.491 -179.605 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.3 t-20 -59.12 125.54 24.03 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 120.876 0.369 . . . . 38.35 111.206 -179.765 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.431 ' HG3' ' CE1' ' A' ' 60' ' ' TYR . 10.2 mmtt -129.02 117.57 19.22 Favored Pre-proline 0 CA--C 1.539 0.549 0 CA-C-N 116.089 -0.505 . . . . 42.35 110.424 179.719 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.7 Cg_endo -71.63 139.1 33.41 Favored 'Trans proline' 0 C--N 1.354 0.855 0 C-N-CA 121.838 1.692 . . . . 40.8 112.295 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 39.6 p -112.98 -48.97 2.95 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.192 -0.458 . . . . 55.75 110.817 179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 84.24 79.58 1.08 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.778 -0.725 . . . . 34.94 112.508 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 65.0 m-85 -158.63 124.28 4.44 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.743 0.306 . . . . 34.26 110.954 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 76.33 71.19 1.2 Allowed Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.715 -0.755 . . . . 36.13 112.47 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 48.3 t -102.55 100.64 10.75 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-O 120.786 0.327 . . . . 57.93 110.936 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 17.7 m -163.48 -65.45 0.04 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.198 -0.455 . . . . 72.85 110.927 -179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 8.4 m -87.8 -169.96 2.8 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.896 179.972 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 65.2 mtm-85 -60.29 142.96 53.91 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.284 -0.416 . . . . 0.0 110.862 179.992 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.9 ttt85 -77.35 165.9 23.85 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.904 -179.967 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -90.19 166.47 19.96 Favored Pre-proline 0 CA--C 1.533 0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 111.053 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 38.0 Cg_endo -65.74 -168.17 0.12 Allowed 'Trans proline' 0 C--N 1.358 1.036 0 C-N-CA 121.938 1.759 . . . . 0.0 112.243 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -70.59 123.73 22.54 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.018 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 65.9 p -152.47 119.97 6.01 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.124 -0.489 . . . . 64.04 110.871 -179.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -149.87 -94.64 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.673 -0.775 . . . . 35.08 112.529 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.517 HD13 ' CE2' ' A' ' 60' ' ' TYR . 2.3 tp -81.53 -36.96 15.02 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 CA-C-O 120.87 0.367 . . . . 25.61 111.076 -179.866 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -58.1 -59.53 3.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.27 -0.423 . . . . 29.9 111.537 -179.866 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.42 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.43 -21.56 63.73 Favored 'General case' 0 C--N 1.326 -0.435 0 N-CA-C 112.06 0.393 . . . . 39.04 112.06 -179.71 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -90.14 -24.11 21.16 Favored 'General case' 0 C--N 1.333 -0.131 0 N-CA-C 112.258 0.466 . . . . 45.6 112.258 -179.209 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 75.9 m -116.49 -45.57 2.81 Favored 'General case' 0 N--CA 1.464 0.238 0 N-CA-C 112.13 0.419 . . . . 28.23 112.13 -179.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 9.2 t -71.88 -53.03 14.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.752 0.31 . . . . 25.89 110.995 -179.668 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.42 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 22.5 m-85 -67.45 -37.16 82.53 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.358 -0.383 . . . . 32.64 110.57 179.721 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 4.0 mtt-85 -134.01 145.86 49.85 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.082 -0.508 . . . . 41.06 110.347 179.405 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.3 p -66.87 124.24 22.42 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.287 -0.415 . . . . 42.62 111.038 -179.831 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 29.3 p -111.99 -174.92 2.57 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.148 -0.478 . . . . 28.05 111.278 -179.739 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -109.88 138.64 45.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.917 -0.583 . . . . 46.35 109.951 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.75 HD23 ' CD1' ' B' ' 110' ' ' LEU . 3.2 mp -53.55 -31.45 46.49 Favored 'General case' 0 N--CA 1.467 0.41 0 N-CA-C 112.134 0.42 . . . . 23.79 112.134 -179.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 7.8 mtp180 -57.66 -28.45 63.76 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.494 -0.321 . . . . 74.93 111.424 -179.915 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 50.2 mmm-85 -68.87 -22.5 64.19 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.515 -0.311 . . . . 64.42 111.609 179.693 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 9.1 mt -59.54 -40.53 87.53 Favored 'General case' 0 N--CA 1.462 0.136 0 CA-C-O 120.871 0.367 . . . . 32.64 110.592 179.813 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -62.5 -32.95 73.96 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.046 -0.525 . . . . 41.86 109.887 178.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 0.3 OUTLIER -54.69 -31.37 57.83 Favored 'General case' 0 N--CA 1.462 0.172 0 CA-C-N 115.711 -0.677 . . . . 38.66 111.335 179.416 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.517 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.3 m-85 -85.37 -29.15 24.68 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.089 -0.505 . . . . 25.27 111.569 -179.411 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 65.4 m -58.34 130.39 46.51 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.954 0.407 . . . . 25.04 111.258 -179.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.684 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -62.36 163.42 14.55 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-N 116.015 -0.538 . . . . 36.05 111.313 -179.953 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.479 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 83.8 Cg_endo -80.64 -24.89 4.8 Favored 'Trans proline' 0 C--N 1.356 0.963 0 C-N-CA 122.101 1.867 . . . . 54.36 112.872 -179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.562 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -60.75 163.86 5.23 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.855 0.36 . . . . 71.54 111.151 -179.718 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -147.91 167.23 13.81 Favored Pre-proline 0 CA--C 1.537 0.472 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.612 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 43.7 Cg_endo -67.35 152.15 79.48 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.876 1.717 . . . . 0.0 112.271 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -93.86 -70.99 0.68 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.221 -0.445 . . . . 0.0 111.159 -179.908 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 24.5 mmtp -134.67 35.29 3.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.869 -179.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 27.9 t -144.23 106.55 4.38 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.282 -0.417 . . . . 0.0 110.849 179.956 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.028 0 CA-C-O 118.225 -0.893 . . . . 20.0 111.081 179.972 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.341 0 CA-C-O 120.838 0.352 . . . . 0.0 111.21 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -93.98 124.59 38.09 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.229 -0.442 . . . . 0.0 110.859 179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 14.5 m -82.9 -41.7 18.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.911 -179.878 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.561 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.7 m-85 -83.34 66.28 8.74 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.134 0.492 . . . . 0.0 110.947 -179.87 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 5.7 tp10 -124.33 -45.07 1.98 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.843 -0.617 . . . . 0.0 110.611 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 17.0 p -147.0 174.94 11.06 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.58 179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 22.1 t -71.92 -31.02 39.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 CA-C-N 116.344 -0.389 . . . . 0.0 111.004 179.99 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.66 -39.46 70.28 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.143 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -56.3 -36.55 68.78 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.076 -0.511 . . . . 0.0 111.79 -179.782 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.75 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.9 OUTLIER -56.46 -48.04 77.91 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 116.291 -0.413 . . . . 0.0 111.372 -179.786 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 28.6 mtm180 -65.06 -45.65 84.48 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.271 -0.422 . . . . 0.0 111.16 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 68.7 mmt-85 -59.38 -36.69 76.25 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.175 -179.83 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 88.3 m -63.88 -59.12 4.92 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.28 -0.418 . . . . 0.0 111.104 -179.824 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 11.3 tpt -63.87 -51.92 62.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.298 -0.41 . . . . 0.0 111.039 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 86.0 m-85 -82.59 71.19 9.68 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.094 0.473 . . . . 0.0 110.779 -179.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.072 0 CA-C-O 118.409 -1.217 . . . . 20.0 112.493 -179.98 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.177 0 CA-C-O 119.67 -0.517 . . . . 0.0 112.545 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 58.5 Cg_endo -70.95 144.95 49.05 Favored 'Trans proline' 0 C--N 1.355 0.897 0 C-N-CA 121.984 1.789 . . . . 0.0 112.242 179.905 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -112.27 106.39 14.93 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.238 -0.437 . . . . 75.5 110.967 -179.951 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.682 ' O ' HG11 ' B' ' 107' ' ' VAL . 54.2 p -137.64 176.5 8.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.158 -0.474 . . . . 31.38 110.596 179.679 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.549 HD13 HG13 ' B' ' 107' ' ' VAL . 9.9 tp -135.93 110.08 8.33 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.42 -0.355 . . . . 28.27 111.251 -179.635 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 68.4 m -140.22 159.32 42.44 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.147 -0.479 . . . . 32.91 110.963 179.716 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.04 -144.79 40.26 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.854 -0.688 . . . . 19.09 112.915 179.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.65 -29.75 64.85 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.785 0.326 . . . . 21.73 111.561 -179.784 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -60.67 -46.52 90.05 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.373 -0.376 . . . . 63.42 110.805 -179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.414 HD11 HG12 ' A' ' 43' ' ' ILE . 58.7 tp -64.37 -44.94 89.82 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.052 -0.522 . . . . 20.39 110.766 179.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.4 t -69.77 -33.96 58.57 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.227 0 CA-C-N 116.099 -0.5 . . . . 19.22 111.139 179.914 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.9 m-20 -65.69 -31.02 71.79 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.181 -0.463 . . . . 31.0 110.953 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.795 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -74.66 -47.49 31.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 18.28 110.966 179.749 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.749 HD13 ' CD1' ' A' ' 23' ' ' PHE . 14.8 mt -61.73 -47.09 86.82 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.209 -0.451 . . . . 22.05 110.871 179.846 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.06 -32.29 73.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.392 -0.367 . . . . 32.76 110.665 179.781 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.8 t80 -76.68 -34.38 58.22 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.138 -0.483 . . . . 27.25 110.971 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.6 t -86.71 -61.78 1.71 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.112 -0.494 . . . . 25.51 110.96 -179.833 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 24.1 m -76.78 -51.58 11.12 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.129 -0.487 . . . . 29.49 111.139 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.22 -122.46 29.13 Favored Glycine 0 CA--C 1.519 0.293 0 C-N-CA 120.895 -0.669 . . . . 40.61 113.059 179.77 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 18.4 m-20 -58.71 -25.71 63.18 Favored 'General case' 0 C--N 1.33 -0.26 0 N-CA-C 111.855 0.317 . . . . 79.05 111.855 -179.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.592 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 mtm-85 -56.02 -30.03 61.27 Favored 'General case' 0 N--CA 1.463 0.211 0 CA-C-O 120.75 0.31 . . . . 50.6 111.751 -179.641 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 82.01 104.99 0.4 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.686 -0.769 . . . . 35.48 111.955 -179.653 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.749 ' CD1' HD13 ' A' ' 14' ' ' LEU . 41.4 p90 -93.21 153.37 18.66 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 121.047 0.451 . . . . 25.52 111.554 -179.327 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 69.5 m-85 -111.6 139.74 46.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 115.783 -0.644 . . . . 56.07 110.469 179.644 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -84.38 -30.5 25.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.37 -0.377 . . . . 29.3 110.862 -179.857 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.5 m120 -120.9 92.05 3.67 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.394 -0.366 . . . . 38.35 111.038 179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 2.2 mmmp? -59.99 139.38 90.76 Favored Pre-proline 0 CA--C 1.533 0.321 0 CA-C-N 116.245 -0.434 . . . . 42.35 110.775 179.877 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.26 135.56 31.98 Favored 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.915 1.743 . . . . 40.8 112.257 -179.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 8.4 t -169.94 124.09 0.76 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.173 -0.467 . . . . 55.75 110.922 179.904 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -151.16 -75.43 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.765 -0.731 . . . . 34.94 112.458 -179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 35.5 p90 -74.55 138.44 43.08 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.739 0.304 . . . . 34.26 111.026 179.973 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 175.23 139.79 3.16 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.739 -0.743 . . . . 36.13 112.55 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.3 m -94.36 -51.72 4.66 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.817 0.341 . . . . 57.93 110.86 -179.955 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 50.5 m -73.49 167.14 21.9 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.215 -0.448 . . . . 72.85 110.894 179.989 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 47.5 m -153.5 33.4 0.46 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.165 -0.471 . . . . 0.0 110.906 -179.991 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 13.5 ptm180 -79.83 -31.77 40.61 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.961 180.0 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.27 -176.3 3.04 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.265 -0.425 . . . . 0.0 110.814 179.947 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -57.71 156.97 15.77 Favored Pre-proline 0 CA--C 1.533 0.319 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.411 -179.854 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_endo -75.01 -168.83 0.55 Allowed 'Trans proline' 0 C--N 1.357 0.987 0 C-N-CA 121.978 1.785 . . . . 0.0 112.555 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 13.2 mt-30 -86.59 90.8 8.37 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.382 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 17.4 p -151.66 146.11 25.56 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.266 -0.424 . . . . 64.04 111.01 -179.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -76.76 -146.28 2.09 Favored Glycine 0 N--CA 1.45 -0.408 0 C-N-CA 120.82 -0.705 . . . . 35.08 112.606 -179.798 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.759 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.2 tp -93.27 -36.46 7.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.875 0.369 . . . . 25.61 110.941 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 18.1 t -62.22 -66.71 0.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.214 -0.448 . . . . 29.9 111.104 -179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.418 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.9 m-20 -61.06 -20.73 62.91 Favored 'General case' 0 C--N 1.322 -0.607 0 N-CA-C 112.11 0.411 . . . . 39.04 112.11 -179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.96 -28.79 17.81 Favored 'General case' 0 CA--C 1.53 0.192 0 N-CA-C 113.261 0.837 . . . . 45.6 113.261 -178.669 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -124.79 -33.95 2.89 Favored 'General case' 0 N--CA 1.469 0.521 0 N-CA-C 112.937 0.717 . . . . 28.23 112.937 -178.75 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 45.5 t -73.67 -33.66 64.56 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.874 -0.33 . . . . 25.89 110.478 -179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.418 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.9 m-85 -84.84 -47.75 10.05 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.169 -0.469 . . . . 32.64 110.342 179.375 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.02 160.71 22.25 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 115.805 -0.634 . . . . 41.06 109.957 179.25 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 10.7 p -79.25 116.4 19.48 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-O 120.735 0.303 . . . . 42.62 111.059 -179.61 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -109.59 -171.06 1.77 Allowed 'General case' 0 CA--C 1.534 0.344 0 CA-C-O 120.799 0.333 . . . . 28.05 110.911 179.85 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -102.28 134.6 45.3 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.181 -0.463 . . . . 46.35 110.338 179.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.687 ' O ' HD12 ' A' ' 57' ' ' LEU . 1.0 OUTLIER -57.6 -27.39 62.69 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.005 -0.543 . . . . 23.79 111.759 -179.105 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -58.21 -26.21 62.54 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 111.636 0.236 . . . . 74.93 111.636 -179.774 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.9 mmm180 -62.31 -28.4 69.71 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-O 120.601 0.238 . . . . 64.42 111.192 179.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.687 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.6 mt -56.1 -29.15 60.2 Favored 'General case' 0 N--CA 1.463 0.178 0 CA-C-O 120.745 0.307 . . . . 32.64 111.627 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 22.7 mt-10 -69.71 -29.74 67.22 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.319 -0.401 . . . . 41.86 111.396 -179.705 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 32.3 mtm -65.23 -49.84 68.14 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.841 0.353 . . . . 38.66 111.265 -179.725 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.759 ' CE2' HD13 ' A' ' 43' ' ' ILE . 87.7 m-85 -56.52 -25.59 52.06 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.06 -0.518 . . . . 25.27 111.855 -179.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 10.2 m -64.64 134.66 54.75 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-O 120.937 0.398 . . . . 25.04 111.055 -179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.592 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -64.61 158.67 66.44 Favored Pre-proline 0 C--N 1.328 -0.367 0 CA-C-N 115.94 -0.573 . . . . 36.05 111.024 179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -65.0 -30.33 56.83 Favored 'Trans proline' 0 C--N 1.357 1.011 0 C-N-CA 121.897 1.731 . . . . 54.36 112.757 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.521 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -60.51 174.46 0.57 Allowed 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.912 0.387 . . . . 71.54 110.875 -179.865 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 40.3 mtmt -142.13 162.71 44.13 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.954 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_endo -63.67 115.79 3.27 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.88 1.72 . . . . 0.0 112.268 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -173.87 175.76 2.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.998 179.981 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.33 85.87 3.75 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.94 179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 50.2 m -163.25 175.07 11.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.842 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.026 0 CA-C-O 118.278 -0.868 . . . . 20.0 111.153 179.971 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 19.8 mmt180 . . . . . 0 N--CA 1.486 1.367 0 CA-C-O 120.81 0.338 . . . . 0.0 111.22 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 34.6 m-80 -63.18 145.04 56.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.753 179.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 37.1 t -75.27 -35.3 61.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.231 -179.802 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.595 ' C ' HD13 ' A' ' 54' ' ' LEU . 20.3 m-85 -98.6 32.86 2.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.456 -0.338 . . . . 0.0 111.041 -179.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 19.1 tt0 -86.47 -33.08 20.48 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.54 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.437 ' O ' HD21 ' A' ' 54' ' ' LEU . 13.1 t -158.58 174.84 14.46 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.528 179.78 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.682 HG11 ' O ' ' A' ' 4' ' ' THR . 22.0 t -65.02 -31.06 52.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.292 -0.413 . . . . 0.0 111.162 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.17 -39.35 71.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 0.0 111.289 -179.93 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.52 -50.2 70.6 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.204 -0.453 . . . . 0.0 111.888 -179.699 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.513 HD12 HD22 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -60.08 -42.65 95.06 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.458 -0.337 . . . . 0.0 111.051 -179.947 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 4.4 mtm180 -56.38 -42.81 78.5 Favored 'General case' 0 N--CA 1.463 0.222 0 CA-C-O 120.929 0.395 . . . . 0.0 111.348 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -67.01 -35.75 80.62 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.685 179.619 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 77.5 m -63.86 -46.76 83.52 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.828 179.789 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.464 ' HE2' HD23 ' B' ' 110' ' ' LEU . 16.5 ptp -73.97 -45.36 50.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.989 -179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 45.5 m-85 -91.02 71.2 6.38 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.196 0.522 . . . . 0.0 110.901 -179.929 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.063 0 CA-C-O 118.338 -1.257 . . . . 20.0 112.416 -179.911 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.197 0 CA-C-O 119.807 -0.441 . . . . 0.0 112.556 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 73.4 Cg_endo -75.33 122.09 6.84 Favored 'Trans proline' 0 C--N 1.355 0.9 0 C-N-CA 121.989 1.793 . . . . 0.0 112.228 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 10.9 mp0 -127.37 97.6 4.95 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.221 -0.445 . . . . 75.5 110.978 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.549 ' O ' HG11 ' B' ' 107' ' ' VAL . 10.9 p -122.1 171.05 9.26 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.085 -0.507 . . . . 31.38 110.609 179.729 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.814 HD13 HG13 ' B' ' 107' ' ' VAL . 8.1 tp -128.66 113.32 15.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.386 -0.37 . . . . 28.27 111.035 -179.527 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.6 m -140.18 164.09 31.0 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.915 0.388 . . . . 32.91 111.234 -179.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 57.5 -137.86 48.94 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 121.016 -0.612 . . . . 19.09 113.003 179.516 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.7 -33.86 66.88 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.687 0.279 . . . . 21.73 111.664 -179.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.7 mt-10 -58.03 -38.97 77.24 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-O 120.823 0.344 . . . . 63.42 111.278 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 37.9 tp -72.33 -39.92 67.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.101 -0.499 . . . . 20.39 110.493 179.675 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 22.4 t -72.74 -33.19 43.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.059 -0.518 . . . . 19.22 111.143 179.795 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.0 t70 -63.67 -50.13 70.47 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.247 -0.433 . . . . 31.0 110.782 179.875 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.776 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.69 -50.78 72.52 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.152 -0.476 . . . . 18.28 111.147 179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.549 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -60.28 -42.21 94.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.269 -0.423 . . . . 22.05 110.875 179.795 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -71.84 -31.8 66.87 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.18 -0.463 . . . . 32.76 110.69 179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 32.1 t80 -78.09 -31.28 50.03 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.189 -0.459 . . . . 27.25 110.871 179.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.776 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.5 t -89.13 -60.08 2.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.252 -0.431 . . . . 25.51 111.038 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 10.0 m -78.61 -51.54 9.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.241 -0.436 . . . . 29.49 111.033 -179.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 68.88 -103.67 1.1 Allowed Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.702 -0.761 . . . . 40.61 113.14 179.671 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -89.93 -5.28 56.91 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 113.074 0.768 . . . . 79.05 113.074 -179.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.474 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.0 OUTLIER -59.25 -42.51 91.29 Favored 'General case' 0 C--O 1.231 0.131 0 CA-C-N 118.205 0.457 . . . . 50.6 111.113 -179.929 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.24 65.78 0.81 Allowed Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.702 -0.761 . . . . 35.48 112.342 -179.856 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.549 ' CD1' HD13 ' A' ' 14' ' ' LEU . 26.6 p90 -58.87 156.36 11.51 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.921 0.391 . . . . 25.52 111.411 -179.712 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -127.44 117.07 21.44 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.928 -0.578 . . . . 56.07 110.212 179.624 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 39.3 m-85 -57.68 -42.33 83.38 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.421 -0.354 . . . . 29.3 111.493 -179.579 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.8 m120 -81.77 142.53 32.53 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.011 0.434 . . . . 38.35 111.093 -179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HD2' ' CE1' ' A' ' 60' ' ' TYR . 5.6 tttp -134.66 106.94 10.78 Favored Pre-proline 0 CA--C 1.536 0.413 0 CA-C-N 115.945 -0.57 . . . . 42.35 110.629 179.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.1 Cg_endo -70.41 156.62 61.25 Favored 'Trans proline' 0 C--N 1.358 1.052 0 C-N-CA 121.865 1.71 . . . . 40.8 112.638 -179.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 21.8 p -112.01 135.06 53.15 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.161 -0.472 . . . . 55.75 110.778 179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -79.27 -43.24 10.78 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.733 -0.746 . . . . 34.94 112.575 -179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 74.6 m-85 -68.3 148.56 50.59 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.808 0.337 . . . . 34.26 110.996 -179.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.85 113.39 3.66 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.795 -0.717 . . . . 36.13 112.449 -179.906 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 21.4 p -133.72 34.66 3.4 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-O 120.8 0.333 . . . . 57.93 110.848 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 78.9 p -99.21 35.96 1.82 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.241 -0.436 . . . . 72.85 110.941 179.998 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 74.1 m -91.3 -51.78 5.13 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.112 -0.494 . . . . 0.0 110.961 -179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 21.1 ttp-105 -88.61 -67.6 0.82 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.998 179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 19.2 tpt85 -176.68 155.78 1.36 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.213 -0.448 . . . . 0.0 110.905 -179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -174.75 94.88 0.29 Allowed Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.063 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.14 -178.92 3.51 Favored 'Trans proline' 0 C--N 1.358 1.027 0 C-N-CA 121.796 1.664 . . . . 0.0 112.31 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -86.68 107.05 18.04 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.147 -0.479 . . . . 0.0 110.94 -179.995 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 19.1 p -142.11 172.91 12.05 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.257 -0.429 . . . . 64.04 110.832 -179.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -145.6 -125.74 1.77 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.651 -0.785 . . . . 35.08 112.698 -179.867 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.86 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.7 tt -78.5 -24.25 13.44 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.339 0 N-CA-C 111.755 0.28 . . . . 25.61 111.755 -179.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -56.34 -55.4 19.12 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.177 0 CA-C-O 120.939 0.4 . . . . 29.9 111.582 -179.816 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.413 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -69.11 -21.75 64.02 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 116.262 -0.426 . . . . 39.04 111.906 -179.987 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 10.7 tp10 -90.39 -25.11 20.57 Favored 'General case' 0 CA--C 1.529 0.166 0 N-CA-C 112.192 0.441 . . . . 45.6 112.192 -179.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 50.8 m -114.36 -45.03 3.05 Favored 'General case' 0 N--CA 1.465 0.288 0 N-CA-C 112.265 0.469 . . . . 28.23 112.265 -178.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 10.3 t -73.25 -55.14 6.83 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.623 0.249 . . . . 25.89 111.167 -179.606 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.413 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 20.7 m-85 -63.81 -33.81 76.52 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-O 120.884 0.373 . . . . 32.64 110.873 179.948 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 1.4 ptm85 -142.05 150.69 41.58 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 41.06 110.854 179.541 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 12.1 p -62.87 137.29 58.23 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-N 115.892 -0.594 . . . . 42.62 110.949 -179.805 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.9 p -128.12 175.09 8.69 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.056 -0.52 . . . . 28.05 110.904 -179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -99.84 128.06 45.96 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.213 -0.448 . . . . 46.35 110.291 179.327 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.731 HD11 ' O ' ' B' ' 106' ' ' SER . 86.0 mt -54.12 -25.72 23.61 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.819 -0.628 . . . . 23.79 112.274 -179.091 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 73.9 mtt-85 -59.53 -30.02 68.3 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.785 0.326 . . . . 74.93 111.011 179.638 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.491 ' HB3' ' HE2' ' A' ' 59' ' ' MET . 11.5 mmm-85 -65.96 -26.87 67.77 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.266 -0.424 . . . . 64.42 111.393 179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . . . . . . . . . 7.0 mt -56.51 -30.95 63.61 Favored 'General case' 0 N--CA 1.462 0.156 0 CA-C-O 120.869 0.366 . . . . 32.64 111.491 -179.625 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 10.6 mt-10 -66.28 -26.63 67.42 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.125 -0.489 . . . . 41.86 111.809 -179.204 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.491 ' HE2' ' HB3' ' A' ' 56' ' ' ARG . 57.4 mtm -67.56 -52.2 41.6 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.86 0.362 . . . . 38.66 111.545 -179.672 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.86 ' CE2' HD12 ' A' ' 43' ' ' ILE . 93.0 m-85 -54.48 -25.45 25.41 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.049 -0.523 . . . . 25.27 112.222 -179.198 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 64.0 m -61.74 131.11 48.84 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.826 0.346 . . . . 25.04 110.979 -179.983 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.69 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -58.65 169.87 0.94 Allowed Pre-proline 0 CA--C 1.534 0.36 0 CA-C-N 116.155 -0.475 . . . . 36.05 111.079 -179.966 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.69 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.6 Cg_endo -76.7 -33.2 3.12 Favored 'Trans proline' 0 C--N 1.357 1.019 0 C-N-CA 121.847 1.698 . . . . 54.36 112.488 -179.799 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.433 HD23 ' H ' ' A' ' 64' ' ' LEU . 0.5 OUTLIER -60.01 179.04 0.15 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.421 -0.354 . . . . 71.54 110.986 -179.99 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 7.4 mtmp? -142.35 159.41 58.22 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.862 -179.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -65.21 -167.8 0.11 Allowed 'Trans proline' 0 C--N 1.357 0.989 0 C-N-CA 121.867 1.712 . . . . 0.0 112.241 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -59.71 -52.25 66.32 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.126 -179.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.9 mtpm? -136.31 149.83 48.6 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.872 179.993 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.4 m -98.56 131.55 44.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.145 -0.479 . . . . 0.0 110.987 179.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.219 -0.896 . . . . 20.0 111.115 179.997 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.2 tmt_? . . . . . 0 N--CA 1.488 1.439 0 CA-C-O 120.831 0.348 . . . . 0.0 111.27 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 15.0 t-20 -109.08 130.67 55.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.266 -0.425 . . . . 0.0 110.75 179.976 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 24.7 t -83.13 -31.12 27.39 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.242 -0.435 . . . . 0.0 111.451 -179.647 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.429 ' HA ' HD12 ' A' ' 54' ' ' LEU . 18.6 m-85 -97.27 32.82 2.1 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.448 -0.342 . . . . 0.0 111.099 -179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.7 tp10 -80.03 -51.12 9.43 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.912 0.387 . . . . 0.0 110.459 179.58 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.731 ' O ' HD11 ' A' ' 54' ' ' LEU . 34.4 p -143.44 173.92 11.2 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 115.94 -0.573 . . . . 0.0 110.425 179.494 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.814 HG13 HD13 ' A' ' 5' ' ' LEU . 22.4 t -61.74 -30.45 48.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.308 -179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -71.46 -39.47 70.93 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.312 -0.404 . . . . 0.0 111.412 -179.91 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -55.39 -48.37 74.44 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.201 -0.454 . . . . 0.0 112.05 -179.54 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.681 HD12 HD13 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -59.01 -49.71 76.85 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.532 -0.304 . . . . 0.0 111.115 -179.599 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 7.2 ttp-105 -60.07 -42.8 95.35 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.876 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -65.83 -35.05 79.6 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.486 . . . . 0.0 111.288 -179.904 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 65.4 m -56.81 -46.01 81.89 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.333 -0.394 . . . . 0.0 111.908 -179.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 9.5 ttt -76.06 -52.43 10.19 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 112.061 0.393 . . . . 0.0 112.061 -178.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 55.1 m-85 -67.67 -49.27 63.68 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.789 0.328 . . . . 0.0 111.47 -179.21 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.103 0 CA-C-O 118.311 -1.272 . . . . 20.0 112.502 179.971 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.191 0 CA-C-O 119.784 -0.453 . . . . 0.0 112.524 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -75.79 121.33 6.22 Favored 'Trans proline' 0 C--N 1.355 0.912 0 C-N-CA 121.989 1.792 . . . . 0.0 112.411 -179.907 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 44.4 mp0 -101.33 106.96 18.19 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.258 -0.428 . . . . 75.5 110.787 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' HG11 ' B' ' 107' ' ' VAL . 44.8 p -133.46 177.1 7.95 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.332 -0.395 . . . . 31.38 111.156 -179.836 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.468 HD11 ' HB3' ' A' ' 9' ' ' GLU . 10.3 tp -140.22 118.74 12.24 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.272 -0.422 . . . . 28.27 111.318 -179.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 82.0 m -140.44 159.52 42.01 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.354 -0.385 . . . . 32.91 111.072 179.691 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.1 -149.53 47.61 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.953 -0.642 . . . . 19.09 113.017 179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -56.82 -28.87 62.16 Favored 'General case' 0 C--N 1.333 -0.125 0 CA-C-O 120.748 0.309 . . . . 21.73 111.65 -179.824 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.468 ' HB3' HD11 ' A' ' 5' ' ' LEU . 46.7 mt-10 -60.07 -39.5 86.24 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.995 0.426 . . . . 63.42 110.685 179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 67.0 tp -71.11 -47.5 57.7 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.058 -0.519 . . . . 20.39 110.314 179.313 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.89 -31.61 54.5 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 115.958 -0.565 . . . . 19.22 110.948 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 34.0 m-20 -65.72 -42.64 90.82 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.14 -0.482 . . . . 31.0 110.782 179.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.683 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -62.28 -46.49 88.56 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.462 . . . . 18.28 111.087 179.853 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.589 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.4 mt -59.7 -42.59 93.35 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.232 -0.44 . . . . 22.05 110.939 179.962 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 13.5 mm-40 -71.32 -31.33 67.27 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.27 -0.423 . . . . 32.76 110.876 179.869 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -76.84 -31.77 57.1 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.205 -0.452 . . . . 27.25 110.943 -179.996 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.683 HG23 ' O ' ' A' ' 13' ' ' ALA . 28.9 t -90.07 -59.21 2.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.206 -0.452 . . . . 25.51 110.927 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 12.4 m -77.86 -51.59 10.21 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 29.49 110.949 -179.667 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.79 -121.89 26.55 Favored Glycine 0 CA--C 1.518 0.255 0 C-N-CA 120.939 -0.648 . . . . 40.61 113.108 179.754 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -61.25 -24.58 66.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 111.845 0.313 . . . . 79.05 111.845 -179.816 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.598 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 12.0 mtm-85 -55.46 -27.31 47.39 Favored 'General case' 0 N--CA 1.463 0.198 0 N-CA-C 111.897 0.332 . . . . 50.6 111.897 -179.605 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.58 109.58 0.24 Allowed Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.563 -0.827 . . . . 35.48 111.973 -179.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.589 ' CD1' HD13 ' A' ' 14' ' ' LEU . 39.7 p90 -102.0 160.34 14.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.109 0.481 . . . . 25.52 111.632 -179.22 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.438 ' CE1' ' HB3' ' A' ' 27' ' ' LYS . 5.8 p90 -134.58 128.71 33.77 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.628 -0.715 . . . . 56.07 110.2 179.626 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -63.37 -68.93 0.3 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.27 -0.423 . . . . 29.3 111.387 -179.517 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 7.5 t-20 -88.85 117.16 27.65 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.863 0.363 . . . . 38.35 111.16 -179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 10.6 pttp -114.02 152.39 45.71 Favored Pre-proline 0 CA--C 1.534 0.342 0 CA-C-N 116.135 -0.484 . . . . 42.35 110.71 179.709 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_endo -61.69 136.56 63.22 Favored 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.924 1.749 . . . . 40.8 112.358 -179.85 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 60.2 p -126.41 -58.08 1.36 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.061 -0.518 . . . . 55.75 110.847 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -107.34 -129.62 6.2 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.748 -0.739 . . . . 34.94 112.507 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 90.9 m-85 -158.5 179.09 9.45 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.813 0.34 . . . . 34.26 111.001 179.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 99.36 147.24 21.47 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.734 -0.746 . . . . 36.13 112.546 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 49.3 m -90.12 140.78 29.33 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.819 0.342 . . . . 57.93 110.876 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 47.3 t -95.75 148.33 22.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.235 -0.439 . . . . 72.85 110.89 -179.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 78.3 p -91.35 -64.06 1.17 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.841 179.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 18.1 mtt85 -128.75 -47.32 1.26 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.837 179.974 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 7.7 tpt180 -135.84 153.95 51.34 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.895 -179.9 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.64 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -159.04 166.25 16.78 Favored Pre-proline 0 CA--C 1.534 0.341 0 CA-C-N 116.103 -0.498 . . . . 0.0 111.105 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.64 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 27.8 Cg_endo -62.12 101.26 0.23 Allowed 'Trans proline' 0 C--N 1.357 0.99 0 C-N-CA 121.937 1.758 . . . . 0.0 112.194 -179.98 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 11.4 tt0 -106.47 126.53 52.37 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.924 179.758 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -158.13 130.63 7.14 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.14 -0.482 . . . . 64.04 110.705 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -130.99 -126.04 2.74 Favored Glycine 0 C--N 1.331 0.289 0 C-N-CA 120.803 -0.713 . . . . 35.08 112.791 -179.756 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.965 HD13 ' CE2' ' A' ' 60' ' ' TYR . 9.2 tp -81.78 -36.95 14.74 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.235 0 CA-C-O 120.7 0.286 . . . . 25.61 111.207 -179.777 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -59.38 -60.54 2.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-O 121.105 0.479 . . . . 29.9 111.198 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 12.3 m-20 -56.1 -20.31 16.76 Favored 'General case' 0 CA--C 1.536 0.408 0 CA-C-N 116.178 -0.465 . . . . 39.04 112.195 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 28.0 mm-40 -86.56 -48.41 8.38 Favored 'General case' 0 CA--C 1.531 0.241 0 N-CA-C 112.677 0.621 . . . . 45.6 112.677 -179.002 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -106.55 -36.24 6.82 Favored 'General case' 0 N--CA 1.467 0.409 0 N-CA-C 112.69 0.626 . . . . 28.23 112.69 -178.313 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 42.8 t -70.28 -49.07 53.49 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.677 -0.409 . . . . 25.89 110.502 -179.779 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -79.69 -56.58 4.18 Favored 'General case' 0 C--N 1.33 -0.264 0 N-CA-C 109.711 -0.477 . . . . 32.64 109.711 179.031 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 55.7 mtp85 -103.33 170.28 8.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.824 -0.626 . . . . 41.06 109.339 178.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 2.8 p -95.15 110.46 22.41 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 120.788 0.328 . . . . 42.62 111.354 -179.78 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.77 -169.2 1.42 Allowed 'General case' 0 CA--C 1.533 0.3 0 CA-C-N 116.23 -0.441 . . . . 28.05 110.804 179.725 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 3.2 p-10 -108.51 168.04 9.61 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.324 -0.398 . . . . 46.35 110.828 179.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.622 HD22 ' HA ' ' B' ' 104' ' ' PHE . 6.6 mp -76.25 -30.49 57.91 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.218 -0.447 . . . . 23.79 110.995 -179.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 56.6 mtm-85 -55.53 -26.76 44.87 Favored 'General case' 0 CA--C 1.532 0.254 0 CA-C-N 116.336 -0.393 . . . . 74.93 111.712 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.2 mmm180 -64.5 -28.89 69.96 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-O 120.698 0.285 . . . . 64.42 111.005 179.605 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.557 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.1 mt -57.24 -30.29 64.51 Favored 'General case' 0 C--O 1.231 0.117 0 CA-C-O 120.856 0.36 . . . . 32.64 111.4 -179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 35.6 mt-10 -68.82 -31.2 70.02 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.163 -0.471 . . . . 41.86 111.433 -179.358 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 38.7 mtm -61.32 -30.24 70.37 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.316 -0.402 . . . . 38.66 111.549 -179.559 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.965 ' CE2' HD13 ' A' ' 43' ' ' ILE . 56.4 m-85 -83.68 -24.83 31.13 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.283 -0.417 . . . . 25.27 111.999 -178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -67.27 130.35 42.8 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.787 0.327 . . . . 25.04 110.892 179.821 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.598 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -58.03 164.05 3.76 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.133 -0.485 . . . . 36.05 111.19 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.516 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.1 Cg_endo -74.37 -28.67 10.16 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.92 1.746 . . . . 54.36 112.598 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.49 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -59.48 169.83 1.17 Allowed 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.883 0.373 . . . . 71.54 111.065 -179.977 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 9.3 mtmp? -148.85 159.76 37.05 Favored Pre-proline 0 CA--C 1.533 0.307 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.853 179.954 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -72.39 -170.03 0.54 Allowed 'Trans proline' 0 C--N 1.356 0.927 0 C-N-CA 121.945 1.763 . . . . 0.0 112.308 -179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -156.2 -173.16 4.38 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.185 179.951 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 38.2 mmtm -67.9 -69.44 0.32 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.824 -179.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 88.2 p -84.21 127.84 34.19 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 0.0 110.892 -179.947 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.132 0 CA-C-O 118.287 -0.863 . . . . 20.0 111.148 179.989 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 13.7 mmt180 . . . . . 0 N--CA 1.485 1.322 0 CA-C-O 120.812 0.339 . . . . 0.0 111.25 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 29.7 m120 -115.68 115.11 25.81 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.797 179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 41.9 m -82.63 -38.65 23.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.987 -179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.622 ' HA ' HD22 ' A' ' 54' ' ' LEU . 1.2 m-85 -81.75 66.79 7.47 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.777 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -127.92 -46.38 1.4 Allowed 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.013 -0.54 . . . . 0.0 110.685 179.689 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 56.4 m -141.36 174.75 10.25 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.606 179.628 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 4' ' ' THR . 30.7 t -74.39 -30.68 26.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 116.385 -0.37 . . . . 0.0 111.037 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -66.38 -39.93 89.39 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.284 -0.416 . . . . 0.0 111.042 179.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -62.27 -36.56 82.44 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.144 -0.48 . . . . 0.0 111.214 -179.952 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.612 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -56.94 -45.4 82.8 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.148 -0.478 . . . . 0.0 111.36 -179.781 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 6.3 mmp_? -65.05 -56.83 10.78 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.207 -0.451 . . . . 0.0 111.372 -179.606 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.81 -43.96 90.72 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.266 -179.8 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 22.6 m -59.5 -49.62 77.1 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.22 -0.445 . . . . 0.0 111.163 -179.817 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 32.5 ttm -71.09 -51.66 23.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.264 -0.426 . . . . 0.0 110.87 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 74.2 m-85 -81.65 71.08 8.65 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.166 0.508 . . . . 0.0 110.832 179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.003 0 CA-C-O 118.375 -1.236 . . . . 20.0 112.56 -179.889 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.186 0 CA-C-O 119.772 -0.46 . . . . 0.0 112.521 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.7 Cg_endo -90.25 43.53 0.55 Allowed 'Trans proline' 0 C--N 1.355 0.882 0 C-N-CA 122.313 2.009 . . . . 0.0 112.873 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.409 ' O ' HG21 ' B' ' 107' ' ' VAL . 2.7 mp0 -99.26 92.7 5.57 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 120.836 0.35 . . . . 75.5 110.747 179.801 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.442 ' O ' HG11 ' B' ' 107' ' ' VAL . 11.2 p -118.2 176.17 5.35 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.138 -0.483 . . . . 31.38 110.65 -179.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.556 HD13 HG13 ' B' ' 107' ' ' VAL . 10.0 tp -130.99 114.44 15.21 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.531 -0.304 . . . . 28.27 111.446 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 38.7 m -140.46 158.71 43.59 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.271 -0.422 . . . . 32.91 111.042 179.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.76 -145.45 41.85 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.929 -0.653 . . . . 19.09 113.083 179.507 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -30.34 65.5 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.839 0.352 . . . . 21.73 111.461 -179.771 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -60.21 -37.65 80.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.213 -0.449 . . . . 63.42 110.856 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.441 HD11 HG12 ' A' ' 43' ' ' ILE . 63.1 tp -73.18 -47.94 39.47 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.25 -0.432 . . . . 20.39 110.721 179.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -68.21 -30.99 49.75 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.11 -0.496 . . . . 19.22 111.19 179.909 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.66 -45.65 78.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.12 -0.491 . . . . 31.0 111.025 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.646 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -61.57 -48.77 79.47 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.295 -0.411 . . . . 18.28 111.242 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.748 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.2 mt -59.48 -44.67 93.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.339 -0.391 . . . . 22.05 111.049 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 33.4 mm-40 -65.37 -32.27 73.82 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.359 -0.382 . . . . 32.76 110.821 179.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.466 ' CZ ' ' HE2' ' B' ' 114' ' ' MET . 30.0 t80 -76.54 -34.48 58.53 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.044 -0.525 . . . . 27.25 110.936 -179.998 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 13' ' ' ALA . 26.1 t -88.25 -66.21 0.86 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.184 -0.462 . . . . 25.51 111.048 -179.733 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -77.42 -51.44 10.78 Favored 'General case' 0 C--N 1.327 -0.396 0 CA-C-N 116.17 -0.468 . . . . 29.49 111.019 -179.715 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 56.9 -121.25 24.38 Favored Glycine 0 CA--C 1.518 0.252 0 C-N-CA 120.913 -0.66 . . . . 40.61 113.286 179.515 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -62.06 -22.96 66.19 Favored 'General case' 0 C--N 1.331 -0.219 0 N-CA-C 112.14 0.422 . . . . 79.05 112.14 -179.403 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.476 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 8.3 mtm-85 -54.88 -25.62 30.1 Favored 'General case' 0 N--CA 1.464 0.228 0 N-CA-C 111.992 0.367 . . . . 50.6 111.992 -179.556 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 85.14 85.52 0.98 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.642 -0.79 . . . . 35.48 112.037 -179.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.748 ' CD1' HD13 ' A' ' 14' ' ' LEU . 30.3 p90 -81.38 135.46 35.67 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-O 120.918 0.39 . . . . 25.52 111.51 -179.249 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.43 ' CE1' ' HA ' ' A' ' 60' ' ' TYR . 1.6 p90 -105.74 151.6 24.24 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.945 -0.571 . . . . 56.07 110.335 179.325 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 29.8 m-85 -93.08 -39.26 11.17 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.365 -0.38 . . . . 29.3 111.269 -179.607 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -97.51 123.65 41.45 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.316 -0.402 . . . . 38.35 111.105 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' ' CD1' ' A' ' 60' ' ' TYR . 0.2 OUTLIER -96.72 150.44 36.95 Favored Pre-proline 0 CA--C 1.532 0.284 0 CA-C-N 116.273 -0.421 . . . . 42.35 110.789 179.953 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 26.9 Cg_endo -66.38 -61.59 0.09 OUTLIER 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.543 1.495 . . . . 40.8 112.382 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 2.1 t -179.2 -50.37 0.01 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 CA-C-O 120.853 0.358 . . . . 55.75 110.757 179.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 163.02 -96.81 0.14 Allowed Glycine 0 N--CA 1.451 -0.365 0 C-N-CA 120.84 -0.695 . . . . 34.94 112.499 -179.911 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.5 m-85 -148.57 -52.64 0.18 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.821 0.343 . . . . 34.26 110.908 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -136.18 136.07 8.18 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.7 -0.762 . . . . 36.13 112.556 179.977 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.3 m -102.88 170.83 7.75 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.742 0.306 . . . . 57.93 110.952 179.928 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 15.3 p -155.18 -70.67 0.12 Allowed 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.263 -0.426 . . . . 72.85 110.877 179.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 7.0 t -170.17 34.69 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.828 179.995 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 48.5 mtt85 -102.49 170.56 7.97 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.212 -0.449 . . . . 0.0 110.898 -179.992 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.0 ttp-105 -78.27 148.96 33.67 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.143 -0.481 . . . . 0.0 111.011 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -162.75 83.52 1.54 Allowed Pre-proline 0 CA--C 1.533 0.299 0 CA-C-N 116.165 -0.47 . . . . 0.0 111.194 -179.984 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 98.8 Cg_endo -79.21 -168.46 0.63 Allowed 'Trans proline' 0 C--N 1.356 0.939 0 C-N-CA 121.932 1.754 . . . . 0.0 112.206 179.914 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 7.9 pt20 -100.6 98.91 9.43 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.293 -0.412 . . . . 0.0 110.926 179.968 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 72.0 p -148.95 136.2 20.11 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.149 -0.478 . . . . 64.04 110.906 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -113.71 -140.05 7.44 Favored Glycine 0 C--N 1.331 0.257 0 C-N-CA 120.905 -0.664 . . . . 35.08 112.347 -179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.772 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.1 tp -78.79 -40.33 23.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-O 120.862 0.363 . . . . 25.61 111.0 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.8 t -57.6 -59.14 3.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.166 -0.47 . . . . 29.9 111.657 -179.709 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.429 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 7.5 m-20 -66.9 -24.0 66.05 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.266 -0.424 . . . . 39.04 112.113 -179.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -90.11 -21.78 22.1 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 112.634 0.605 . . . . 45.6 112.634 -178.937 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 56.3 m -121.77 -47.8 2.18 Favored 'General case' 0 N--CA 1.463 0.199 0 N-CA-C 112.326 0.491 . . . . 28.23 112.326 -178.821 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 38.7 t -70.03 -44.18 69.79 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.885 -0.326 . . . . 25.89 111.018 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.429 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 14.5 m-85 -73.17 -38.19 66.27 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.459 -0.337 . . . . 32.64 110.56 179.74 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -139.32 153.92 47.81 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.177 -0.465 . . . . 41.06 110.705 179.536 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 23.9 p -58.87 153.39 17.27 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.1 -0.5 . . . . 42.62 111.185 -179.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 30.4 p -151.14 -172.62 4.26 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.23 -0.441 . . . . 28.05 111.043 -179.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -110.7 130.08 55.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.978 -0.555 . . . . 46.35 110.031 178.962 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.74 HD11 ' O ' ' B' ' 106' ' ' SER . 47.6 mt -55.58 -25.29 37.55 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.177 -0.465 . . . . 23.79 112.184 -178.811 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.23 -27.12 63.66 Favored 'General case' 0 CA--C 1.532 0.273 0 CA-C-O 120.615 0.245 . . . . 74.93 111.341 179.831 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.435 ' CD ' ' HE2' ' A' ' 59' ' ' MET . 12.6 mmm180 -63.18 -28.36 69.99 Favored 'General case' 0 C--O 1.232 0.153 0 CA-C-N 116.632 -0.258 . . . . 64.42 111.298 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.636 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.9 mt -55.72 -28.25 54.79 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.557 -0.292 . . . . 32.64 111.754 -179.777 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.0 mt-10 -70.37 -28.77 65.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.338 -0.392 . . . . 41.86 111.591 -179.453 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.435 ' HE2' ' CD ' ' A' ' 56' ' ' ARG . 71.0 mtm -66.17 -51.97 52.73 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.983 0.42 . . . . 38.66 111.298 -179.757 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.772 ' CE2' HD13 ' A' ' 43' ' ' ILE . 82.5 m-85 -54.32 -22.76 12.93 Favored 'General case' 0 CA--C 1.533 0.309 0 CA-C-N 115.86 -0.609 . . . . 25.27 112.234 -179.271 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 5.3 m -67.92 145.47 54.53 Favored 'General case' 0 C--N 1.333 -0.15 0 CA-C-O 120.782 0.325 . . . . 25.04 110.639 179.812 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.813 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -80.16 175.23 5.0 Favored Pre-proline 0 CA--C 1.535 0.386 0 CA-C-N 116.341 -0.391 . . . . 36.05 111.145 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.813 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 85.8 Cg_endo -77.82 -30.84 3.49 Favored 'Trans proline' 0 C--N 1.356 0.968 0 C-N-CA 121.961 1.774 . . . . 54.36 112.697 -179.764 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.97 178.82 0.16 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.898 0.38 . . . . 71.54 111.092 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 14.6 mtpp -131.03 163.69 47.4 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 116.064 -0.516 . . . . 0.0 110.892 -179.946 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -64.8 137.83 55.44 Favored 'Trans proline' 0 C--N 1.357 1.025 0 C-N-CA 122.014 1.809 . . . . 0.0 112.287 179.949 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -170.89 118.93 0.51 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.168 -0.469 . . . . 0.0 111.127 179.993 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 6.0 ttpm? -77.29 118.05 19.4 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.884 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.2 m -96.14 -50.47 4.81 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.154 -0.476 . . . . 0.0 110.876 -179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.052 0 CA-C-O 118.212 -0.899 . . . . 20.0 111.112 -179.975 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 35.3 mmt180 . . . . . 0 N--CA 1.487 1.393 0 CA-C-O 120.828 0.347 . . . . 0.0 111.093 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 49.5 m-80 -107.45 145.0 33.59 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.14 -0.482 . . . . 0.0 110.916 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 48.7 t -80.95 -28.03 35.84 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.24 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 19.4 m-85 -97.87 35.8 1.65 Allowed 'General case' 0 C--N 1.332 -0.192 0 CA-C-O 120.723 0.297 . . . . 0.0 110.867 179.841 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.96 -51.37 10.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.881 0.372 . . . . 0.0 110.481 179.672 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.74 ' O ' HD11 ' A' ' 54' ' ' LEU . 13.3 p -146.72 173.33 12.47 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.515 179.431 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.556 HG13 HD13 ' A' ' 5' ' ' LEU . 22.7 t -58.03 -27.93 32.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.546 -0.297 . . . . 0.0 111.572 -179.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -72.64 -39.04 67.51 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.957 0.408 . . . . 0.0 111.016 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.88 -50.95 67.46 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 116.047 -0.524 . . . . 0.0 112.115 -179.514 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.622 HD12 HD13 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.98 -45.26 91.03 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.736 0.303 . . . . 0.0 111.032 -179.754 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 49.4 mtm180 -65.04 -45.02 87.16 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.608 179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 10.6 mmm180 -64.21 -35.59 81.3 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.982 -0.554 . . . . 0.0 110.896 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 19.4 m -58.0 -51.96 67.51 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.203 -179.934 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.466 ' HE2' ' CZ ' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -75.91 -51.96 11.34 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.119 -0.491 . . . . 0.0 110.901 179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 82.7 m-85 -82.85 71.34 9.94 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.843 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.057 0 CA-C-O 118.348 -1.251 . . . . 20.0 112.494 -179.945 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.2 0 CA-C-O 119.788 -0.451 . . . . 0.0 112.492 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 64.7 Cg_endo -72.78 150.07 49.29 Favored 'Trans proline' 0 C--N 1.356 0.945 0 C-N-CA 122.02 1.813 . . . . 0.0 112.337 -179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.514 ' OE2' ' HB2' ' B' ' 108' ' ' ALA . 4.2 mm-40 -144.61 115.1 7.63 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.5 111.101 -179.975 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.69 ' O ' HG11 ' B' ' 107' ' ' VAL . 16.1 p -137.96 -176.03 4.29 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.905 -0.589 . . . . 31.38 110.512 179.738 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 10.1 tp -140.18 112.93 8.06 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.83 0.347 . . . . 28.27 111.131 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.4 m -140.21 162.58 34.92 Favored 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.203 -0.453 . . . . 32.91 111.195 179.78 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 64.97 -145.78 49.67 Favored Glycine 0 N--CA 1.45 -0.368 0 C-N-CA 120.92 -0.657 . . . . 19.09 113.166 179.559 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.94 -29.46 65.17 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.725 0.298 . . . . 21.73 111.508 -179.662 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 41.3 mt-10 -60.13 -38.6 83.54 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.398 -0.365 . . . . 63.42 110.961 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 62.9 tp -73.17 -48.82 32.08 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.198 -0.455 . . . . 20.39 110.57 179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -65.68 -31.71 54.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.088 -0.505 . . . . 19.22 110.972 179.762 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -65.82 -46.34 78.95 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.16 -0.473 . . . . 31.0 110.849 -179.973 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.806 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.3 -47.59 84.81 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.187 -0.46 . . . . 18.28 110.998 179.874 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.921 HD13 ' CD2' ' A' ' 23' ' ' PHE . 14.9 mt -60.66 -41.0 94.13 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.235 -0.438 . . . . 22.05 110.77 179.814 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.1 mm-40 -70.73 -32.75 70.04 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.247 -0.433 . . . . 32.76 110.568 179.754 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 36.5 t80 -77.62 -32.67 53.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 27.25 110.624 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.806 HG23 ' O ' ' A' ' 13' ' ' ALA . 36.3 t -86.43 -65.11 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.156 -0.474 . . . . 25.51 110.8 179.921 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.8 m -71.1 -51.46 24.96 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.211 -0.45 . . . . 29.49 111.008 -179.844 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.0 -119.75 17.28 Favored Glycine 0 CA--C 1.519 0.301 0 C-N-CA 121.058 -0.592 . . . . 40.61 112.843 179.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -59.33 -27.38 65.85 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.579 0.228 . . . . 79.05 111.386 -179.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 4.7 mmm180 -56.56 -67.28 0.32 Allowed 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.826 0.346 . . . . 50.6 111.511 -179.812 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 123.76 141.87 5.91 Favored Glycine 0 N--CA 1.453 -0.184 0 C-N-CA 121.083 -0.58 . . . . 35.48 111.864 -179.591 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.921 ' CD2' HD13 ' A' ' 14' ' ' LEU . 25.5 p90 -132.3 139.97 48.41 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 121.011 0.434 . . . . 25.52 111.361 -179.545 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.8 p90 -113.09 146.92 38.33 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.793 -0.64 . . . . 56.07 110.484 179.567 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 43.8 m-85 -94.41 24.2 4.67 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.453 -0.34 . . . . 29.3 111.786 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 25.8 m120 -158.74 93.53 1.18 Allowed 'General case' 0 C--N 1.333 -0.139 0 CA-C-O 120.836 0.35 . . . . 38.35 110.614 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 10.8 mmtp -57.82 -48.14 97.69 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.254 -0.43 . . . . 42.35 111.389 -179.914 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 87.7 Cg_endo -81.39 -168.53 0.63 Allowed 'Trans proline' 0 C--N 1.355 0.92 0 C-N-CA 121.925 1.75 . . . . 40.8 112.244 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 29' ' ' THR . 10.0 t -160.04 115.17 2.33 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.238 -0.437 . . . . 55.75 110.821 179.994 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 179.04 -50.76 0.09 OUTLIER Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.726 -0.75 . . . . 34.94 112.501 179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -78.89 121.22 24.58 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.857 0.36 . . . . 34.26 110.915 -179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 147.29 59.9 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.403 0 C-N-CA 120.795 -0.716 . . . . 36.13 112.508 179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 t -102.49 33.78 3.02 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.92 0.391 . . . . 57.93 110.902 179.966 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 4.0 p -142.39 155.98 45.18 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.251 -0.431 . . . . 72.85 110.921 179.978 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 20.9 m -96.37 -55.48 2.92 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.221 -0.445 . . . . 0.0 110.911 179.908 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 37.4 ttt85 -71.29 -49.99 37.16 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.165 -0.47 . . . . 0.0 110.863 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 1.9 tpt85 -78.35 127.94 32.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.897 179.943 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -164.58 96.97 0.9 Allowed Pre-proline 0 C--N 1.328 -0.339 0 CA-C-N 116.288 -0.415 . . . . 0.0 111.109 -179.935 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.9 Cg_endo -72.44 167.33 27.29 Favored 'Trans proline' 0 C--N 1.358 1.029 0 C-N-CA 121.864 1.709 . . . . 0.0 112.332 179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -110.69 131.21 55.24 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.954 -179.97 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 34.5 p -157.09 -178.23 7.21 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.291 -0.413 . . . . 64.04 110.911 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 113.66 -103.73 1.39 Allowed Glycine 0 C--N 1.329 0.176 0 C-N-CA 120.929 -0.653 . . . . 35.08 112.473 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.764 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.1 tt -84.47 -26.85 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-O 120.599 0.238 . . . . 25.61 111.51 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.0 t -57.89 -56.12 17.61 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.172 0 CA-C-O 120.981 0.42 . . . . 29.9 111.3 -179.871 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -68.08 -21.41 64.98 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.075 -0.511 . . . . 39.04 111.933 179.897 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.5 tp10 -90.02 -28.37 19.13 Favored 'General case' 0 C--O 1.232 0.169 0 N-CA-C 111.845 0.313 . . . . 45.6 111.845 -179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 54.6 m -111.0 -51.95 2.83 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 112.053 0.39 . . . . 28.23 112.053 -178.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 12.6 t -65.36 -53.45 43.32 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.64 0.257 . . . . 25.89 111.182 -179.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 12.3 m-85 -66.01 -45.2 82.4 Favored 'General case' 0 C--N 1.326 -0.417 0 CA-C-O 120.776 0.322 . . . . 32.64 110.739 -179.931 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -128.94 148.29 50.92 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.272 -0.422 . . . . 41.06 110.604 179.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.9 p -60.39 139.63 57.58 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.176 -0.466 . . . . 42.62 110.872 179.909 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.5 p -131.43 -173.81 3.22 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.23 -0.441 . . . . 28.05 111.017 -179.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -108.58 132.21 54.09 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 115.974 -0.557 . . . . 46.35 110.208 179.096 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.704 ' HG ' HD12 ' B' ' 110' ' ' LEU . 0.7 OUTLIER -57.27 -28.1 62.67 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.955 -0.566 . . . . 23.79 111.704 -179.031 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 76.6 mtt-85 -59.15 -29.28 67.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.661 0.267 . . . . 74.93 111.323 -179.827 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.498 ' HD2' ' HE1' ' A' ' 59' ' ' MET . 3.5 mmt85 -61.12 -27.59 68.49 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.449 -0.342 . . . . 64.42 111.601 -179.967 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.625 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.7 mt -57.02 -29.87 63.71 Favored 'General case' 0 N--CA 1.463 0.19 0 CA-C-O 120.777 0.322 . . . . 32.64 111.555 -179.805 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 16.4 mt-10 -69.84 -29.73 67.05 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.232 -0.44 . . . . 41.86 111.407 -179.538 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.498 ' HE1' ' HD2' ' A' ' 56' ' ' ARG . 38.1 mtm -64.91 -47.54 77.42 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.433 -0.349 . . . . 38.66 111.323 -179.843 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.764 ' CE2' HD12 ' A' ' 43' ' ' ILE . 97.8 m-85 -60.21 -30.68 69.54 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.235 -0.439 . . . . 25.27 111.501 -179.421 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 34.5 m -60.16 129.51 42.11 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.886 0.374 . . . . 25.04 110.873 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.58 ' HB3' HD11 ' A' ' 64' ' ' LEU . . . -57.28 151.84 34.89 Favored Pre-proline 0 CA--C 1.536 0.442 0 CA-C-N 116.18 -0.464 . . . . 36.05 111.346 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -68.41 -22.6 38.99 Favored 'Trans proline' 0 C--N 1.356 0.966 0 C-N-CA 122.022 1.814 . . . . 54.36 112.979 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.58 HD11 ' HB3' ' A' ' 62' ' ' ALA . 0.3 OUTLIER -55.94 179.44 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 120.929 0.395 . . . . 71.54 111.57 -179.726 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -163.62 136.27 4.07 Favored Pre-proline 0 CA--C 1.535 0.392 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.708 179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.96 -179.75 4.14 Favored 'Trans proline' 0 C--N 1.357 1.015 0 C-N-CA 121.807 1.671 . . . . 0.0 112.339 -179.968 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -99.28 163.83 12.38 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.085 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 2.0 tmmm? -99.39 121.6 41.34 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.975 179.96 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 70.1 p -157.5 130.4 7.57 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.867 -179.921 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.017 0 CA-C-O 118.153 -0.927 . . . . 20.0 111.153 179.928 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 1.3 mmp_? . . . . . 0 N--CA 1.486 1.326 0 CA-C-O 120.805 0.335 . . . . 0.0 111.308 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -105.42 135.3 47.06 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.786 179.997 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 1.5 m -82.99 -30.85 27.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.256 -0.429 . . . . 0.0 111.024 -179.93 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 21.3 m-30 -98.34 32.77 2.39 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.202 179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 -79.77 -33.5 40.56 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.424 179.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.691 ' C ' HD21 ' A' ' 54' ' ' LEU . 24.8 t -157.08 174.36 15.62 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 115.861 -0.609 . . . . 0.0 110.391 179.594 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.69 HG11 ' O ' ' A' ' 4' ' ' THR . 32.1 t -68.06 -30.67 48.85 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.476 -0.329 . . . . 0.0 110.96 179.908 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . 0.514 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . . . -69.51 -39.83 77.35 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.369 -0.378 . . . . 0.0 111.176 179.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -63.78 -42.65 97.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.33 -0.395 . . . . 0.0 111.473 -179.732 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.704 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.6 OUTLIER -58.21 -42.5 86.32 Favored 'General case' 0 C--N 1.332 -0.173 0 CA-C-N 116.322 -0.399 . . . . 0.0 111.279 -179.794 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.556 ' HA ' ' HE3' ' B' ' 114' ' ' MET . 0.0 OUTLIER -56.85 -62.42 1.75 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.273 -179.992 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.44 -35.04 73.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.025 179.808 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 19.4 t -61.12 -53.92 50.97 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.158 -0.474 . . . . 0.0 111.514 -179.575 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.556 ' HE3' ' HA ' ' B' ' 111' ' ' ARG . 11.1 ptt? -76.17 -48.66 19.66 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 111.81 0.3 . . . . 0.0 111.81 -179.336 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 42.9 m-85 -69.47 -49.14 57.68 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.806 0.336 . . . . 0.0 111.222 -179.625 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.105 0 CA-C-O 118.36 -1.245 . . . . 20.0 112.524 179.969 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.273 0 CA-C-O 119.759 -0.467 . . . . 0.0 112.503 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.71 121.57 6.77 Favored 'Trans proline' 0 C--N 1.355 0.901 0 C-N-CA 121.992 1.795 . . . . 0.0 112.33 -179.975 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 33.8 mp0 -107.89 102.84 12.0 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.153 -0.476 . . . . 75.5 110.884 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.662 ' O ' HG11 ' B' ' 107' ' ' VAL . 31.1 p -133.16 178.85 6.58 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.304 -0.407 . . . . 31.38 110.902 179.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.481 HD13 HG13 ' B' ' 107' ' ' VAL . 10.1 tp -136.6 109.48 7.61 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.374 -0.375 . . . . 28.27 111.322 -179.651 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 27.3 m -140.19 164.72 29.32 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 32.91 110.666 179.645 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.06 -146.83 43.59 Favored Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.759 -0.734 . . . . 19.09 112.742 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.94 -32.08 69.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.821 0.343 . . . . 21.73 111.373 -179.818 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 32.5 mt-10 -59.08 -37.42 77.07 Favored 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.233 -0.439 . . . . 63.42 111.14 179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.419 HD11 ' CG1' ' A' ' 43' ' ' ILE . 31.2 tp -73.94 -51.22 16.75 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.186 -0.461 . . . . 20.39 110.974 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.87 -30.1 48.52 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.272 -0.422 . . . . 19.22 111.242 -179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 31.6 m-20 -67.71 -48.78 65.55 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.321 -0.4 . . . . 31.0 111.051 -179.89 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.4 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.55 -45.61 91.31 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.355 -0.384 . . . . 18.28 111.258 -179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.751 HD13 ' CD1' ' A' ' 23' ' ' PHE . 11.7 mt -60.65 -40.62 92.68 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.841 0.353 . . . . 22.05 110.809 179.866 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 11.2 mm-40 -74.02 -32.84 63.54 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.176 -0.465 . . . . 32.76 110.434 179.466 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.437 ' CE2' ' HG3' ' B' ' 114' ' ' MET . 0.1 OUTLIER -66.31 -41.97 88.93 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.022 -0.535 . . . . 27.25 110.515 179.748 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.448 HG22 ' HZ ' ' B' ' 104' ' ' PHE . 25.4 t -86.8 -61.85 1.69 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.389 0 CA-C-N 115.898 -0.592 . . . . 25.51 111.198 -179.653 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 11.1 m -75.87 -51.35 12.7 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.267 -0.424 . . . . 29.49 111.224 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 65.9 -117.15 9.39 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.736 -0.745 . . . . 40.61 112.693 179.901 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 14.8 m-20 -82.47 7.73 13.55 Favored 'General case' 0 CA--C 1.537 0.463 0 N-CA-C 112.772 0.656 . . . . 79.05 112.772 -179.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -68.83 -36.0 77.66 Favored 'General case' 0 C--O 1.23 0.078 0 O-C-N 122.036 -0.415 . . . . 50.6 110.891 179.905 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 100.33 59.54 0.84 Allowed Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.811 -0.709 . . . . 35.48 112.382 -179.848 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.751 ' CD1' HD13 ' A' ' 14' ' ' LEU . 29.8 p90 -58.71 133.88 56.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.812 0.339 . . . . 25.52 111.422 -179.864 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -86.47 142.37 28.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.165 -0.471 . . . . 56.07 110.779 179.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -90.8 -29.13 17.77 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 116.341 -0.391 . . . . 29.3 110.886 179.861 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.79 67.88 1.4 Allowed 'General case' 0 C--O 1.233 0.186 0 CA-C-O 121.219 0.533 . . . . 38.35 110.733 179.872 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.432 ' HE3' ' CD1' ' A' ' 60' ' ' TYR . 5.1 ptpp? -67.63 -177.23 0.3 Allowed Pre-proline 0 CA--C 1.541 0.614 0 CA-C-N 115.933 -0.576 . . . . 42.35 109.802 179.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 75.3 Cg_endo -84.72 -169.87 0.71 Allowed 'Trans proline' 0 C--N 1.352 0.719 0 C-N-CA 121.75 1.633 . . . . 40.8 112.39 -179.796 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.833 HG22 ' HB3' ' A' ' 38' ' ' ALA . 77.5 p -58.83 -75.48 0.05 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.302 -0.408 . . . . 55.75 111.192 -179.675 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -178.05 -135.66 2.33 Favored Glycine 0 N--CA 1.45 -0.399 0 C-N-CA 120.807 -0.711 . . . . 34.94 112.538 -179.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 29.5 m-85 -150.06 157.99 43.7 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.839 0.352 . . . . 34.26 110.934 -179.977 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 159.22 -172.15 35.85 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.7 -0.762 . . . . 36.13 112.408 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 76.7 p -93.64 -30.86 14.72 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-O 120.759 0.314 . . . . 57.93 110.972 179.892 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 26.9 p -153.67 134.15 13.56 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.336 -0.393 . . . . 72.85 111.003 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 24.3 m -152.16 157.13 41.1 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.156 -0.475 . . . . 0.0 110.755 179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -88.21 -70.93 0.61 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.477 -179.824 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 16.9 ttp180 -178.45 152.63 0.67 Allowed 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.705 -179.968 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.833 ' HB3' HG22 ' A' ' 29' ' ' THR . . . -124.16 145.93 49.92 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.933 179.821 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -68.82 173.41 10.16 Favored 'Trans proline' 0 C--N 1.357 1.014 0 C-N-CA 121.9 1.733 . . . . 0.0 112.254 -179.999 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.453 ' O ' HG23 ' A' ' 41' ' ' THR . 23.8 tt0 -80.74 105.17 11.78 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.166 -0.47 . . . . 0.0 111.013 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.453 HG23 ' O ' ' A' ' 40' ' ' GLN . 24.1 p -158.11 -179.55 8.22 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.111 -0.495 . . . . 64.04 110.834 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -157.17 -110.61 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.663 -0.78 . . . . 35.08 112.548 179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.916 HD13 ' CE2' ' A' ' 60' ' ' TYR . 8.2 tp -101.55 -36.74 4.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.876 0.369 . . . . 25.61 110.954 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.7 t -69.23 -65.72 0.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.034 -0.53 . . . . 29.9 110.958 -179.965 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 19.1 m-20 -61.29 -21.07 63.61 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.226 -0.443 . . . . 39.04 111.791 179.858 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.58 -36.97 14.13 Favored 'General case' 0 C--N 1.333 -0.139 0 N-CA-C 111.974 0.361 . . . . 45.6 111.974 -179.565 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 1.6 t -106.44 -50.33 3.16 Favored 'General case' 0 N--CA 1.464 0.263 0 N-CA-C 112.41 0.522 . . . . 28.23 112.41 -179.025 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 37.2 t -60.42 -50.32 74.06 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.763 0.316 . . . . 25.89 111.071 -179.418 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 11.0 m-85 -67.21 -56.22 10.79 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.338 -0.392 . . . . 32.64 110.219 179.465 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -118.22 145.99 44.58 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.164 -0.471 . . . . 41.06 110.354 178.854 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -57.36 136.51 56.59 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.207 -0.451 . . . . 42.62 111.77 -179.242 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.6 p -126.47 -160.47 0.99 Allowed 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 116.132 -0.485 . . . . 28.05 110.483 179.58 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 6.1 p-10 -128.11 145.71 50.92 Favored 'General case' 0 C--N 1.332 -0.165 0 CA-C-O 120.907 0.384 . . . . 46.35 110.578 179.054 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 1.021 HD23 HD12 ' B' ' 110' ' ' LEU . 1.6 mp -59.23 -26.38 64.83 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 116.168 -0.469 . . . . 23.79 111.535 -179.645 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 19.6 mtp180 -57.82 -28.58 64.19 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-O 120.651 0.262 . . . . 74.93 111.442 179.927 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . 0.462 ' NE ' ' HE1' ' A' ' 59' ' ' MET . 8.4 mmm180 -68.75 -26.71 65.37 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.523 -0.308 . . . . 64.42 111.206 179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.563 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.0 mt -55.45 -47.81 75.47 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-O 120.785 0.326 . . . . 32.64 111.78 -179.728 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 13.5 mt-10 -58.49 -29.08 65.97 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.201 -0.454 . . . . 41.86 111.519 -179.629 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . 0.462 ' HE1' ' NE ' ' A' ' 56' ' ' ARG . 30.3 mtm -63.77 -50.01 70.69 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.838 0.352 . . . . 38.66 111.465 -179.611 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.916 ' CE2' HD13 ' A' ' 43' ' ' ILE . 93.2 m-85 -56.82 -28.26 61.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.095 -0.502 . . . . 25.27 111.813 -179.258 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 21.1 m -60.35 127.15 30.33 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.369 . . . . 25.04 111.025 179.849 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.647 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -70.69 168.82 17.16 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.116 -0.493 . . . . 36.05 110.951 -179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.647 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 82.7 Cg_endo -77.76 -30.62 3.68 Favored 'Trans proline' 0 C--N 1.358 1.07 0 C-N-CA 121.832 1.688 . . . . 54.36 112.842 -179.693 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -60.02 155.13 17.52 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.877 0.37 . . . . 71.54 110.995 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 13.5 ptpt -158.34 153.81 22.4 Favored Pre-proline 0 CA--C 1.536 0.417 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.823 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -77.8 129.29 9.83 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.917 1.744 . . . . 0.0 112.383 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -163.86 165.13 23.15 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.289 -0.414 . . . . 0.0 111.124 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -90.18 -40.03 12.46 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.15 -0.477 . . . . 0.0 110.791 179.918 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.0 t -75.1 -58.51 3.24 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.092 -0.504 . . . . 0.0 110.827 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.074 0 CA-C-O 118.258 -0.877 . . . . 20.0 111.125 -179.984 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 8.8 tpt180 . . . . . 0 N--CA 1.487 1.38 0 CA-C-O 120.833 0.349 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 8.9 m120 -113.81 100.56 8.54 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.106 -0.497 . . . . 0.0 110.821 179.963 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 11.5 m -82.52 -35.44 27.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.278 -0.419 . . . . 0.0 111.028 179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.618 ' C ' HD13 ' A' ' 54' ' ' LEU . 14.5 m-30 -82.05 67.02 7.89 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 121.246 0.546 . . . . 0.0 111.029 179.975 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -116.01 -41.0 3.23 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.451 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.443 ' O ' HD11 ' A' ' 54' ' ' LEU . 20.2 t -142.96 178.3 7.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.543 179.746 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.662 HG11 ' O ' ' A' ' 4' ' ' THR . 23.8 t -73.9 -31.49 30.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.801 0.334 . . . . 0.0 111.034 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -70.82 -39.58 72.97 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.185 -0.461 . . . . 0.0 111.057 -179.97 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -57.55 -36.6 71.86 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.47 -179.842 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 1.021 HD12 HD23 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -57.23 -53.25 60.21 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.346 -0.388 . . . . 0.0 111.332 -179.734 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.421 ' HG3' ' CD1' ' B' ' 115' ' ' TYR . 4.7 ttt-85 -62.49 -49.06 76.88 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.119 -179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 4.7 mmp_? -59.9 -44.65 94.12 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.35 -0.387 . . . . 0.0 111.235 -179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 18.4 m -69.55 -45.02 69.72 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.331 -0.395 . . . . 0.0 111.547 -179.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.542 ' SD ' HD23 ' B' ' 110' ' ' LEU . 0.0 OUTLIER -70.45 -52.35 22.78 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.411 -0.359 . . . . 0.0 111.674 -179.306 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' B' ' 111' ' ' ARG . 74.5 m-85 -79.78 -49.08 12.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.745 0.307 . . . . 0.0 111.173 -179.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.12 0 CA-C-O 118.395 -1.225 . . . . 20.0 112.464 179.924 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.176 0 CA-C-O 119.788 -0.451 . . . . 0.0 112.435 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 69.5 Cg_endo -73.97 124.7 9.32 Favored 'Trans proline' 0 C--N 1.356 0.936 0 C-N-CA 122.028 1.819 . . . . 0.0 112.298 -179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 9.3 mp0 -132.56 103.45 6.16 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.222 -0.445 . . . . 75.5 110.863 179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.575 ' O ' HG11 ' B' ' 107' ' ' VAL . 60.9 p -128.43 176.1 7.99 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.322 -0.399 . . . . 31.38 111.048 -179.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.519 HD11 ' HB3' ' A' ' 9' ' ' GLU . 11.6 tp -140.2 117.92 11.65 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.271 -0.422 . . . . 28.27 111.045 -179.746 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 5.9 m -140.25 164.97 28.66 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.92 0.39 . . . . 32.91 110.963 179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.64 -149.76 48.64 Favored Glycine 0 N--CA 1.452 -0.292 0 C-N-CA 120.9 -0.667 . . . . 19.09 112.959 179.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.91 -29.83 65.42 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.745 0.307 . . . . 21.73 111.475 -179.687 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.519 ' HB3' HD11 ' A' ' 5' ' ' LEU . 34.0 mt-10 -59.78 -39.41 84.83 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.308 -0.406 . . . . 63.42 110.92 -179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.518 HD11 HG12 ' A' ' 43' ' ' ILE . 58.1 tp -72.69 -49.26 32.62 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.146 -0.479 . . . . 20.39 110.773 179.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -65.67 -31.9 55.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.064 -0.516 . . . . 19.22 110.952 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -66.3 -45.55 80.01 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.175 -0.466 . . . . 31.0 111.025 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.531 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -61.43 -42.8 99.32 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.245 -0.434 . . . . 18.28 111.223 -179.834 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.901 HD13 ' CD2' ' A' ' 23' ' ' PHE . 12.1 mt -60.53 -38.31 84.0 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.881 0.372 . . . . 22.05 110.551 179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . 0.405 ' HG2' ' CE1' ' A' ' 23' ' ' PHE . 1.5 mm-40 -76.5 -33.51 58.63 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.033 -0.53 . . . . 32.76 110.177 179.137 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.45 ' CD2' ' CG ' ' B' ' 114' ' ' MET . 0.1 OUTLIER -68.34 -44.96 74.13 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 115.884 -0.598 . . . . 27.25 110.622 179.736 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.531 HG23 ' O ' ' A' ' 13' ' ' ALA . 33.5 t -78.88 -65.62 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 115.804 -0.634 . . . . 25.51 111.289 -179.706 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 23.7 m -64.6 -51.72 61.24 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.074 -0.512 . . . . 29.49 111.426 -179.526 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.96 -109.07 1.29 Allowed Glycine 0 CA--C 1.52 0.402 0 C-N-CA 120.96 -0.638 . . . . 40.61 113.18 179.811 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -64.79 -37.61 88.21 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.72 0.295 . . . . 79.05 111.301 -179.727 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.646 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.6 mtm180 -58.52 -28.97 65.93 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.391 -0.368 . . . . 50.6 111.446 -179.709 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 79.86 174.56 46.97 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.555 -0.831 . . . . 35.48 111.721 -179.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.901 ' CD2' HD13 ' A' ' 14' ' ' LEU . 13.6 p90 -150.37 156.0 40.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 121.097 0.475 . . . . 25.52 111.546 -179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 0.7 OUTLIER -127.51 112.45 14.95 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.646 -0.706 . . . . 56.07 110.285 179.801 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 6.3 m-85 -52.68 -42.11 64.46 Favored 'General case' 0 N--CA 1.466 0.354 0 CA-C-N 116.206 -0.452 . . . . 29.3 112.206 -179.264 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 28.8 m120 -83.79 137.75 33.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.898 0.38 . . . . 38.35 111.358 -179.592 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.439 ' HD3' ' CE2' ' A' ' 60' ' ' TYR . 25.6 mtpp -154.8 159.7 31.61 Favored Pre-proline 0 CA--C 1.533 0.302 0 CA-C-N 115.991 -0.549 . . . . 42.35 110.811 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -71.41 120.45 6.97 Favored 'Trans proline' 0 C--N 1.357 0.991 0 C-N-CA 121.986 1.791 . . . . 40.8 112.403 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 65.8 p -138.21 122.77 18.53 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.167 -0.469 . . . . 55.75 110.913 179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 90.65 174.55 44.43 Favored Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.677 -0.773 . . . . 34.94 112.583 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 14.0 m-85 -82.06 -73.06 0.41 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.745 0.307 . . . . 34.26 110.854 179.866 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 60.81 -167.99 10.24 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.729 -0.748 . . . . 36.13 112.652 179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 17.6 t -149.3 -63.61 0.23 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.848 0.356 . . . . 57.93 110.896 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 68.9 m -161.09 146.8 14.37 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.166 -0.47 . . . . 72.85 110.857 179.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 42.8 m -143.36 148.0 35.55 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.902 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 28.9 mmt85 -86.21 -49.21 7.89 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.169 -0.468 . . . . 0.0 110.928 -179.817 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 15.0 tpt180 -90.56 136.35 33.12 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.978 -179.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -93.84 102.7 8.46 Favored Pre-proline 0 C--N 1.327 -0.376 0 CA-C-N 116.228 -0.442 . . . . 0.0 110.983 -179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 59.8 Cg_endo -71.56 170.86 17.5 Favored 'Trans proline' 0 C--N 1.357 1.008 0 C-N-CA 121.82 1.68 . . . . 0.0 112.416 -179.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 26.1 mm-40 -108.66 91.61 3.71 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.025 -0.534 . . . . 0.0 110.175 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 18.1 p -150.99 156.77 41.86 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.942 0.401 . . . . 64.04 111.377 -179.314 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . 167.05 -95.56 0.12 Allowed Glycine 0 N--CA 1.452 -0.242 0 CA-C-N 115.922 -0.581 . . . . 35.08 112.023 -179.775 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.518 HG12 HD11 ' A' ' 10' ' ' LEU . 1.1 tp -84.91 -35.46 10.09 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.37 0 CA-C-O 120.827 0.346 . . . . 25.61 110.353 179.372 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -60.05 -48.72 86.83 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 29.9 111.327 -179.885 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -72.15 -25.61 61.77 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.149 -0.478 . . . . 39.04 111.936 -179.552 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -90.34 -26.18 20.09 Favored 'General case' 0 C--N 1.329 -0.296 0 N-CA-C 111.867 0.321 . . . . 45.6 111.867 -179.082 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 67.6 m -107.12 -41.09 5.24 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.016 0.376 . . . . 28.23 112.016 -179.081 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 3.9 t -80.72 -57.98 3.31 Favored 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.974 -0.29 . . . . 25.89 110.907 -179.618 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -65.1 -37.43 87.45 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-O 120.864 0.364 . . . . 32.64 110.488 179.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 17.0 mtt85 -126.91 158.87 35.62 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.093 -0.503 . . . . 41.06 110.253 179.362 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 3.0 p -82.2 113.19 19.86 Favored 'General case' 0 C--N 1.327 -0.413 0 CA-C-O 120.915 0.388 . . . . 42.62 110.99 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 23.7 p -99.21 -171.86 2.16 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.069 -0.514 . . . . 28.05 111.05 -179.833 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -125.0 147.61 48.86 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.943 -0.571 . . . . 46.35 110.082 179.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.788 HD23 ' CD1' ' B' ' 110' ' ' LEU . 2.1 mp -55.32 -28.72 55.58 Favored 'General case' 0 N--CA 1.465 0.293 0 CA-C-N 116.207 -0.451 . . . . 23.79 111.824 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 8.6 mtp-105 -59.63 -28.21 67.01 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.28 -0.418 . . . . 74.93 111.323 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 14.1 mmm180 -66.44 -32.18 73.4 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 120.847 0.356 . . . . 64.42 111.031 -179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 54' ' ' LEU . 5.5 mt -55.1 -28.61 53.8 Favored 'General case' 0 N--CA 1.463 0.2 0 CA-C-N 116.019 -0.537 . . . . 32.64 111.88 -179.345 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 41.4 mt-10 -71.12 -35.95 71.94 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.433 -0.349 . . . . 41.86 111.287 -179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 27.7 mtm -59.02 -37.14 76.24 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.36 -0.382 . . . . 38.66 111.292 -179.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.451 ' CE1' ' CD1' ' A' ' 43' ' ' ILE . 84.8 m-85 -71.94 -29.59 64.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.243 -0.435 . . . . 25.27 111.324 -179.595 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 35.1 m -62.66 128.85 37.91 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.893 0.377 . . . . 25.04 111.122 -179.807 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.646 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -61.71 171.29 1.46 Allowed Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 115.992 -0.549 . . . . 36.05 111.213 -179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.57 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 83.5 Cg_endo -88.06 -21.75 1.56 Allowed 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.312 2.008 . . . . 54.36 113.23 -179.626 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.465 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.8 OUTLIER -54.8 153.86 5.68 Favored 'General case' 0 N--CA 1.465 0.31 0 CA-C-O 120.928 0.394 . . . . 71.54 111.872 -179.411 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -144.97 158.25 52.81 Favored Pre-proline 0 CA--C 1.535 0.374 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.807 -179.902 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 42.4 Cg_endo -66.97 -167.99 0.15 Allowed 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.933 1.755 . . . . 0.0 112.232 179.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -81.52 -76.11 0.26 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 0.0 111.16 -179.908 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -145.77 109.57 4.82 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.905 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 69.4 m -163.13 33.54 0.09 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.879 179.986 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.048 0 CA-C-O 118.277 -0.868 . . . . 20.0 111.123 179.976 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.487 1.403 0 CA-C-O 120.77 0.319 . . . . 0.0 111.166 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 3.4 m120 -88.55 124.55 34.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.26 -0.427 . . . . 0.0 110.898 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 86.5 m -83.05 -40.9 19.29 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.921 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.506 ' C ' HD13 ' A' ' 54' ' ' LEU . 1.5 m-85 -86.08 57.49 4.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.46 0.648 . . . . 0.0 110.824 -179.866 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 24.9 tt0 -118.9 -42.82 2.69 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 115.764 -0.653 . . . . 0.0 110.495 179.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.434 ' O ' HD11 ' A' ' 54' ' ' LEU . 44.1 p -143.63 175.02 10.27 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.586 179.619 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.575 HG11 ' O ' ' A' ' 4' ' ' THR . 22.0 t -74.34 -30.96 27.35 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.31 -0.405 . . . . 0.0 111.109 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.42 -39.73 85.49 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.246 -0.434 . . . . 0.0 111.039 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.01 -36.61 75.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 0.0 111.327 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.788 ' CD1' HD23 ' A' ' 54' ' ' LEU . 0.4 OUTLIER -57.59 -43.72 84.83 Favored 'General case' 0 CA--C 1.532 0.272 0 CA-C-N 116.326 -0.397 . . . . 0.0 111.18 -179.829 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 31.9 ttp85 -65.21 -53.23 47.67 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.146 -0.479 . . . . 0.0 111.275 -179.794 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 22.1 tpt85 -62.57 -47.32 84.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 0.0 111.37 -179.656 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 13.2 m -58.98 -59.27 5.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.415 -179.531 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.683 ' SD ' HD23 ' B' ' 110' ' ' LEU . 0.0 OUTLIER -63.12 -52.59 61.96 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.384 -0.371 . . . . 0.0 110.989 -179.615 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -92.17 71.12 5.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.091 0.472 . . . . 0.0 110.935 -179.882 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.996 0 CA-C-O 118.431 -1.205 . . . . 20.0 112.593 -179.893 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.139 0 CA-C-O 119.752 -0.471 . . . . 0.0 112.518 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -69.31 117.1 4.84 Favored 'Trans proline' 0 C--N 1.355 0.874 0 C-N-CA 121.913 1.742 . . . . 0.0 112.251 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . 0.572 ' OE2' ' HB2' ' B' ' 108' ' ' ALA . 3.5 mm-40 -145.8 112.67 6.02 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.217 -0.447 . . . . 75.5 110.941 -179.896 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.52 ' O ' HG11 ' B' ' 107' ' ' VAL . 16.5 p -130.97 167.4 19.08 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.098 -0.501 . . . . 31.38 110.75 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.537 HD13 HG13 ' B' ' 107' ' ' VAL . 9.1 tp -122.05 113.25 19.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.375 -0.375 . . . . 28.27 111.095 -179.576 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.3 m -140.22 162.74 34.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.217 -0.447 . . . . 32.91 111.216 179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 59.68 -139.64 48.41 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.879 -0.677 . . . . 19.09 112.949 179.551 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.74 -29.62 64.91 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.665 0.269 . . . . 21.73 111.494 -179.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -61.58 -38.53 87.88 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.417 -0.356 . . . . 63.42 110.841 179.891 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 53.9 tp -71.63 -45.38 62.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.196 -0.456 . . . . 20.39 110.873 179.777 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.68 -30.79 39.55 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.177 -0.465 . . . . 19.22 111.241 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.6 m-20 -66.59 -43.37 85.08 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.182 -0.463 . . . . 31.0 111.066 -179.855 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.778 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -67.9 -48.52 65.79 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.333 -0.394 . . . . 18.28 111.393 -179.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.55 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.3 mt -59.65 -37.9 79.94 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.246 -0.433 . . . . 22.05 110.99 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 2.1 mm-40 -75.52 -32.09 60.37 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.225 -0.443 . . . . 32.76 110.725 179.644 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 33.3 t80 -79.29 -31.6 43.35 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.042 -0.526 . . . . 27.25 110.921 179.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.778 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.7 t -86.51 -63.25 1.31 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.162 -0.472 . . . . 25.51 110.928 -179.82 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 17.0 m -74.26 -51.34 15.6 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.194 -0.457 . . . . 29.49 111.244 -179.681 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 66.95 -112.51 4.92 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.771 -0.728 . . . . 40.61 112.758 179.765 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 2.6 m-20 -83.74 7.49 17.55 Favored 'General case' 0 CA--C 1.537 0.458 0 N-CA-C 112.758 0.651 . . . . 79.05 112.758 -179.614 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.607 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.5 mmm180 -75.84 -33.59 60.06 Favored 'General case' 0 C--O 1.231 0.12 0 O-C-N 121.974 -0.454 . . . . 50.6 111.123 -179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 90.32 80.85 1.37 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.721 -0.752 . . . . 35.48 112.19 -179.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.55 ' CD1' HD13 ' A' ' 14' ' ' LEU . 26.9 p90 -74.7 154.23 38.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-O 121.062 0.458 . . . . 25.52 111.396 -179.522 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -130.95 120.78 24.03 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 115.771 -0.65 . . . . 56.07 110.423 179.619 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 60.0 m-85 -57.32 -71.92 0.09 Allowed 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.176 -0.465 . . . . 29.3 111.544 -179.505 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 8.3 t-20 -59.8 113.52 2.31 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.339 -0.392 . . . . 38.35 111.094 -179.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 39.3 tttm -105.39 137.89 19.4 Favored Pre-proline 0 C--N 1.328 -0.352 0 CA-C-N 116.229 -0.441 . . . . 42.35 110.686 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -71.07 155.93 60.71 Favored 'Trans proline' 0 C--N 1.357 0.992 0 C-N-CA 121.902 1.735 . . . . 40.8 112.247 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.9 t -153.31 129.61 10.53 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 55.75 110.924 179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -154.78 -49.62 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.774 -0.727 . . . . 34.94 112.476 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 96.9 m-85 -71.55 139.92 49.65 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.817 0.341 . . . . 34.26 110.935 179.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 158.34 160.6 10.39 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.704 -0.76 . . . . 36.13 112.476 179.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 55.7 m -149.95 -55.37 0.17 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.78 0.324 . . . . 57.93 110.908 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 77.2 p -151.87 131.5 13.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.193 -0.458 . . . . 72.85 110.804 -179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 33.9 t -165.93 169.96 14.23 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.211 -0.45 . . . . 0.0 110.977 179.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.94 -51.32 12.68 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.713 -179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 4.8 ptp180 -130.27 108.94 10.39 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.172 -0.467 . . . . 0.0 110.864 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -159.28 48.93 0.28 Allowed Pre-proline 0 CA--C 1.538 0.494 0 CA-C-N 116.151 -0.477 . . . . 0.0 111.158 179.831 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -77.64 177.26 9.04 Favored 'Trans proline' 0 C--N 1.356 0.958 0 C-N-CA 121.899 1.733 . . . . 0.0 112.328 179.884 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . 0.537 ' O ' HG23 ' A' ' 41' ' ' THR . 34.4 tt0 -90.13 93.31 9.32 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.88 179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . 0.537 HG23 ' O ' ' A' ' 40' ' ' GLN . 16.8 p -160.18 177.22 10.89 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.035 -0.53 . . . . 64.04 110.909 -179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -107.4 -119.63 4.46 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.822 -0.704 . . . . 35.08 112.49 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.732 HD13 ' CE2' ' A' ' 60' ' ' TYR . 3.6 tp -106.8 -41.78 6.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-O 120.844 0.354 . . . . 25.61 110.989 -179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.2 t -58.07 -57.28 11.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.238 0 CA-C-N 116.232 -0.44 . . . . 29.9 111.415 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 11.0 m-20 -68.99 -21.88 64.12 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 112.064 0.394 . . . . 39.04 112.064 -179.763 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -90.4 -25.5 20.36 Favored 'General case' 0 C--N 1.332 -0.167 0 N-CA-C 112.117 0.414 . . . . 45.6 112.117 -179.159 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 46.3 m -112.66 -46.45 3.14 Favored 'General case' 0 N--CA 1.464 0.271 0 N-CA-C 112.118 0.414 . . . . 28.23 112.118 -179.222 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 11.0 t -71.67 -57.48 4.34 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-O 120.756 0.313 . . . . 25.89 110.987 -179.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 24.2 m-85 -63.54 -35.29 79.99 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.266 -0.425 . . . . 32.64 110.739 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 33.0 mtp85 -137.83 146.78 43.89 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.149 -0.478 . . . . 41.06 110.42 179.656 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 8.1 p -60.59 147.88 40.17 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.156 -0.475 . . . . 42.62 110.957 -179.847 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 31.3 p -141.14 -173.84 3.84 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.146 -0.479 . . . . 28.05 111.047 -179.79 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.6 p-10 -111.24 128.71 56.01 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.024 -0.535 . . . . 46.35 110.137 179.04 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.701 HD21 ' C ' ' B' ' 106' ' ' SER . 0.2 OUTLIER -52.76 -23.2 6.35 Favored 'General case' 0 N--CA 1.466 0.33 0 N-CA-C 112.413 0.523 . . . . 23.79 112.413 -178.996 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtm180 -61.47 -28.4 69.26 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.684 0.278 . . . . 74.93 111.296 179.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 12.7 mmm180 -64.73 -29.22 70.2 Favored 'General case' 0 C--N 1.332 -0.162 0 CA-C-N 116.567 -0.288 . . . . 64.42 111.218 -179.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.421 HD12 ' O ' ' A' ' 54' ' ' LEU . 6.5 mt -56.22 -28.71 59.38 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 116.422 -0.354 . . . . 32.64 111.654 -179.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.1 mt-10 -70.66 -29.94 66.41 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.393 -0.367 . . . . 41.86 111.256 -179.843 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.7 mtm -63.86 -50.09 70.21 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.465 -0.334 . . . . 38.66 111.2 -179.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.732 ' CE2' HD13 ' A' ' 43' ' ' ILE . 97.7 m-85 -57.22 -29.15 63.51 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.229 -0.441 . . . . 25.27 111.491 -179.615 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.2 m -59.26 134.17 56.76 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.898 0.38 . . . . 25.04 111.071 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.607 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -67.44 163.81 43.82 Favored Pre-proline 0 CA--C 1.533 0.31 0 CA-C-N 116.077 -0.51 . . . . 36.05 111.138 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.451 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 94.5 Cg_endo -82.45 -23.12 4.33 Favored 'Trans proline' 0 C--N 1.357 0.982 0 C-N-CA 122.136 1.891 . . . . 54.36 113.01 -179.747 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.57 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.5 OUTLIER -57.59 148.44 24.15 Favored 'General case' 0 CA--C 1.528 0.109 0 CA-C-O 120.921 0.391 . . . . 71.54 111.538 -179.491 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 16.6 mtpt -162.7 170.93 7.0 Favored Pre-proline 0 CA--C 1.538 0.487 0 CA-C-N 115.889 -0.596 . . . . 0.0 110.578 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -73.66 -28.87 11.31 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.864 1.709 . . . . 0.0 112.372 -179.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -65.56 137.77 57.61 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.189 -0.459 . . . . 0.0 111.128 -179.928 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 8.8 mmmt -106.25 -176.69 3.15 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.926 -179.985 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 38.1 m -90.35 122.87 33.62 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.93 179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.024 0 CA-C-O 118.217 -0.897 . . . . 20.0 111.113 179.966 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 16.5 tpt85 . . . . . 0 N--CA 1.486 1.343 0 CA-C-O 120.817 0.342 . . . . 0.0 111.266 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 13.3 t30 -75.26 145.0 42.26 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.825 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 33.6 t -71.98 -32.16 66.97 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.22 -0.446 . . . . 0.0 111.062 -179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 56.2 m-85 -98.64 32.74 2.47 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.233 -0.44 . . . . 0.0 110.877 179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -89.24 -38.43 14.24 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.761 179.828 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.701 ' C ' HD21 ' A' ' 54' ' ' LEU . 33.2 t -155.8 174.96 14.55 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.756 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.537 HG13 HD13 ' A' ' 5' ' ' LEU . 46.0 t -67.24 -31.09 51.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.987 179.957 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . 0.572 ' HB2' ' OE2' ' A' ' 3' ' ' GLU . . . -73.3 -42.71 62.08 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.321 -0.399 . . . . 0.0 111.243 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.89 -36.84 82.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.523 -179.71 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.493 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.3 OUTLIER -68.5 -42.55 78.42 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.335 -0.393 . . . . 0.0 111.263 -179.778 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 43.2 ttt-85 -56.99 -49.1 76.78 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.304 -0.407 . . . . 0.0 111.64 -179.466 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 9.4 ptm180 -57.75 -34.55 69.67 Favored 'General case' 0 N--CA 1.463 0.21 0 CA-C-N 116.482 -0.326 . . . . 0.0 111.439 -179.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 81.5 m -58.41 -47.66 83.2 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.759 0.314 . . . . 0.0 111.468 -179.827 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 11.8 tpt -76.15 -48.81 19.18 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.299 -0.41 . . . . 0.0 111.902 -179.314 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 41.9 m-85 -67.53 -49.13 64.77 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.669 0.271 . . . . 0.0 111.313 -179.381 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.037 0 CA-C-O 118.455 -1.192 . . . . 20.0 112.491 179.972 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.153 0 CA-C-O 119.769 -0.462 . . . . 0.0 112.531 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 66.9 Cg_endo -72.99 152.0 50.97 Favored 'Trans proline' 0 C--N 1.356 0.942 0 C-N-CA 122.0 1.8 . . . . 0.0 112.437 179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 13.1 mp0 -112.09 100.99 9.29 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.158 -0.474 . . . . 75.5 110.89 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.461 ' O ' HG11 ' B' ' 107' ' ' VAL . 28.7 p -120.02 174.37 6.51 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 31.38 110.857 -179.908 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.475 HD11 ' HB3' ' A' ' 9' ' ' GLU . 11.6 tp -140.12 116.57 10.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.346 -0.388 . . . . 28.27 111.146 -179.869 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 11.1 m -140.11 168.2 20.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.129 -0.487 . . . . 32.91 110.834 179.743 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.39 -150.11 49.43 Favored Glycine 0 N--CA 1.45 -0.398 0 C-N-CA 120.748 -0.739 . . . . 19.09 112.856 179.793 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.74 -30.05 67.18 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.752 0.311 . . . . 21.73 111.319 -179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.475 ' HB3' HD11 ' A' ' 5' ' ' LEU . 32.8 mt-10 -59.19 -43.0 92.22 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.879 0.371 . . . . 63.42 111.046 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 57.2 tp -69.24 -43.52 73.83 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.199 -0.455 . . . . 20.39 110.595 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -69.75 -30.74 45.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.109 -0.496 . . . . 19.22 111.152 179.735 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 55.6 m-20 -68.77 -37.53 79.4 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.231 -0.44 . . . . 31.0 111.057 -179.896 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.527 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -70.31 -42.43 71.99 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.471 -0.331 . . . . 18.28 111.002 179.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.453 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.2 mt -60.25 -42.16 94.74 Favored 'General case' 0 C--N 1.333 -0.113 0 CA-C-O 120.854 0.359 . . . . 22.05 110.516 179.472 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 14.9 mm-40 -68.57 -32.52 72.49 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.025 -0.534 . . . . 32.76 110.325 179.101 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.404 ' CE2' ' HA ' ' B' ' 114' ' ' MET . 0.1 OUTLIER -71.07 -43.3 68.05 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.069 -0.514 . . . . 27.25 110.737 179.723 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.527 HG23 ' O ' ' A' ' 13' ' ' ALA . 22.6 t -81.76 -52.29 13.98 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-N 115.879 -0.601 . . . . 25.51 111.413 -179.369 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 46.9 m -83.23 -51.58 7.34 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.174 -0.466 . . . . 29.49 111.436 -179.327 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 59.17 -109.83 2.34 Favored Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.752 -0.737 . . . . 40.61 112.797 179.891 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.1 t70 -81.87 7.3 13.22 Favored 'General case' 0 CA--C 1.538 0.511 0 N-CA-C 112.889 0.7 . . . . 79.05 112.889 -179.528 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.614 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 3.0 mmm180 -77.11 -39.82 48.04 Favored 'General case' 0 C--O 1.231 0.119 0 CA-C-N 118.05 0.386 . . . . 50.6 111.061 -179.868 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 95.39 78.18 1.4 Allowed Glycine 0 N--CA 1.453 -0.229 0 C-N-CA 120.737 -0.744 . . . . 35.48 112.172 -179.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.453 ' CD1' HD13 ' A' ' 14' ' ' LEU . 27.5 p90 -72.06 163.17 28.35 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.079 0.466 . . . . 25.52 111.494 -179.497 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.434 ' CE1' ' HB3' ' A' ' 27' ' ' LYS . 0.6 OUTLIER -143.99 151.82 40.23 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.694 -0.684 . . . . 56.07 110.543 179.894 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . 0.423 ' CD2' HG22 ' A' ' 43' ' ' ILE . 73.9 m-85 -97.37 35.56 1.6 Allowed 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.322 -0.399 . . . . 29.3 111.258 -179.616 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.1 m-80 -176.36 126.12 0.19 Allowed 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.377 -0.374 . . . . 38.35 110.907 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.434 ' HB3' ' CE1' ' A' ' 24' ' ' TYR . 20.3 pttp -148.67 149.52 31.1 Favored Pre-proline 0 CA--C 1.534 0.348 0 CA-C-N 116.167 -0.469 . . . . 42.35 110.97 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.9 Cg_endo -72.0 170.24 19.39 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.883 1.722 . . . . 40.8 112.313 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 4.4 t -158.19 140.53 14.32 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.45 . . . . 55.75 110.853 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -93.21 -33.98 6.97 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.703 -0.76 . . . . 34.94 112.466 -179.981 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 77.1 m-85 -80.47 -59.09 2.82 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.853 0.359 . . . . 34.26 110.987 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -82.12 71.92 2.88 Favored Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.767 -0.73 . . . . 36.13 112.54 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 8.0 t -127.64 103.57 7.39 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.883 0.373 . . . . 57.93 110.924 179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 8.0 m -158.25 151.78 23.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.167 -0.47 . . . . 72.85 110.921 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 30.4 t -107.86 -33.39 7.25 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 0.0 110.918 -179.962 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? -60.46 -45.55 93.28 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.197 -0.456 . . . . 0.0 110.915 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -66.86 -168.84 0.07 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.194 -0.457 . . . . 0.0 110.618 179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.42 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -56.77 159.47 7.05 Favored Pre-proline 0 CA--C 1.535 0.373 0 CA-C-N 116.635 -0.257 . . . . 0.0 111.473 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.42 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 52.5 Cg_endo -68.64 160.11 50.8 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.969 1.78 . . . . 0.0 112.381 -179.804 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -88.11 129.21 35.37 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.828 -179.99 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.8 p -136.08 -178.28 5.08 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 64.04 110.916 -179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -89.21 -118.17 1.64 Allowed Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.691 -0.766 . . . . 35.08 112.766 -179.892 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.792 HD12 ' CE2' ' A' ' 60' ' ' TYR . 1.5 tt -103.9 -25.05 3.82 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.303 0 N-CA-C 111.609 0.226 . . . . 25.61 111.609 -179.755 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -56.6 -61.17 1.3 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.288 0 CA-C-O 120.9 0.381 . . . . 29.9 111.449 -179.829 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 5.3 m-20 -66.26 -17.11 64.55 Favored 'General case' 0 C--N 1.323 -0.549 0 CA-C-N 116.395 -0.366 . . . . 39.04 111.955 179.588 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 15.6 tp10 -90.28 -32.74 16.4 Favored 'General case' 0 CA--C 1.531 0.213 0 N-CA-C 112.807 0.669 . . . . 45.6 112.807 -179.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.2 OUTLIER -118.45 -29.05 5.57 Favored 'General case' 0 N--CA 1.468 0.463 0 N-CA-C 112.805 0.668 . . . . 28.23 112.805 -178.651 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -79.95 -46.13 17.26 Favored 'General case' 0 C--N 1.327 -0.411 0 C-N-CA 120.871 -0.331 . . . . 25.89 110.698 -179.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 11.9 m-85 -74.53 -37.7 62.99 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.052 0.453 . . . . 32.64 110.212 179.46 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp85 -130.11 159.23 37.41 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.785 -0.643 . . . . 41.06 109.865 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.4 p -78.74 127.12 31.64 Favored 'General case' 0 C--N 1.324 -0.508 0 CA-C-O 120.788 0.328 . . . . 42.62 111.389 -179.519 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -123.78 -160.86 0.94 Allowed 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 116.3 -0.409 . . . . 28.05 110.46 179.551 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -112.9 175.06 5.6 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.47 -0.332 . . . . 46.35 110.403 179.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.745 ' HG ' HD12 ' B' ' 110' ' ' LEU . 0.3 OUTLIER -91.11 -28.18 18.08 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.385 -0.37 . . . . 23.79 111.499 -179.529 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 82.2 mtt85 -55.7 -26.01 42.9 Favored 'General case' 0 CA--C 1.533 0.327 0 N-CA-C 111.706 0.262 . . . . 74.93 111.706 -179.967 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 9.2 mmm180 -61.19 -29.16 69.64 Favored 'General case' 0 C--O 1.232 0.179 0 CA-C-O 120.663 0.268 . . . . 64.42 110.919 179.597 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.697 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.4 mt -55.44 -37.45 67.72 Favored 'General case' 0 N--CA 1.463 0.18 0 CA-C-O 120.783 0.325 . . . . 32.64 111.567 -179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 34.4 mt-10 -65.22 -31.93 73.34 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.148 -0.478 . . . . 41.86 111.394 -179.736 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 29.1 mtm -63.29 -53.08 58.44 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.359 -0.382 . . . . 38.66 111.217 -179.707 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.792 ' CE2' HD12 ' A' ' 43' ' ' ILE . 86.7 m-85 -57.16 -26.12 60.06 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.189 -0.46 . . . . 25.27 111.721 -179.584 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 59.7 m -59.43 130.39 46.65 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-O 120.84 0.353 . . . . 25.04 111.038 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.614 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -57.75 168.56 1.06 Allowed Pre-proline 0 CA--C 1.534 0.33 0 CA-C-N 116.233 -0.44 . . . . 36.05 111.286 -179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.609 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 84.2 Cg_endo -81.2 -30.11 1.72 Allowed 'Trans proline' 0 C--N 1.357 1.021 0 C-N-CA 122.088 1.859 . . . . 54.36 112.813 -179.643 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -59.44 149.56 29.11 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.878 0.37 . . . . 71.54 111.093 -179.774 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 51.7 pttt -150.26 157.93 36.74 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.863 179.921 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 73.5 Cg_endo -75.21 134.55 17.61 Favored 'Trans proline' 0 C--N 1.356 0.972 0 C-N-CA 121.866 1.711 . . . . 0.0 112.331 -179.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -161.25 -53.41 0.05 OUTLIER 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.193 -0.458 . . . . 0.0 111.079 -179.966 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 55.0 tttp -147.41 -47.64 0.17 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.271 -0.422 . . . . 0.0 110.945 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 57.4 m -96.58 145.83 25.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.874 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 0.984 0 CA-C-O 118.209 -0.901 . . . . 20.0 111.053 -179.958 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 6.7 mmp_? . . . . . 0 N--CA 1.487 1.392 0 CA-C-O 120.858 0.361 . . . . 0.0 111.215 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 14.0 m-80 -78.58 125.06 28.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.823 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 44.6 t -83.0 -24.13 33.0 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.624 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.519 ' C ' HD23 ' A' ' 54' ' ' LEU . 13.6 m-85 -96.0 36.98 1.26 Allowed 'General case' 0 CA--C 1.529 0.164 0 CA-C-O 120.795 0.331 . . . . 0.0 111.335 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.3 tp10 -90.63 -33.81 15.69 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 120.915 0.388 . . . . 0.0 110.48 179.557 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.473 ' C ' HD21 ' A' ' 54' ' ' LEU . 70.3 m -150.97 174.45 13.12 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.607 179.723 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.461 HG11 ' O ' ' A' ' 4' ' ' THR . 21.0 t -73.43 -29.32 27.19 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 CA-C-N 116.422 -0.354 . . . . 0.0 111.337 -179.881 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -69.85 -39.82 76.18 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.926 0.393 . . . . 0.0 111.12 179.864 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -61.99 -38.0 86.97 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.417 -179.92 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.745 HD12 ' HG ' ' A' ' 54' ' ' LEU . 0.4 OUTLIER -60.02 -42.01 93.43 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.319 -0.4 . . . . 0.0 111.109 -179.858 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 91.6 mtm-85 -54.78 -42.67 72.03 Favored 'General case' 0 N--CA 1.465 0.286 0 CA-C-N 116.389 -0.368 . . . . 0.0 111.636 -179.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 4.2 ttp-105 -60.37 -52.44 65.24 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.976 179.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 5.8 m -67.76 -41.8 82.76 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.281 -0.418 . . . . 0.0 110.904 -179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.468 ' HE2' ' CE2' ' B' ' 115' ' ' TYR . 50.6 ttp -62.12 -53.14 59.64 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.935 -0.575 . . . . 0.0 111.223 -179.7 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . 0.468 ' CE2' ' HE2' ' B' ' 114' ' ' MET . 84.0 m-85 -93.38 71.09 4.39 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.223 -0.444 . . . . 0.0 111.082 179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.248 1.028 0 CA-C-O 118.367 -1.241 . . . . 20.0 112.43 179.939 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 CA-C-O 119.731 -0.483 . . . . 0.0 112.547 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 68.9 Cg_endo -73.63 152.58 48.28 Favored 'Trans proline' 0 C--N 1.357 0.985 0 C-N-CA 121.937 1.758 . . . . 0.0 112.506 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -97.88 110.47 23.03 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.101 -0.5 . . . . 75.5 110.826 179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . . . . . . . . . 33.5 p -135.68 166.78 22.45 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.169 -0.468 . . . . 31.38 110.783 -179.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.508 HD11 ' HB3' ' A' ' 9' ' ' GLU . 10.1 tp -124.13 116.33 22.58 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.372 -0.376 . . . . 28.27 111.431 -179.412 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 15.7 m -140.56 161.32 38.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.206 -0.452 . . . . 32.91 110.933 179.591 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.03 -147.67 44.96 Favored Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.77 -0.729 . . . . 19.09 113.047 179.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.89 -31.15 66.46 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-O 120.825 0.345 . . . . 21.73 111.475 -179.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . 0.508 ' HB3' HD11 ' A' ' 5' ' ' LEU . 48.8 mt-10 -60.63 -40.06 90.52 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.426 . . . . 63.42 110.805 179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 69.7 tp -68.98 -43.58 74.64 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.105 -0.498 . . . . 20.39 110.587 179.534 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -71.94 -31.25 40.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.083 -0.508 . . . . 19.22 111.069 179.827 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 7.9 m-20 -70.45 -31.0 67.98 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.155 -0.475 . . . . 31.0 111.008 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.819 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -74.1 -47.2 37.98 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.296 -0.411 . . . . 18.28 110.755 179.702 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.62 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.8 mt -60.46 -49.04 79.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.114 -0.494 . . . . 22.05 110.763 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.05 -30.39 71.47 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.13 -0.487 . . . . 32.76 110.672 179.554 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . 0.452 ' CE2' ' CE ' ' B' ' 114' ' ' MET . 48.2 t80 -79.68 -35.16 39.55 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-N 116.427 -0.351 . . . . 27.25 110.937 -179.884 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.819 HG23 ' O ' ' A' ' 13' ' ' ALA . 34.3 t -85.01 -57.47 4.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.362 -0.381 . . . . 25.51 111.039 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 36.4 m -77.67 -51.26 10.89 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 29.49 111.442 -179.46 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 67.37 -115.09 6.78 Favored Glycine 0 N--CA 1.453 -0.201 0 C-N-CA 120.61 -0.805 . . . . 40.61 112.691 179.937 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 25.6 m-20 -82.5 7.55 14.08 Favored 'General case' 0 CA--C 1.537 0.476 0 N-CA-C 112.686 0.624 . . . . 79.05 112.686 -179.789 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.627 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 4.9 mmm180 -75.57 -32.7 60.48 Favored 'General case' 0 C--N 1.338 0.071 0 O-C-N 121.973 -0.455 . . . . 50.6 111.017 -179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 89.04 83.3 1.29 Allowed Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.61 -0.805 . . . . 35.48 112.151 -179.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.62 ' CD1' HD13 ' A' ' 14' ' ' LEU . 35.6 p90 -76.96 157.88 31.0 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.972 0.415 . . . . 25.52 111.318 -179.651 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 8.2 p90 -134.69 131.2 37.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 56.07 110.605 179.837 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -67.19 -52.02 46.31 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.245 -0.434 . . . . 29.3 111.156 -179.858 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 22.0 m120 -75.87 116.49 16.62 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.32 -0.4 . . . . 38.35 110.955 -179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.9 tttm -112.37 96.91 37.78 Favored Pre-proline 0 CA--C 1.533 0.318 0 CA-C-N 116.22 -0.445 . . . . 42.35 110.888 179.887 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 60.2 Cg_endo -71.62 171.85 15.52 Favored 'Trans proline' 0 C--N 1.359 1.085 0 C-N-CA 121.854 1.703 . . . . 40.8 112.359 -179.966 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 45.5 p -153.4 -54.32 0.11 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.171 -0.468 . . . . 55.75 110.901 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -60.17 139.41 48.31 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.723 -0.751 . . . . 34.94 112.567 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -94.7 -169.21 1.97 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 120.881 0.372 . . . . 34.26 110.626 -179.806 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -97.17 79.12 0.67 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.818 -0.706 . . . . 36.13 112.53 179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.9 p -149.27 -47.17 0.14 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.862 0.363 . . . . 57.93 110.962 179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 9.8 m -72.1 176.87 4.77 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.187 -0.461 . . . . 72.85 110.829 -179.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 5.1 t -78.64 177.3 8.72 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.865 179.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -54.3 89.39 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.692 0 CA-C-O 121.159 0.504 . . . . 0.0 111.849 -179.668 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 34.0 ttm-85 -159.53 122.4 3.56 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.984 179.89 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -147.52 135.98 11.16 Favored Pre-proline 0 CA--C 1.533 0.322 0 CA-C-N 116.159 -0.473 . . . . 0.0 110.961 179.869 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_endo -81.0 112.86 2.66 Favored 'Trans proline' 0 C--N 1.356 0.97 0 C-N-CA 121.988 1.792 . . . . 0.0 112.382 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -77.35 104.3 7.78 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.162 -0.472 . . . . 0.0 110.884 179.914 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 5.0 t -176.75 150.23 0.8 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.181 -0.463 . . . . 64.04 110.923 179.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -147.18 -128.41 1.86 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.751 . . . . 35.08 112.475 179.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.691 HD13 ' CE2' ' A' ' 60' ' ' TYR . 5.3 tp -87.4 -42.63 15.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 CA-C-O 120.7 0.286 . . . . 25.61 111.081 -179.995 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.5 t -59.28 -52.46 60.5 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-O 120.962 0.41 . . . . 29.9 111.293 -179.839 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.421 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 4.2 m-20 -69.97 -24.71 63.37 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.198 -0.456 . . . . 39.04 111.811 -179.66 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -90.51 -23.71 20.86 Favored 'General case' 0 C--N 1.331 -0.235 0 N-CA-C 112.283 0.475 . . . . 45.6 112.283 -179.102 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 55.8 m -116.0 -44.78 2.89 Favored 'General case' 0 N--CA 1.464 0.236 0 N-CA-C 112.337 0.495 . . . . 28.23 112.337 -178.76 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 8.7 t -75.02 -49.26 20.4 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.924 -0.311 . . . . 25.89 111.008 -179.433 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.421 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 29.3 m-85 -72.15 -34.3 68.41 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-O 120.859 0.362 . . . . 32.64 110.577 179.779 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 10.4 mtp85 -134.68 149.86 50.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.077 -0.51 . . . . 41.06 110.273 179.538 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 4.9 p -67.41 136.54 54.89 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 120.906 0.384 . . . . 42.62 110.821 -179.876 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 25.4 p -130.1 -171.94 2.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.061 -0.518 . . . . 28.05 111.156 -179.573 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -115.16 139.37 49.97 Favored 'General case' 0 N--CA 1.463 0.22 0 CA-C-N 115.914 -0.585 . . . . 46.35 110.007 179.058 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.557 ' H ' HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -58.18 -28.84 65.13 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 23.79 111.541 -179.125 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 41.1 mtp85 -58.47 -29.21 66.02 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.776 0.322 . . . . 74.93 111.282 179.731 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 1.9 mmt85 -66.12 -28.37 68.75 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 116.378 -0.374 . . . . 64.42 111.302 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.449 HD12 ' HA ' ' A' ' 54' ' ' LEU . 6.2 mt -56.93 -29.21 62.9 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 116.544 -0.298 . . . . 32.64 111.482 -179.642 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 19.0 mt-10 -69.5 -31.37 69.58 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.848 0.356 . . . . 41.86 111.047 -179.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 64.8 mtm -61.36 -48.11 82.78 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.197 -0.456 . . . . 38.66 110.958 -179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.691 ' CE2' HD13 ' A' ' 43' ' ' ILE . 96.0 m-85 -59.15 -29.93 67.79 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.123 -0.489 . . . . 25.27 111.234 -179.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 58.5 m -58.91 132.72 54.82 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.932 0.396 . . . . 25.04 111.08 179.98 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.627 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -63.06 161.96 26.72 Favored Pre-proline 0 CA--C 1.534 0.358 0 CA-C-N 116.141 -0.481 . . . . 36.05 111.111 179.993 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.458 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 89.1 Cg_endo -77.81 -27.16 6.18 Favored 'Trans proline' 0 C--N 1.356 0.921 0 C-N-CA 121.964 1.776 . . . . 54.36 112.545 -179.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.608 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -59.54 161.01 6.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.915 0.388 . . . . 71.54 111.071 -179.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 44.8 mttp -140.14 157.61 68.67 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.812 179.959 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_endo -73.92 132.56 17.1 Favored 'Trans proline' 0 C--N 1.357 0.986 0 C-N-CA 121.928 1.752 . . . . 0.0 112.242 -179.832 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -102.39 -54.13 2.74 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.137 -0.483 . . . . 0.0 111.116 179.978 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.09 31.31 3.08 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.889 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 71.1 m -141.53 32.95 1.65 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.255 -0.429 . . . . 0.0 110.838 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.065 0 CA-C-O 118.186 -0.911 . . . . 20.0 111.118 -179.975 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 35.0 ttp85 . . . . . 0 N--CA 1.488 1.434 0 CA-C-O 120.812 0.339 . . . . 0.0 111.221 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 37.0 m-80 -81.72 110.91 17.49 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.231 -0.44 . . . . 0.0 111.019 -179.958 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.9 m -82.96 -28.76 29.57 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.198 -0.455 . . . . 0.0 111.256 179.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.449 ' C ' HD23 ' A' ' 54' ' ' LEU . 0.3 OUTLIER -97.68 33.19 2.11 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-O 120.779 0.323 . . . . 0.0 111.049 -179.804 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -96.48 -34.12 11.61 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-O 121.001 0.429 . . . . 0.0 110.602 179.721 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.536 ' C ' HD21 ' A' ' 54' ' ' LEU . 70.6 m -154.38 175.16 13.9 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 115.791 -0.64 . . . . 0.0 110.298 179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . . . . . . . . . 15.4 t -76.62 -30.91 19.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-O 120.876 0.37 . . . . 0.0 111.193 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -65.95 -39.62 90.63 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.246 -0.434 . . . . 0.0 110.893 179.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -59.76 -36.84 77.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.337 -179.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.481 ' CD1' HD12 ' A' ' 54' ' ' LEU . 1.3 mt -57.65 -44.71 85.83 Favored 'General case' 0 CA--C 1.531 0.212 0 CA-C-N 116.401 -0.363 . . . . 0.0 111.235 -179.796 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 6.3 tmm_? -64.8 -51.11 63.92 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.975 179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 12.9 ttt-85 -61.64 -37.88 85.66 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.212 -0.449 . . . . 0.0 111.026 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 58.6 m -64.29 -58.55 6.21 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.22 -0.446 . . . . 0.0 110.795 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . 0.452 ' CE ' ' CE2' ' A' ' 16' ' ' PHE . 0.1 OUTLIER -61.98 -51.57 67.51 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.839 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 96.3 m-85 -86.1 71.17 10.6 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.174 0.512 . . . . 0.0 110.915 -179.971 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.05 0 CA-C-O 118.423 -1.209 . . . . 20.0 112.509 -179.921 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 2.137 0 CA-C-O 119.744 -0.476 . . . . 0.0 112.589 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -75.61 -168.97 0.59 Allowed 'Trans proline' 0 C--N 1.356 0.922 0 C-N-CA 121.959 1.773 . . . . 0.0 112.433 -179.927 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -82.21 102.09 10.9 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 75.5 111.04 -179.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.749 ' O ' HG11 ' B' ' 107' ' ' VAL . 43.0 p -119.91 174.2 6.6 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.12 -0.491 . . . . 31.38 110.775 179.901 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.823 HD13 HG13 ' B' ' 107' ' ' VAL . 7.2 tp -133.54 106.96 7.72 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.291 -0.413 . . . . 28.27 111.174 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 9.2 m -140.13 162.38 35.38 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.286 -0.415 . . . . 32.91 110.845 179.812 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.78 -143.35 38.2 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.713 -0.756 . . . . 19.09 112.634 179.851 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -59.79 -30.72 69.09 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.711 0.291 . . . . 21.73 111.218 -179.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 36.7 mt-10 -60.42 -41.91 94.92 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.327 -0.397 . . . . 63.42 110.974 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.548 HD12 HD23 ' A' ' 5' ' ' LEU . 29.6 tp -70.46 -41.95 72.12 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.256 -0.429 . . . . 20.39 111.089 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.2 t -72.98 -33.47 43.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.171 -0.468 . . . . 19.22 111.142 -179.931 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 21.6 m-20 -70.54 -30.8 67.64 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 31.0 111.036 -179.971 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.805 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -73.52 -47.27 42.27 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.326 -0.397 . . . . 18.28 110.902 179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.758 HD13 ' CD1' ' A' ' 23' ' ' PHE . 12.6 mt -62.39 -50.26 72.24 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.102 -0.499 . . . . 22.05 110.647 179.785 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 3.8 pp0? -61.33 -32.02 71.89 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.191 -0.459 . . . . 32.76 110.702 179.704 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -77.02 -36.4 56.25 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.095 -0.502 . . . . 27.25 110.91 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.805 HG23 ' O ' ' A' ' 13' ' ' ALA . 33.9 t -85.15 -66.12 0.81 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.173 -0.467 . . . . 25.51 110.844 -179.819 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.4 m -72.17 -51.39 21.47 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.204 -0.453 . . . . 29.49 110.96 -179.857 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 57.97 -126.08 41.26 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.899 -0.667 . . . . 40.61 112.983 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -56.2 -25.02 45.54 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 111.941 0.348 . . . . 79.05 111.941 -179.664 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.508 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 9.5 mtm-85 -55.33 -25.97 37.93 Favored 'General case' 0 CA--C 1.532 0.264 0 N-CA-C 111.918 0.34 . . . . 50.6 111.918 -179.628 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 80.31 94.03 0.4 Allowed Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.558 -0.829 . . . . 35.48 112.12 -179.804 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.758 ' CD1' HD13 ' A' ' 14' ' ' LEU . 46.1 p90 -84.03 151.85 24.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 121.004 0.43 . . . . 25.52 111.552 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 3.2 p90 -131.41 134.64 46.45 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 115.884 -0.598 . . . . 56.07 110.386 179.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 38.9 m-85 -71.07 -65.9 0.68 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.247 -0.433 . . . . 29.3 111.176 -179.616 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -68.18 128.21 35.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.32 -0.4 . . . . 38.35 111.163 -179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 1.1 mmmp? -101.32 157.1 34.3 Favored Pre-proline 0 CA--C 1.534 0.335 0 CA-C-N 116.075 -0.511 . . . . 42.35 110.659 179.771 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -59.19 143.87 99.6 Favored 'Trans proline' 0 C--N 1.356 0.957 0 C-N-CA 121.936 1.757 . . . . 40.8 112.201 -179.952 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 9.9 t -86.71 -43.22 12.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.128 -0.487 . . . . 55.75 110.963 -179.961 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . -177.43 -172.01 41.52 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.715 -0.755 . . . . 34.94 112.562 179.992 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 82.5 m-85 -97.6 -57.05 2.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.716 0.293 . . . . 34.26 110.92 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . -73.03 80.95 0.69 Allowed Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.736 -0.745 . . . . 36.13 112.499 -179.908 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.3 m -150.01 114.32 5.18 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.812 0.339 . . . . 57.93 110.861 179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 72.7 p -102.94 -39.26 7.01 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.196 -0.456 . . . . 72.85 110.993 -179.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.0 m -78.58 112.5 15.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.266 -0.424 . . . . 0.0 110.843 -179.945 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -81.22 159.8 24.46 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.23 -0.441 . . . . 0.0 111.003 -179.968 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -150.14 -177.96 6.23 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.82 179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -115.88 73.78 4.81 Favored Pre-proline 0 CA--C 1.537 0.449 0 CA-C-N 116.348 -0.387 . . . . 0.0 111.256 -179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -81.17 170.98 14.43 Favored 'Trans proline' 0 C--N 1.356 0.944 0 C-N-CA 122.049 1.832 . . . . 0.0 112.189 179.904 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 9.2 pt20 -158.44 93.4 1.2 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.356 -0.384 . . . . 0.0 110.918 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 7.1 t -177.6 125.1 0.13 Allowed 'General case' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 64.04 110.83 179.874 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -162.24 -128.33 0.94 Allowed Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.668 -0.777 . . . . 35.08 112.546 179.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.472 HD13 ' CE1' ' A' ' 60' ' ' TYR . 5.6 tp -58.57 -34.93 52.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-O 120.845 0.355 . . . . 25.61 111.202 -179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 19.9 t -64.97 -62.6 1.16 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.124 -0.489 . . . . 29.9 111.122 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.43 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 1.2 m-20 -63.68 -24.03 67.62 Favored 'General case' 0 C--N 1.325 -0.479 0 CA-C-N 116.251 -0.431 . . . . 39.04 111.976 -179.748 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 6.7 tp10 -90.77 -31.54 16.48 Favored 'General case' 0 C--N 1.331 -0.224 0 N-CA-C 112.448 0.536 . . . . 45.6 112.448 -179.126 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.9 OUTLIER -111.21 -48.48 3.1 Favored 'General case' 0 N--CA 1.466 0.334 0 N-CA-C 112.393 0.516 . . . . 28.23 112.393 -179.251 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 13.9 t -63.41 -51.33 66.21 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 120.981 -0.287 . . . . 25.89 110.914 -179.514 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.43 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 13.0 m-85 -65.38 -49.99 67.22 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.866 0.365 . . . . 32.64 110.271 179.544 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 2.2 ptp180 -124.28 141.74 51.83 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.152 -0.476 . . . . 41.06 110.285 178.981 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 7.5 p -56.71 131.31 48.77 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 116.126 -0.488 . . . . 42.62 111.732 -179.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -123.32 -163.29 1.1 Allowed 'General case' 0 CA--C 1.533 0.289 0 CA-C-N 116.329 -0.396 . . . . 28.05 110.844 179.702 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 1.9 p-10 -117.63 134.84 54.46 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.166 -0.47 . . . . 46.35 110.128 179.13 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.624 ' O ' HD12 ' A' ' 57' ' ' LEU . 0.0 OUTLIER -55.64 -27.28 48.91 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.191 -0.459 . . . . 23.79 112.005 -179.085 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 3.1 mpt_? -58.26 -26.22 62.69 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.549 -0.296 . . . . 74.93 111.618 -179.839 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 11.6 mmm180 -65.13 -26.85 68.37 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-O 120.55 0.214 . . . . 64.42 111.238 179.86 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.624 HD12 ' O ' ' A' ' 54' ' ' LEU . 5.2 mt -56.18 -30.84 62.8 Favored 'General case' 0 N--CA 1.463 0.196 0 CA-C-O 120.777 0.323 . . . . 32.64 111.545 -179.831 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 12.8 mt-10 -68.35 -30.34 69.27 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.082 -0.508 . . . . 41.86 111.524 -179.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 25.9 mtm -66.13 -39.39 89.85 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.855 0.36 . . . . 38.66 111.451 -179.699 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 43' ' ' ILE . 70.9 m-85 -69.96 -24.61 63.37 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.037 -0.529 . . . . 25.27 112.045 -178.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 8.6 m -65.11 138.45 58.3 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 120.879 0.371 . . . . 25.04 110.789 179.89 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.711 ' HB1' ' HD2' ' A' ' 63' ' ' PRO . . . -65.61 173.76 1.83 Allowed Pre-proline 0 CA--C 1.534 0.339 0 CA-C-N 116.165 -0.471 . . . . 36.05 110.915 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.711 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 92.6 Cg_endo -83.06 -26.77 2.18 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 122.03 1.82 . . . . 54.36 112.731 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -59.98 174.4 0.5 Allowed 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.942 0.401 . . . . 71.54 111.224 -179.724 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.13 161.93 58.44 Favored Pre-proline 0 CA--C 1.535 0.367 0 CA-C-N 115.969 -0.559 . . . . 0.0 110.713 -179.855 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 90.9 Cg_endo -83.08 132.94 6.36 Favored 'Trans proline' 0 C--N 1.355 0.869 0 C-N-CA 121.985 1.79 . . . . 0.0 112.534 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -73.3 155.14 39.76 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.222 -0.445 . . . . 0.0 111.146 -179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -178.04 94.75 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.178 -0.464 . . . . 0.0 110.881 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 17.0 t -77.44 143.88 38.24 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.028 -0.533 . . . . 0.0 110.844 -179.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.073 0 CA-C-O 118.236 -0.888 . . . . 20.0 111.063 -179.972 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 29.5 mmt180 . . . . . 0 N--CA 1.488 1.447 0 CA-C-O 120.769 0.319 . . . . 0.0 111.151 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 13.9 m120 -78.26 115.92 18.32 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.837 179.779 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 67.5 m -83.0 -41.92 18.15 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.216 -0.447 . . . . 0.0 111.12 -179.824 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 20.5 m-85 -82.11 62.73 5.99 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-O 121.387 0.613 . . . . 0.0 110.949 -179.915 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -120.44 -44.27 2.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 115.689 -0.687 . . . . 0.0 110.543 179.698 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 45.9 p -149.91 174.84 12.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.844 -0.616 . . . . 0.0 110.497 179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.823 HG13 HD13 ' A' ' 5' ' ' LEU . 23.7 t -71.05 -35.57 59.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-O 120.885 0.374 . . . . 0.0 111.009 179.944 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.3 -39.97 64.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.161 -0.472 . . . . 0.0 111.176 179.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.02 -42.33 85.07 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.178 -0.464 . . . . 0.0 111.594 -179.765 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -60.44 -42.99 97.24 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.366 -0.379 . . . . 0.0 110.848 179.984 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . . . . . . . . . 52.3 mtm180 -61.3 -42.96 99.53 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.86 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 7.3 tmm_? -63.12 -35.96 82.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.177 -0.465 . . . . 0.0 110.935 -179.957 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 65.9 m -60.62 -47.7 85.07 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.207 -0.452 . . . . 0.0 110.889 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 72.6 mtm -75.43 -51.66 12.56 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.932 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . . . . . . . . . 70.0 m-85 -82.55 71.17 9.63 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 121.165 0.507 . . . . 0.0 110.829 -179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.116 0 CA-C-O 118.388 -1.229 . . . . 20.0 112.511 -179.959 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.194 0 CA-C-O 119.745 -0.475 . . . . 0.0 112.546 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -70.26 172.49 13.03 Favored 'Trans proline' 0 C--N 1.356 0.954 0 C-N-CA 121.975 1.784 . . . . 0.0 112.276 179.957 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 1.7 mp0 -104.28 97.88 7.76 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.144 -0.48 . . . . 75.5 111.093 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.518 ' O ' HG11 ' B' ' 107' ' ' VAL . 37.8 p -133.98 -178.33 4.98 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.141 -0.481 . . . . 31.38 110.74 179.813 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . . . . . . . . . 9.1 tp -137.91 107.4 6.16 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.489 -0.323 . . . . 28.27 111.247 -179.646 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 10.0 m -140.2 157.13 46.07 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.284 -0.416 . . . . 32.91 111.029 179.811 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 70.0 -142.88 36.99 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.926 -0.654 . . . . 19.09 112.878 179.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -57.45 -28.69 63.55 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.691 0.281 . . . . 21.73 111.633 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 -60.33 -40.82 92.02 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.912 0.386 . . . . 63.42 110.918 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.551 HD11 HG12 ' A' ' 43' ' ' ILE . 21.9 tp -71.94 -44.89 62.86 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.205 -0.452 . . . . 20.39 110.643 179.846 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.6 t -70.12 -29.91 41.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.237 -0.438 . . . . 19.22 111.238 -179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 1.4 m-20 -69.54 -41.08 76.42 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.329 -0.396 . . . . 31.0 111.02 -179.853 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.721 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -65.57 -48.93 70.69 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.304 -0.407 . . . . 18.28 111.194 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.583 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.4 mt -59.91 -46.08 90.5 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.259 -0.428 . . . . 22.05 110.919 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 15.7 mm-40 -66.44 -31.6 72.45 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.273 -0.421 . . . . 32.76 110.783 179.639 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 27.9 t80 -77.32 -31.96 54.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.177 -0.465 . . . . 27.25 110.808 179.872 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.721 HG23 ' O ' ' A' ' 13' ' ' ALA . 39.4 t -89.48 -67.82 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.188 -0.46 . . . . 25.51 110.804 179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 13.2 m -70.45 -51.64 27.82 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.103 -0.499 . . . . 29.49 111.173 -179.656 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 71.63 -115.88 5.82 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.633 -0.794 . . . . 40.61 112.739 179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 4.1 m-20 -84.45 7.53 19.43 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 112.825 0.676 . . . . 79.05 112.825 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.574 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 1.2 mmm180 -69.11 -30.47 68.76 Favored 'General case' 0 C--O 1.231 0.09 0 O-C-N 122.032 -0.418 . . . . 50.6 111.052 179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 91.31 60.63 1.29 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.711 -0.757 . . . . 35.48 111.906 -179.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.583 ' CD1' HD13 ' A' ' 14' ' ' LEU . 22.1 p90 -57.1 155.33 8.58 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 121.159 0.504 . . . . 25.52 111.783 -179.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . 0.4 ' CE1' ' HB3' ' A' ' 27' ' ' LYS . 0.8 OUTLIER -136.23 147.94 47.84 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 115.499 -0.773 . . . . 56.07 110.214 179.525 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 17.1 m-85 -78.81 -57.49 3.73 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.546 -0.297 . . . . 29.3 111.133 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 27.7 m120 -87.88 121.7 30.61 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.371 -0.377 . . . . 38.35 111.039 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.428 ' HE3' ' CE2' ' A' ' 60' ' ' TYR . 22.1 pttp -143.09 143.56 25.3 Favored Pre-proline 0 CA--C 1.536 0.406 0 CA-C-N 116.225 -0.443 . . . . 42.35 110.823 179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 73.6 Cg_endo -74.07 127.62 11.52 Favored 'Trans proline' 0 C--N 1.356 0.953 0 C-N-CA 121.843 1.695 . . . . 40.8 112.463 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . . . . . . . . . 5.7 t -112.38 -35.65 5.51 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.174 -0.466 . . . . 55.75 110.738 179.961 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 166.0 91.45 0.08 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.74 -0.743 . . . . 34.94 112.456 -179.937 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -86.78 123.01 31.46 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.829 0.347 . . . . 34.26 110.886 -179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . . . . . . . . . . . 170.96 60.84 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.243 0 C-N-CA 120.774 -0.727 . . . . 36.13 112.514 -179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 22.0 t -150.03 -54.44 0.16 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.87 0.367 . . . . 57.93 110.947 179.982 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 21.8 m -148.23 118.17 7.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.85 110.834 179.942 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 48.3 t -105.85 31.04 5.31 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.247 -0.433 . . . . 0.0 111.015 -179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 1.6 tmm_? -80.31 -38.91 29.75 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.296 -0.411 . . . . 0.0 110.842 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 8.4 tpp180 -149.62 155.84 40.93 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.759 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . . . . . . . . . . . -98.28 99.59 7.48 Favored Pre-proline 0 CA--C 1.534 0.357 0 CA-C-N 116.248 -0.433 . . . . 0.0 111.276 -179.84 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -75.16 144.65 29.99 Favored 'Trans proline' 0 C--N 1.356 0.95 0 C-N-CA 121.886 1.724 . . . . 0.0 112.306 179.869 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -97.54 104.84 16.9 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.852 179.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 62.5 p -148.54 138.81 22.52 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.124 -0.489 . . . . 64.04 110.892 -179.95 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -155.85 -105.4 0.24 Allowed Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.768 -0.73 . . . . 35.08 112.403 180.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.551 HG12 HD11 ' A' ' 10' ' ' LEU . 2.6 tp -105.29 -30.71 2.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.778 0.323 . . . . 25.61 110.933 179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 21.4 t -65.73 -65.42 0.58 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.307 -0.406 . . . . 29.9 111.073 179.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -63.17 -22.95 67.2 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.376 -0.375 . . . . 39.04 111.784 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 9.5 tp10 -90.43 -30.65 17.22 Favored 'General case' 0 CA--C 1.528 0.128 0 N-CA-C 112.263 0.468 . . . . 45.6 112.263 -179.197 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -110.21 -51.12 2.9 Favored 'General case' 0 N--CA 1.466 0.358 0 N-CA-C 112.274 0.472 . . . . 28.23 112.274 -179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 33.3 t -61.24 -55.26 34.09 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-O 120.73 0.3 . . . . 25.89 110.92 -179.629 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . . . . . . . . . 10.9 m-85 -61.98 -55.0 33.87 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.956 0.408 . . . . 32.64 110.216 179.365 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 3.8 ptp180 -122.87 147.15 46.89 Favored 'General case' 0 C--O 1.224 -0.284 0 CA-C-N 116.004 -0.544 . . . . 41.06 109.967 178.756 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 61.6 p -58.73 133.98 56.42 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-O 120.78 0.324 . . . . 42.62 111.461 -179.343 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 3.4 p -118.65 -164.47 1.04 Allowed 'General case' 0 CA--C 1.534 0.351 0 CA-C-O 120.892 0.377 . . . . 28.05 111.016 179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.31 129.61 56.48 Favored 'General case' 0 N--CA 1.466 0.326 0 CA-C-N 116.051 -0.522 . . . . 46.35 110.398 179.336 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.789 HD22 ' CD1' ' B' ' 110' ' ' LEU . 92.8 mt -54.08 -35.52 62.16 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.794 -0.639 . . . . 23.79 112.346 -178.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 14.1 mmm-85 -55.74 -26.43 45.56 Favored 'General case' 0 CA--C 1.532 0.266 0 N-CA-C 111.779 0.289 . . . . 74.93 111.779 -179.618 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -59.32 -29.77 67.87 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-O 120.697 0.284 . . . . 64.42 111.115 179.41 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 54' ' ' LEU . 4.6 mt -55.05 -29.28 57.13 Favored 'General case' 0 N--CA 1.463 0.182 0 CA-C-N 116.28 -0.418 . . . . 32.64 111.799 -179.839 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 26.8 mt-10 -71.56 -25.89 62.4 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.237 -0.438 . . . . 41.86 112.0 -179.274 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 1.9 mpp? -73.19 -45.54 55.78 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 120.782 0.325 . . . . 38.66 110.906 -179.667 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.528 ' CE1' HD13 ' A' ' 43' ' ' ILE . 55.9 m-85 -60.85 -26.26 67.25 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.164 -0.471 . . . . 25.27 111.312 -179.829 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 61.6 m -59.23 147.12 36.74 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 120.746 0.308 . . . . 25.04 110.902 179.778 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.574 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -80.47 160.71 66.79 Favored Pre-proline 0 C--N 1.329 -0.323 0 CA-C-N 116.274 -0.421 . . . . 36.05 110.929 179.843 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.424 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 72.5 Cg_endo -75.9 -30.17 6.19 Favored 'Trans proline' 0 C--N 1.356 0.94 0 C-N-CA 121.905 1.737 . . . . 54.36 112.499 -179.767 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -62.16 172.56 1.39 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.414 -0.357 . . . . 71.54 111.058 -179.918 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 23.9 mtmm -150.18 155.84 37.33 Favored Pre-proline 0 CA--C 1.534 0.347 0 CA-C-N 116.187 -0.461 . . . . 0.0 110.79 179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 67.5 Cg_endo -73.58 86.61 1.17 Allowed 'Trans proline' 0 C--N 1.358 1.035 0 C-N-CA 121.86 1.707 . . . . 0.0 112.363 -179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -165.43 32.12 0.06 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 0.0 111.181 179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 14.1 pttp -101.93 -169.63 1.71 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.209 -0.45 . . . . 0.0 110.614 179.917 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.8 m -57.15 -49.88 74.56 Favored 'General case' 0 N--CA 1.464 0.23 0 CA-C-N 116.531 -0.304 . . . . 0.0 111.346 -179.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.083 0 CA-C-O 118.335 -0.841 . . . . 20.0 111.115 179.949 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.493 1.684 0 CA-C-O 120.811 0.338 . . . . 0.0 111.183 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 6.6 t-20 -101.18 145.26 29.03 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.859 179.89 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 29.3 t -76.76 -28.5 55.74 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.288 -179.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . 0.533 ' HA ' HD12 ' A' ' 54' ' ' LEU . 18.8 m-85 -105.35 33.45 3.69 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.782 0.325 . . . . 0.0 111.125 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 7.0 tp10 -79.43 -51.04 9.88 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.923 0.392 . . . . 0.0 110.574 179.573 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . 0.724 ' O ' HD11 ' A' ' 54' ' ' LEU . 49.7 p -149.4 174.14 12.78 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 115.976 -0.556 . . . . 0.0 110.373 179.363 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.518 HG11 ' O ' ' A' ' 4' ' ' THR . 21.2 t -56.01 -29.72 27.31 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.259 0 CA-C-O 120.871 0.367 . . . . 0.0 111.673 -179.851 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -67.88 -39.08 83.72 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.957 179.539 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -54.59 -54.25 43.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.035 -0.529 . . . . 0.0 112.025 -179.531 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.789 ' CD1' HD22 ' A' ' 54' ' ' LEU . 0.2 OUTLIER -59.63 -42.67 93.22 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-O 120.836 0.35 . . . . 0.0 110.728 -179.888 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.426 ' HG3' ' CD2' ' B' ' 115' ' ' TYR . 1.1 tpp85 -58.85 -46.28 88.11 Favored 'General case' 0 C--N 1.332 -0.184 0 CA-C-N 116.275 -0.42 . . . . 0.0 110.86 179.882 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -70.17 -35.7 74.16 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.711 179.666 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 10.4 m -58.84 -59.1 5.97 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.066 -0.516 . . . . 0.0 111.278 -179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -65.76 -52.35 51.71 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.145 -0.48 . . . . 0.0 111.15 -179.894 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . 0.426 ' CD2' ' HG3' ' B' ' 111' ' ' ARG . 3.3 m-85 -86.53 71.18 10.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 121.096 0.474 . . . . 0.0 110.822 -179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.124 0 CA-C-O 118.33 -1.261 . . . . 20.0 112.554 -179.898 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.237 0 CA-C-O 119.77 -0.461 . . . . 0.0 112.486 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 70.0 Cg_endo -73.46 -169.08 0.49 Allowed 'Trans proline' 0 C--N 1.356 0.967 0 C-N-CA 121.985 1.79 . . . . 0.0 112.421 -179.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLU . . . . . . . . . . . . . 2.4 mp0 -72.1 101.83 2.86 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.062 -0.517 . . . . 75.5 110.96 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' THR . . . . . 0.678 ' O ' HG11 ' B' ' 107' ' ' VAL . 43.8 p -127.35 170.88 12.03 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.082 -0.508 . . . . 31.38 110.807 179.907 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' LEU . . . . . 0.588 HD13 HG13 ' B' ' 107' ' ' VAL . 11.5 tp -133.05 109.82 9.79 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.499 -0.319 . . . . 28.27 111.265 -179.72 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 12.4 m -140.07 163.24 33.23 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.178 -0.465 . . . . 32.91 110.902 179.666 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 69.97 -146.15 42.64 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.833 -0.699 . . . . 19.09 112.867 179.671 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -58.22 -31.81 67.7 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.804 0.335 . . . . 21.73 111.533 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLU . . . . . . . . . . . . . 35.8 mt-10 -59.61 -44.09 93.55 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.234 -0.439 . . . . 63.42 110.905 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 41.5 tp -66.05 -44.97 83.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.312 -0.404 . . . . 20.39 110.697 179.861 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' VAL . . . . . . . . . . . . . 21.5 t -66.25 -31.53 54.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.106 -0.497 . . . . 19.22 111.101 -179.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASP . . . . . . . . . . . . . 2.5 t0 -63.58 -49.24 74.16 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.281 -0.418 . . . . 31.0 110.988 -179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' ALA . . . . . 0.799 ' O ' HG23 ' A' ' 17' ' ' VAL . . . -59.44 -50.69 72.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.084 -0.507 . . . . 18.28 111.339 -179.906 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.661 HD13 ' CD1' ' A' ' 23' ' ' PHE . 13.3 mt -58.61 -43.12 89.52 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 116.303 -0.408 . . . . 22.05 111.068 179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' GLN . . . . . . . . . . . . . 50.1 mt-30 -70.42 -32.03 69.46 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 32.76 110.667 179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' PHE . . . . . . . . . . . . . 31.1 t80 -79.04 -31.35 44.56 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.056 -0.52 . . . . 27.25 110.986 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' VAL . . . . . 0.799 HG23 ' O ' ' A' ' 13' ' ' ALA . 38.3 t -88.28 -68.33 0.67 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 CA-C-N 116.229 -0.441 . . . . 25.51 111.112 -179.685 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' CYS . . . . . . . . . . . . . 14.2 m -71.22 -51.66 23.45 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.248 -0.433 . . . . 29.49 111.21 -179.534 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 55.94 -112.87 3.48 Favored Glycine 0 CA--C 1.519 0.318 0 C-N-CA 120.995 -0.622 . . . . 40.61 113.089 179.851 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 3.0 p30 -64.89 -27.98 69.23 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.674 0.273 . . . . 79.05 111.449 179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ARG . . . . . 0.696 ' O ' ' HB3' ' A' ' 62' ' ' ALA . 0.7 OUTLIER -55.47 -27.31 47.54 Favored 'General case' 0 CA--C 1.53 0.174 0 N-CA-C 111.796 0.295 . . . . 50.6 111.796 -179.789 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLY . . . . . . . . . . . . . . . 77.45 108.63 0.16 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.534 -0.841 . . . . 35.48 112.033 -179.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' PHE . . . . . 0.661 ' CD1' HD13 ' A' ' 14' ' ' LEU . 29.2 p90 -95.82 150.06 20.83 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.04 0.448 . . . . 25.52 111.266 -179.469 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' TYR . . . . . . . . . . . . . 6.2 p90 -126.62 120.6 29.93 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.822 -0.626 . . . . 56.07 110.492 179.51 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' PHE . . . . . . . . . . . . . 21.2 m-85 -57.84 -49.67 75.9 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.266 -0.425 . . . . 29.3 111.401 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -71.16 121.74 18.88 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.31 -0.405 . . . . 38.35 111.0 -179.971 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.438 ' HD3' ' CE1' ' A' ' 60' ' ' TYR . 11.2 tptp -101.72 131.96 22.26 Favored Pre-proline 0 CA--C 1.534 0.343 0 CA-C-N 116.22 -0.446 . . . . 42.35 110.654 -179.99 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -69.72 109.73 2.37 Favored 'Trans proline' 0 C--N 1.357 0.988 0 C-N-CA 121.866 1.711 . . . . 40.8 112.334 179.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' THR . . . . . 0.494 ' O ' HG23 ' A' ' 29' ' ' THR . 4.9 t -149.28 91.79 1.88 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 55.75 110.892 179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 142.37 -110.19 0.61 Allowed Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.794 -0.717 . . . . 34.94 112.482 179.986 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' TYR . . . . . 0.405 ' CD2' ' N ' ' A' ' 32' ' ' GLY . 42.1 p90 -99.63 -46.43 5.44 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.843 0.354 . . . . 34.26 110.925 -179.944 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLY . . . . . 0.405 ' N ' ' CD2' ' A' ' 31' ' ' TYR . . . -172.4 -101.51 0.15 Allowed Glycine 0 N--CA 1.45 -0.391 0 C-N-CA 120.758 -0.734 . . . . 36.13 112.518 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 67.0 m -139.86 164.95 28.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.817 0.341 . . . . 57.93 110.942 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 83.3 p -75.9 153.41 36.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.219 -0.446 . . . . 72.85 110.921 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' SER . . . . . . . . . . . . . 49.4 m -153.0 -64.41 0.15 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.149 -0.478 . . . . 0.0 110.773 179.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' ARG . . . . . . . . . . . . . 3.6 tmt_? -90.56 -60.21 1.98 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.217 -0.447 . . . . 0.0 110.833 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 2.2 tmm_? -161.65 111.16 1.57 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.179 -0.464 . . . . 0.0 110.908 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ALA . . . . . 0.428 ' HB1' ' HD2' ' A' ' 39' ' ' PRO . . . -155.01 160.34 31.0 Favored Pre-proline 0 CA--C 1.532 0.277 0 CA-C-N 116.1 -0.5 . . . . 0.0 111.069 179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.428 ' HD2' ' HB1' ' A' ' 38' ' ' ALA . 59.3 Cg_endo -71.49 121.04 7.37 Favored 'Trans proline' 0 C--N 1.357 0.984 0 C-N-CA 121.846 1.698 . . . . 0.0 112.335 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' GLN . . . . . . . . . . . . . 4.4 pt20 -102.06 134.52 45.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.925 -179.966 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' THR . . . . . . . . . . . . . 1.4 t -177.6 107.48 0.06 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.226 -0.443 . . . . 64.04 110.777 179.978 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' GLY . . . . . . . . . . . . . . . -118.79 -104.92 2.18 Favored Glycine 0 C--N 1.33 0.212 0 C-N-CA 120.851 -0.69 . . . . 35.08 112.623 -179.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ILE . . . . . 0.785 HD13 ' CE2' ' A' ' 60' ' ' TYR . 4.6 tp -87.51 -32.31 6.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-O 120.797 0.332 . . . . 25.61 111.094 -179.917 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' VAL . . . . . . . . . . . . . 20.6 t -67.59 -65.56 0.59 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.249 -0.432 . . . . 29.9 111.16 -179.825 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.417 ' HA ' ' CD1' ' A' ' 49' ' ' PHE . 3.1 m-20 -60.86 -22.38 64.18 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 116.277 -0.419 . . . . 39.04 111.897 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLU . . . . . . . . . . . . . 8.8 tp10 -90.68 -38.04 13.34 Favored 'General case' 0 C--N 1.333 -0.142 0 N-CA-C 112.115 0.413 . . . . 45.6 112.115 -179.283 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' CYS . . . . . . . . . . . . . 0.6 OUTLIER -105.42 -49.73 3.38 Favored 'General case' 0 N--CA 1.463 0.209 0 N-CA-C 112.362 0.504 . . . . 28.23 112.362 -179.006 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' CYS . . . . . . . . . . . . . 16.0 t -60.67 -50.77 72.17 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.728 0.299 . . . . 25.89 111.134 -179.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PHE . . . . . 0.417 ' CD1' ' HA ' ' A' ' 45' ' ' ASP . 10.5 m-85 -66.99 -49.92 63.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.393 -0.367 . . . . 32.64 110.513 179.656 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -123.53 140.58 52.85 Favored 'General case' 0 CA--C 1.518 -0.274 0 CA-C-N 116.107 -0.497 . . . . 41.06 110.449 179.273 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' SER . . . . . . . . . . . . . 6.3 p -57.09 125.01 20.77 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 116.018 -0.537 . . . . 42.62 111.565 -179.647 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' CYS . . . . . . . . . . . . . 1.4 p -117.0 -163.06 0.89 Allowed 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 116.327 -0.397 . . . . 28.05 110.937 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -112.34 141.22 46.33 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.144 -0.48 . . . . 46.35 110.149 179.139 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.73 HD12 ' CD1' ' B' ' 110' ' ' LEU . 3.4 mm? -64.59 -27.55 69.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.143 -0.48 . . . . 23.79 111.531 -179.147 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ARG . . . . . . . . . . . . . 6.2 mtp-105 -58.13 -29.0 65.19 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.693 0.282 . . . . 74.93 111.314 179.917 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' ARG . . . . . . . . . . . . . 8.9 mmt180 -61.23 -26.69 67.92 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.452 -0.34 . . . . 64.42 111.504 179.94 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' LEU . . . . . 0.491 HD12 ' O ' ' A' ' 54' ' ' LEU . 9.8 mt -55.77 -29.23 59.28 Favored 'General case' 0 N--CA 1.463 0.181 0 CA-C-O 120.719 0.295 . . . . 32.64 111.679 -179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -73.01 -30.69 63.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.326 -0.397 . . . . 41.86 111.029 -179.611 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' MET . . . . . . . . . . . . . 31.3 mtm -61.9 -49.47 76.07 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.41 -0.359 . . . . 38.66 111.186 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . 0.785 ' CE2' HD13 ' A' ' 43' ' ' ILE . 98.7 m-85 -58.44 -28.77 65.59 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.043 -0.526 . . . . 25.27 111.527 -179.527 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' CYS . . . . . . . . . . . . . 54.1 m -59.42 138.76 57.55 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.908 0.385 . . . . 25.04 111.241 -179.711 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ALA . . . . . 0.696 ' HB3' ' O ' ' A' ' 21' ' ' ARG . . . -74.44 166.14 47.53 Favored Pre-proline 0 CA--C 1.533 0.303 0 CA-C-N 116.016 -0.538 . . . . 36.05 111.165 -179.978 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' PRO . . . . . 0.526 ' HD2' ' HB1' ' A' ' 62' ' ' ALA . 87.6 Cg_endo -81.63 -25.13 3.84 Favored 'Trans proline' 0 C--N 1.357 1.005 0 C-N-CA 122.145 1.897 . . . . 54.36 112.869 -179.79 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' LEU . . . . . 0.566 HD23 ' HB1' ' A' ' 62' ' ' ALA . 0.6 OUTLIER -58.31 173.27 0.38 Allowed 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 120.907 0.384 . . . . 71.54 111.368 -179.672 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LYS . . . . . . . . . . . . . 12.3 mmtp -141.28 161.3 53.73 Favored Pre-proline 0 CA--C 1.535 0.378 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.796 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 21.2 Cg_endo -60.45 -32.29 93.6 Favored 'Trans proline' 0 C--N 1.355 0.919 0 C-N-CA 122.013 1.809 . . . . 0.0 112.226 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' ALA . . . . . . . . . . . . . . . -96.07 121.68 38.09 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.29 -0.414 . . . . 0.0 111.16 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -83.23 103.3 12.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.875 -179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 28.1 t -96.41 -42.36 8.15 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.208 -0.451 . . . . 0.0 110.9 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.25 1.087 0 CA-C-O 118.26 -0.876 . . . . 20.0 111.002 179.996 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' B' B ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.486 1.362 0 CA-C-O 120.787 0.327 . . . . 0.0 111.24 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 102' ' ' ASN . . . . . . . . . . . . . 23.7 m120 -87.34 113.28 22.92 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.931 -179.969 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 103' ' ' CYS . . . . . . . . . . . . . 49.6 t -82.86 -28.76 29.85 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.215 -179.802 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 104' ' ' PHE . . . . . . . . . . . . . 29.9 m-85 -92.62 47.9 1.33 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 121.154 0.502 . . . . 0.0 111.095 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 105' ' ' GLU . . . . . . . . . . . . . 30.0 tt0 -93.17 -34.18 13.71 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.153 -0.476 . . . . 0.0 110.527 179.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 106' ' ' SER . . . . . . . . . . . . . 14.2 t -160.12 174.67 13.94 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.029 -0.532 . . . . 0.0 110.599 179.762 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 107' ' ' VAL . . . . . 0.678 HG11 ' O ' ' A' ' 4' ' ' THR . 33.1 t -67.14 -34.95 72.8 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.386 -0.37 . . . . 0.0 110.797 179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 108' ' ' ALA . . . . . . . . . . . . . . . -73.2 -39.76 65.3 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.154 -0.475 . . . . 0.0 111.079 179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 109' ' ' ALA . . . . . . . . . . . . . . . -58.32 -42.11 86.03 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.252 -0.431 . . . . 0.0 111.515 -179.757 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 110' ' ' LEU . . . . . 0.73 ' CD1' HD12 ' A' ' 54' ' ' LEU . 0.6 OUTLIER -59.79 -43.12 94.59 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.422 -0.354 . . . . 0.0 110.958 -179.853 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' B' B ' 111' ' ' ARG . . . . . 0.423 ' HG3' ' CE1' ' B' ' 115' ' ' TYR . 49.0 ttp180 -64.08 -42.71 96.86 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.25 -0.432 . . . . 0.0 110.748 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 112' ' ' ARG . . . . . . . . . . . . . 13.7 mtp-105 -58.61 -35.6 72.71 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.146 -179.975 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 113' ' ' CYS . . . . . . . . . . . . . 91.5 m -58.57 -53.18 61.2 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.309 -0.405 . . . . 0.0 111.188 -179.931 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 114' ' ' MET . . . . . . . . . . . . . 7.6 tpt -74.96 -42.04 58.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.18 -0.464 . . . . 0.0 110.94 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' B' B ' 115' ' ' TYR . . . . . 0.423 ' CE1' ' HG3' ' B' ' 111' ' ' ARG . 10.0 m-85 -69.13 71.17 0.24 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.149 0.499 . . . . 0.0 110.976 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' B' B ' 116' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 C--O 1.249 1.047 0 CA-C-O 118.384 -1.231 . . . . 20.0 112.499 -179.901 . . . . . . . . 0 0 . 1 stop_ save_